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Summary 
Architecture of eukaryotic mRNA 3' end processing machinery and insights into the 
mechanism of polyadenylation 
 
This dissertation is submitted for the degree of Doctor of Philosophy by Ananthanarayanan 
Kumar 
  
Almost all eukaryotic messenger RNAs (mRNAs) have a polyadenosine (polyA) tail at their 
3′ end that is added by a multi-protein complex known as cleavage and polyadenylation factor 
(CPF). CPF, along with accessory cleavage factors (CF) IA and IB, cleaves the pre-mRNA 
within the 3' untranslated region (UTR) and adds a poly(A) tail. Previous work has shown that 
CPF is a fourteen-subunit complex that is organised into three enzymatic modules: 
phosphatase, nuclease and polymerase.  
 
The polymerase module consists of the poly(A) polymerase Pap1, three RNA binding 
proteins (Cft1, Pfs2 and Yth1) and an unstructured protein Fip1. To understand how 
polymerase module recognizes specific RNA elements and how polyA tail addition is 
coordinated with other factors, I recombinantly expressed and purified a five-subunit 
polymerase module. Electron cryomicroscopy analysis resulted in a 3.5 Å resolution structure 
of Cft1-Pfs2-Yth1, revealing four β propellers in an arrangement reminiscent of other nucleic 
acid binding complexes. Using biochemical assays, I show that CF IA stimulates 
polyadenylation activity of CPF by interacting with polymerase module and tethering it to 
substrate RNA. Thus polymerase module acts as a hub to bring together the RNA, Pap1 and 
cleavage factors for specific and efficient polyadenylation.  
 
The poly(A) tail length of newly made pre-mRNAs in S. cerevisiae is ~ 60 As. The nuclear 
poly(A) binding protein Nab2 is known to have a role in poly(A) tail length control. The 
molecular mechanism behind how CPF terminates polyadenylation to regulate uniform 
poly(A) tail length remains elusive. Using an in vitro polyadenylation assay with highly pure 
protein complexes, I have studied the mechanism of poly(A) tail length control by CPF. The 
assays highlight the contribution of the cleavage factors and the phosphatase module of CPF 
towards regulating the poly(A) tail length of a substrate RNA. Taken together, the findings 
discussed in this dissertation provide new insights into the architecture of eukaryotic mRNA 
3' end processing machinery and into the mechanism of polyadenylation by CPF.  
 
  
 vi 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 vii 
Acknowledgements 
 
First and foremost, I am very grateful to my supervisor Lori Passmore for her support and 
supervision throughout my PhD. I would like to thank Lori for providing me with a lot of 
freedom to pursue interesting trajectories in the projects. I feel privileged to have been under 
Lori's tutelage at the LMB for my PhD. Thank you for everything Lori.  
 
Next, I would like to thank my co-worker Ana Casañal.  It was a great learning experience 
working together with Ana on the structure determination of polymerase module. We've had 
the joy of seeing many things together for the first time. I vividly remember the time in 
graphics room when we were able to see how Pfs2 inserts into Cft1 once we built the N-
terminal alpha helix of Pfs2. Thank you Ana for all the good times. Big thanks to Chris Hill 
for all his help. I would like to thank Juan Rodríguez for being a solid source of support, for 
all the late night discussions about CPF and importantly for always being super excited about 
my new results. Thank you Manuel Carminati for being a wonderful colleague and a friend. 
We had lots of fun cloning the phosphatase module and APT together. It has been a pleasure 
working with Vytaute Boreikaite, both during her summer project and now during her PhD. I 
would also like to acknowledge Jana Wolf, Katrin Wiederhold, Gillian Dornan and Ashley 
Easter’s contribution to the CPF project. Their work forms the foundation for almost all the 
experiments I present in this dissertation. It was an interesting experience for me working 
together as a team for the CPF project. I have learnt a lot of important lessons that I will carry 
with me.  
 
I am glad to have found a friend in James Stowell, Michael Webster and Terence Tang. Thank 
you Michael for helping me get a head start with my project. I am forever grateful for all your 
advice. I would not have managed to make recombinant CPF if not for the motivation I 
received from James. You have had a tremendous influence on me during my PhD; thank you 
very much comrade! Terence, allow me to express my immense gratitude for everything 
you’ve done. I certainly would not have made it through if not for you. Thank you Fanconi 
boys - Shabih Shakeel and Pablo Alcon for all the good times in the lab. And Shabih, for 
those late night counsels. I feel privileged to be working alongside Conny Yu on the NMR 
project. You have not only taught me the basics of NMR but you remain an inspiration for me 
about how to approach science. I am beholden to Terence, Juan, Ana, Conny, Shabih, Pablo 
  
 viii 
and Lori for proof reading my thesis. All of you have made the lab a remarkable and an 
absolutely enjoyable place to work. And you all wonder why I am always in the lab?  
 
I thank all the facilities at the LMB without which none of these experiments would have 
been possible: the EM facility, mass spec facility, the NMR facility, the biophysics facility, 
scientific computing, the media kitchen and Jianguo Shi (insect cell facility). I wish to 
acknowledge the technical help and advice from Chris Russo, Vinoth Kumar, Christos Savva, 
Alan Brown and Andy Boland. I would also like to thank my second supervisor Kiyoshi and 
my University supervisor Luca Pellegrini for their guidance. I thank Maud Pilkington, Jennie 
Lightfoot and Georgia Ntatsiou from the LMB, and Rebecca Sawalmeh from Churchill 
College for their support. A special thank you to Cristina Rada, Madan Babu and Vish 
Chandrashekaran for their guidance and wise words during challenging times.  
 
My PhD was possible thanks to the generous funding I received from GATES Cambridge and 
the MRC. I feel very lucky to be a part of such a diverse GATES community. I would also 
like to thank Churchill college for making me feel home in Cambridge (and for instilling a 
love for Brutalism in me). I thank the Addenbrooke's Japanese Society for letting me be their 
honorary member. I always missed Japan a little less after our weekly Tuesday lunches. I 
would also like to thank my landlady Sarah Chivers for making me feel like family. Big 
thanks to my aunt Archana Venkat in London for letting me spend several end of term 
holidays with her family.  
 
I am extremely grateful to have the love of my friends and family all over the world. 
Especially Sandhya Krishnan, Shrinidhi Guru, Surya Swaminathan, Arun Mohit, Ramya 
Chandran, Vijay Ravikumar, Siddarth Narasimhan, Paulina Rowicka, Shridhar Jagannathan, 
Eric Dawson, Krishna Sharma, Sankar Narayanan and Girish Krishnan. None of this would 
have been possible without my mother Usha and my father Kumar. I am so glad that you let 
me have a secret chemistry lab in my cupboard when I was twelve. I cannot thank you enough 
for everything you have done for me. I am forever indebted.  Once again, thank you Lori for 
believing in my abilities and giving me this opportunity to work in your lab.  Four years ago 
when I interviewed at the LMB on that cold January morning, never did I imagine that I 
would be spending the next four years of my life trying to answer such extremely interesting 
biological problems.  
 
 
  
 ix 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 x 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 xi 
Table of Contents 
 
1 Introduction .............................................................................................................. 9 
1.1 Messenger RNA processing and regulation ................................................... 10 
1.2 Cleavage and polyadenylation at 3' ends of mRNA ...................................... 14 
1.2.1 Historical overview ..................................................................................... 15 
1.2.2 Understanding the mRNA 3' end processing machinery .......................... 19 
1.2.2.1 Cleavage and polyadenylation factor .................................................... 22 
1.2.2.2 Cleavage Factors .................................................................................. 28 
1.2.2.3 Cis-regulatory elements ....................................................................... 30 
1.2.3 Ysh1 and endonuclease mechanism .......................................................... 34 
1.2.4 Pap1 and polyadenylation mechanism ...................................................... 36 
1.2.5 Regulation of poly(A) tail length ............................................................... 39 
1.3 Overview of 3' end processing:  links to other pathways ........................... 41 
1.4 Questions addressed in this dissertation ...................................................... 44 
2 Architecture of the Polymerase Module of CPF .................................................. 47 
2.1 Purification of recombinant polymerase module from Sf9 cells .................. 48 
2.1.1 Purification of isoforms of polymerase module that vary in Pap1 stoichiometry
 49 
2.1.2 Purification of the poly(A) polymerase Pap1 .............................................. 54 
2.2 Reconstitution of in vitro poly(A) tail addition .............................................. 56 
2.2.1 Comparison of the polyadenylation activity of polymerase module and Pap157 
2.2.2 RNA binding gel shift assays of polymerase module ................................. 60 
2.3 Structure of Cft1-Pfs2-Yth1 subunits of the polymerase module ............... 62 
2.3.1 Negative stain electron microscopy of the polymerase module .................. 62 
2.3.2 Preliminary cryo-EM ................................................................................... 65 
2.3.3 Overcoming the resolution barrier .............................................................. 68 
2.4 Analysis of the cryo-EM structure of Cft1-Pfs2-Yth1 .................................. 72 
2.4.1 Atomic model of the polymerase module ................................................... 72 
2.4.2 Interaction of Pfs2 with Cft1 ....................................................................... 75 
2.4.3 Interaction of Yth1 with Cft1 and Pfs2 ....................................................... 76 
2.4.4 Polymerase module has a similar architecture to DDB1-DDB2 / SF3b ..... 79 
2.4.5 A potential RNA binding surface on Pfs2 ................................................... 81 
  
 xii 
2.4.6 Comparing the structures of the yeast and human polymerase module subunits
 83 
2.4.7 A mechanism for disruption of mRNA 3' end processing by influenza protein 
NS1A 85 
2.5 Pap1 is flexibly tethered to the polymerase module ...................................... 87 
2.5.1 Cryo-EM demonstrates the flexible association of Pap1 ............................. 88 
2.5.2 Cross-linking mass spectrometry reveals extensive inter-subunit interaction92 
2.5.3 Pull downs reveal the molecular topology of  the polymerase module ....... 94 
2.5.4 Fip1 directly contacts Zinc finger 4 of Yth1 ............................................... 96 
2.6 Discussion .......................................................................................................... 99 
3 CF IA stimulates polyadenylation by tethering CPF to RNA ........................... 105 
3.1 Cleavage Factor CF IA Stimulates Polyadenylation by CPF ..................... 107 
3.2 CF IA does not affect polyadenylation by Pap1 .......................................... 112 
3.3 CF IA interacts with the polymerase module of CPF ................................. 114 
3.3.1 In vitro pull-downs .................................................................................... 114 
3.3.2 Hydrogen Deuterium Exchange of Polymerase Module-Rna14-Rna15 ... 118 
3.3.3 Rna14/Rna15 can stimulate the activity of polymerase module with a Fip1 
truncation .............................................................................................................. 120 
3.4 Rna14 HAT domains interact with the polymerase module ...................... 122 
3.4.1 Cross-linking mass spectrometry of polymerase module - Rna14/Rna15 complex
 123 
3.4.2 Cryo-EM of polymerase module - Rna14/Rna15 complex ....................... 125 
3.5 An RNA binding mutant of Rna14/Rna15 fails to stimulate polyadenylation128 
3.6 Model for stimulation of polyadenylation by CF IA ................................... 130 
4 Progress Towards Understanding Poly(A) Tail Length Control ...................... 133 
4.1 CPF restricts poly(A) tail length ................................................................... 135 
4.1.1 CPF purified from S. cerevisiae has intrinsic poly(A) tail length control . 135 
4.1.2 Intrinsic length control is not salt dependent ............................................. 139 
4.1.3 Cleavage is not coupled to intrinsic poly(A) tail length control ................ 141 
4.1.4 The entire 3' end processing machinery is required for length control ..... 142 
4.1.4.1 The absence of CF IA or CF IB results in hyper-polyadenylation ...... 144 
4.1.4.2 Core-CPF does not have intrinsic poly(A) tail length control ............. 146 
4.1.5 Cleaved RNA remains bound to CPF and Cleavage factors ..................... 147 
4.2 Length control: Molecular Ruler or Kinetic Effect? ................................... 149 
  
 xiii 
4.2.1 Purification of mature polyadenylated RNA ............................................. 149 
4.2.2 CPF cleaves a mature polyadenylated RNA ............................................. 149 
4.2.3 The eight subunit core-CPF does not re-cleave a polyadenylated RNA ... 151 
4.3 Production and Characterization of a 14-subunit recombinant CPF ....... 153 
4.3.1 Producing a fully recombinant CPF (rCPF) .............................................. 154 
4.3.1.1 Cloning a full 14-subunit complex into a single vector ...................... 156 
4.3.1.2 Attempts at over-expressing the 14-subunit bacmid ........................... 159 
4.3.1.3 Co-infection of core-CPF and phosphatase module viruses results in 
production of recombinant full CPF ................................................................. 161 
4.3.2 Purifying and characterizing recombinant CPF ........................................ 163 
4.3.2.1 Overall purification strategy ................................................................ 163 
4.3.2.2 Negative stain electron microscopy of rCPF ....................................... 167 
4.3.3 Biochemistry of rCPF ................................................................................ 168 
4.3.3.1 rCPF does not have inherent length control ........................................ 168 
4.3.3.2 rCPF and native CPF has different post-translational modifications .. 170 
4.4 Discussion ........................................................................................................ 171 
5 Conclusion and Future Directions ...................................................................... 177 
5.1 Structural Architecture of the Polymerase Module .................................... 178 
5.2 Effects of Cleavage Factors ........................................................................... 180 
5.3 Polyadenylation mechanism .......................................................................... 183 
5.4 Final conclusions ............................................................................................ 185 
6 Materials and Methods ........................................................................................ 187 
6.1 Common reagents and methods ................................................................... 187 
6.1.1 Generic buffers .......................................................................................... 187 
6.1.2 Media ......................................................................................................... 187 
6.1.2.1 Bacterial overexpression ..................................................................... 187 
6.1.2.2 Insect cells over expression ................................................................. 188 
6.1.2.3 E.coli minimal media for isotope labelling ......................................... 188 
6.1.2.4 Antibiotics ........................................................................................... 188 
6.1.3 Cells and strains ........................................................................................ 189 
6.1.4 Making competent cells ............................................................................ 189 
6.1.5 Plasmid transformation ............................................................................. 190 
6.1.6 Bacmid transformation .............................................................................. 190 
6.1.7 Plasmid isolation ....................................................................................... 190 
  
 xiv 
6.1.8 Nucleic acids quantification ...................................................................... 191 
6.1.9 DNA Sanger sequencing ............................................................................ 191 
6.1.10 Nucleic acid electrophoresis .................................................................... 191 
6.1.10.1 DNA agarose gel ................................................................................ 191 
6.1.10.2 RNA polyacrylamide gel .................................................................... 191 
6.1.11 SDS-PAGE .............................................................................................. 192 
6.2 Cloning ............................................................................................................ 194 
6.2.1 Restriction based cloning ........................................................................... 194 
6.2.1.1 PCR ...................................................................................................... 194 
6.2.1.2 PCR purification and gel extraction ..................................................... 195 
6.2.1.3 Restriction digestion ............................................................................ 195 
6.2.1.4 Ligation ................................................................................................ 196 
6.2.1.5 Verification of clones ........................................................................... 196 
6.2.2 biGBac cloning .......................................................................................... 197 
6.2.2.1 PCR for making gene expression cassettes .......................................... 199 
6.2.2.2 Gibson assembly .................................................................................. 200 
6.2.2.3 Verifying clones by Swa1 digestion .................................................... 202 
6.2.2.4 Cloning into pBIG2 series of vectors .................................................. 203 
6.2.2.5 Verifying clones by Pac1 digestion ..................................................... 204 
6.2.3 Pap1 ........................................................................................................... 205 
6.2.4 Polymerase module .................................................................................... 205 
6.2.4.1 Polymerase module truncations ........................................................... 205 
6.2.5 CF IA/CF IB .............................................................................................. 207 
6.2.5.1 Rna14/Rna15 RRM mutants ................................................................ 207 
6.2.6 Yth1 and Fip1 constructs for NMR ........................................................... 208 
6.2.7 Phosphatase module ................................................................................... 209 
6.2.8 Core-CPF ................................................................................................... 209 
6.2.9 Full CPF ..................................................................................................... 210 
6.2.10 RNA production ....................................................................................... 211 
6.3 Protein expression .......................................................................................... 214 
6.3.1 Bacterial expression ................................................................................... 214 
6.3.2 Bacterial expression of Isotopically labelled proteins ............................... 214 
6.3.3 Baculovirus mediated insect cell over-expression ..................................... 215 
6.3.3.1 Bacmid preparation .............................................................................. 215 
6.3.3.2 Verifying clones by PCR ..................................................................... 216 
  
 xv 
6.3.3.3 Sf9 cell transfections ........................................................................... 217 
6.3.3.4 Primary virus amplification ................................................................. 218 
6.3.3.5 Protein over-expression ....................................................................... 218 
6.4 Protein purification ........................................................................................ 220 
6.4.1 Polymerase module ................................................................................... 220 
6.4.2 Pap1 ........................................................................................................... 221 
6.4.3 CF IA ......................................................................................................... 221 
6.4.4 CF IB ......................................................................................................... 222 
6.4.5 Rna14/Rna15 Y21A, Y61A, F63A ........................................................... 223 
6.4.6 Yth1 and Fip1 constructs for SEC-MALS and NMR ............................... 224 
6.4.7 Core-CPF ................................................................................................... 224 
6.4.8 Recombinant CPF ..................................................................................... 225 
6.4.9 Nuclease module subunits ......................................................................... 226 
6.5 RNA production ............................................................................................. 227 
6.6 Biochemical assays ......................................................................................... 228 
6.6.1 In vitro cleavage and polyadenylation assays ........................................... 228 
6.6.1.1 Polyadenylation assays of 5ʹ-FAM-CYC1-pc ..................................... 228 
6.6.1.2 Cleavage and polyadenylation assays of CYC13ʹ-UTR, 5ʹ-CYC1-pc and 5ʹ-
CYC1-pc-A30 .................................................................................................... 229 
6.6.2 In vitro pull downs .................................................................................... 230 
6.6.3 EMSA ........................................................................................................ 230 
6.6.4 Protein-RNA pull downs ........................................................................... 231 
6.6.5 Analytical Size Exclusion Chromatography ............................................. 232 
6.6.5.1 Cross-linking of polymerase module .................................................. 232 
6.6.5.2 Interaction between Rna14/Rna15 ...................................................... 232 
6.7 Electron microscopy studies .......................................................................... 233 
6.7.1 Negative stain electron microscopy .......................................................... 233 
6.7.2 Electron cryomicroscopy ........................................................................... 234 
6.7.3 Sample screening ....................................................................................... 234 
6.7.4 Data acquisition and image processing ..................................................... 234 
6.7.5 Model building and refinement of Cft1-Pfs2-Yth1 subunits .................... 236 
6.8 Biophysical techniques ................................................................................... 238 
6.8.1 Protein and nucleic acid quantification ..................................................... 238 
6.8.2 Tandem mass spectrometry ....................................................................... 239 
6.8.3 Cross-linking mass spectrometry .............................................................. 239 
  
 xvi 
6.8.4 HDX ........................................................................................................... 240 
6.8.5 NMR .......................................................................................................... 241 
6.8.6 SEC MALS ................................................................................................ 242 
6.9 Bioinformatics ................................................................................................. 243 
6.9.1 Sequence analysis ...................................................................................... 243 
6.9.2 Structural analysis ...................................................................................... 243 
7 References .............................................................................................................. 245 
8 Appendix ................................................................................................................ 273 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 1 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 2 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 3 
List of Abbreviations 
 
2D two-dimensional 
3D three-dimensional 
APT associated with Pta1 complex 
ATP adenosine triphosphate 
BEST–TROSY band selective excitation short transients transverse relaxation 
optimized spectroscopy 
BP beta propeller 
BuUrBu disuccinimidyl dibutyric urea 
CCB competent cell buffer 
CCCH cysteine cysteine cysteine histidine 
CF IA cleavage factor IA 
CF IB cleavage factor IB 
CF II cleavage factor II 
cm centimetre 
CPF cleavage and polyadenylation factor 
CPSF cleavage and polyadenylation specificity factor 
Cryo-EM electron cryomicroscopy  
CstF cleavage and stimulatory factor 
CTD c-terminal domain 
CTF contrast transfer function 
CYC1 cytochrome c1 
DEPC diethyl pyrocarbonate 
DNA deoxy ribonucleic acid 
dNTP deoxyribonucleotide triphosphate 
DQE detective quantum efficiency  
EB elution buffer 
eBIC electron bio imaging centre 
EDTA ethylenediaminetetraaceticacid 
EMS electron microscopy sciences 
EMSA electrophoretic mobility shift assays 
FAM carboxyfluorescein 
FBS fetal bovine serum 
FEI field electron and ion company 
  
 4 
FSC Fourier shell correlation 
GAL7 galactose-1-phosphate uridylyltransferase 
GCN4 general control protein 
GE general electrical 
GIF gatan image filter 
GOI gene of interest  
HAT histone acetyltransferases 
HDX hydrogen deuterium exchange 
HEAT huntingtin, elongation factor 3, protein phosphatase 2A, yeast kinase TOR1 
His histidine 
IAB isothermal assembly buffer 
IgG immunoglobulin G 
IPTG isopropyl β-D-1-thiogalactopyranoside 
IVT in vitro transcription 
kDa kilo daltons 
L litre  
LDS lithium dodecyl sulphate 
LMB laboratory of molecular biology 
M molar 
m7G 7-methylguanosine 
MFA2 mating hormone A-factor 2 
mL milli litre 
mM milli molar 
MOPS 3-(N-morpholino)propanesulfonic acid 
MQ milli-Q water 
MRC medical research council 
mRNA messenger RNA 
MS mass spectrometry 
nanoESI-MS nanoelectrospray ionisation mass spectrometry 
NEB New England biolabs 
NHS N-hydroxysuccinimide 
nM nano molar 
NMR nuclear magnetic resonance 
NRD N-terminal RNA binding domain 
PABN1 nuclear poly(A) binding protein 1 
  
 5 
PAGE polyacrylamide gel electrophoresis 
PAP poly(A) polymerase 
PBS phosphate buffer saline 
PCR polymerase chain reaction 
PDB protein data bank 
PF polyadenylation factor 
Pol I RNA polymerase I 
Pol II RNA polymerase II 
Pol III RNA polymerase III 
Poly(A) polyadenosine 
PTM post translational modification 
Py pyrimidine 
rcf relative centrifugal force 
rCPF recombinant cleavage and polyadenylation factor 
RELION regularized likelihood optimization 
ResQ resource Q 
RMSD root mean square deviation 
RNA ribonucleic acid 
rpm rotations per minute 
RRM RNA recognition motif  
rRNA ribosomal RNA 
SDS sodium dodecyl sulfate 
SEC-MALS size exclusion chromatography with multi-angle light scattering 
Sf9 spodoptera frugiperda 9 
SnRNP small nuclear ribonucleotide particle 
TAE tris-acetate-EDTA 
TAPS tandem-affinity purification (protein A and streptactin) 
TBE tris-borate-EDTA 
TE tris-EDTA 
TEMED tetramethylethylenediamine 
Tm annealing temperature 
tRNA transfer RNA 
TY tryptone yeast extract 
UBL ubiquitin like 
UTR untranslated region 
  
 6 
UV ultra violet 
WD40 beta-transducin  
YFP yellow fluorescent protein 
ZF zinc finger 
µ M micro molar 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 7 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 8 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 9 
1 Introduction 
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1.1 Messenger RNA processing and regulation 
 
Genes contain the blueprints that instruct the cell how to make proteins (in the case of 
protein-coding genes), or functional RNAs in the case of ribosomal RNAs (rRNAs) or 
transfer RNAs (tRNAs) for example. Gene expression is the procesess by which the 
instructions encoded in genes are utilised by the cellular machinery to synthesise the 
final gene products. Gene expression broadly involves the following steps: 
transcription of the genomic DNA into an intermediate RNA, processing of the 
intermediate RNA into its mature form, export into the cytoplasm and translation 
into proteins in case of messenger RNAs (mRNAs). 
 
Genes coding for rRNAs are transcribed into a pre-rRNA by the RNA polymerase I 
(Pol I) and the genes coding for tRNAs are transcribed into pre-tRNA by RNA 
polymerase III (Pol III) (Paule and White 2000). These functional RNA molecules 
then undergo a series of modifications before being exported into the cytoplasm 
(Wang and He 2014). In the case of rRNAs, they go on to play important structural 
and enzymatic roles in the protein synthesis machinery of the cell - the ribosome 
(Brimacombe and Stiege 1985). rRNAs not only contribute to the assembly of the 
ribosomes but also function as a ribozyme in catalysing peptide bond formation. On 
the other hand, tRNAs function in decoding the instructions contained in the mRNA 
and act as an adaptor molecule bringing amino acids to the ribosome to carryout 
protein synthesis (Agirrezabala and Valle 2015). There are several other functional 
RNAs  in  the  cell  that  perform  various  other  functions  e.g. the RNA components 
of telomerase and spliceosome etc. 
 
Pre-mRNAs are synthesised from protein coding genes by RNA polymerase II (Pol II) 
machinery. As the pre-mRNA emerges out of Pol II, it undergoes several 
modifications that render the nascent RNA fit for export into the cytoplasm. These 
include addition of a 7-methylguanosine (m7G) cap at the 5' end, splicing of the non-
coding intronic regions and cleavage at specific sites in the 3' untranslated region 
(UTR) followed by addition of multiple adenosine monophosphates at the 3' end 
(polyadenylation) (Figure 1.1). These three modifications transform the pre-mRNA 
into a mature mRNA that is then used by ribosomes to make proteins (Figure 1.1). It 
is thought that the components of the mRNA export adaptor interacts efficiently with 
properly synthesized poly(A) tails bound by poly(A) binding protein Nab2. Nab2 and 
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the export adaptor components subsequently interact with the nuclear pore complex 
resulting in efficient export of mRNA into the cytoplasm. In humans and budding 
yeast, pre-mRNA splicing defects leads to nuclear retention of polyadenylated 
transcripts. Intriguingly, such polyadenylated transcripts retained in the nucleus can 
then serve as substrates in mRNA decay pathways (Tudek, Lloret-Llinares, and 
Jensen 2018).  Studies performed in fission yeast and human systems suggest a role 
for nuclear poly(A) binding proteins and the MTR4 helicase in recruiting poly(A) 
containing RNAs to the exosome nuclease. I n  b u d d i n g  y e a s t ,  N a b 2  h a s  a l s o  
b e e n  i m p l i c a t e d  i n  n u c l e a r  m R N A  d e c a y  v i a  i t s  i n t e r a c t i o n  w i t h  
t h e  s p l i c e o s o m a l  p r o t e i n s .  In summary, the various mRNA processing 
machineries including the spliceosome, the cleavage and polyadenylation factor 
(CPF), the various poly(A) binding proteins and the exosome work together to 
regulate the state and levels of mRNA in the nucleus. 
 
By regulating the stability and the chemical properties of the mRNA, cells can fine 
tune how much of a given protein an mRNA can produce, as well as its spatio-
temporal properties. Any changes in the interaction between the mRNA and its 
binding partners (that are involved in transcription, pre-mRNA processing, export 
or translation) can alter the stability or the fate of the mRNA. These changes are 
usually a result of environmental, epigenetic or developmental factors. For example, 
alternative polyadenylation is a phenomenon in which the mRNA 3' end processing 
machinery cleaves and polyadenylates at a different site in the 3' UTR rather than 
the consensus polyadenylation site. This may be caused in part by an increase in the 
expression levels of cleavage factor proteins that recognize the cleavage site. Changes 
in the habitual cleavage site in the 3' end of a pre-mRNA results in mRNAs with 
different UTR lengths, effectively altering the proteome that could interact with the 3' 
UTR. Such changes play a crucial role in the life of an mRNA and could lead to 
changes in gene expression. For example in human cells, a normal 3' UTR of the 
cell surface protein CD47 enables efficient cell surface expression, which protects 
cells from phagocytosis by macrophages. The uridine-rich elements in the longer form 
of the CD47 3' UTR i n t e r a c t s  w i t h  t h e  R N A  b i n d i n g  p r o t e i n  
H u R ,  w h i c h  i n  t u r n  i s  r e s p o n s i b l e  f o r  b r i n g i n g  t h e  p r o t e i n  
S E T  t o  t h e  s i t e  o f  t r a n s l a t i o n  o f  C D 4 7 .  S E T  t h e n  i n t e r a c t s  
w i t h  t h e  C D 4 7  p r o t e i n s  a n d  r e c r u i t s  i t  t o  t h e  p l a s m a  
m e m b r a n e  v i a  i t s  a s s o c i a t i o n  w i t h  R A C .  A shorter form of the 3' 
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UTR  that can no longer interact with HuR, does not recruit SET to the site of 
translation. This  results  in  localisation  of  CD47  protein  to  the site of translation 
i.e. endoplasmic reticulum (Berkovits and Mayr 2015). Thus, the various mRNA 
processing steps such as splicing or 3' end processing not only contribute to the 
normal functioning of an mRNA but also play a crucial role in regulating its 
functions. 
 
The focal point of this dissertation is to understand the mechanism of mRNA 3' 
end processing by using a structural and biochemical approach. The introduction 
chapter begins with a focus on the historical overview of the "mRNA 3' end" field. 
This is followed by a description of the properties and functions of the components of 
the mRNA 3' end-processing machinery. Emphasis has been placed on discussing the 
experiments carried out using Saccharomyces cerevisiae as the model organism. 
The chapter ends by listing the specific aims of this dissertation and how they are 
addressed. 
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Figure 1.1: The life of an mRNA inside a cell. RNA polymerase II (shown in light 
blue) transcribes the information in the DNA (in black) into an intermediate pre-
mRNA (in brown). As the pre-mRNA emerges out of RNA polymerase II, it undergoes 
several modifications. The capping enzyme complex carries out the capping at the 5' 
end, whereas the spliceosome (in peach) removes the introns. The cleavage and 
polyadenylation factor (CPF) along with the accessory cleavage factors (CFs) cleaves at 
specific sites in the 3' end, followed by the addition of a poly(A) tail. Nab2 bound 
mature mRNAs are exported into the cytoplasm by the nuclear pore complex. In the 
cytoplasm, the information in the mRNA sequence is decoded by the ribosome to 
synthesize linear chains of amino acids. Alternatively, the mRNA deadenylation 
complexes including Ccr4-Not targets poly(A) containing RNAs and primes them for 
subsequent degradation. 
AA
AA
Rat15'-cap
Pol II
Transcription
initiation
Spliceosome
Pol II Pol II Pol II
Intron
Cleavage
site
CPF
CF
CPF
CF
Pol II
poly(A) tail
AA
AA
AAAA Nab2 bound poly(A) tail
ready for export
Mature mRNA
Nab2
AA
Export into 
cytoplasm
m(7G) cap 
at 5' end
Removal 
of introns
Cleavage 
by CPF
Transcription
termination
Pab1
Ribosome
Translation of mature mRNA
Polyadenylation
by CPF and CF
Deadenylation 
Deadenylation and degradadation of mRNA
Protein synthesis
Ccr4-NotPab1
. .
AA
AA
AAAAAA
. .
AA
AA
AAAAAA
. .
pre-mRNA
60
60
60
  14 
1.2 Cleavage and polyadenylation at 3' ends of mRNA 
 
The cleavage and polyadenylation at the 3' end of an mRNA is carried out by a large 
multi-subunit protein machinery that includes the Cleavage and Polyadenylation 
Factor (CPF), and accessory cleavage factors (CF) IA and IB.  As the pre-mRNA 
emerges out of pol II, CPF and CF IA/B recognises specific cis elements in the 
nascent RNA, cleaves at a specific site and adds a poly(A) tail to the cleaved 3' end 
(Figure 1.1) (Hollerer et al. 2014). The cleavage of the mRNA is coupled tightly to the 
termination of transcription by pol II. In the torpedo model of transcription 
termination, the cleavage of mRNA by CPF is followed by recruitment of the Rat1 
exonuclease to the nascent mRNA. Rat1 degrades the free end of the mRNA and stops 
transcription when it reaches pol II. The length of the poly(A) tails of newly made 
pre-mRNAs in humans is ~250 As and in Saccharomyces cerevisiae  is ~ 60 As (M 
Edmonds, Vaughan, and Nakazato 1971; Mclaughlin et al. 1973; Groner and Phillips 
1975). Defects in cleavage and polyadenylation are associated with diseases including 
cancer and β- thalassemia (Curinha et al. 2014). 
 
In the past 59 years, there has been tremendous progress in our understanding of how 
mRNA 3' ends are formed. However, there are still many fundamental questions that 
remain to be addressed. It is interesting to note that some of the major advancements 
in the field were always accompanied by important technical developments in 
molecular biology. Similarly, the results published in this thesis are also a result of 
major technical progress made in electron cryomicroscopy (cryo-EM) and 
recombinant protein production. Discussed below are some of the important 
discoveries that resulted in the birth and evolution of the mRNA 3' end-processing 
field, thus sparking an interest in the study of mRNA 3' ends. 
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1.2.1 Historical overview 
 
An enzyme that catalyses the ATP-dependent synthesis of a linear sequence of 
adenosines was discovered in 1960 (Mary Edmonds and Abrams 1960). The linear 
poly(A) chain was linked via the 3' to 5'- phosphodiester linkage. An elegant study by 
Nakazato and co-workers demonstrated that the poly(A) tails were indeed covalently 
linked to the end of an mRNA (M Edmonds, Vaughan, and Nakazato 1971).  This was 
one of the earliest studies also to report the observation of a homogenous poly(A) 
chain length (~200As) in nuclear RNA from humans. The functional importance for 
poly(A) tails were soon recognised. Injection of polyadenylated mRNAs into Xenopus 
oocytes conferred stability in vivo (Georges Huez et al. 1975). It was also shown that 
polyadenylation functionally stabilizes histone RNAs  (G. Huez et al. 1978). Much 
later, in vitro and genetic studies revealed an involvement of poly(A) tails in the 
synthesis of proteins (Sachs and Davis 1989; Tarun and Sachs 1995). The discovery 
of poly(A) tails and emerging understanding of it’s properties led to development 
of mRNA purification techniques and cDNA generation protocols (Venkatesan, 
Elango, and Chanock 1983). 
 
In the 1970s, there were many studies involving the purification and characterization 
of the enzymes that add the poly(A) tail (Mary Edmonds and Winters 1976). It was 
found that the poly(A) polymerase enzyme alone did not have any substrate 
specificity (Winters and Edmonds 1973; Tsiapalis, Dorson, and Bollum 1975). 
However, in vivo pulse labelling studies showed that the 3' end of an mRNA is 
formed by cleavage and polyadenylation at specific sites (Nevins and Darnell 1978). 
In vitro experiments using a HeLa cell lysate then demonstrated the sequence 
specificity of mRNA polyadenylation (J L Manley 1983), but this study did not find 
any cleavage activity. Moore and Sharp were the first to demonstrate site and 
sequence specificity in cleavage coupled with polyadenylation (C L Moore and Sharp 
1984). They attributed the specificity of this polyadenylation to the endogenously 
produced RNA. The exogenously added RNA did not have specific polyadenylation, 
thus showing that transcription was somehow connected with cleavage and that 
transcription was not a prerequisite for polyadenylation. Yet, the factors contributing 
to the specificity of cleavage and polyadenylation remained elusive. 
 
The development of improved HeLa nuclear extracts for reconstituting the splicing 
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reaction furthered the biochemical advancements in the field of 3'-end processing. 
Using non hydrolysable ATP analogs, Claire Moore showed that cleavage still occurs 
in the absence of polyadenylation and that cleavage and polyadenylation can occur 
independent of each other in vitro (Claire L Moore and Sharp 1985). Subsequent 
experiments demonstrated that the cleavage reaction was endonucleolytic in 
nature (C L Moore, Skolnik-David, and Sharp 1986). Studies by Butler and Pratt 
in 1988 showed that the mature 3'-end of yeast mRNAs were formed by 
endonucleolytic cleavage followed by polyadenylation and not due to transcription 
termination (Butler and Platt 1988). 
 
The contribution of the RNA elements to the cleavage and polyadenylation reaction 
was also extensively researched. Proudfoot and Brownlee found a six-nucleotide 
AAUAAA sequence in all of the  six mRNAs  they  studied  (N. J. Proudfoot and 
Brownlee 1976).   Later  this  sequence  was  shown  to  be important for proper 
formation of mRNA 3' ends by using genetic means (Fitzgerald and Shenk 1981). 
Higgs and colleagues showed that a single point mutation in the AAUAAA site in 
either human α2-globin gene or the human Fl-globin gene led to defects in mRNA 3'-
end processing, and provided the molecular basis for α-thalassemia and in β-
thalassemia (Higgs et al. 1983). This study was one of the first to highlight the 
medical importance of 3'-end  processing.  The progress made  in  our  understanding  
of  these  cis- elements aided in the discovery of the 3'-end processing protein 
complex as discussed below. 
 
Using an RNAse H protection experiment, Zarkower and Wickens found that some 
protein factors in HeLa nuclear extract form a complex with the AAUAAA region of 
the substrate RNA and that this complex formation is necessary for cleavage and 
polyadenylation (Zarkower and Wickens 1987). Around the same time, work from 
Walter Keller's lab also demonstrated the existence of an mRNA 3' end processing 
complex using native gel shift assays (Humphrey et al. 1987). Attempts were made to 
fractionate the nuclear extracts to identify the components that make up these 
complexes. The obvious candidates were a poly(A) polymerase and an endonuclease. 
The lack of substrate specificity in polyadenylation by the polymerase alone suggested 
that the 3' end processing reaction was made up of other unknown proteins that could 
confer specificity. The breakthrough came in 1988 when the labs of James Manley, 
Walter Keller and Joseph Nevins isolated separate complexes from HeLa nuclear 
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extracts (James L. Manley 1988; Christofori and Keller 1988; Mcdevitt et al. 1988). 
Some of these individual complexes could perform the cleavage reaction in a site-
specific manner. None of these separate fractions had specific polyadenylation 
activity, but when combined together could restore the specificity that is found in 
nuclear extracts. This is highly reminiscent of RNA polymerases from eukaryotes 
that function efficiently only upon formation of ternary complexes with initiation and 
elongation factors. Figure 1.2 visually highlights some of these major milestones in 
the mRNA 3' end-processing field. 
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Figure 1.2: A historical timeline of some of the major discoveries in the mRNA 3' 
end-processing field. 
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1.2.2 Understanding the mRNA 3' end processing machinery 
 
Using anion exchange chromatography of a yeast nuclear extract, Chen and Moore 
isolated four different fractions that when combined could reconstitute the  cleavage  
and  polyadenylation  of substrate RNAs (J. Chen and Moore 1992). They named 
these four fractions cleavage factor (CF) I and II, polyadenylation factor (PF) I and 
polyA polymerase (PAP). They found that CFI and CFII when combined together 
could cleave a substrate RNA, whereas PFI and PAP could not cleave the RNA. 
However, PFI and PAP when combined with CFI and CFII could specifically 
polyadenylate the cleaved RNA. At this stage, the idea of a multi-protein complex 
being responsible for the specific cleavage and polyadenylation of mRNA 3'-ends 
began to emerge, but the composition of such a complex was still unknown. These 
above studies set the stage for detailed biochemical characterization of the mRNA 3' 
end-processing complex described below. 
 
Purification of these individual factors from endogenous sources revealed the 
numbers and identities of their components (Preker et al. 1997; Zhao, Kessler, and 
Moore 1997). Endogenous purifications from the lab of Walter Keller showed that the 
S. cerevisiae Cleavage and Polyadenylation Factor (CPF) contains the proteins Cft1, 
Cft2, Ysh1, Pta1, Pap1, Fip1, Yth1, Pfs2 and other unidentified proteins. Proteomic 
studies using affinity purification of CPF coupled with mass spectrometry identified 
12 known interaction partners of CPF and 7 additional components (Gavin et al. 
2002). Subsequent pull downs from S. cerevisiae using a TAP tag on the Ref2 
protein, further characterized the holo-CPF that contained 15 subunits.  This new 
holo-CPF consisted of all the known components as well as the newly discovered 
components Syc1, Pti1, Swd2, and two protein phosphatases Glc7, Ssu72 (Nedea et al. 
2003). Thus our current understanding of the yeast mRNA 3' end processing 
machinery is that it is made up of the CPF and CFI complexes (Figure 1.3). 
 
CPF has three enzymatic activities: two protein phosphatases (Glc7 and Swd2), an 
endonuclease (Ysh1) and a polymerase (Pap1). Importantly, the accessory CFI has 
two components: CF IA and CF IB (Figure 1.3). CF IA is made up of four proteins - 
Rna14, Rna15 and two unknown proteins (Kessler, Zhao, and Moore 1996), which 
were subsequently identified as Clp1 and Pcf11 (Minvielle-Sebastia et al. 1997; 
Gross and Moore 2001).  CF IB is made up of a single polypeptide (Hrp1) that is 
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critical for cleavage site selection. CF IA and CF IB act together with intact CPF to 
perform accurate, site-specific cleavage and polyadenylation of pre-mRNAs (Kessler 
et al. 1997; Kessler, Zhao, and Moore 1996; Minvielle-Sebastia, Preker, and Keller 
1994). 
A crude purification of the mRNA 3'-end processing machinery from HeLa nuclear 
extracts revealed the identities of the ~85 proteins that forms the human complex (Shi 
et al. 2009). Those 85 proteins not only included several 3'-end processing 
components but also factors associated with transcription, splicing, DNA-damage 
repair and translation. Bonafied components of the human 3'-end processing 
machinery includes the poly(A) polymerase (PAP) and four different multi-subunit 
protein complexes: cleavage and polyadenylation specificity factor (CPSF), cleavage 
factor I (CFI), cleavage factor II (CFII) and cleavage stimulatory factor (CstF). In 
addition to the abovementioned factors, the nuclear poly(A)  binding  protein  
PABN1,  the  scaffolding  protein  Symplekin  and  the  CTD  of  pol  II  are 
additional components of the mammalian 3'-end processing machinery (Xiang et al. 
2010). 
 
 
 
 
Figure 1.3: (a) The composition of S.cerevisiae CPF and its protein-protein 
interaction network from nanoESI-MS data and in vitro pull downs. Protein symbols 
are scaled down to have an area proportionate to their molecular weights. 
Interaction between proteins is represented by contact between the symbols. Yellow 
stars denote enzymes. (b) The composition of S.cerevisiae CF I and its protein-
protein interaction network from in vitro pull downs and previous literature. 
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Recent work from our lab has resulted in a clear understanding of how the three-
enzymatic activities of CPF are segregated in the organisation of the complex in 
S. cerevisiae (Easter 2014). Native mass spectrometry analysis of several different 
preparations of CPF found that CPF consists of three enzymatic modules: a six 
subunit phosphatase module that includes subunits Glc7 and Ssu72, a three subunit 
nuclease module that includes the endonuclease Ysh1, and a five subunit polymerase 
module that includes the poly(A) polymerase Pap1 (Figure 1.3a). This work provided 
biophysical evidence of the stoichiometry and composition of CPF. Thus, the 
previous nomenclature of the S. cerevisiae 3' end processing machinery that includes 
it’s segregation into CFII, PFI and PAP has been rendered obsolete with this 
newfound architecture of CPF (Figure 1.3a). 
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1.2.2.1 Cleavage and polyadenylation factor 
 
Outlined below is the description of proteins that make up the three-enzymatic modules 
of CPF.  
 
1.2.2.1.1 The polymerase module 
 
The polymerase module in yeast is made up of five proteins: Cft1, Pfs2, Yth1, Fip1 
and Pap1 (Figure 1.4). A very similar polymerase complex was purified from human 
cells and was sufficient to reconstitute specific polyadenylation (Schönemann et al. 
2014). 
 
 
 
 
Figure 1.4: Schematic representation of yeast polymerase module subunits. Cft1 is 
predicted to contain three β-propeller repeats (Scrima et al. 2008). The predicted 
WD40 domain of Pfs2 is highlighted in yellow. Pap1 contains an N-terminal polymerase 
domain (in blue) and a C-terminal RNA binding surface (in purple) (Bard et al. 2000). 
The five zinc fingers of Yth1 are colored in pink. Fip1 is an unstructured protein with 
residues 80 to 105 involved in binding Pap1 (in grey).   
 
Cft1 is rich in β-strands and is the largest of all the CPF proteins (154 kDa in size). It 
was identified in yeast  owing  to  its  sequence  similarity  to  the  mammalian  
counterpart  that  was  known  to  bind AAUAAA (Stumpf and Domdey 1996). Using 
purified Cft1, it had been shown that the central region in the sequence of Cft1 can 
mediate binding to RNA (Dichtl et al. 2002). The human Cft1 (or CPSF-160) 
interacts with the nuclease Ysh1 (or CPSF-73), the scaffolding protein Pta1 (or 
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Symplekin) and the pseudo-nuclease Cft2 (or CPSF-100) to form the core of the 
human CPSF complex (Sullivan, Steiniger, and Marzluff 2009). Similar to its yeast 
counterpart, CPSF-160 is rich in β-strands and binds RNA in vitro (Keller et al. 
1991; Dichtl et al. 2002). 
 
Pfs2 was identified as a component of CPF during the purification of a multi-subunit 
complex that had specific polyadenylation activity (Preker et al. 1997). Pfs2 is a 
WD40 repeat-containing protein that has been proposed to mediate the interaction of 
CPF with the cleavage factors (Ohnacker et al. 2000). The human polymerase 
complex directly binds the polyadenylation signal via Pfs2 (or WDR33) and Yth1 (or 
CPSF 30) (Chan, Huppertz, Yao, Weng, Moresco, Yates Iii, et al. 2014). The human 
homologue of Pfs2 (WDR33) has an N-terminal WD40 domain and it is not 
uncommon for WD40 domains to mediate nucleic acid binding (Jin et al. 2016). 
Unlike Pfs2 that only contains the WD40 domain, WDR33 also contains a central 
collagen like domain and a C-terminal GPR rich sequence. The roles of the central 
and the C-terminal domains remain unclear. 
 
Yth1 is another RNA binding component of the polymerase module that contains five 
CCCH zinc finger (ZF) domains (Tacahashi, Helmling, and Moore 2003; Barabino et 
al. 1997). Yth1 and its human counterpart CPSF30 are thought to recognise the RNA 
cleavage sites (Barabino, Ohnacker, and Keller 2000b; Chan, Huppertz, Yao, Weng, 
Moresco, Yates, et al. 2014). CPSF-30 interacts with the AAUAAA sequence via 
zinc fingers two and three (Chan, Huppertz, Yao, Weng, Moresco, Yates Iii, et al. 
2014). CPSF-30 also contains a zinc knuckle at its C-terminal end that is not present 
in Yth1.  Similarly, zinc fingers two and three of Yth1 specifically mediate the RNA 
binding, whereas zinc finger four and five are thought to interact with the unstructured 
protein Fip1 (Tacahashi, Helmling, and Moore 2003). 
 
Fip1 was discovered as an interaction partner of Pap1 (Preker et al. 1995). Fip1 has an 
acidic stretch at its N-terminus, and a proline-rich C-terminal region. Human Fip1 
(hFIP1) is almost two times bigger in size compared to the S. cerevisiae Fip1 due to 
the additional R-rich and RD- rich domains in the C-terminal region. The N-terminal 
residues 80-105 of Fip1 interact with Pap1, whereas the C- terminal residues 206-220 
interact with Yth1. A crystal structure of the Fip1 peptide 80-105 bound to Pap1 
reveals molecular details of this interaction (Meinke et al. 2008). Fip1 is thought to 
tether Pap1 to the rest of CPF via a central flexible linker and also provide a platform 
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for protein-protein interaction for other CPF components (Helmling, Zhelkovsky, and 
Moore 2001; Ezeokonkwo et al. 2011). Deletion of the last 107 residues of Fip1 (that 
lies after the Yth1 binding site) had an insignificant effect on yeast viability and on 
polyadenylation by CPF. hFIP1 binds U-rich containing RNA via its C- terminal 
arginine rich domain (Kaufmann et al. 2004). 
 
Pap1 is the enzyme that synthesizes the poly(A) tail at the mRNA 3' ends (Lingner et 
al. 1991) and is one of the most extensively characterised subunits of CPF. Pap1 
belongs to the DNA polymerase β family of enzymes. Although Pap1 loses its 
substrate specificity when in isolation, it has nucleotide specificity (M Edmonds 
1990). The human homologue of Pap1 (PAP) acquires substrate specificity for 
polyadenylation upon associating with the CPSF complex (Schönemann et al. 2014).  
The N-terminal region of the yeast and mammalian PAPs share substantial sequence 
identities, whereas the C-terminal domains do not share this similarity. A deletion of 
the first 18 amino acids of Pap1 affects the specific polyadenylation of pre-mRNA 3' 
ends by CPF as this region is thought to contact other CPF subunits (Zhelkovsky, 
Kessler, and Moore 1995; Ezeokonkwo et al. 2012). The C-terminal end of Pap1 also 
has an RNA binding domain, the exact role of which is still unknown (Zhelkovsky, 
Kessler, and Moore 1995). Unlike yeast that contains only two poly(A) polymerase 
(Pap1 and Trf4), mammals have different nuclear PAPs - canonical PAP, neo-PAP, 
star-PAP etc (Vaňáčová et al. 2005; Laishram 2014). The canonical PAP is the most 
similar one to the yeast Pap1. Although the molecular details of nucleotidyl transfer 
are conserved between PAP and Pap1, the extended C-terminus of PAP is subjected to 
several post- transcriptional modifications that ultimately regulate its function. The 
detailed mechanism of how Pap1 adds multiple adenosine tails to the 3' end of the 
RNA is discussed in section 1.2.4. It is to be noted that there are no experimentally 
determined three-dimensional structures for any of the polymerase module 
components except for Pap1 and a Fip1 peptide that interacts with Pap1 (Bard et al. 
2000). 
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1.2.2.1.2 The nuclease module 
 
The nuclease module in yeast is made up of three proteins: Cft2, Ysh1 and Mpe1. 
Cft2 is an inactive pseudo-nuclease that belongs to the β-CASP family. The exact role 
of Cft2 in cleavage and polyadenylation remains obscure but Cft2 has been shown to 
be essential for cell viability, and recognition of 3' end processing mRNA cleavage 
site in vivo (Kyburz et al. 2003). UV cross-linking experiments proposed a role for 
Cft2 in RNA binding (Zhao, Kessler, and Moore 1997), and pull down experiments 
with Pol II also suggest that Cft2 has a role in coupling 3' end processing and 
transcription (Kyburz et al. 2003). The crystal structure of Cft2 revealed an N-
terminal metallo-β-lactamase domain and a C- terminal β-CASP domain (Mandel et 
al. 2006). Cft2 and Ysh1 not only share an overall sequence identify of 19.5 %, but 
the structural architecture of Cft2 is very similar to that of Ysh1 or CPSF-73. 
Interestingly, the zinc coordinating residues found in Ysh1 are not conserved in Cft2 
and hence it does not bind zinc. This explains why Cft2 does not possess any nuclease 
activity. 
 
Ysh1 is the endonuclease that cleaves the mRNA 3' end (Mandel et al. 2006; 
Zhelkovsky et al. 2006). Interestingly, strains harbouring mutations in Ysh1 have been 
found to be defective in splicing (Garas, Dichtl, and Keller 2008). Mutating the 
conserved  metal  coordinating  residues  in  the  metallo-β-lactamase  and  β-CASP  
domains  of  Ysh1 results in lethality, showing that Ysh1 requires divalent ion binding 
for its nuclease activity (Ryan, Calvo, and Manley 2004). 
 
Mpe1 is a zinc knuckle containing protein that is known to be important for 
specificity of mRNA cleavage activity (Vo et al. 2001). Mpe1 was found to contain an 
ubiquitin-like (UBL) domain, a RING finger domain in addition to the zinc knuckle 
(Lee and Moore 2014). The zinc knuckle and RING finger have been shown to play 
an important role in specific RNA binding. The functional role of the UBL domain of 
Mpe1 remains to be explored. 
 
 
 
 
 
 
 
 
  26 
1.2.2.1.3 The phosphatase module 
 
The phosphatase module in yeast is made up of six proteins: Pta1, Ref2, Pti1, Swd2, 
Glc7 and Ssu72. The identities of Pti1, Swd2, Glc7 and Ssu72 in CPF purifications 
remained unknown and were the last of the yeast CPF proteins to be described (Dichtl 
et al. 2002; He et al. 2003; Gavin et al. 2002; Nedea et al. 2003).  It is to be noted that 
some of the earlier purifications of CPF had some additional unidentified bands that 
could have been some of the phosphatase subunits. For example, it is plausible that 
the bands labelled as p 35 and p 36 in pull downs of the polyadenylation complex 
performed in Walter Keller's lab could be Swd2 and Glc7 (Preker et al. 1997). But 
interestingly none of these early purifications had any obvious bands on SDS-gels 
that could likely correspond to Ref-2 (Ohnacker et al. 2000). The large-scale 
proteomic study that involved co-immunoprecipitation of the polyadenylation 
complex using Pti1 as bait identified Ref2, Pti1, Glc7 and Ssu72 (Gavin et al. 2002). 
In absence of detailed experimental conditions (such as the number of washes 
between each steps) of these  and  earlier  pull  downs,  it  is  difficult  to  ascertain  
why  the  phosphatase  subunits  were  not identified earlier. 
 
Pta1  was  originally  discovered  as  a  gene  that  functions  in  pre-tRNA  processing  
(O’Connor and Peebles 1992). Extracts prepared from a Pta1 mutant strain were 
found to be defective in both steps of mRNA 3' end processing (Preker et al. 1997; 
Zhao et al. 1999). The human homologue of Pta1, known as symplekin, is thought 
to act as a scaffold for protein-protein interaction within CPF (Xiang, Manley, and 
Tong 2012). The N-terminus of Pta1 harbours HEAT repeats similar to its metazoan 
counterpart and further supports the idea that Pta1 could act as a structural scaffold for 
CPF (Kennedy et al. 2009). Previous work from our lab has shown that Pta1 mediates 
the interaction between the phosphatase module and the rest of CPF via its 
association with the nuclease module (Figure 1.3a). This role of pta1 in bridging CPF 
components is further supported by previous studies where symplekin forms a tight 
complex with the nuclease module components Ysh1 (or CPSF-73) and Cft2 (or 
CPSF-100) (Sullivan, Steiniger, and Marzluff 2009). It is thought to influence the 
nuclease activity of CPSF-73 by bringing other regulatory proteins to the complex. 
 
Ref2 was discovered as an RNA binding protein that plays a key role in 
poly(A) site selection (Russnak, Nehrke, and Platt 1995). A role for Ref2 in 
snoRNA formation has also been reported (Dheur et al. 2003). Interestingly, Ref2 
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is the only component of CPF that is not essential for the viability of the yeast 
cells. Swd2 is a WD40 repeat containing protein that is involved in Pol II termination 
and is a shared subunit of the histone H3-K4 methylation complex, COMPASS 
(Roguev et al. 2001; Cheng, He, and Moore 2004). Overexpression of Ref2 can 
rescue the growth defect phenotype of a Swd2 deletion in yeast, highlighting a 
functional  interaction  between  the  two  proteins  (Cheng, He, and Moore 2004).  
The phosphatase enzymes Ssu72 and Glc7 are the newest addition to the family of 
CPF subunits (Edmund P. Walsh et al. 2002). 
 
Ssu72 is the phosphatase that acts on the Ser-5 and Ser-7 of the pol II CTD and helps 
the initiation-elongation cycle of pol II (Krishnamurthy et al. 2004; Reyes-Reyes and 
Hampsey 2007; Rosado-Lugo and Hampsey 2014; Xiang, Manley, and Tong 2012). 
The three-dimensional structure of Ssu72 bound to its substrate (Ser5 
phosphorylated pol II CTD) and in complex with the N-terminus of the scaffolding 
protein Pta1 (Symplekin) has been determined (Xiang et al. 2010).  This structure 
revealed details about how Ssu72 specifically recognises the Ser5 phosphorylated 
CTD and how Pta1 could stimulate the phosphatase activity of Ssu72. In the 
structure, the CTD is bound in the active site of Ssu72 with the Ser5-Pro6 peptide 
bond in an unusual cis configuration. This unusual geometry could explain the 
specificity of Ssu72 for Ser5 phosphorylated CTD peptide.  
 
Glc7 is a PP1 family phosphatase that acts on the Tyr-1 of the pol II CTD and 
coordinates transcription termination (Schreieck et al. 2014). The CTD of the largest 
subunit of Pol II consists of 26-tandem heptapeptide repeats in yeast, and 52- tandem 
heptapeptide repeats in humans. Almost all of the 26-heptapeptide repeats in yeast 
follow the consensus sequence Tyr1-Ser2-Pro3-Thr4-Ser5-Pro6-Ser7 (Eick and Geyer 
2013). However, in mammals the repeats vary from the consensus sequence towards 
the distal end of the CTD.  The CTD repeats are important for coupling transcription 
termination to cleavage and polyadenylation of pre- mRNAs (Hsin and Manley 2012). 
The CTD undergoes several post-translational modifications with phosphorylation 
being the most important for mRNA 3' end processing ( M c C r a c k e n  e t  
a l .  1 9 9 7 ;  H i r o s e  a n d  M a n l e y  1 9 9 8 ) . The CTD repeat is intrinsically 
disordered and can adopt diverse structural architecture upon interactions with 
different 3' end processing proteins such as Pcf11, Ssu72 and Glc7. These interactions 
are not only regulated by PTMs such as phosphorylation but also by other factors such 
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as cis-trans isomerisation of the peptide bonds (Xiang et al. 2010; Werner-Allen 
et al. 2011). The CTD modification changes throughout the different stages of 
transcription and the 3' end processing factors  are  recruited  just  before  
termination.  The exact molecular  details  of  CTD  mediated transcription 
termination and pre-RNA cleavage is still elusive. 
 
1.2.2.2 Cleavage Factors 
 
CF IA and CF IB are the two cleavage factors in yeast. CF IA is a hexamer that 
consists of a hetero- tetramer of Rna14 and Rna15, and a single copy of Pcf11 and 
Clp1 (Gordon et al. 2011) (Figure 1.3b). In humans, the cleavage factors are more 
complicated than their yeast counterparts. There exists a similar complex known 
as the cleavage stimulatory factor or CstF. The three proteins that make up CstF 
are CstF-77 (or Rna14), CstF-64 (or Rna15) and CstF-50 (no yeast homologs). In 
addition to CstF, there also exists hCFI and hCFII. hCFI is made up of proteins that 
contain no known yeast homologs (Rüegsegger, Blank, and Keller 1998).  hCFII is 
made up of hPcf11 and hClp1, the human homologs to yeast Pcf11 and Clp1. 
 
1.2.2.2.1 Cleavage Factor IA 
 
Rna14 consists of a large HAT domain in the N-terminus and a monkey tail region in 
its C-terminus (Paulson and Tong 2012). The HAT domain of Rna14 is made up of 12 
HAT motifs and is thought to act as a protein-protein interaction platform for bringing 
together CPF and CFI (Ohnacker et al. 2000). Similar to Rna14, CstF-77 is a HAT 
domain-containing protein that dimerizes via its HAT-domain (Preker and Keller 
1998; Paulson and Tong 2012; Bai et al. 2007). CstF-77 (or Rna14) interacts with 
CstF-64 (or Rna15) via a C-terminal proline rich region (Hockert, Yeh, and 
MacDonald 2010). Experiments show that extracts prepared from Rna15 or Rna14 
mutant cells cannot restore mRNA 3’ end processing when mixed together. This 
shows that both Rna14 and Rna15 are essential for 3’ end processing and that either 
subunit cannot substitute for the other. 
 
Rna15 is an RRM-domain containing protein that contributes to the RNA binding 
property of CF IA (Minvielle-Sebastia et al. 1991), and has been shown to bind A-rich 
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signals in the mRNA 3' UTR (Gross and Moore 2001). Cstf-64 binds RNA via an N-
terminal RRM domain (Takagaki et al. 1992). A later study also demonstrated that 
Rna15 prefers binding U or G/U rich tracts of a substrate RNA (Pancevac et al. 2010). 
The NMR structure of the RRM domain of CstF-64 reveals the molecular details of its 
interaction with U or G/U rich RNA (Perez Canadillas and Varani 2003). It has been 
hypothesized that the proximity of the downstream U-rich and GU-rich sequences in 
human UTRs might enable binding of two copies of CstF-64 next to each other, 
connected by the CstF-77 HAT domains (Xiang, Tong, and Manley 2014). Cstf-64 
contains a central proline-glycine rich region followed by an alpha helical MEARA/G 
repeat which is not present in its yeast homologue, Rna15. The C-terminal end of 
Cstf-64 and Rna15, however, is highly conserved in eukaryotes and is required for 
polyadenylation (Qu et al. 2007). The C-terminal conserved region of Rna15 
interacts with Pcf11 and this region is necessary for efficient mRNA 3' end 
processing. The central hinge domain of Rna15 and the monkey tail domain of Rna14 
are the minimal regions required for a stable complex formation between the two 
(Moreno-Morcillo et al. 2011). CstF-50 (no known yeast homologue) contains a 
dimerization domain in its N-terminal end and a WD40  domain  in  its  C-
terminus.  Dimerization  of  CstF-50  along  with  the  hetero-tetramer  CstF-77/CstF-
64 results in the formation of a hexameric CstF complex. 
 
Pcf11 was identified as a component of CF IA in a two hybrid screen and a strain 
harbouring a Pcf11 mutant demonstrated shortening of poly(A) tails (Amrani, Minet, 
Wyers, et al. 1997). In vitro binding studies have shown that recombinant Pcf11 can 
interact with the CTD of pol II (Barilla, Lee, and Proudfoot 2001), but a later study 
from Keller and colleagues showed that the CTD binding of Pcf11 and its 
participation in mRNA 3' end processing  are  not  coupled  (Sadowski et al. 2003).  
The  N-terminus  of  Pcf11  contains  a  pol  II CTD binding region, the central 
region harbours the Rna14/Rna15 binding site and the C-terminus contains a Clp1 
binding site followed by a CCHC zinc finger domain (Guéguéniat et al. 2017). Clp1 
was identified as one of the co-purification partners of CF IA that interacts tightly 
with Pcf11 but not with Rna14 or Rna15 (Minvielle-Sebastia et al. 1997; Gordon et al. 
2011). CF IA is thought to activate pre-mRNA cleavage by CPF by mechanism that 
remains to be understood. 
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1.2.2.2.2 Cleavage Factor IB 
 
CF IB or Hrp1 was discovered as a suppressor of a temperature sensitive allele of the 
gene NPL3 involved in mRNA export (Henry et al. 1996) UV crosslinking 
experiments demonstrated sequence specific binding of Hrp1 to RNA (Kessler et al. 
1997; Chen and Hyman 1998), and overexpression of Hrp1 influences the cleavage 
site selection in yeast (Bucheli et al. 2007). Hrp1 contains a central RRM domain that 
mediates its interaction with Rna14. Mutants that disrupt this interaction failed to 
cleave and polyadenylate a substrate RNA (Barnwal et al. 2012). The same study also 
showed that Hrp1 binding to RNA via its RRM domains enhances its interaction with 
Rna14/Rna15, therefore suggesting that RNA binding may trigger the assembly of the 
3' end-processing complex. 
 
1.2.2.3 Cis-regulatory elements 
 
The mRNA signals in budding yeast and humans that recruits and directs the 3' end 
processing machinery f o r  c l e a v a g e /polyadenylation h a v e  similarities a n d  
d i f f e r e n c e s .  The sequences of the yeast signals and the order in which they are 
distributed in the 3' UTR are somewhat different when compared to human signals. In 
vivo studies on ACT1, ADH1, CYC1, and YPT1 mRNAs found that the signals that 
direct polyadenylation site selection are dispersed across several hundred nucleotide 
stretches and it was unlikely that there existed a single polyadenylation signal 
sequence in yeast (Heidmann et al. 1992). However many human mRNA 3' UTRs 
contain a conserved six nucleotide AAUAAA sequence (or a close variant such as 
AUUAAA) known as the polyadenylation signal and is present 10 - 30 nucleotides 
upstream of the cleavage site (N. J. Proudfoot and Brownlee 1976; Beaudoing et al. 
2000; B. Tian et al. 2005; Derti et al. 2012). 
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Figure 1.5: The cis-elements of yeast and human 3' UTR. EE: Efficiency element, PE: 
Positioning element, UUE: upstream U-rich element, DSE: Downstream U-rich 
element. Red arrows indicate the protein binding sites. Py(A)N  is the site of cleavage. 
Py stands for pyrimidine.  
 
There are five predominant motifs in yeast that constitute the cis-regulatory elements: 
the UA rich efficiency element, the A rich positioning element, the U-rich upstream 
element, the Py(A)N cleavage site and the downstream U rich element (Figure 1.5). In 
humans, biochemical studies coupled with bioinformatics have shown that the 
sequences downstream of the human cleavage sites are rich in U/GU sequences 
(Salisbury, Hutchison, and Graber 2006). The sequences upstream of AAUAAA are 
rich in multiple UGUA elements, two of which are specifically and simultaneously 
recognised by hCFI ( H u  e t  a l .  2 0 0 5 ;  Y a n g ,  G i l m a r t i n ,  a n d  
D o u b l i é  2 0 1 0 ) . Auxiliary sequences elements including the upstream U-rich 
sequences and the downstream G-rich regions provide protein-binding surfaces and 
S. cerevisiae
PEEE UUE DUE
UAUAUA
AAUAAA
AAAAAA U-rich U-rich
Py(A)N
CFIB CFIACPF
H. sapiens
PEEE UUE DSE-1
UGUA AAUAAA U-rich U-rich
Py(A)N
CFIM CstF
CPSF
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DSE-II
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contribute to efficient mRNA 3'- end processing (Hu et al. 2005; Yang and Doublié 
2011) (Figure 1.5).  
 
The efficiency element consists of alternating UA dinucleotides in some genes or a 
mixture of U-rich and UA dinucleotide stretches in others. A consensus efficiency 
element was found to be a hexanucleotide UAYRUA and more specifically a 
UAUAUA. The Us in position one and five of this sequence are the most essential 
residues for mRNA 3' end formation (Irniger and Braus 1994). It is interesting to note 
that the efficiency elements are somewhat degenerate in different mRNAs in spite of 
the proposed UAUAUA consensus sequence. GCN4 and ADH1 use UUUUAUA as 
their efficiency elements (Egli, Springer, and Braus 1995).  GCN4 represent a class of 
mRNAs where the polyadenylation signals are strictly uni directional whereas ADH1 
polyadenylation sites are bi directional in nature (Irniger, Egli, and Braus 1991). 
Most of the yeast genes including GAL7 use UAUAUA as the efficiency element. 
However genes such as CYC1 and GCN4 use different but related sequences like 
UAUUA, UUUAUA, UAUGUU, and UAUUUA (Egli, Springer, and Braus 1995; 
Guo et al. 1995). The yeast positioning elements are the ones functionally similar to 
the human AAUAAA. They are usually A rich stretches that dictate the position of the 
endonucleolytic cleavage and are located around 10 to 30 nucleotides upstream of the 
exact cleavage site (Heidmann et al. 1994). Removal of the positioning element from 
the RNA results in shift of the cleavage site (P. Russo et al. 1991). Some of the 
most commonly found positioning elements are UUAAGAAC, AAUAAA and 
AAAAAA. Deletion of the positioning element of ADH2 and GAL7 resulted in a 
decrease in the use of the strong cleavage sites (Hyman et al. 1991; Abe, Hiraoka, 
and Fukasawa 1990). Analysis of 1352 unique pre-mRNA 3′-end-processing sites 
have identified U-rich sequences both upstream and downstream of the cleavage site 
(Graber et al. 1999). Importantly, the human polyadenylation signals also contain 
similar U-rich elements near the cleavage site. Mutating either the upstream or the 
downstream U-rich elements to Gs did not have any effect on the cleavage activity. 
However, when U → G mutations were introduced upstream and downstream of the 
cleavage site, cleavage was strongly affected (Dichtl and Keller 2001). The interaction 
of these U-rich elements with the CPF or CFI subunits is yet to be studied in detail. 
Yeast possesses a cluster of cleavage sites downstream of the positioning element. 
The most common cleavage site is a pyrimidine (C or U) followed by one or two 
As (PyAAA), (Heidmann et al. 1992; Bennetzen and Hall 1982). Tian and Graber 
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provide a comprehensive review comparing the poly(A) signals in different 
organisms (Bin Tian and Graber 2012). 
 
A recent study combining in cell structure probing coupled with high-throughput 
functional assays and bioinformatics analysis, have found that folded RNA structures 
near the mRNA 3′-ends facilitate cleavage and polyadenylation (Wu and Bartel 2017). 
This adds a new layer of regulation associated with mRNA 3′ end processing, and 
suggest that the contributions from RNA elements are more complex than previously 
thought. 
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1.2.3 Ysh1 and endonuclease mechanism 
 
Ysh1  (CPSF-73 in humans)  follows  a  general  two-metal  ion  dependent  
mechanism  for  the endonuclease cleavage reaction (Steitz and Steitz 1993). The 
crystal structure of CPSF-73 in a closed state revealed an N-terminal metallo-β-
lactamase domain and a C-terminal β-CASP domain (Mandel et al. 2006). The 
metallo-β-lactamase domain is not only found in β-lactamases but also prevalent in 
different protein families such as thiolesterases, glyoxalase II family and nucleases. 
The crystal structure reveals two zinc ions bound in the active site between the two 
domains. The ions have an octahedral coordination with a hydroxyl ion as one of the 
bridging molecules. Although this structure does not have a substrate RNA bound in 
the active site, conclusions can be made about the possible mechanism via which 
cleavage can occur.  In the metallo-β-lactamase domain of  CPSF-73,  the bridging 
molecule of the two zinc ions acts as a nucleophile to hydrolyse the phosphodiester 
linkage (Mandel et al. 2006). The bridging hydroxyl molecule is right beneath the 
sulfate group that the authors argue is the chemical mimic of the phosphate group of 
the RNA. In a similar study of the RnaseJ enzyme, the position occupied by a sulfate 
ion in the apo structure of RnaseJ was found to be occupied by the phosphate group 
of an UMP in the structure bound to UMP (Sierra-Gallay et al. 2008). So the 
position where they have modelled the sulfate group (or the phosphate group) could 
be the receiver of the nucleophilic attack leading to nuclease reaction (Figure 1.6). 
Direct proof of the postulated two metal ion endonuclease mechanism will require a 
structure of the enzyme in an open state, with an RNA substrate bound in the active 
site, and two divalent ions coordinated octahedrally by the phosphate group and the 
side chains of Asp or His from Ysh1. 
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Figure 1.6: The structure of CPSF-73 (or Ysh1) in a closed state [PDB ID: 2I7V]. 
CPSF-73 contains an N-terminal metallo-β-lactamase domain shown in light cyan, the 
middle region forms a β-CASP domain shown in sand yellow and the C-terminal end 
also forms a part of the metallo-β-lactamases domain shown in light blue. The two 
bound zinc ions are shown in grey, a sulfate group (that mimics the phosphate of the 
substrate) is shown in pink and the bridging hydroxyl ion is shown in yellow. 
 
 
 
 
 
 
 
 
 
 
 
 
 
The active siteCPSF-73: Closed state
β-CASP domain 
Metallo-β-lactamase domain
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1.2.4 Pap1 and polyadenylation mechanism 
 
Pap1 is the yeast poly(A) polymerase that adds a chain of adenosines to the 3′ 
hydroxyl of a substrate RNA via a two-metal ion dependent nucleotidyl transferase 
mechanism.  The crystal structure of Pap1 revealed three globular domains that 
surround a central substrate binding cleft of 20 Å by 30 Å by 45 Å (Figure 1.7a) 
(Bard et al. 2000). The three domains of Pap1 consist of a palm, finger and thumb 
domains. Furthermore, the arrangement of these respective domains in Pap1 is 
different from that seen in other template dependent polymerases (Figure 1.7a). The 
N-terminus of Pap1 is structurally similar to the palm domains, and the middle 
domain of Pap1 is functionally similar to the finger domains of pol β nucleotidyl 
transferases. The active site in the palm domain of Pap1 is structurally similar to the 
other polymerases in this family of two metal ion dependent nucleotidyl 
transferases. The Aspartates 100, 102 and 154 are required to coordinate the divalent 
cations (Figure 1.7b). The active site also shows that there are extensive contacts 
made by Pap1 to the mononucleotide primer. 
 
The mechanism of poly(A) polymerase activity was determined when the structure of 
a catalytically inactive Pap1 mutant (D154A) was determined in complex with 
MgATP and a poly(A) RNA (Balbo and Bohm 2007). This 1.8 Å resolution crystal 
structure of the ternary complex has clear electron density for MgATP and the RNA 
(Figure 1.7b). However, there is no electron density accounting for a second 
magnesium ion, likely due to the catalytically inactive mutant used in the study. 
 
When compared to the apo open structure of Pap1, this active structure is more closed 
with the N- terminal domain being rotated by ~23°. In this closed state, the N-terminal 
and C-terminal domains interact with the substrate mainly mediating contacts across 
the domains. Interestingly, the single stranded poly(A) chain does not form base 
stacking interactions. The poly(A) substrate remained solvated in the ternary structure 
with 24 of the protein-RNA interactions occurring through an ordered network of 
water molecules. Some of the water molecules that contact the base of ATP could 
impart substrate specificity. 
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Figure 1.7: (a) The structure of Pap1 with MgATP in the open conformation [PDB 
ID:1FA0]. The two divalent cations are shown in grey, the phosphates of the incoming 
3’-dATP is shown in ruby and the mononucleotide primer is shown in yellow.  The 
active site cleft is ~ 20 Å by 30 Å by 45 Å. (b) The active site of Pap1 showing the Mg 
coordination and the incoming ATP in ruby poised for a nucleophilic attack on the 3' 
hydroxyl of the substrate RNA in yellow [PDB ID: 2Q66]. 
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Pap1 interacts with the 2' hydroxyl groups of the adenine bases at the 3' end of the 
poly(A) RNA, one and two positions upstream of the 3' end. This explains why Pap1 
does not prefer DNA substrates as templates  for  polyadenylation.  The  adenines  at  
these  positions  are  well  anchored  and  buried completely within the active site. 
However, the adenine residue three positions before the 3' end remains surface 
exposed on the C-terminal domain of Pap1. This adenine makes base specific contacts 
with Pap1 residues Lys392, Glu487, Leu388 and Leu 491. The three adenosines 
coming after this also makes base specific contacts with highly conserved residues on 
Pap1. 
 
Resembling a substrate ready for a nucleophilic attack, the 3' hydroxyl end of the 
poly(A) RNA is located 3.2 Å from the α phosphorous of ATP. The ternary structure 
provides a structural basis for nucleotide base recognition in spite of the absence of 
any observed direct hydrogen bonding between the base and Pap1. Base stacking 
interactions between the 3' end of the poly(A) RNA substrate and the incoming ATP 
can be observed in the structure. From a thermodynamic point of view, A-A 
stacking is more favourable than A-C or A-U stacking. This could explain why Pap1 
is less efficient to add a poly(A) tail to an RNA 3' end that ends with C or U. The 
discrimination between A and G is largely due to electrostatic reasons and steric 
hindrances due to differences in shape (Balbo and Bohm 2007). 
 
Detailed kinetic studies show that Pap1 switches between the open and closed 
conformation during nucleotidyl transfer. Formation of the closed state results in the 
active site assembly, and subsequently correct substrate recognition and catalysis.  
Interestingly, the nucleotide specificity is manifested in the Vmax term rather than the 
Km. ATP binding promotes the reaction velocity via a ground-state destabilisation 
mechanism. Substrate binding results in domain closure and adenylate transfer 
occurs in the closed conformational state. The mechanism of ground state 
destabilisation and catalysis in the closed state remains unanswered in the field. 
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1.2.5 Regulation of poly(A) tail length 
 
It is thought that a newly synthesised RNA has a poly(A) tail length of ~60 As in S. 
cerevisiae (M Edmonds, Vaughan, and Nakazato 1971; Mclaughlin et al. 1973). Why 
is the length of a poly(A) tail an important cellular property that deserves 
attention? Depending on their lengths, poly(A) tails can either help in stabilizing the 
mRNA or aiding in 3' → 5' exosome mediated RNA degradation.  The rate of removal 
of a poly(A) tail is the major determinant of mRNA degradation and subsequently it’s 
half life. The newly added poly(A) tail of different mRNAs have similar lengths, 
whereas the rate of removal of the poly(A) tail in the cytoplasm is different for 
different mRNAs. Specific RNAs are targeted for deadenylation over others based in 
part on sequences in their 3' UTRs. This allows the cell to control the half-life of an 
mRNA as a function of the intrinsic property of the mRNA only. In addition, mRNA 
poly(A) tail length also has an influence on translation efficiency (Preiss ,  
Muckenthaler ,  and Hentze 1998;  Bei lharz  and Preiss  2007). Therefore 
the length of the poly(A) tail controls the fate of the mRNA and hence gene 
expression. 
 
As CPF adds a poly(A) tail to the cleaved 3' end of a pre-mRNA, poly(A) binding 
proteins in the nucleus are thought to bind the poly(A) tail and somehow restrict their 
length. The zinc finger protein, Nab2, is the major poly(A) binding protein in the 
nucleus, although there are reports suggesting the presence of the cytoplasmic poly(A) 
binding protein Pab1 in the nucleus (Brune et al. 2005). Nab2 was discovered as a 
protein that associates with nuclear polyadenylated RNA in vivo (Anderson et al. 
1993). Nab2 is also required for the efficient export of mRNAs into the cytoplasm 
and in addition to its role in the control of poly(A) tail length in vivo (Green et al. 
2002; Hector et al. 2002). Although Pab1 may have a role in the regulation of poly(A) 
tail length in yeast (Amrani, Minet, Le Gouar, et al. 1997), Nab2 is thought to be the 
functionally relevant protein in poly(A) tail length control owing to its nuclear 
localization. However the exact amounts of Nab2 or Pab1 inside the nucleus is 
unknown. It was found that over-expression of Pab1 with a nuclear localisation 
signal cannot rescue a hyper-polyadenylation phenotype of Nab2 deletion (Hector et 
al. 2002). 
 
Nab2 binds specifically to poly(A) sequences with high affinity (Kelly et al. 2007). 
Nab2 is made up of three functionally distinct domains. The N-terminal domain of 
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Nab2 is involved in poly(A) RNA export, a central domain mediates Nab2’s nuclear 
import and the C-terminal domain harbours seven tandem  zinc  finger  repeats,  of  
which  ZF5-ZF7  are  necessary  for  specific  poly(A)  RNA  binding (Soucek, 
Corbett, and Fasken 2012).  Recognition of poly(A) RNA by Nab2 is essential for 
proper control of mRNA poly(A) tail length ( K e l l y  e t  a l .  2 0 1 0 ) , and rapid 
removal of Nab2 from the nucleus of yeast cells results in disappearance of 
polyadenylated transcripts due to enhanced mRNA decay (Schmid et al. 2015). In 
accordance with the in vivo data, addition of recombinant Nab2 to in vitro 
polyadenylation reactions of CPF results in controlled poly(A) tail addition, but the 
exact molecular mechanism behind how  Nab2  can  impart  length  control  to  the  
polyadenylation  machinery  of  S.  cerevisiae  is  not understood (Viphakone, 
Voisinet-Hakil, and Minvielle-Sebastia 2008). 
 
In humans however, there is a model for the control of mRNA poly(A) tail length 
(Wahle 1995).  It is based on the fully distributive property of the human poly(A) 
polymerase, PAP,  which means it has a low affinity for RNA. The nuclear 
poly(A) binding protein PABN1 forms a stable ternary complex with the PAP, the 
human polyadenylation machinery CPSF and the substrate RNA. This transforms the 
polyadenylation activity of PAP from a distributive to a processive manner. After 
adding a poly(A) tail of ~250 As, for reasons that are currently unknown, PABN1 
dislodges from this stable ternary complex resulting in the termination of this 
processive poly(A) tail synthesis. In cells, the mRNA polyadenylation complex 
consists of additional factors such as  CstF,  CFI  and  CFII  that  were  not  included  
in  the  abovementioned  study.   It  remains  to  be determined whether they influence 
this process. 
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1.3 Overview of 3' end processing:  links to other pathways 
 
Maturation of pre-mRNAs transcribed by pol II requires capping at the 5' end, 
splicing at intronic sites, 3' end cleavage / polyadenylation and export into the 
cytoplasm. Although these diverse nuclear pathways function via separate protein and 
nucleic acid complexes, there exists a great deal of cross- talk between these 
processes (Tudek, Lloret-Llinares, and Jensen 2018; Giammartino and Manley 2014). 
 
The CTD of pol II can recruit a variety of protein factors that are involved in pre-
mRNA processing. The dynamic phosphorylation states of the CTD regulate this 
process. When transcription begins, the CTD is unphosphorylated, and becomes 
differentially phosphorylated throughout the different stages of transcription. We 
know, for example, that Ser5 phosphorylation recruits the 5' capping complex and that 
Ser2 phosphorylation results in assembly of the 3' end processing machinery. The 
Pcf11 subunit of CF IA, contains a CTD interaction domain that specifically 
recognises Ser2 phosphorylated CTD. It is plausible that CF IA is first recruited to the 
CTD through its interaction with Ser2 phosphorylation, and this brings CPF to the 
CTD. The Glc7 phosphatase of CPF can then dephosphorylate the Tyr1 of CTD and 
triggers transcription termination (Schreieck et al. 2014). As the pre-mRNA emerges 
out of the pol II, the various cis-acting elements in the RNA start to attract the binding 
of different proteins, eventually  assembling  a  competent  3'  end  processing  
machinery.  The  CPF  and  CFI  protein components interact both with the pol II 
CTD and the newly synthesized pre-mRNA. The RRM domains of Rna15 (CF IA) 
can recognise GU rich elements that are found downstream of the cleavage site 
(Pancevac et al. 2010) as well as the AAUAA of the positioning element, whereas the 
RRM domains of Hrp1 (CF IB) recognises AU rich efficiency element upstream of 
the cleavage site (Leeper et al. 2010). An open question that remains in the field is 
whether CF IA and CF IB bind upstream or downstream of the cleavage sites 
(Gross  and  Moore  2001;  Dich t l  e t  a l .  2002;  Pancevac  e t  a l .  2010;  
Bae jen  e t  a l .  2014) . CPF likely binds to the AU rich positioning element usually 
present ~ 20 nucleotides upstream of the cleavage site (Chan, Huppertz, Yao, Weng, 
Moresco, Yates, et al. 2014). After the assembly of a competent 3' end processing 
complex involving CF IA, CF IB and CPF, the endonuclease Ysh1 is activated and 
performs cleavage of the pre-mRNA at a specific site Surprisingly, some of the 
spliceosomal proteins can exert influence on pre-mRNA 3' end cleavage and 
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polyadenylation. Binding of the splicing factor U2AF 65 to the pyrimidine tract of 
the intron 3' site that lies upstream of the cleavage site enhances the 3' end cleavage 
activity (Millevoi et al. 2009). Similarly, PAP interacts directly with U2AF 65 and 
increases splicing efficiency (Vagner, Vagner, and Mattaj 2000). A direct interaction 
of the U1A snRNP with PAP has been reported to inhibit polyadenylation (Gunderson 
et al. 1994). However, in vitro assays show that U1A snRNP can stimulate 
polyadenylation by interacting directly with CPSF-160 (Lutz and Alwine 1994). The 
exact role of U1A snRNP in polyadenylation remains to be clarified. 
 
Once the activated Ysh1 in the 3' end processing machinery carries out the pre-mRNA 
cleavage, it is uncertain whether there could be any conformational rearrangement of 
the machinery. The poly(A) polymerase Pap1 can now access the free 3' hydroxyl of 
the end of the pre-mRNA and start adding a tail of multiple adenosines. After 
reaching a tail length of ~60As, the polyadenylation reaction is terminated by a 
mechanism involving the poly(A) binding protein Nab2. The Nab2-bound mature 
(spliced and polyadenylated) mRNA is now competent for export into the cytoplasm. 
The Nab2-bound poly(A) tail can recruit the mRNA export adaptor complex 
Mex67/Mtr2 (Iglesias et al. 2010). Mex67 and Nab2 also interact directly with 
the nuclear pore complex and aid in the efficient export of the mature mRNA 
(Fasken, Stewart, and Corbett 2008). Those mRNAs that are not exported into the 
cytoplasm are targeted for degradation by the nuclear exosome. Studies in humans 
have identified a complex named PAXT that can selectively bind polyadenylated 
mature transcripts via PABN1 and perform exosome-mediated decay. This provides a 
pathway through which polyadenylated RNAs are targeted for degradation in the 
nucleus. Those RNAs that do not have a mature poly(A) tail, are targeted by the 
TRAMP complex that adds a short tail of As and subsequently triggers their exosome-
mediated decay (Schmidt and Butler 2013) . 
 
In summary, CPF (along with the cleavage factors) cleaves and adds a poly(A) tail at 
the 3' end of a pre-mRNA. This is a multistep process involving a large set of protein 
and RNA factors, and is regulated by cross talk between various other mRNA 
processing complexes including Pol II, spliceosome and nuclear export factors. The 
poly(A) tails can either stabilize the mature mRNA, aid in their export or alternatively 
result in nuclear exosome mediated decay or deadenylation. Research in the past two 
decades has aided in our understanding of the composition and functions of the 
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individual components of this machinery. However, very little is known about how 
they work together as a complex to coordinate specific and efficient mRNA 3' end 
processing. 
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1.4 Questions addressed in this dissertation 
 
Prior work from our lab h a s  advanced our knowledge of the architecture of CPF; 
the three-enzymatic activities are segregated into three different modules (Figure 
1.3). Isolated Pap1 enzyme can add a multiple adenosine tail to a substrate RNA in a 
nonspecific manner. It has been shown in humans that the non-enzymatic 
subunits that associate with PAP confer specificity to the reaction. Furthermore, they 
transform the polyadenylation reaction from distributive to processive in nature. In 
chapter 2 of this dissertation, I aim to clarify the function of the non-enzymatic 
polymerase module subunits in yeast and provide a better understanding of how they 
are structurally associated with each other including the substrate RNA. I have taken 
an in vitro biochemistry approach coupled with integrative structural biology 
techniques.  
 
The cleavage factors CF IA and CF IB are known to be important for proper cleavage 
site selection and influence the efficiency of cleavage (Minvielle-Sebastia, 
Preker, and Keller 1994; Kessler, Zhao, and Moore 1996; Kessler et al. 
1997). Although there are prior reports concerning the role of the cleavage factors in 
polyadenylation, the lack of a highly pure and homogeneous in vitro system to study 
polyadenylation has hampered progress. I have used purified protein complexes to 
study the polyadenylation of a pre-cleaved substrate RNA in vitro in order to 
systematically test the role of specific components during the reaction.  In addition, I 
have employed complimentary biophysical techniques to characterize the interaction 
between the cleavage factors and CPF. The main findings from this study are in 
chapter 3.  
 
In S. cerevisiae, newly synthesized pre-mRNAs have a poly(A) tail length of ~ 60 As. 
The exact molecular mechanism behind how CPF terminates polyadenylation after 60 
As remains unknown. In humans, the poly(A) binding protein PABN1 has been 
shown to play a role in regulating the pre-mRNA poly(A) tail lengths. S. cerevisiae 
does not have any PABN1 homologue. The tandem zinc finger-containing protein, 
Nab2, is thought to impart poly(A) tail length control on pre-mRNAs. By using a 
fourteen-subunit CPF purified from both native and recombinant sources, I have 
performed cleavage and polyadenylation reaction of a substrate RNA to 
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investigate pre-mRNA poly(A) tail length control. These results are presented in 
chapter 4. 
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2 Architecture of the Polymerase Module of CPF 
 
The identities and functional properties of the subunits that make up the polymerase 
module are relatively well understood. The polymerase module in yeast is strikingly 
similar to a four-subunit mammalian complex that has been shown to be necessary and 
sufficient for specific in vitro polyadenylation (Schönemann et al. 2014).  However, it is 
unknown how the five proteins constituting the module function together to facilitate 
polyadenylation of a cleaved substrate RNA. A comprehensive understanding of 
subunit interactions within the complex has remained elusive due to the complexity 
involved in producing the polymerase module with high yields and purity for 
biochemical or biophysical experiments. Furthermore, there is a lack of insight into how 
the polymerase module subunits are arranged in 3D space and how this gives rise to the 
function of the module. In this chapter, I describe a method to stringently purify high 
quantities of the polymerase module. I then study a purified, homogenous preparation 
using cryo-EM, and determine the 3D structure of the Cft1-Pfs2-Yth1 subunits of the 
polymerase module. Using cross-linking mass spectrometry, in vitro pull downs and 
nuclear magnetic resonance (NMR) spectroscopy, I further elucidate the molecular 
architecture of the polymerase module, showing how the polymerase Pap1 is flexibly 
tethered to the rest of the complex.   
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2.1 Purification of recombinant polymerase module from Sf9 cells 
 
In order to purify the polymerase module in the correct stoichiometry, polymerase 
module subunits were co-expressed and co-purified. Five genes encoding subunits of 
the polymerase module were cloned into one single vector using the MultiBac 
expression system (Figure 2.1a). Each gene had its own polyhedrin promoter and SV40 
late terminator. The genes coding for Cft1, Pfs2, and Yth1 were cloned into the acceptor 
plasmid pACEBac1, whereas the genes coding for Pap1 and Fip1 were cloned into the 
donor plasmid pIDC. By means of Cre-Lox recombination, a final vector containing all 
polymerase module subunits was generated (section 6.2.4). The subunit Pfs2 contains 
an N-terminal twin StrepII-tag and the subunit Yth1 contains an N-terminal His tag. 
Polymerase module subunits were over-expressed in Sf9 cells by means of baculovirus 
mediated over-expression system (section 6.3.3).  
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2.1.1 Purification of isoforms of polymerase module that vary in Pap1 
stoichiometry 
 
The polymerase module was purified by a three-step protocol (Figure 2.1b). The 
polymerase module was pulled down from Sf9 lysates via the Strep-II tag on the N-
terminus of Pfs2 using streptavidin resin, and eluted with desthiobiotin (Figure 2.1c). 
Analysis of the pull-downs by SDS-PAGE revealed a complex containing all five 
polymerase module subunits and additional bands whose identities were unknown 
(Marked by asterisks in Figure 2.1c).  
 
 
 
 
Figure 2.1: Purification of recombinant polymerase module. (a) Overview of steps 
involved in cloning of polymerase module subunits and baculovirus mediated insect cell 
over-expression (b) Purification scheme of polymerase module (c) Streptavidin pull 
down of the Sf9 cell lysate was analyzed by SDS-PAGE.  
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Furthermore, visual inspection of the bands revealed that the intensity of Pap1 was 
fainter compared to that of Pfs2. This suggested that Pap1 was either present in sub-
stoichiometric amounts, or that the elution fractions from affinity purification contain 
multiple protein complex species.  In order to further clarify this, the elution fractions 
were pooled and loaded onto a pre-equilibrated anion exchange column. Bound protein 
complexes were eluted using a very shallow gradient of increasing salt concentration. 
The shallow gradient allowed the resolution of three peaks at ~300 mM, ~350 mM, and 
~380 mM NaCl (Figure 2.2a). The peaks are referred to as “shoulder”, “peak 1” and 
“peak 2” respectively. SDS-PAGE analysis of the three peaks showed highly pure 
polymerase module complex being eluted across the fractions. Further analysis reveals 
that the stoichiometry of Pap1 subunit varies across the elution fractions (highlighted in 
a red box in Figure 2.2b). The fractions at  ~300 mM NaCl seem to contain excess 
Pap1, and as the salt concentration is increased, complexes with stoichiometric amounts 
of Pap1 are eluted (~350 mM NaCl), followed by complexes containing no Pap1 (~380 
mM NaCl) (Figure 2.2b).  
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Figure 2.2: Anion exchange chromatography separates polymerase module with 
multiple, one or no copy of Pap1 (a) Anion exchange chromatography using a monoQ 
column. Proteins are eluted over a shallow salt gradient starting from 150 mM NaCl 
until 1000 mM NaCl over a 100 ml volume. (b) SDS-PAGE analysis of the eluted 
fractions reveals polymerase module containing multiple Pap1, single Pap1 or no Pap1. 
Varying amounts of Pap1 is highlighted by a red box. 
 
The presence of Pap1 likely alters the ionic property of the complex therefore leading to 
different elution profiles for the complexes with Pap1 and without Pap1. The 
observation of polymerase modules with varied stoichiometry of Pap1 is highly 
reminiscent of earlier observations during native CPF purifications from S. 
cerevisiae.  CPF species containing multiple copies of Pap1 were observed when CPF 
from S. cerevisiae is subjected to anion exchange chromatography and a very shallow 
salt gradient elution (Easter 2014). It is interesting to note that CPF without any 
polymerase was eluted first at ~280 mM salt concentration, followed by CPF containing 
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one copy of Pap1 and CPF with two copies of polymerase as the salt concentration is 
increased (Easter 2014). However, in the case of the polymerase module, the complex 
containing excess Pap1 subunit was eluted first, followed by the other species (Figure 
2.2b). It is possible that the absence of the nuclease and phosphatase modules alter the 
surface chemistry of the polymerase module in comparison with full CPF, thus 
explaining the different elution profiles of CPF compared to polymerase module on an 
anion exchange column.   
 
The three different polymerase module species from the anion exchange step were 
further purified using size exclusion chromatography. The size exclusion 
chromatograms show a well-dispersed and homogenous peak for all three species 
(Figure 2.3a).  
 
 
 
Figure 2.3: Size exclusion chromatography of the three polymerase module variants 
(a) Size exclusion chromatograms of polymerase module variants. (b) SDS-PAGE 
analysis of the polymerase module variants after size exclusion chromatography. (c) 
Representative negative stain micrographs of the three polymerase module variants. 
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The ratio of UV absorption at 260 nm and 280 nm suggests that there are no nucleic 
acid contaminants. SDS-PAGE analysis of the peak fractions further reveals highly pure 
polymerase module complexes (Figure 2.3b). Transmission electron microscopy images 
of negatively stained polymerase module further confirm sample homogeneity (Figure 
2.3c). The micrographs reveal well distributed ~14 nm particles. However, micrographs 
of samples containing Pap1 showed smaller particles in addition to the ~14 nm 
polymerase module. One likely explanation is that the polymerase Pap1 dissociates 
from the complex during preparation of negatively stained sample. The absence of such 
additional small particles in the micrographs of polymerase module without Pap1 (peak 
2) further supports this hypothesis.    
 
In summary, I have established a protocol for the recombinant expression and 
purification of the S. cerevisiae polymerase module. 
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2.1.2 Purification of the poly(A) polymerase Pap1 
 
In order to compare the activity of the polymerase module and the poly(A) polymerase 
Pap1 alone, I sought to recombinantly express and purify S. cerevisiae Pap1, a well-
folded globular protein which has been previously purified and crystallized (Bard et al. 
2000). The gene coding for S. cerevisiae Pap1 was cloned with a N-terminal His tag 
into pET-28a vector. Protein overexpression was carried out in BL21 Star (DE3) cells 
by IPTG induction (Figure 2.4a). The overall purification scheme is shown in Figure 
2.4b Pap1 was isolated from E. coli lysate by affinity chromatography via the His-tag of 
Pap1. The eluate was subjected to ion exchange chromatography using a heparin 
column. The eluate from the heparin column was further purified using size exclusion 
chromatography (Figure 2.4c). The size exclusion chromatography revealed a void peak 
and a homogenous protein peak. SDS-PAGE analysis of the fractions showed the 
presence of highly pure Pap1 in the elution fractions. The peak fraction was further 
concentrated, flash frozen and stored in -80 C for use in biochemical experiments. 
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Figure 2.4: Purification of recombinant poly(A) polymerase Pap1. (a) Overview of 
steps invovled in cloning and IPTG induced bacterial over-expression of Pap1 (b) 
Purification scheme of Pap1 (c) Size exclusion chromatography using a S200 10/300 
GL column. (d) SDS-PAGE of fractions from size exclusion chromatography. 
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2.2 Reconstitution of in vitro poly(A) tail addition        
 
The recombinant production of large amounts of highly pure polymerase module has 
enabled us to characterize the polyadenylation activity of the complex using in vitro 
assays. Here, I describe in vitro polyadenylation assays of a fluorescently labeled 
substrate RNA.  
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2.2.1 Comparison of the polyadenylation activity of polymerase module and Pap1  
 
Before setting up polyadenylation assays of Pap1 and the polymerase module 
complexes, it was necessary to normalize protein samples for the amount of the 
polymerase Pap1. This was carried out using Coomassie staining and densitometry 
analysis of the protein band corresponding to Pap1 (Figure 2.5a). Similarly, the 
polymerase module containing excess Pap1 was loaded onto an SDS-gel alongside 
twice the amount of isolated Pap1 (Figure 2.5b). The amount of Pap1 in the polymerase 
module containing excess Pap1 was found to be similar to twice the amount of Pap1 in 
the isolated sample, further confirming that this preparation contains two copies of Pap1 
(Figure 2.5b). These samples were used in subsequent polyadenylation assays. 
 
 
 
 
 
Figure 2.5: Quantification of Pap1 amounts by densitometry.  (a) SDS-PAGE of 
purified polymerase module and Pap1. The gel was visualized after staining by 
Coomassie blue. The intensity of the band corresponding to Pap1 was analyzed by 
Image J (Schneider, Rasband, and Eliceiri 2012).  After normalizing for the intensity of 
Pap1, the proteins were further used in polyadenylation assay described in figure 2.6. 
(b) SDS-PAGE of purified polymerase module variant containing 2 Pap1 and Pap1 
alone. The intensity of the band corresponding to Pap1 was analyzed by Image J.  After 
normalizing for the intensity of Pap1, the proteins were further used in polyadenylation 
assay described in figure 2.7 
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In vitro polyadenylation assays were carried out using purified polymerase module 
containing one copy of Pap1 and its polyadenylation activity was compared to isolated 
Pap1. 3' end of the yeast CYC1 mRNA has been historically used as a model substrate 
to study cleavage and polyadenylation (Butler and Platt 1988). CYC1 mRNA contains 
several cis-elements known to be important for efficient 3' end processing (Dichtl and 
Keller 2001). A synthetic 42-mer CYC1 3' UTR with a 5' 6-FAM label (hereafter 
referred to as 5'-FAM-CYC1-pc) was used as the substrate in the assays (Schmid et al. 
2012). Products of polyadenylation assays were analyzed by denaturing urea-PAGE 
(Figure 2.6). Pap1 appears to add poly(A) tail faster than the polymerase module.  All 
substrate RNA is polyadenylated after 8 minutes, as seen by the disappearance of the 
band corresponding to 5'-FAM-CYC1-pc. (Figure 2.6a). The differences in speed 
between Pap1 and polymerase module can be appreciated at early time points. Similar 
to the reaction containing polymerase module, all substrate RNA is polyadenylated after 
time 8 minutes by Pap1 (Figure 2.6b). The final length of the poly(A) tail in both cases 
seem similar (~260 As).  
 
 
 
Figure 2.6: Recombinantly purified polymerase module and Pap1 can add a poly(A) 
tail to a pre-cleaved CYC1 RNA.  Polyadenylation assay of (a) purified polymerase 
module and (b) Pap1 analyzed by denaturing urea-PAGE.  A 5ʹ fluorescently labeled 42 
mer CYC1 RNA that has been pre-cleaved is the substrate for polyadenylation. The 
assays were carried out with a final concentrations of 1 µM substrate RNA and 50 nM 
purified proteins. Reactions were initiated by the addition of 2 mM ATP.  * denotes 
degraded RNA. 
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Next, the activity of the polymerase module containing two Pap1s was compared to that 
of isolated Pap1 (present in twofold excess). Isolated Pap1 was found to be faster than 
the polymerase module containing two Pap1s (Figure 2.7a). Moreover, polyadenylation 
by polymerase module containing two copies of Pap1 occurs more rapidly compared to 
that containing one Pap1 subunit. In all cases, polyadenylation appears to be 
distributive, as all substrate RNA is rapidly polyadenylated. 
 
 
 
 
Figure 2.7: Comparing the polyadenylation of polymerase module variant and Pap1.  
Polyadenylation assay of purified (a) polymerase module with two copies of Pap1, and 
(b) Pap1 alone present in two times molar excess amounts was analyzed by denaturing 
urea-PAGE.  A 5ʹ fluorescently labeled 42 mer CYC1 RNA that has been pre-cleaved 
is the substrate for polyadenylation. The assays were carried out with a final 
concentration of 400 nM substrate RNA and either 50 nM purified polymerase module 
or 100 nM Pap1. Reactions were initiated by the addition of 2 mM ATP. 
 
Interestingly, the results obtained here are contradictory to the assays performed with 
human complex where isolated PAP (or Pap1) was less active compared with the 
mammalian polyadenylation specificity factor (similar to yeast polymerase module) 
(Schönemann et al. 2014). It is well known that isolated polymerase does not bind RNA 
tightly and hence adds a poly(A) tail to the substrate RNA in a distributive manner 
(Wahle 1991; Bienroth, Keller, and Wahle 1993; Wahle 1995). In contrast, the binding 
affinity of the human complex for an AAUAAA-containing RNA was reported to be ~2 
nM (Schönemann et al. 2014; Chan, Huppertz, Yao, Weng, Moresco, Yates, et al. 
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2014), potentially explaining the increased processivity and increased activity of the 
human complex relative to PAP. 
 
2.2.2 RNA binding gel shift assays of polymerase module 
 
While the human complex binds to RNA with higher affinity than PAP alone, it is 
unknown if the yeast complex shows similar relative binding behaviour. To assess the 
RNA binding of yeast polymerase module, electrophoretic mobility shift assays 
(EMSAs) were carried out with a variety of fluorescently labeled substrate RNAs 
(Figure 2.8a). At 500 nM protein concentrations, almost all RNA was bound to the 
polymerase module, as observed by the disappearance of the band corresponding to free 
RNA. (Figure 2.8b). To assess the relative contributions of various cis-elements to RNA 
binding, point mutations were introduced in the positioning element and/or the upstream 
U-rich elements of the 5'-FAM-CYC1-pc RNA. The polymerase module appears to bind 
these mutant RNAs with slightly reduced affinity. Therefore, it is likely that there are 
additional binding sites in the RNA for the polymerase module. Furthermore, a 42-mer 
wild type adenovirus L3 RNA (containing the AAUAAA hexamer) with a 5' 
fluorescein-label was also tested for its ability to bind to the polymerase module. 
Interestingly, the viral RNA did not bind polymerase module as tightly as the yeast 
sequence (Figure 2.8c). Therefore, the yeast polymerase module displays binding 
specificity towards the yeast sequence.  
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Figure 2.8: Electrophoretic mobility band shift assay (EMSA) of polymerase module 
with various substrate RNA (a) RNA sequences used in the study. (b) Recombinantly 
purified polymerase module (without Pap1) was mixed with 50 nM of a fluorescently 
labeled 42 nt long pre-cleaved CYC1 3ʹ UTR and the resulting complex was analyzed 
by 6% native-PAGE. (c) The yeast polymerase module does not bind the adenovirus 
L3 RNA UTR. 
 
Nonetheless, the binding affinity of the yeast polymerase module is in the range of 
several hundred nanomolar lower than that shown by the human polymerase module. 
These results suggest that the yeast polymerase module may act less processively on the 
CYC1 RNA, providing a potential explanation for why the polymerase module is less 
active than the polymerase alone.  
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2.3 Structure of Cft1-Pfs2-Yth1 subunits of the polymerase module 
 
While the non-catalytic subunits do not appear to be important for polymerase module 
activity in vitro, they are highly conserved and functionally significant in vivo. In order 
to better understand and characterize the roles of these components of the polymerase 
module, I sought to study the architecture and structural composition of the module 
using electron microscopy.  
 
2.3.1 Negative stain electron microscopy of the polymerase module 
 
Electron microscopy of a negatively stained protein or protein complex is a good way to 
assess the quality of the sample. It can provide us with valuable information such as the 
size (or molecular dimension) of the sample, the homogeneity or purity of the protein 
preparation and a low resolution initial 3D model of the specimen being studied 
(Kiselev, Sherman, and Tsuprun 1990). In negative stain EM, the protein of interest is 
mixed with a heavy metal stain such as uranyl acetate or uranyl formate. The contrast 
produced by a biomolecule upon interaction with a low dose of electrons is weak. 
However, in case of negatively stained particles, the electrons interact with the coating 
of the negative stain around the protein and hence produce images with very good 
contrast. Furthermore, negative staining also preserves the structure of the proteins in 
the vacuum chamber of the microscope. Given the relative ease of preparing negative 
stain grids, it is a recommended first step in any new structural biology project.  
 
Previous characterization of the polymerase module (with and without Pap1) by 
negative stain electron microscopy showed individual ~14-15 nm particles with uniform 
distribution (Figure 2.3c).  2D classification of particles revealed class averages 
containing well-aligned polymerase module complexes (Figure 2.9a). The classes have 
a wide range of views and suggest that the particles are present in a variety of 
orientations on the grid. Interestingly, the size and shape of 2D class averages of the 
polymerase module look strikingly similar to those of the human 3' end processing 
machinery as reported in an earlier study (Shi et al. 2009).    
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Figure 2.9: Negative stain electron microscopy of polymerase module variants (a)  
Selected 2-D class averages of aligned particles of polymerase module with one copy 
(top) and no copy of Pap1 (bottom). (b) A 3-D reconstruction of the negative stain 
data of the polymerase module variants. 
 
Compared to 2D class averages of the Pap1-containing polymerase module, those 
lacking Pap1 appear to show more detail and display less background noise. This is 
consistent with the observation where micrographs of the polymerase module without 
Pap1 look more homogeneous and contain uniformly sized and uniformly distributed 
particles (Figure 2.3c). Further 3D classification of selected 2D classes showed that the 
polymerase module particle adopts an overall P-shape (Figure 2.9b).  Similar to the 2D 
class averages, the complex containing Pap1 showed less structural detail compared to 
that lacking Pap1 (Figure 2.9b). Moreover, the sample containing Pap1 did not contain 
any significant additional density that could account for Pap1.  
 
In summary, negative stain EM revealed the size and shape of the polymerase module. 
The polymerase module (without Pap1) appeared promising in comparison with the 
sample with Pap1. To further understand the molecular basis of subunit association 
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within the protein complex, I used cryo-EM. The structure determination of the 
polymerase module was done in collaboration with Ana Casañal. 
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2.3.2 Preliminary cryo-EM  
 
The four-subunit polymerase module was vitrified in a layer of un-supported ice on 
UltrAufoil gold grids (C. J. Russo and Passmore 2014). Cryo-EM micrographs revealed 
well-separated particles of uniform size and distribution (Figure 2.10a). Given the 
particles were well-distributed and appeared intact, I proceeded to collect micrographs 
on a 300 kV FEI Titan Krios electron microscope equipped with a Falcon II detector. 
From these, I obtained 2D classes containing high-resolution features (Figure 2.10b). 
The overall shape of the 2D classes was consistent with those obtained from negative 
stain electron microscopy.  
 
 
 
Figure 2.10: Preliminary structural characterization of polymerase module (a) 
Representative micrographs of the polymerase module without Pap1 (b) Selected 2D 
class averages of aligned particles of polymerase module without Pap1. Green arrows 
indicate the “Y” shaped 2-D classes. Yellow arrows indicate the additional density 
found on top of the “Y” shaped classes. White arrows indicate 2D classes containing a 
possible top view  (c) A 3D reconstruction of the polymerase module. Yellow arrow 
indicates a putative beta propeller domain (d) Angular distribution plot of the 3D 
reconstruction shows preferred orientation of the aligned particles. 
(a) Representative cryo-EM micrograph (b) Selected reference free 2-D classes
50 nm 
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Upon closer inspection, the sample shows some inherent heterogeneity (Figure 2.10b). 
For example, some 2D classes adopt a Y-shape (dark green), whereas others contain 
additional density on top of the Y-shaped particle (yellow). Selected 2D classes 
containing extra density were subjected to 3D refinement using the 3D map of full 
native-CPF as an initial model (Casañal et al. 2017b). The 3D refinement, comprising 
56,341 particles, yielded a map of the polymerase module at ~ 7 Å resolution (Figure 
2.10c). At this resolution, clear density corresponding to a beta propeller was observed 
(yellow arrow). The angular distribution plot of the 3D reconstruction revealed that the 
side-on view was predominant, as evidenced in the 2D class averages, hindering further 
improvements in resolution (Figure 2.10d). The rare top views that are poorly 
represented in the 3D map are highlighted in the 2D classes using a white arrow. Thus, 
the preferred orientation problem might prevent the reconstruction of a high-resolution 
3D map, in spite of obtaining 2D classes with secondary structural details. Furthermore, 
at this preliminary resolution, it is difficult to assign the subunits to the observed 
density. 
 
More micrographs of the polymerase module were collected in order to overcome the 
preferred orientation problem by obtaining additional views and enriching existing rare 
views. The new data was combined with the previous dataset; Figure 2.11 shows a 
flowchart of how the combined data were processed, again revealing sample 
heterogeneity. From further classification, I observed the characteristic Y-shaped 2D 
classes (Class 6) as well as classes that contain or lack side density (pink arrow). A final 
refinement of the selected particles resulted in a 3D map of ~ 7 Å resolution and with 
enriched rare views that were not present in earlier reconstructions. It is possible that the 
additional data were collected at a range of ice thicknesses, resulting in different sample 
orientation and thus views of the protein complex. Nonetheless, despite collecting more 
data, there was little to no improvement in the final map resolution (Figure 2.10c, 
Figure 2.11), and the final resolution following post-processing was reported to be ~7 
Å. Data collection and processing details are described in section 6.7.4. 
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Figure 2.11: Summary of cryo-EM data processing of the polymerase module. Two 
data sets were collected in a Titan Krios operating at 300 kv and equipped with a 
Falcon-II direct electron detector. Yellow and pink arrows indicate densities that were 
missing in some 3D classes. 3D classification without alignments were employed to 
further remove incomplete density maps. The final 3D map and its particle distribution 
are shown. 
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2.3.3 Overcoming the resolution barrier  
 
In order to improve the resolution of the polymerase module, I sought to investigate the 
data collection parameters that could be limiting the resolution of the map. One such 
parameter is the detective quantum efficiency (DQE) of the detector, which represents 
the signal:noise ratio contributed by the detector. An ideal detector with a DQE value of 
1 will not contribute to any noise in the image, and will detect all incident electrons. All 
cryo-EM data were thus far collected on a Falcon-II detector in integration mode at a 
magnification of 47000X (1.77 Å/pixel). A comparative analysis of the DQE of three 
different commercially available detectors show that the K2 detector operating in 
counting mode has higher DQE compared to Falcon II or DE-20 at low spatial 
frequency (McMullan et al. 2014) (appendix 8.2.) The DQE of K2 detector increases 
almost linearly with decreasing spatial frequency (appendix 8.2.). This means that K2 
detector will have better signal-noise at higher magnifications. Furthermore, a higher 
magnification allows the pixel size to be reduced, increasing the maximum attainable 
resolution. A higher DQE will also allow a desired resolution to be reached with 
reduced amounts of particles and time.  
 
Taking these parameters into consideration, I decided to image the four-subunit 
polymerase module in a Titan Krios microscope operating at 300 keV and using a K2 
summit detector in super-resolution mode (81000X, 1.4 Å/pixel). A Gatan Imaging 
Filter (GIF) with a slit width of 20 eV was used to enhance contrast. The cryo-EM 
micrograph of the polymerase module revealed well-separated particles of uniform size 
and distribution (Figure 2.12a), consistent with earlier observations. 2D classes of 
selected particles reveal very high-resolution secondary structural information as well as 
a variety of views of the complex (Figure 2.12b).  
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Figure 2.12: Cryo-EM analysis of the polymerase module using a K2 direct electron 
detector. (a) Representative micrograph of the polymerase module showing well-
distributed and homogenous particles. (b) Selected 2D class averages showing high-
resolution secondary structural details and a variety of views. 
 
Two separately collected datasets were merged using the procedure illustrated in 
appendix 8.3. The data were independently processed and two final 3D maps were 
obtained separately from the two data sets. As the absolute pixel sizes on each 
microscope were undetermined, the micrographs needed to be rescaled relative to each 
other. By cross-correlating the 3D maps, a scaling factor was calculated. Once the 
scaling factor was calculated, all the micrographs from the first dataset were rescaled 
accordingly. The rescaled micrographs were subjected to a previously established data 
processing pipeline (section 6.7.4) and all particles were merged. Ana Casañal 
performed the data merging. A total of 460,167 particles from the two data sets were 
subjected to initial 2D clean up and 3D classification. 3D refinement following particle 
polishing led to a 3.6 Å resolution map of the polymerase module (Figure 2.13). Further 
3D classification without alignments separated maps that either contained or lacked the 
additional density highlighted in pink. A final map of the polymerase module was 
obtained from 77,917 particles and at an overall resolution of 3.5 Å based on the gold 
standard Fourier shell correlation (FSC) at 0.143, which in turn is derived from 
comparisons between reconstructions from two independently refined half-sets.  
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Figure 2.13: Steps in the cryo-EM data processing of the polymerase module. 
Particle picking followed by initial 2D and 3D classifications, resulted in 460,167 
particles. They were then polished and subjected to 3D refinement, resulting in a 3.6 Å 
density map. Further 3D classification without alignments resulted in separation of 
maps that contained or lacked the density corresponding to Yth1 (shown in pink). The 
map containing density for Yth1 refined to 3.5 Å, whereas the map without any density 
for Yth1 refined to 4.1 Å. 
 
A local resolution map of the polymerase module shows that the resolution at the core 
of the map is ~ 3.4 Å, which drops to ~ 4 Å towards the outer regions (Figure 2.14b). 
Furthermore, the orientation distribution profile of the final map showed a variety of 
views, contrasting with previously collected data (Figure 2.14c). I speculate that the 
improved data collection parameters and use of the K2 detector in super-resolution 
mode and the additional views obtained from collecting in different ice thickness 
enabled the significant improvement in the resolution of the map of the polymerase 
module.  
 
 2D clean up and 3D classification
(460,167 particles)
Particle polishing
3D Refinement
3D Classification
3.6 Å
50,283 particles
4.1 Å
77,917 particles
3.5 Å 
11 % 3 % 10 % 3 % 17 % 9 % 31 % 12 % 3 % 5 %
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Figure 2.14: Resolution assessment of the polymerase module and orientation 
distribution of the particles in the final map. (a) Fourier shell correlation plots for gold 
standard refinements and model vs. map. Fourier shell correlation plots for model 
refined against each half map.  The final map of the polymerase module at 3.5 Å 
resoluton. (b) The local resolution map shows that the resolution varies from ~ 3.4 Å 
at the core to ~ 4 Å at the surface. (c) Orientation distribution of 77,917 particles 
used in the final model, calculated using RELION (Scheres 2012) and visualized with 
Chimera (Pettersen et al. 2004). 
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2.4 Analysis of the cryo-EM structure of Cft1-Pfs2-Yth1 
 
2.4.1 Atomic model of the polymerase module 
 
The improved resolution of the map allowed regions of electron density to be 
interpreted, as side chains from alpha helices (Figure 2.15a) and beta strands (Figure 
2.15b) could be clearly identified, particularly in the core of the complex. Homology 
models of Cft1 and Pfs2 from Phyre (Kelley et al. 2015), along with the crystal 
structures of DDB1 and DDB2, were used as templates to build the full, de novo, atomic 
model of the polymerase module. After modeling the Cft1 and Pfs2 subunits into the 
density map, the shape of the unmodeled density (shown in pink in Figure 2.15c) 
resembled that of a zinc finger protein. It is known that the Yth1 subunit consists of five 
zinc fingers (Barabino et al. 1997; Tacahashi, Helmling, and Moore 2003) and the 
crystal structure of the zinc finger domains two and three of CPSF30 has been 
determined (Das et al. 2008). Molecular replacement (performed by Alan Brown from 
the Ramakrishnan group) with the CPSF30 structure enabled the unambiguous 
identification of the unassigned density as that of Yth1. Appendix 8.4 details all the data 
collection and refinement statistics.  
 
This model represents the first high-resolution structure available for the eukaryotic 3′-
end processing complex. The cryo-EM map colored according to the subunit 
assignment and the corresponding model are shown in Figure 2.15c and Figure 2.15d 
respectively. The overall architecture of the polymerase module involves four beta 
propellers with two zinc fingers anchored on the side (Figure 2.15c). In the cryo-EM 
map, residues 1–1356 of Cft1, 27–414 of Pfs2 and 1–97 of Yth1 were well ordered and 
modeled. However, zinc fingers three, four, and five, and the C-terminal end of Yth1, 
along with the whole of Fip1, could not be modeled. Also not visible were several loops 
in Cft1. This is likely because those regions are disordered, as confirmed by 
bioinformatic predictions (appendix 8.5). The predicted disordered regions in the yeast 
proteins are predicted to be disordered in humans as well. For example, the C-terminus 
of Pfs2 (residues 412–465) that is not visible in the cryo-EM map is predicted to be 
disordered. Similarly, the human orthologue WDR33 contains a poorly conserved and 
disordered C-terminal region. Interestingly, this C-terminal disordered region in Pfs2 is 
not required for viability of yeast (Ohnacker et al. 2000).  
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Figure 2.15: Atomic model of the Cft1-Pfs2-Yth1 subunits of the polymerase 
module. (a) Example density for an alpha helix in Pfs2. (b) Example density for a beta-
strand in Cft1. (c) Cryo-EM map and (d) cartoon representation of the atomic model 
of the Cft1–Pfs2–Yth1 complex of the polymerase module. Yth1 (magenta), Pfs2 
(yellow), Cft1 (green), and zinc ions (pale cyan) are depicted. The three β-propeller 
domains of Cft1 (BP1, BP2, and BP3) are colored in different shades. 
 
Cft1 is a multi-domain protein that consists of three seven-bladed beta propellers 
followed by a C-terminal helical domain (Figure 2.15c and Figure 2.16a), forming the 
core of this three-subunit polymerase complex. Beta propeller (BP) 1 and BP2 are each 
formed of contiguous sequences. Notably, the density for BP2 was less well defined 
compared to BP1 and BP3, and it appeared to be more flexible (Figure 2.16a). BP3 is 
made up of residues mainly from the C-terminal region, but also contains one beta 
strand from the N-terminus, and three beta strands from the middle of Cft1, creating a 
rigid structural core (Figure 2.15d). A helical domain at the C-terminus of Cft1 is 
(a) (b)
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located at the nexus of the three beta propellers, further securing the fold (Figure 2.15d). 
BP1 and BP3 interact with each other at a ~60° angle, forming a deep cavity.  
 
Pfs2 consists of an N-terminal alpha helix followed by a central WD40 domain (Figure 
2.15d). This WD40 is made up of a seven-bladed beta propeller (Figure 2.16a). The C-
terminal end in the model of Pfs2 consists of a loop protruding out of the last blade of 
the WD40 and lies adjacent to a loop in the N-terminal end of the model (Figure 
2.16.A).  
 
Yth1 is an RNA binding protein containing five zinc fingers. An N-terminal loop and 
the first two zinc fingers of Yth1 are found to lie next to the BP2 of Cft1 and the WD40 
domain of Pfs2 (Figure 2.15d). 
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2.4.2 Interaction of Pfs2 with Cft1 
 
Previous nanoESI-MS data from our lab had reported a strong direct interaction 
between Cft1 and Pfs2 (Easter 2014; Casañal et al. 2017b). In agreement with this, the 
surface area of the interaction interface between Pfs2 and Cft1 is >4,200 Å2 (Figure 
2.16b). Almost 50 amino acids in the N-terminal region of Pfs2 are inserted into a deep 
cavity between BP1 and BP3 of Cft1. The alpha helix in this region of Pfs2 is likely 
stabilized by its interaction with Cft1 (Figure 2.16b). The WD40 domain of Pfs2 sits on 
top of Cft1, with the loops extending from BP1 and BP3 cradling Pfs2 to further 
stabilize the interaction. Many of the interacting residues between Pfs2 and Cft1 are 
conserved in the human orthologs CPSF160 and WDR33 (appendix 8.6).  
 
 
 
 
 
Figure 2.16: Interaction between the Cft1 and Pfs2 subunits of the polymerase 
module. (a) The three beta propellers from Cft1 are shown in ribbon diagram where 
the entire Cft1 chain is colored in rainbow from N- to C-terminus. Pfs2 is shown as 
ribbon diagram, colored in rainbow from N- to C-terminus. (b) Cartoon 
representation of the atomic model of the Cft1–Pfs2–Yth1 complex of the polymerase 
module.  The N-terminal α-helix of Pfs2 inserts into the cavity formed between the β-
propeller BP1 and BP3 of Cft1. Inset: details of the interaction between Cft1 and Pfs2.  
The residues involved in the interaction that are also conserved in humans are 
highlighted in orange. Yth1 (magenta), Pfs2 (yellow), Cft1 (green), and zinc ions (pale 
cyan) are depicted.   
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2.4.3 Interaction of Yth1 with Cft1 and Pfs2 
 
Yth1 latches onto the Cft1-Pfs2 complex by inserting its N-terminal extended region 
into the central cavity of Cft1s BP3, and continues across a hydrophobic external face 
(Figure 2.17a). A surface representation of the structure reveals a hydrophobic patch in 
the interaction interface in Cft1 as well as a corresponding hydrophobic Yth1 surface, 
showing that the interaction is driven by hydrophobic effects (Figure 2.17b and Figure 
2.17c). In agreement with the importance of the N-terminus for interaction with CPF, 
deletion of the first 25 residues in Yth1 results in a slow growth and temperature 
sensitive phenotype in yeast (Barabino, Ohnacker, and Keller 2000b).  
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Figure 2.17: Interaction between the BP3 of Cft1 and N-terminal loop of Yth1 
subunits of the polymerase module. (a) Cartoon representation of the atomic model 
of the Cft1–Pfs2–Yth1 complex of the polymerase module.  An N-terminal loop in 
Yth1 inserts into the β-propeller BP3 of Cft1.   Selected electrostatic and hydrophobic 
interactions between the N-terminal loop and BP3 are depicted in the inset.  (b) 
Cartoon representation and the corresponding hydrophobic surface representation of 
Cft1-Pfs2 subunits showing a hydrophobic surface at the Yth1 interacting surface.  (c) 
The hydrophobic surface rendering of Yth1 reveals a lining of hydrophobic residues 
that interacts with the BP3 of Cft1.  Yth1 (magenta), Pfs2 (yellow), Cft1 (green), and 
zinc ions (pale cyan) are depicted.    
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The first two of the five Cys-Cys-Cys-His (CCCH) zinc fingers pack into the interface 
between Cft1 and Pfs2 (Figure 2.18). Zinc finger 1 (ZnF1) lies adjacent to Cft1-BP3, 
and second zinc finger (ZnF2) contacts both Cft1 and the side of the Pfs2 beta propeller. 
Furthermore, it has been shown that ZnF2 can directly bind RNA (Barabino, Ohnacker, 
and Keller 2000b; Tacahashi, Helmling, and Moore 2003; Chan, Huppertz, Yao, Weng, 
Moresco, Yates, et al. 2014).  A previous study showed that mutation of Yth1-W70 to 
alanine causes Yth1 to dissociate from CPF (Barabino, Ohnacker, and Keller 2000a). In 
the structure, it can be seen that W70 forms pi-stacking interactions with the zinc-
coordinating H85 in ZnF2 (Figure 2.18). Disruption of this interaction by mutating the 
tryptophan to alanine may destabilize zinc binding, and hence the interaction of Yth1 
with the other subunits. 
 
 
 
Figure 2.18: Yth1 harbors a CCCH zinc finger repeat. The first two of the five zinc 
fingers of Yth1 are displayed.  The zinc fingers belong to the CCCH family and pack 
into the interface between Cft1 and Pfs2. The residue -W70 of Yth1 ZnF2 pi stacks 
with Yth1-H85 and stabilizes the zinc finger fold. Also shown are the hydrogen-
bonding interactions between side chains of Pfs2 and backbone atoms of Yth1.  Yth1 
(magenta), Pfs2 (yellow), Cft1 (green), and zinc ions (pale cyan) are depicted.  
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2.4.4 Polymerase module has a similar architecture to DDB1-DDB2 / SF3b 
 
The characteristic four-beta propeller arrangement of the polymerase module is very 
similar to other nucleic acid binding protein complexes such as DDB1-DDB2 and SF3b 
(Figure 2.19a) (Scrima et al. 2008; Cretu et al. 2016). DDB1-DDB2 is a complex that 
recognizes UV-damaged DNA, and acts as an adapter for a cullin-RING E3 ubiquitin 
ligase to trigger nucleotide excision repair (Scrima et al. 2008; Li et al. 2006). DDB1 
has three beta propellers in a tripartite arrangement reminiscent of the Cft1 (Figure 
2.19). Superposition of Cft1 onto the structure of DDB1 revealed an RMSD of 7.53 Å 
(Figure 2.19b). Despite not displaying significant sequence homology, DDB2 is 
strikingly similar to Pfs2 (RMSD = 3.3 Å) with an N-terminal alpha helix that inserts 
into the cavity between BP1 and BP3 of DDB1, followed by a WD40 domain.  
 
 
 
 
 
Figure 2.19: Structural comparison of Cft1-Pfs2-Yth1, DDB1–DDB2 DNA repair 
and SF3b splicing complexes. (a) Cft1, DDB1 and Rse1 contain three beta-propellers 
followed by a C-terminal alpha helical domain. DDB2 interacts with DDB1 by inserting 
an N-terminal alpha-helix into the cavity between two beta-propellers of DDB1, very 
similar to how Pfs2 interacts with Cft1 (highlighted by a square with dotted red lines). 
In SF3b, helical regions of Hsh155 and Rds3 inserts between the cavity between the 
beta-propellers of Rse1. (b) Structural superimposition of the structures of DDB1-
DDB2 and Cft1-Pfs2. [PDB of DDB1-DDB2: 3ei3, PDB of Sf3b: 5gm6] 
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SF3b is part of the U2snRNP complex essential for pre-mRNA splicing and plays a key 
role in branch site recognition. The scaffolding protein Rse1/SF3b130 forms the core of 
the SF3B complex (Yan et al. 2016; Plaschka, Lin, and Nagai 2017). Similar to the fold 
of Cft1, Rse1 also contains three beta-propellers followed by a C-terminal alpha helical 
domain. In SF3b, two predominantly helical subunits (Hsh155 and Rds3) insert into the 
cavity formed between the two beta propellers of Rse1 and additionally bind another 
protein Cus1 (Figure 2.19a). 
 
In summary, DDB1-DDB2, SF3b, and CPF all use a tripartite scaffold protein (DDB1, 
Rse1 or Cft1) to assemble a rigid and structurally stable complex. Although the core 
scaffolding proteins DDB1, Rse1 and Cft1 share low sequence homology (~15% 
sequence identity), they are highly structurally similar. Furthermore, their interaction 
partners (DDB2, Hsh155/Rds3 or Pfs2) inserts an N-terminal alpha helix into a cavity 
between BP1 and BP3, but the exact interaction mechanism is not conserved. These 
structural similarities may suggest that these complexes are evolutionarily related and 
adapted for different nucleic acid binding and processing complexes. The complexes 
also contact other binding partners through their beta propellers (e.g. DDB1-BP2 binds 
cullin-RING proteins). Similarly, Cft1 may contact other CPF subunits through the beta 
propeller domains. 
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2.4.5 A potential RNA binding surface on Pfs2 
 
Using iCLIP experiments, previous studies have shown that WDR33 can directly bind 
RNA. Furthermore, numerous biochemical experiments support the RNA binding 
property of ZnF2 of Yth1. Interestingly, the aforementioned complexes that are similar 
to the polymerase module also directly bind nucleic acids. In the SF3b complex, 
subunits Hsh155 and Cus1 are known to contact RNA. On the other hand, the DDB2 
substrate receptor of DDB1-DDB2 complex directly binds UV-damaged DNA lesions. 
A hairpin on the top surface of the beta propeller of DDB2 (rich in basic amino acid 
residues) extends into the minor groove of DNA, pushing the damaged base into a 
binding pocket. Similarly, the equivalent surface on Pfs2 contains a cluster of conserved 
lysine, arginine and aromatic residues that could form a putative RNA binding surface 
(Figure 2.20a). The electrostatic surface potential of the polymerase module reveals a 
patch of positively charged residues on top of Pfs2 and on the ZnF2 of Yth1 that lies 
adjacent to Pfs2 (Figure 2.20b). Together, the Pfs2 top surface and the ZnF2 of Yth1 
could provide a composite RNA binding platform. A previous study implicated the 
central region (residues 586 - 749) of Cft1 in contacting RNA directly (Dichtl et al. 
2002). This region lies within the BP2 of Cft1 in the cryo-EM structure. Visualization 
of the electrostatic surface potential of BP2 revealed a positively charged patch enriched 
in lysine, phenylalanine, and arginine (Figure 2.20c).   
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Figure 2.20: Potential RNA binding regions in Cft1–Pfs2–Yth1 complex of the 
polymerase module. (a) The top region of Pfs2 has several surface exposed lysines, 
arginines, histidines and phenylalanines.  The putative RNA binding residues in Pfs2 are 
also conserved across 35 Pfs2 orthologs. (b) Electrostatic surface potential of the 
Cft1–Pfs2–Yth1 reveal a patch of positively charged residues on top of Pfs2 and around 
zinc finger 2 of Yth1. (c) The region in BP3 of Cft1 previously shown to bind RNA 
(Dichtl and Keller 2001) is coloured in blue in the surface representation. Interestingly, 
electrostatic surface potential reveal a stretch of positively charged residues in BP3 
that might potentially contact RNA. Electrostatic surface potential is plotted onto the 
solvent-accessible surface (blue is positive, red is negative, in the range ± 5 kT/e). 
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2.4.6 Comparing the structures of the yeast and human polymerase module 
subunits 
 
The cryo-EM structure of the human equivalent of the polymerase module bound to an 
AAUAAA-containing RNA was recently determined (Sun et al. 2018; Clerici et al. 
2018, 2017). The structure revealed four beta propellers in a tripartite arrangement 
similar to Cft1-Pfs2. Structural alignment of the human polymerase components with 
the yeast subunits revealed a high degree of similarity (Figure 2.21b). In contrast to the 
structure of the yeast polymerase module, the RNA-bound structure also contained the 
third zinc finger of CPSF30 in addition to ZnF1 and ZnF2 (Figure 2.21a). It is likely 
that the presence of RNA makes ZnF3 less flexible, allowing the zinc finger to be 
visualized. The structures also reveal that the ribophosphate backbone of the RNA 
substrate adopts an S-shaped structure. The residues A1, A4, and A5 in AAUAAA 
make base specific contacts with residues in CPSF30 and WDR33 (Figure 2.21c). 
Interestingly, these amino acid residues are also conserved in Yth1. Of note, U3 and A6 
form a non-canonical Hoogsteen base pair, and are sandwiched by π- π stacking 
between F153 and F43 of WDR33 (Figure 2.21d). Nonetheless, the residue F43 is not 
conserved in Pfs2, providing a potential explanation for why yeast-positioning elements 
differ from the human AAUAAA.   
 
In summary, the human structure bound to RNA provides insights into the molecular 
mechanism behind how AAUAAA is specifically recognized by the human polymerase 
module. Moreover, it also suggests how the yeast and human machinery, despite having 
a similar overall architecture, might have distinct structural features that are involved in 
RNA recognition.  
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Figure 2.21: Structure of the human polymerase module. (a) Overall structure of 
CPSF160 - WDR33- CPSF30 bound to an AAUAAA containing RNA (b) Structural 
alignment of the polymerase module subunits from humans and yeast (c) AAUAAA 
recognition by CPSF30 and WDR33 (d) U3 and A6 forms a Hoogsteen base pair and 
is sandwiched between F153 and F43 of WDR33. CPSF160 in smudge, WDR33 in 
wheat, CPSF30 in dirty violet, RNA in pink and zinc ions in grey.   
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2.4.7 A mechanism for disruption of mRNA 3' end processing by influenza 
protein NS1A  
 
It is known that the influenza viral protein NS1A binds to host CPSF30 and inhibits the 
production of antiviral mRNAs. Shutting down normal host 3' end processing is also 
beneficial to the viral life cycle. A crystal structure of the C-terminal domain of the 
NS1A protein bound to human CPSF30 reveals the molecular details of this interaction, 
including a conserved CPSF30 binding pocket in NSIA (Das et al. 2008). Although it is 
known that NS1A blocks RNA binding by CPSF30, the exact molecular mechanism 
behind this remains unclear. The high sequence and structural similarities between the 
human and yeast polymerase module subunits enabled us to hypothesize how NS1A 
hijacks the 3' end processing machinery. Superposing the crystal structure of CPSF30-
NS1A CTD on the Cft1-Pfs2-Yth1 cryo-EM structure revealed that NS1A may dislodge 
Yth1/CPSF30 from Pfs2/WDR33, as binding of Yth1/CPSF30 to NS1A is mutually 
exclusive with binding to Pfs2/WDR33. Furthermore, NS1A binding could obstruct the 
proposed composite RNA binding site on the polymerase module (Figure 2.22). 
Interestingly, the N-terminal RNA binding domain (NRD) is connected to the C-
terminal domain via a flexible linker. It is plausible that, upon binding the polymerase 
module, NRD of NS1A could sequester the host mRNA and hence result in inhibition 
of mRNA processing. 
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Figure 2.22: NS1A hijacks the 3'-end processing machinery. Docking the crystal 
structure of a complex of the influenza protein NS1A with the zinc fingers 2 and 3 of 
human CPSF30 into the polymerase module structure. The zinc finger 2 of CPSF30 and 
Yth1 superpose well on top of each other (yeast and human structures superimposed 
in magenta and orange, respectively). Yth1 (magenta), CPSF30 (orange), NS1A (light 
purple), Pfs2 (yellow), Cft1 (green), and zinc ions (dark grey) are depicted.    
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2.5 Pap1 is flexibly tethered to the polymerase module 
 
The cryo-EM structure of the Cft1-Pfs2-Yth1 complex reveals for the first time how the 
RNA binding subunits of the polymerase module are arranged in 3D space. However, 
we don't yet have a detailed understanding of how Pap1 associates with the polymerase 
module and how the interaction influences its function. In order to characterize the 
molecular topology of polymerase module and its interconnection with Pap, I used an 
integrative structural biology approach as described below.  
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2.5.1 Cryo-EM demonstrates the flexible association of Pap1 
 
In order to understand how Pap1 interacts with the polymerase module, I studied the 
“peak 1” fraction containing polymerase module (with Pap1) by cryo-EM (Section 
3.1.1). This fraction was predicted to have one stably-associated Pap1 subunit (Sections 
3.1.1 and 3.2.1). Cryo-EM micrograph of polymerase module containing Pap1 shows 
well-separated, homogeneous particles (Figure 2.23a). 2D classification revealed 
polymerase module class averages with high resolution-information; in particular, the 
central Cft1-Pfs2-Yth1 core of the polymerase module is clearly visible (Figure 2.23b). 
Interestingly, some 2D classes (red) contain an additional horseshoe shaped density, 
characteristic of the structure of Pap1. Such a characteristic density is seen in the 2D 
projection of the 3D crystal structure of Pap1 (blue) (Figure 2.23c). Interestingly, Pap1 
appears to be flexible with respect to the central Cft1-Pfs2-Yth1 density, as it is not 
found at a consistent location relative to the central core. Comparison of the 2D class 
averages of the polymerase module with and without Pap1 further supports the flexible 
nature of Pap1 (Figure 2.23d).  
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Figure 2.23: Cryo-EM analysis of the polymerase module containing Pap1. (a) 
Representative micrograph of the polymerase module containing Pap1. (b) Selected 
2D class averages showing high-resolution secondary structural details and a variety of 
views.  (c) A characteristic horseshoe shaped Pap1 density is seen near the 
polymerase module. The 2D classes reveal that Pap1 is flexibly tethered to the 
polymerase module (shown by blue arrow). (d) Comparing 2D classes with similar 
views of polymerase module without Pap1 and with Pap1. 
 
Unfortunately, only ~ 0.5 % of all particles contained additional density that 
corresponds to Pap1. It is possible that Pap1 is present in other particles but is obscured 
by the core of the polymerase module. Alternatively, the flexibility of Pap1 could mean 
that most particles containing Pap1 do not average together to yield a 2D class with 
clear Pap1 density. Another possible explanation could be that Pap1 interaction is 
disrupted by the sample preparation process. In order to overcome the problem of Pap1 
flexibility, I crosslinked the polymerase module containing two Pap1 subunits using 
BS3. The polymerase module containing two Pap1 subunits was used as the 
concentration of Pap1 would be higher in the sample, increasing the probability of 
obtaining Pap1-associated polymerase module. The cross-linked sample was further 
purified on a size exclusion column (Figure 2.24a) and eluted fractions were analyzed 
by tris-acetate PAGE (Figure 2.24b). The chromatogram revealed that the un-
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crosslinked and crosslinked samples were eluted at the same volume, suggesting that 
crosslinking did not result in the aggregation or formation of oligomers of the 
polymerase module.  
 
I studied the crosslinked sample by cryo-EM. Cryo-EM micrographs of the cross-linked 
polymerase module (with two Pap1s) showed significantly bigger particles (Figure 
2.24c). 2D classification of selected particles resulted in class averages containing high-
resolution information. Upon further analysis, the 2D class averages appear to consist of 
a dimer of the polymerase module (red arrows in Figure 2.24d). The 2D classes also 
contain density that was not well resolved  (blurred density) at different positions along 
the polymerase module (green arrows in Figure 2.24d). Similar to the un-crosslinked 
sample, it is possible that Fip1 and Pap1 are present at different positions with respect to 
the core of the polymerase module, resulting in their densities being averaged out 
during 2D classification. 
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Figure 2.24: Cryo-EM analysis of cross-linked polymerase module containing two 
Pap1s. (a) Size exclusion chromatography of the cross-linked polymerase module with 
two Pap1s.  The sample runs at similar elution volume compared to the un-crosslinked 
complex.  (b) Tris-acetate-PAGE of cross-linked polymerase module containing two 
Pap1s.  The high molecular band at ~ 330 kDa contains cross-linked polymerase 
module.  * represents a possible Cft1 degradation band. (c) Representative micrograph 
of a cross-linked sample of the polymerase module containing Pap1. (d) Selected 2D 
class averages showing high-resolution secondary structural details and a variety of 
views. Red arrow indicates possible polymerase module dimers. Green arrow indicates 
an extra region of fuzzy density. 
 
Thus, preliminary cryo-EM analysis suggests that Fip1 and Pap1 are flexible relative to 
the stable polymerase module core. Further biochemical optimization is likely required 
before further analysis of the Pap1-bound polymerase module by cryo-EM. 
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2.5.2 Cross-linking mass spectrometry reveals extensive inter-subunit interaction 
 
In order to interrogate the architecture of a Pap1-bound polymerase module, the 
complex (with and without Pap1) was crosslinked using BS3, which covalently links 
lysines, serines, threonines or tyrosines that are within 27 Å of each other. The observed 
inter- and intra-molecular crosslinks were in agreement with the atomic models for 
Cft1, Yth1 and Pfs2 (Figure 2.25a, appendix 8.7). The intra-molecular cross-links found 
within Pap1 are also consistent with the crystal structure of Pap1 (Bard et al. 2000) 
(Figure 2.25a).  
 
 
 
 
Figure 2.25: Cross-linking mass spectrometry of the polymerase module. (a) Lysine- 
lysine intra- (red) and inter- (blue) protein cross-links were mapped onto the cryo-EM 
structure of Cft1–Pfs2–Yth1 and the crystal structure of Pap1 (PDB:2Q66). The cross- 
link marked with an asterisk is 33 Å, but has a similar xQuest (Leitner, Walzthoeni, 
and Aebersold 2014) score to other validated cross-links and appears reasonable upon 
inspection of the structure. Lysine-lysine cross-links between Pap1 and polymerase 
module are shown in grey. (b) Linkage map showing all identified lysine-lysine 
crosslinks. Intermolecular cross-links are shown in blue; intramolecular in red and the 
cross-links that could not be mapped on any available 3D structures are shown by a 
dotted line. 
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Inspection of the crosslinking data revealed that Fip1 K219 crosslinks to Yth1 K182, 
K191 and K196 (Figure 2.25b), in agreement with previous work where Fip1 residues 
206–220 were shown to bind to the C-terminal half of Yth1 (Barabino, Ohnacker, and 
Keller 2000b; Helmling, Zhelkovsky, and Moore 2001; Tacahashi, Helmling, and 
Moore 2003). Fip1 also crosslinks with the polymerase domain of Pap1 (Figure 2.25b). 
A previous crystallographic study has identified the C-terminal domain of Pap1 as Fip1 
binding (Meinke et al. 2008). Interestingly, Pap1 crosslinked with all other polymerase 
module subunits, including Fip1, the C-terminal helical domain of Cft1, zinc finger 1 of 
Yth1, and the C-terminal region of Pfs2. This agrees with previous data suggesting a 
close association of Pap1 with Cft1 and Fip1 (Easter 2014), and with previous literature 
(Murthy and Manley 1992; Meinke et al. 2008). It is likely that the observed crosslinks 
of Pap1 with all subunits of polymerase module reflects the flexibility of Pap1 relative 
to the central core, and that chemical cross-linking captures the transient interactions of 
Pap1. Thus suggesting that the Pap1 interface with the complex is more extensive.  
 
Thus, the data obtained by crosslinking mass spectrometry support both our model of 
the polymerase module core, as well as previous models of how Fip1 and Pap1 are 
associated with the complex (Ezeokonkwo et al. 2011; Helmling, Zhelkovsky, and 
Moore 2001; Tacahashi, Helmling, and Moore 2003; Barabino, Ohnacker, and Keller 
2000a; Barabino et al. 1997). The promiscuous crosslinking of Pap1 also supports my 
observation that Pap1 appears to be flexible relative to the polymerase module core. 
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2.5.3 Pull downs reveal the molecular topology of  the polymerase module 
 
To clarify the nature of the interaction of Pap1 with the polymerase module core, and to 
dissect the contributions of Fip1 and Yth1 to this interaction, I carried out pull-downs of 
the polymerase module containing truncated versions of Fip1 and Yth1. The truncations 
include deletion of the C-terminal 91 residues in Yth1 (referred to as Yth1 ΔZnF45C), 
residues 145 - 170 in Fip1 (referred to as Fip1Δ145-170), and the potential Yth1 
binding region in Fip1 (referred to as Fip1 Δ180-220) (Figure 2.26a).  
 
 
 
 
Figure 2.26: Physical interactions linking Pap1 to the polymerase module. (a) A 
cartoon representation of the various mutants that were employed in the pull downs.  
The red region in Fip1 highlights the potential interaction interface with Yth1. (b) Pull 
down assay of polymerase module constructs harboring truncations in Fip1 and Yth1.  
The polymerase module pull downs were carried via the S-II tag on Pfs2 subunit using 
streptavidin resin and the elution was analyzed by SDS-PAGE.   
 
All polymerase module constructs were expressed in Sf9 insect cells using baculovirus-
mediated insect cell over-expression. Streptavidin pull downs were performed using the 
Strep-II tag in the Pfs2 subunit and the isolated complex from Sf9 cell lysate was 
analyzed on SDS-PAGE (Figure 2.26b). As expected, the elution fraction from the wild 
type complex contains all five polymerase subunits. However, deletion of the C-
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terminal 91 residues in Yth1 yields a polymerase module complex without any Fip1 or 
Pap1 (Figure 2.26b). Similarly, deletion of Fip1 residues 180-220 did not pull-down 
Fip1 or Pap1 (Figure 2.26b). Interestingly, deletion of Fip1 residues 145-170 did not 
affect association of Fip1 or Pap1 with the complex (Figure 2.26b). A recent study on 
the human polymerase complex also identified a conserved domain in FIP1 that 
associates with the polymerase module via its interaction with ZnF45 of CPSF30 
(Clerici et al. 2018). In agreement with this, the residues 180-220 of yeast Fip1 lie 
within this conserved domain in FIP1 whereas the residues 145-170 lie outside this 
domain. 
 
In summary, pull-down experiments have revealed the molecular requirements of Yth1, 
Fip1, and Pap1 association with the polymerase module core. Specifically, the C-
terminal 91 residues of Yth1 and a central region of Fip1 (180-220) appear to be 
necessary for the stable association of Fip1 and Pap1 to the polymerase module core. 
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2.5.4 Fip1 directly contacts Zinc finger 4 of Yth1  
 
Previous nanoESI-MS studies from the lab discovered that endogenous CPF purified 
from S. cerevisiae contains multiple copies of Pap1 (Casañal et al. 2017b). Similarly, 
the recombinantly expressed and purified polymerase module consisted of three variants 
containing two, one, or no copies of Pap1 (Figure 2.2b and Figure 2.5). While the Pap1 
binding site in Fip1 has been well characterized and lies within residues 90-105 
(Helmling, Zhelkovsky, and Moore 2001), it remains unknown where the additional 
copy of Pap1 binds in the complex containing two copies. Furthermore, nanoESI-MS 
data also revealed that CPF containing two copies of Pap1 always contained two copies 
of Fip1 (Casañal et al. 2017b). It is therefore plausible that Yth1 harbors two binding 
sites for Fip1. In order to investigate the molecular details of the Fip1-Yth1 interaction, 
I used NMR spectroscopy in collaboration with Conny Yu.   
 
 
 
 
Figure 2.27: Characterization of a minimal interaction surface between Yth1 and 
Fip1. (a) Schematic for the formation of a minimal Yth1-Fip1 complex.  A construct of 
Yth1 ZF45 with a N-terminal GST tag and a construct of the residues 180-220 of Fip1 
with an N-terminal GST tag are mixed, the GST tags are cleaved by the use of 
precission protease, and the mixture is subjected to size exclusion chromatography. 
(b) Size exclusion chromatogram (HiLoad 26/600 Superdex 200 pg) of a complex of  
ZF 4 and 5 of Yth1, with residues 180 - 220 of Fip1.  (c) SDS -PAGE of the peak 
fraction reveals a stoichiometric complex formation. 
 
Fip1 residues 180-220, which were shown to be important in tethering Fip1 to the 
polymerase module core (Section 3.5.3), were fused to an N-terminal GST tag. The 
ZnF45 of Yth1 were separately fused to an N-terminal GST tag. These two protein 
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constructs were overexpressed in E. coli and purified by affinity chromatography. 
Purified GST-Fip1 180-220 was then mixed with purified GST-Yth1 ZnF45, and the 
GST tags on the two proteins were cleaved (Figure 2.27a). The resulting sample was 
subjected to size-exclusion chromatography to resolve the cleaved GST and the 
remaining proteins (Figure 2.27b). Analysis of the three resulting peaks by SDS-PAGE 
revealed that the first peak contained GST alone, the second contained a complex of 
Fip1 180-220 and Yth1 ZnF45, and the third contains excess Yth1 ZnF45 (Figure 
2.27c). SEC-MALS analysis revealed that this was a 1:1 complex with one copy of 
Yth1 ZnF 45 bound to one copy of Fip1 180-220 (appendix 8.8).  
 
 
 
 
Figure 2.28: Yth1 ZnF 45C shows major chemical shift perturbation upon Fip1 
binding. (a) Overlay of 1H-15N 2D BEST-TROSY spectra of Yth1 (118-208) in its free 
from (blue) and upon adding Fip1 (180-220) addition. Fip1 was added in equal molar 
ratio (red) and in 2:1 excess (yellow). The labelled cross-peaks showed the backbone 
assignment of free Yth1. (b) Weighted chemical shift perturbation in (a) was mapped 
against residue number of Yth1. The identity of cross-peaks in Yth1/Fip1 spectrum was 
determined by mapping and partial assignment. Cross-peaks with line broadening upon 
Fip1 addition was indicated with a blue bar. (c) Sequence of Yth1 (118-170) and Yth1 
(118-208) and secondary structure of free Yth1 (118-208) calculated by TALOS (Shen 
et al. 2009) based on chemical shifts of Cα, Cβ and CO.   
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Crosslinking mass spectrometry of the polymerase module had identified crosslinks 
between Fip1 and the C-terminus of Yth1 (after ZnF45) (Figure 2.25.B, appendix 8.7). 
Thus, I hypothesized that the C-terminal ~50 residues after ZnF5 could also associate 
with Fip1, providing a second binding site. NMR spectroscopy was used to map the 
residues in Yth1 involved in Fip1 binding.  
 
Backbone assignment of Yth1 ZnF45C (residues 188-208) was carried out using a 13C, 
15N labeled sample at 278K to achieve a complete assignment. The assignment was then 
transferred to 298K for binding studies at this temperature. Major chemical shift 
perturbations were observed in Yth1 ZnF domain 4 (residues 122-160) upon the 
addition of equal molar Fip1 180 - 220, with weighted chemical shifts larger than 0.1 
ppm. The largest chemical shift differences occur in 124-131, which coincides a helical 
region identified from secondary structure calculations based on chemical shifts. It is 
speculated that upon Fip1 binding, there is a significant change in the chemical 
environment around Yth1 residues 124-131, highlighting that these residues may be 
essential for Yth1/Fip1 interactions.  
 
To address the stoichiometry of Yth1/Fip1 complex, excess Fip1 180 - 220 was titrated 
into Yth1 ZnF45C and no further perturbation of chemical shifts were observed. This 
concludes that there is no second binding site for Fip1 180 - 220 on Yth1 ZnF45C, and 
it agrees with SEC-MALS data that two proteins bind in 1:1 stoichiometry.  
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2.6 Discussion   
 
In order to biochemically and structurally characterize the polymerase module, I 
established protocols for the recombinant expression and purification for the protein 
complex. In vitro reconstitution of the polyadenylation reaction with pure components 
revealed that the polymerase module surprisingly had similar activity compared to the 
individual polymerase (Figure 2.6 and 3.7). Moreover, Pap1 appeared to add longer 
poly(A) tails compared to the polymerase module. As previously mentioned, this is in 
contrast to previous findings in humans where the polymerase module is efficient and 
specific in polyadenylation in comparison to PAP (Schönemann et al. 2014), likely due 
to an increased RNA binding affinity (~2 nM) for an AAUUAA-containing RNA 
(Clerici et al. 2018; Sun et al. 2018) relative to PAP. From the EMSAs performed in 
this chapter, the apparent affinity of the yeast polymerase module for CYC1 RNA is 
between 500 nM to 1 µM (Figure 2.8). Therefore, the relatively low affinity of the 
polymerase module for RNA provides an explanation for why its activity is not higher 
than that of Pap1 alone. Compared to an in vivo scenario, it is likely that the yeast 
complex is missing additional RNA binding surfaces from other CPF subunits or 
cleavage factors. The association of the polymerase module with additional RNA 
binding proteins may stimulate polyadenylation activity, in comparison with Pap1 
alone. Further experiments addressing this question are described in Chapter 3. 
Interestingly, the yeast polymerase module bound the adenovirus L3 RNA with lower 
affinity in EMSAs (Figure 2.8). Therefore, it is seen that the RNA binding subunits 
within the polymerase module can impart a degree of specificity to the complex. The 
recombinant production of high amounts of polymerase module described in this 
chapter will now allow us to perform biophysical experiments to characterize the 
kinetics of RNA binding and the implication on polyadenylation, relative to the isolated 
polymerase. Furthermore, other yeast RNAs with less idealized efficiency, positioning, 
and U-rich elements should be tested in polyadenylation and binding assays. This will 
allow us to observe whether the low affinity, distributive activity is conserved among 
other RNA species. 
 
The cryo-EM structure of Cft1-Pfs2-Yth1 subunits revealed, for the first time, the 
overall architecture of the polymerase module and the interactions between the three 
proteins. Cft1 and Pfs2 share an extensive interaction surface; most notably, an N-
terminal alpha helix of Pfs2 insets into a cavity formed between two beta propellers in 
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Cft1 (Figure 2.16). An N-terminal loop of Yth1 inserts into the cavity of one of the beta 
propellers of Cft1, anchored by several ionic as well as hydrophobic interactions (Figure 
2.17). The first two zinc fingers in Yth1 also associate at the interface of Cft1 and Pfs2. 
Furthermore, the structure validates previous biochemical and genetic data highlighting 
the importance of the amino acid regions, which we show to be important in inter-
protein interactions (Ohnacker et al. 2000; Barabino, Ohnacker, and Keller 2000b; 
Tacahashi, Helmling, and Moore 2003). The structure of the polymerase module has 
also revealed that the complex forms a structural platform for other polymerase module 
subunits, bringing together the flexibly tethered Fip1 and Pap1 as well as, potentially, 
RNA, via a composite binding surface formed by ZnF23 and the top of the Pfs2 beta 
propeller domain (Figure 2.29b). 
 
During the course of this study, the structure of the human CPSF160-WDR33-CPSF30 
was reported (Sun et al. 2018; Clerici et al. 2018, 2017). The yeast and the human 
complexes share a high degree of structural and sequence similarity (Figure 2.21). The 
structure of the human complex was determined in complex with RNA, thus providing 
molecular insight into how the mammalian poly(A) site AAUAAA is recognized by 
CPSF. The structure also provides a potential explanation for why the yeast RNA 
positioning element does not contain AAUAAA and is more degenerate compared to 
mammalian elements. The structure of the yeast polymerase module bound to RNA will 
provide further insights into RNA recognition and enable better understanding of the 
difference between the yeast and human RNA cis-elements. 
 
Intriguingly, the structure of Cft1-Pfs2 is highly similar to other nucleic acid binding 
complexes such as DDB1-DDB2 and SF3b. In particular, the mode of interaction by 
helix insertion into a cavity lined by beta propellers (seen in the Pfs2-Cft1 and DDB2-
DDB1 interactions) appears to be conserved. This suggests a shared evolutionary origin 
for these complexes.  
 
Cryo-EM of the polymerase module containing Pap1 provides evidence for the flexible 
tethering of Pap1 with the polymerase module (Figure 2.23). Furthermore, crosslinking 
mass spectrometry of the complex shows that Pap1 crosslinks with all subunits of 
polymerase module, highlighting the dynamic nature of Pap1 (Figure 2.25). Docking 
the crystal structure of Pap1 (PDB ID: 1FAO) onto the cryo-EM structure of Cft1 using 
HADDOCK (van Zundert et al. 2016; Cyril Dominguez, Rolf Boelens, and Bonvin 
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2003), and using cross-linking mass spectrometry data as restraints, shows that Pap1 
binds to the BP2 and BP3 of Cft1 (Figure 2.29a).  In the context of our cryo-EM and 
crosslinking mass spectrometry data, it is more likely that Pap1 does not interact 
strongly with Cft1, but rather lies adjacent to it in 3D space. 
 
 
 
 
Figure 2.29: A model for the architecture of the polymerase module. (a) A model 
of the crystal structure of Pap1 docked onto the cryo-EM structure of Cft1 using 
HADDOCK.  Data from cross-linking mass spectrometry experiment were given as 
primary interaction restraints while running HADDOCK. (b) A cartoon 
representation of the topology and architecture of the polymerase module showing 
the inter-protein interactions. The individual domains within the proteins that are 
involved in the interactions are highlighted. Fip1 (black), Pap1 (blue), Yth1 (magenta), 
Pfs2 (yellow), Cft1 (dark green), and zinc ions (dark grey) are depicted. The Yth1 
binding site in Fip1 is depicted in red, the Pap1 binding site in Fip1 is shown in green. 
The RNA is depicted in transparent neon. 
 
Pull-down experiments of the polymerase module using truncated constructs of Fip1 
and Yth1 reveal that Pap1 is anchored to the polymerase module via Fip1 (Figure 2.26). 
Disruption of the interaction between Fip1 and Yth1 causes Pap1 to disassociate from 
the complex. An earlier study showed that replacing the unstructured flexible linker in 
Fip1 with that of human replication protein A resulted in reduction in the efficiency of 
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polyadenylation in vitro (Ezeokonkwo et al. 2011), highlighting the importance of the 
flexible linker of Fip1 in Pap1 activity. It should be noted that this region is known to 
mediate interactions with other components of the 3' end-processing machinery, 
including CF IA (Helmling, Zhelkovsky, and Moore 2001; Ezeokonkwo et al. 2011). 
Therefore, it is imperative to study the effects of the flexible linker of Fip1 on 
polyadenylation in the context of the complete 3′-end processing machinery.  
 
Previous studies from our lab discovered the presence of multiple copies of the 
polymerase Pap1 in endogenously-purified CPF (Easter 2014). The molecular basis of 
the association of multiple polymerases to CPF, as well as the in vivo relevance of this 
complex, is unknown. Further analysis by mass spectrometry revealed that two copies 
of Pap1 are always accompanied by two copies of Fip1 in the complex (Easter 2014; 
Casañal et al. 2017b). Therefore, it is possible that there are two Fip1 binding sites in 
CPF. While Fip1 is anchored to the polymerase module via Yth1 (Figure 2.26), NMR 
experiments revealed that only ZnF4 of Yth1 binds Fip1 residues 180-220. Surprisingly, 
Fip1 binding did not cause any major chemical shift perturbation in the ZnF5 or the C-
terminal end of Yth1, therefore suggesting that there is no additional binding site for 
Fip1 (Figure 2.28). Nonetheless, it is plausible that Fip1 sequences downstream of 
residue 220 might have interactions with additional surfaces in Yth1. Further 
experiments with various truncations of Fip1 and Yth1 are needed to characterize this 
interaction.  
 
In this chapter, the structural architecture of the polymerase module was investigated 
using in vitro biochemistry, cryo-EM, mass spectrometry and NMR (Figure 2.29b). 
Given that WD40 domains are frequently found as protein-protein interaction hubs (van 
der Voorn and Ploegh 1992), it is plausible that other components of the 3' end-
processing machinery could interact with the beta-propellers of Pfs2/Cft1 or the 
unstructured regions in Fip1. The association of other CPF subunits or the cleavage 
factors with the polymerase module could also provide additional RNA binding 
surfaces, thereby increasing the binding affinity for RNA. The role of additional 
proteins in polyadenylation will be further discussed in Chapter 3. 
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3 CF IA stimulates polyadenylation by tethering CPF to 
RNA 
 
 
Isolated Pap1 can add a poly(A) tail to an mRNA substrate in vitro in a manner similar 
to the polymerase module. However, in cells, CPF functions together with the cleavage 
factors IA and IB for specific and efficient polyadenylation (Gross and Moore 2001). 
Both CF IA and CF IB are essential for specific cleavage in vitro (Kessler, Zhao, and 
Moore 1996). Specifically, it has been shown that CF IB is important for mRNA 
cleavage site selection (Minvielle-Sebastia et al. 1998; Kim Guisbert, Li, and Guthrie 
2006). It is thought that CF IB competes with CPF for RNA binding and hence restricts 
CPFs endonuclease activity to the poly(A) site (Dichtl and Keller 2001). NMR 
experiments have revealed that CF IB binds AU-rich efficiency elements, and the 
Rna15 subunit of CF IA binds to the neighbouring A-rich positioning elements (Leeper 
et al. 2010).  
 
On the other hand, CF IA alone is sufficient to activate cleavage, but the exact 
mechanism behind how it activates cleavage remains unknown (Dichtl and Keller 
2001). Specific RNA binding by the cleavage factors occurs as a result of multiple weak 
protein-RNA and protein-protein interactions (Noble et al. 2004; Leeper et al. 2010; 
Barnwal et al. 2012). Mutants defective in RNA binding of cleavage factors result in 
imprecise cleavage, and are lethal in vivo (Kessler et al. 1997; Gross and Moore 2001; 
Pérez-Cañadillas 2006). In mammals, both CstF (homologs of Rna14 and Rna15) and 
CF IIm (containing homologs of Pcf11 and Clp1) are interestingly required only for 
cleavage. In the absence of any cleavage factors, human CPSF is sufficient to 
reconstitute specific and efficient polyadenylation reaction in vitro.   
 
Previous studies using purified individual CF IA subunits have highlighted the 
importance of CF IA in polyadenylation (Gross and Moore 2001). Using fractionated 
yeast extracts and purified subunits of CF IA and CF IB; the study showed that all five-
cleavage factor subunits are required for reconstitution of in vitro polyadenylation 
activity.  However, characterizing the exact nature of this interaction and its 
significance on polyadenylation without highly pure preparation of CPF is challenging. 
To investigate the role of yeast CF IA in polyadenylation, I carried out in vitro assays in 
the presence of cleavage factor sub-complexes. Next, I identified a direct interaction 
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between CPF and CF IA, mediated by Rna14/Rna15 and polymerase module 
subunits.  Using a variety of techniques such as cross-linking mass spectrometry, 
hydrogen-deuterium exchange mass spectrometry, and cryo-EM, I characterize the 
dynamic interaction between Rna14/Rna15 and the polymerase module. Together, I 
propose a model for the stimulation of polyadenylation by CF IA and thus clarify the 
function of CF IA in mRNA polyadenylation.  
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3.1 Cleavage Factor CF IA Stimulates Polyadenylation by CPF 
 
In order to reconstitute polyadenylation in vitro using components of the 3′-end 
processing machinery, I purified CPF and CF IA from endogenous and recombinant 
sources respectively. Native CPF was purified from a yeast strain harboring a C-
terminal TAPS-tag (tandem-affinity purification using protein A and streptactin) 
 in the REF2 gene (Easter 2014). The TAPS tag consists of an N-terminal 3-C protease 
site followed by a Strep-II tag (SII), two TEV protease sites and two repeats of S. 
aureus protein A IgG-binding domain. The purification included two tandem-affinity 
steps. First, lysate was incubated with IgG beads to purify the complex by its protein A 
tag; the SII tag was then affinity purified using StrepTactin resin. Eluate from the 
StrepTactin pull-down was finally subjected to anion exchange chromatography to 
separate the APT complex from the fourteen-subunit CPF complex. The purification is 
described in detail in Ashley, 2014. The identities of the purified proteins were verified 
by tandem mass spectrometry. Cleavage factor IA subunits were recombinantly 
expressed in E.coli and purified using a protocol adapted from a previous study (Gordon 
et al. 2011) and described in section 6.4.3.  
 
An in vitro polyadenylation assay of substrate RNA 5'-FAM-CYC1-pc was carried out 
using purified CPF, in the presence and absence of CF IA (Figure 3.1b). The reaction 
products were analysed using denaturing urea-PAGE. CPF adds poly(A) tail to a pre-
cleaved RNA substrate in a distributive manner, similar to the assays performed using 
the polymerase module (Figure 3.1a and Figure 2.6a). Interestingly, the addition of 
recombinant CF IA to the reaction results in the stimulation of polyadenylation by CPF 
(Figure 2.6b). The stimulatory effect is particularly clear at earlier time points (t=2, 4, 8 
min), where the band corresponding to RNA rapidly increases in size. Densitometry 
analysis of the urea-polyacrylamide gels revealed that the final length of the poly(A) 
tails is longer in the presence of CF IA (Figure 3.1). The two observations suggest that 
CF IA stimulates polyadenylation activity of CPF, potentially via a direct protein-
protein interaction. Previous studies suggest that the WD-40 containing Pfs2 could 
interact with the HAT-domain containing Rna14 subunit of CF IA, linking the cleavage 
factors with CPF (Ohnacker et al. 2000). In vitro pull-downs have also shown a direct 
interaction between Fip1 and Cft1 of CPF, and Rna14 subunit of CF IA (Murthy and 
Manley 1992; Preker et al. 1995; Ezeokonkwo et al. 2011).  The assays performed 
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above provide the first insight towards the functional relevance of the interactions 
between CF IA and CPF.  
 
 
 
 
Figure 3.1: Cleavage factor IA stimulates polyadenylation by CPF.  (a) SDS-PAGE of 
CPF and CF IA used in the assays (b) Polyadenylation assay of purified CPF analyzed 
by denaturing urea-PAGE.  A 5ʹ fluorescently labeled 42 mer CYC1 RNA that has been 
pre-cleaved is the substrate for polyadenylation. The assays were carried out with a 
final concentration of 400 nM substrate RNA, 50 nM purified CPF, 400 nM CF IA and 2 
mM ATP.  Densitometry analyses of the gels are plotted below; RNA length is marked 
based on an RNA ladder. 
 
Notably, three out of the five-polymerase module subunits i.e. Fip1, Pfs2 and Cft1 have 
been shown to bind to CF IA in the past. I hypothesized that CF IA would be able to 
stimulate polyadenylation activity in a minimal reconstituted system containing the 
five-subunit polymerase module. To test this, I carried out in vitro polyadenylation 
assays of 5'-FAM-CYC1-pc using the polymerase module in the presence and absence 
of CF IA (Figure 3.2a and Figure 3.2b). In agreement with the hypothesis, CF IA can 
stimulate the activity of the polymerase module (Figure 3.2b). Densitometry analysis 
revealed that the poly(A) tails are longer and were added faster in the presence of CF IA 
(Figure 3.2b). CF IA consists of four subunits – a heterotetramer of Rna14/Rna15 and a 
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heterodimer of Pcf11–Clp1 (Gordon et al. 2011); among these, the Rna14/Rna15 
heterotetramer mediates RNA binding by CF IA (Noble et al. 2004).  
 
 
 
Figure 3.2: Cleavage factor IA stimulates polyadenylation by the polymerase module.  
Polyadenylation assay of purified polymerase module analyzed by denaturing urea-
PAGE.  A 5ʹ fluorescently labeled 42 mer CYC1 RNA that has been pre-cleaved is the 
substrate for polyadenylation. (a) Assay carried out with only polymerase module and 
RNA. (b) Assay carried out with polymerase module and CF IA. (c) Assay carried out 
with polymerase module and Rna14/Rna15. The assays contained a final concentrations 
of 400 nM substrate RNA, 50 nM purified polymerase module, 400 nM CF IA or 
Rna14/Rna15 and 2 mM ATP. Densitometry analyses of the gels are plotted below; 
RNA length is marked based on an RNA ladder. 
 
To dissect the contribution of subcomplexes of CF IA to polyadenylation, I performed 
in vitro assays of 5'-FAM-CYC1-pc with the polymerase module in the presence of 
Rna14/Rna15. Surprisingly, Rna14/Rna15 is sufficient to stimulate the polyadenylation 
activity of polymerase module (Figure 3.2c). Moreover, the polyadenylation activity of 
the polymerase module in reactions containing CF IA or Rna14/Rna15 is highly similar 
(Figure 3.2b-c), suggesting that Rna14/Rna15 can account for the full stimulatory 
activity of CPF by CF IA.   
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Furthermore, CF IA (and Rna14/Rna15) can stimulate the polyadenylation activity of a 
polymerase module containing two copies of Pap1 (Figure 3.3), demonstrating that the 
stimulatory effect is independent of Pap1 stoichiometry.   
 
 
 
Figure 3.3: Cleavage factor IA stimulates polyadenylation by polymerase module 
with two copies of Pap1.  Polyadenylation assay of purified polymerase module 
analyzed by denaturing urea-PAGE.  A 5ʹ fluorescently labeled 42 mer CYC1 RNA that 
has been pre-cleaved is the substrate for polyadenylation. (a) Assay carried out with 
only polymerase module and RNA. (b) Assay carried out with polymerase module and 
CF IA. (c) Assay carried out with polymerase module and Rna14/Rna15. The assays 
contained a final concentrations of 400 nM substrate RNA, 50 nM purified polymerase 
module, 400 nM CF IA or Rna14/Rna15 and 2 mM ATP. 
 
In addition to CF IA, CF IB also harbours an RNA-binding RRM domain and can bind 
tightly to the AU rich efficiency elements (Pérez-Cañadillas 2006). To probe the role of 
CF IB in polyadenylation, I performed in vitro polyadenylation assays of 5'-FAM-
CYC1-pc using polymerase module in the presence and absence of CF IB. The addition 
of CF IB does not stimulate the activity of the polymerase module as the rate of 
polyadenylation is similar whether or not CF IB is present (Figure 3.4). Therefore, CF 
IB does not affect polyadenylation and likely does not interact with the polymerase 
module.  
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Figure 3.4: CF IB does not stimulate polyadenylation.  Polyadenylation assay by 
purified polymerase module analyzed by denaturing urea-PAGE.  A 5ʹ fluorescently 
labeled 42 mer CYC1 RNA that has been pre-cleaved is the substrate for 
polyadenylation. (a) Assay carried out with only polymerase module. (b) Assay 
carried out with polymerase module and CF IB. The assays contained a final 
concentrations of 400 nM substrate RNA, 50 nM purified polymerase module, 400 nM 
CF IB and 2 mM ATP. 
 
In agreement with an earlier study (Gordon et al. 2011), my experiments using a 
minimal reconstituted system suggest that the Rna14/Rna15 subunits of CF IA are 
sufficient to stimulate polyadenylation by the five-subunit polymerase module and CPF. 
I sought to further investigate the individual subunit contributions and the unexplored 
mechanistic basis of the observed stimulatory effect.  
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3.2 CF IA does not affect polyadenylation by Pap1 
 
 
Earlier experiments demonstrated that the in vitro polyadenylation activity of isolated 
Pap1 enzyme is similar to that of a five-subunit polymerase module (Figure 2.6). This is 
surprisingly different from the human homolog. In humans, the isolated PAP enzyme is 
distributive, but its incorporation within CPSF makes the polyadenylation reaction 
processive due to the additional RNA binding surfaces provided by CPSF (Schönemann 
et al. 2014; Chan, Huppertz, Yao, Weng, Moresco, Yates Iii, et al. 2014). The 
biochemical studies performed so far do not explain the presence of accessory yeast 
polymerase module subunits, and whether these non-catalytic subunits affect the in vitro 
polyadenylation activity of the polymerase module.  
 
In order to better understand the contribution of the polymerase module subunits, I 
performed in vitro assays of 5'-FAM-CYC1-pc using the isolated Pap1 enzyme, in the 
presence and absence of CF IA. CF IA does not stimulate the polyadenylation activity 
of Pap1 (Figure 3.4). In fact, Pap1 activity is slightly reduced in the presence of CF IA 
(compare early time points, e.g. t = 4, 8, 16 min in Figure 3.5.a and Figure 3.5b).  It is 
possible that, in the absence of CF IA, Pap1 can freely access substrate RNA to add 
poly(A) tails in a distributive manner as described earlier. However, the presence of CF 
IA could obstruct Pap1 from accessing the substrate RNA, reducing Pap1 activity 
(Figure 3.4.b). The results here show that CF IA cannot stimulate the activity of isolated 
Pap1 and that additional polymerase module subunits are required for this simulation 
(Figure 3.2). Such an observation underscores the functional importance of other 
polymerase module subunits in the full polyadenylation activity of CPF and the 
polymerase module in the presence of CF IA. 
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Figure 3.5: Activity of isolated Pap1 is not stimulated by CF IA.  Polyadenylation 
assay by purified Pap1 analyzed by denaturing urea-PAGE.  A 5ʹ fluorescently labeled 
42 mer CYC1 RNA that has been pre-cleaved is the substrate for polyadenylation. (a) 
Assay carried out with only Pap1. (b) Assay carried out with Pap1 and CF IA. The 
assays contained a final concentrations of 400 nM substrate RNA, 50 nM purified Pap1, 
400 nM CF IA and 2 mM ATP. 
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3.3 CF IA interacts with the polymerase module of CPF   
 
 
The observation that CF IA (Rna14/Rna15) stimulates the polyadenylation activity of 
CPF and the polymerase module led me to hypothesize that stimulation occurs via a 
direct protein-protein interaction between CF IA and CPF subunits. To investigate the 
interactions between CF IA and CPF subunits, I carried out in vitro pull-down 
experiments on immobilized CPF subunits.   
 
3.3.1 In vitro pull-downs 
 
To study if CPF directly interacts with CF IA, I carried out pull-downs using SII-tagged 
CPF sub-complexes as the bait proteins, and CF IA and CF IB proteins as the prey.  
 
The following CPF sub-complexes were used as bait: a recently described eight-subunit 
core-CPF (Core-CPF), the polymerase module with Cft2 (Polymerase + Cft2), the five-
subunit polymerase module (Polymerase); the polymerase module without Pap1 
(Polymerase – Pap1); Cft2; isolated Pap1; and a hetero-dimer of Ysh1/Mpe1 (Figure 
3.6a). Core-CPF consists of all five polymerase module subunits and three nuclease 
module subunits and has been shown to be sufficient for reconstituting pre-mRNA 
cleavage (Hill et al. 2019). Control reactions for the pull downs were performed with 
Strep beads that did not contain any bait proteins.  
 
Pull-down reactions were first carried out using the full CF IA complex as the prey 
protein complex. Elution fractions from the pull-downs were analysed by SDS-PAGE 
(Figure 3.6b-c). CF IA binds to core-CPF and polymerase module (both with and 
without Pap1), as demonstrated by the presence of bands corresponding to CF IA 
subunits in the pull-down (Figure 3.6b). On the other hand, no interaction was observed 
between CF IA and Cft2, Pap1 or Ysh1/Mpe1 (Figure 3.6b). These results show that the 
core four polymerase module subunits (i.e. Cft1, Pfs2, Yth1 and Fip1) mediate the 
interaction between CPF and CF IA. This provides a potential explanation for why the 
activity of isolated Pap1 is not stimulated by the addition of CF IA, as Pap1 alone 
cannot interact with CF IA, whereas the polymerase module binds to the cleavage 
factor.  
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Next, to understand which subunits of CF IA contact CPF; pull-downs were carried out 
with the Rna14/Rna15 dimer of dimers (Figure 3.6c) or the Pcf11/Clp1 subcomplex 
(Figure 3.6d) as prey. Rna14/Rna15 can interact with core-CPF and polymerase module 
(both with and without Pap1). This is consistent with previous polyadenylation assays 
where Rna14/Rna15 stimulates polyadenylation to a similar degree compared to CF IA 
(Section 4.1, Figures 4.2b-c). In contrast, Pcf11/Clp1 did not stably interact with CPF. 
Interestingly, CF IB does not interact strongly with CPF sub-complexes (Figure 3.6e), 
supporting earlier observations where addition of CF IB to in vitro assays did not have 
any stimulatory effect on polyadenylation (Section 4.1, Figure 3.4b).  
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Figure 3.6: CF IA is recruited to CPF via direct interactions between Rna14/Rna15 
and the polymerase module. (a) Schematic of the protein complexes used in the pull-
downs. CPF proteins and sub-complexes were immobilized on StrepTactin resin (bait). 
(b) Untagged CF IA, (c) Rna14–Rna15, (d) Pcf11–Clp1 and (e) Hrp1 (CF IB) were 
used as prey.  Coomassie-stained SDS-PAGE of pull-down experiments. The input lane 
contains the purified prey proteins that were added.  As a negative control, prey 
proteins alone were added to StrepTactin resin. 
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To further characterize the interaction between CPF and CF IA, a minimal complex 
containing the polymerase module (without Pap1) and the Rna14/Rna15 subunits, 
present in three-fold molar excess, were mixed in vitro and separated using a size 
exclusion column (Figure 3.7a). Polymerase module alone elutes at a volume of ~1.4 ml 
(in pink), Rna14/Rna15 complex elutes at ~1.65 ml (in green) and the complex of 
polymerase module with Rna14/Rna15 elutes at ~1.25 ml (in yellow) (Figure 3.7a).  
The earlier elution of the Rna14/Rna15-polymerase module complex relative to each 
individual complex suggests that the apparent molecular weight is increased. SDS-
PAGE analysis of the eluted fractions reveals the presence of all CF IA and polymerase 
module subunits (Figure 3.7b). Thus, Rna14/Rna15 and the polymerase module 
associate stably and the resulting complex can be separated by size exclusion 
chromatography. Therefore, a protocol to produce a complex containing polymerase 
module and Rna14/Rna15 subunits has been established. This allows further 
characterization of the protein-protein interactions using biophysical techniques. 
 
 
 
 
Figure 3.7: Rna14/Rna15 co-elutes with the polymerase module on a size exclusion 
column.  (a) Purified polymerase module and Rna14/Rna15 complexes were mixed 
together in 1:3 molar ratio, subjected to size exclusion chromatography on a Superose 
6 Increase 3.2/300 column (in yellow).  As a control, samples containing polymerase 
module alone (in pink) and Rna14/Rna15 (in green) alone were run on the same 
column. (b) SDS-PAGE analysis of fractions from the size exclusion column. 
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3.3.2 Hydrogen Deuterium Exchange of Polymerase Module-Rna14-Rna15  
 
Hydrogen deuterium exchange coupled with mass spectrometry (HDX) is a powerful 
biophysical technique that is used to study protein-protein and protein-ligand 
interactions (Shukla et al. 2014; Seckler, Barkley, and Wintrode 2011; Masson, Jenkins, 
and Burke 2017). Furthermore, it is also widely employed to study protein 
conformational dynamics (Wales and Engen 2006). Hydrogen atoms bound to the 
backbone amide group in proteins readily exchanges with protons in the aqueous 
solution. In HDX, deuterated water (D2O) replaces the aqueous environment 
surrounding the protein of interest. Thus, solvent-exposed amide hydrogens will be 
exchanged for deuterium. On the other hand, amide hydrogens that are not exposed to 
solvent will exchange much less readily. The hydrogen deuterium exchange process can 
be monitored in a mass spectrometer owing to the difference in mass between the two 
elements. By comparing different conditions, information on protein-protein 
interactions or conformational changes can be obtained, as long as they affect the extent 
to which amide hydrogens are shielded or exposed to the deuterated solvent, as well as 
the timescale of hydrogen-deuterium exchange.  
 
HDX experiments were performed for the following three samples: five-subunit 
polymerase module with Pap1, four-subunit polymerase module without Pap1, and 
four-subunit polymerase module in complex with Rna14/Rna15. The interaction of 
Pap1 with the polymerase module subunits has been well characterized (Section 3.5). 
Thus, comparison of HDX data from the polymerase module (with and without Pap1) 
should enable us to validate the previously identified Pap1 interaction surface on Fip1.  
 
Cft1 had ~66% coverage across its sequence, Pfs2 ~80%, Yth1 ~68%, and Fip1 ~80%. 
Overall, no difference in deuterium exchange rates were observed in Cft1, Pfs2 and 
Yth1 across the three samples analyzed. Thus, the interaction of Pap1 or Rna14/Rna15 
with the polymerase module did not significantly induce any conformational change in 
Cft1, Pfs2, or Yth1. However, residues 86-101 of Fip1 were protected from deuterium 
exchange in the presence of Pap1 (Figure 3.8a). Thus, this normally solvent-exposed 
region of Fip1 likely becomes buried upon the interaction of Pap1. Interestingly, this 
region of Fip1 contains the peptide sequence (residues 85 - 105) that had been 
previously shown to interact with Pap1, and a crystal structure describing the interaction 
  119 
is available (Meinke et al. 2008), thereby validating HDX as a bona fide technique to 
study protein-protein interactions for CPF and associated complexes.  
 
 
 
 
Figure 3.8: Rna14/Rna15 interacts with residues 147 to 166 of Fip1.  Hydrogen-
deuterium exchange mass spectrometry difference plot showing peptides of Fip1 that 
are exposed (positive) or protected (negative) by (a) Pap1 and (b) Rna14/Rna15.  
Triplicate data from four time points 0.3 sec (orange), 3 sec (red), 30 sec (green) and 
300 sec (blue) are show. Dotted line in grey represents the significance threshold. 
Grey shading represents the standard deviation of all charged states and replicates per 
peptide. 
 
Moreover, amino acids 147-166 of Fip1 was protected from deuterium exchange in the 
presence of Rna14/Rna15 (Figure 3.8.B).  This region of Fip1 lies within the 
“conserved domain” or “CD” of Fip1 (Clerici et al. 2017). Thus, it is likely that 
Rna14/Rna15 interacts with Fip1 via its CD. In addition, previous in vitro pull-downs 
have identified the N-terminal region of human Fip1 (containing the conserved domain) 
as an interaction partner of Cstf-77 (Kaufmann et al. 2004). Therefore, it is likely that 
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this interaction between Fip1 and Rna14/Rna15 is conserved across different species, 
underscoring its functional importance.  
 
3.3.3 Rna14/Rna15 can stimulate the activity of polymerase module with a Fip1 
truncation 
 
The role of Fip1 in tethering Pap1 to the polymerase module is well established (Section 
3.5). Previous studies have highlighted the importance of this flexible conserved 
domain of Fip1 in polyadenylation (Ezeokonkwo et al. 2011). Therefore, in addition to 
its role in linking Pap1 to the remainder of the polymerase complex, Fip1 may also be 
involved in the allosteric regulation of activity of the polymerase module. I 
hypothesized that Rna14/Rna15 could interact with this flexible region of Fip1 and 
allosterically induce a conformational change that results in stimulation of the 
enzymatic activity of Pap1 within the polymerase module.  
 
In order to validate the findings from HDX that region 147-166 of Fip1 interacts with 
Rna14/Rna15, and to test the aforementioned hypothesis, I made truncations within the 
CD of Fip1. I cloned a five-subunit polymerase module containing Fip1 where the 
amino acids 145 to 170 were deleted (Fip1Δ145-170). The truncated polymerase 
module containing Fip1Δ145-170 was purified using a similar protocol to that of the 
wild type polymerase module (Section 6.4.1). The purified complex was analysed by 
SDS-PAGE alongside wild type polymerase module (Figure 3.9a). The truncated 
polymerase module was functionally active and added poly(A) tails to a substrate RNA 
5'-FAM-CYC1-pc in a manner very similar to the wild type polymerase module (Figure 
3.9b). Interestingly, Rna14/Rna15 can still stimulate the activity of this truncated 
polymerase module containing Fip1 Δ145-170 (Figure 3.9b). Thus, the deletion of 
Rna14/Rna15 interaction surface on Fip1 does not affect the ability of Rna14/Rna15 to 
influence polyadenylation activity.  
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Figure 3.9: Deletion of the RNA14/Rna15 interaction surface in Fip1 does not affect 
polyadenylation stimulation. (a) SDS-PAGE analysis of the purified polymerase module. 
The deletion of residues 145 to 170 in Fip1 does not affect the assembly and 
purification of intact polymerase module. (b) Polyadenylation assays analyzed by 
denaturing urea-PAGE.  A 5ʹ fluorescently labeled 42 mer CYC1 RNA that has been 
pre-cleaved is the substrate for polyadenylation. Rna14/Rna15 stimulated the 
polyadenylation activity of both the wild type and Fip1 Δ145-170 containing 
polymerase module. The assays were carried out with a final concentration of 400 nM 
substrate RNA, 50 nM purified polymerase module (WT or Fip1 Δ145-170), 400 nM 
Rna14/Rna15 and 2 mM ATP. 
 
 
 
 
 
 
 
 
 
(b) Rna15/Rna15 stimulates polyadenylation by 
polymerase module containing Fip1 Δ145-170 
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3.4 Rna14 HAT domains interact with the polymerase module 
 
As Rna14/Rna15 can stimulate the activity of the polymerase module containing 
Fip1Δ145-170, it is likely that the CF IA sub-complex can interact with other subunits 
of the polymerase module. A limitation of the HDX experiment is its modest sequence 
coverage of polymerase module proteins, and thus the interaction surface between Fip1 
and polymerase module subunits could lie outside the covered sequences. For example, 
the beta-propellers in Pfs2 or Cft1 can act as a protein-protein interaction hub for the 
structurally rigid HAT domains in Rna14 (Ohnacker et al. 2000). Similarly, in the 
structure of the human SF3b core complex, the HEAT repeats containing SF3155 is 
found to interact with the beta-propellers of SF3b130 (Cretu et al. 2016).  
 
Thus, to fully elucidate the mechanistic basis of CF IA interaction with the polymerase 
module, there was the need to use orthogonal biochemical or biophysical methods. I 
chose to further investigate the interaction using cross-linking mass spectrometry and 
cryo-EM. 
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3.4.1 Cross-linking mass spectrometry of polymerase module - Rna14/Rna15 
complex 
 
 
The complex containing polymerase module and Rna14/Rna15 subunits was cross-
linked with BuUrBu (Disuccinimidyl Dibutyric Urea) (Müller et al. 2010). Similar to 
BS3, BuUrBu contains N-hydroxysuccinimide (NHS) ester functional groups and can 
covalently link two lysine, serine, threonine or tyrosine molecules that are within 27 Å 
of each other.  
 
A total of 82 inter- and intra-subunit crosslinks were found. Several of the crosslinks 
within the polymerase module subunits were consistent with the BS3 crosslinking data 
described earlier (Section 3.5.2). Residues K47, K44 and S38 in the N-terminal region 
of Fip1 cross-linked to the C-terminal HAT domain of Rna14, consistent with previous 
in vitro pull downs where the N-terminus of Fip1 was found to interact with Rna14 
(Kaufmann et al. 2004) (Figure 3.10). In addition to the previously characterized Fip1-
Rna14 interaction, K60 in the N-terminus of Yth1 also crosslinked with residues K170, 
K219 and K28 in the N-terminal HAT domain of Rna14. This region of Rna14 also 
cross-linked with the C-terminus of Pfs2. These results hint at the possibility that the 
HAT domain of Rna14 lies in close proximity to Yth1 ZnF2 and the WD40 of Pfs2 as 
these domains are structurally proximal (Section 3.15). Moreover, the HAT domain of 
Rna14 crosslinked with other polymerase module subunits, including various regions of 
Cft1 (Figure 3.10), which is consistent with a previous study, demonstrating a close 
association between CPSF160 and CstF-77 (Murthy and Manley 1992). It is thus 
possible that Rna14 harbours multiple interaction sites on the polymerase module. 
Interestingly, no crosslinks were found between Rna15 and polymerase module 
subunits. One explanation could be that the region of interaction between Rna15 and the 
polymerase module subunits do not contain any lysines, serines or tyrosines. 
Alternatively, there may not be any direct or proximal contacts between Rna15 and the 
polymerase module.  
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Figure 3.10: Cross-linking mass spectrometry of the polymerase module - 
Rna14/Rna15 complex. Linkage map showing all identified lysine-lysine, lysine-serine 
and lysine-tyrosine crosslinks. Cross-links between the polymerase module and 
Rna14/Rna15 are shown in pink dotted lines. 
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3.4.2 Cryo-EM of polymerase module - Rna14/Rna15 complex 
 
To better understand how Rna14/Rna15 interacts with the polymerase module subunits, 
and to gain insights into how the two complexes bind the substrate RNA, a ternary 
complex consisting of the four-subunit polymerase module, Rna14/Rna15 subunits and 
CYC1-pc RNA was assembled on a size exclusion column (Figure 3.11a). The peak 
fraction containing the entire complex eluted from the column at ~1.25 ml elution 
volume, similar to the previous complex lacking RNA (Section 4.3.1). Comparison of 
the absorbance at 260 nm to that at 280 nm confirmed the presence of nucleic acid in 
the peak fractions (Figure 3.11a). SDS-PAGE analysis of the peak fractions revealed the 
presence of all six-protein subunits in the preparation (Figure 3.11b). Cryo-EM 
micrographs of the ternary complex revealed ~15 nm individual particles that were 
(Figure 3.11c). Further inspection revealed mono-disperse but heterogeneous particles. 
2-D class averages of selected aligned particles show the characteristic polymerase 
module 2-D classes (shown by green arrowhead in Figure 3.11d, and Figure 2.10b). 
Also seen were 2-D classes containing a ~15 nm boomerang shaped density. This 
density resembles projections of the crystal structure of the Rna14 HAT domain from 
Kluyveromyces lactis, which revealed a ~15 nm elongated dimer of the HAT domains 
(Paulson and Tong 2012). Similar boomerang shaped 2-D classes were obtained in a 
previous electron microscopy study of S. cerevisiae Rna14-Rna15 (Noble et al. 2004). 
Thus, the ~15 nm elongated, kinked density (shown by cream arrowhead in Figure 
3.11d) likely corresponds to the dimer of HAT domains formed by Rna14. It is 
interesting to note that in 2-D classes highlighted in red boxes, the HAT domain appears 
to associate with the bottom region of the polymerase module (BP2). In agreement with 
this observation, crosslinks were found between Y914 and T915 of Cft1 and K551 in 
the HAT domain of Rna14.  
 
Overall, the 2-D classes shown here highlight the heterogeneity of the sample under 
investigation. In some of the representative 2-D classes, the particles are aligned on the 
Rna14 HAT domain density, resulting in a blurred density corresponding to the 
polymerase module (highlighted by grey arrows in Figure 3.11d). Conversely, certain 2-
D classes were aligned on the polymerase module, and contain additional blurry 
boomerang-like density surrounding the central module (classes 2, 6). This reflects a 
scenario where Rna14/Rna15 interacts with polymerase module at many sites. As a 
result, the particles of the complex are unable to align as one fixed conformation.  
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Figure 3.11: Cryo-EM analysis of the polymerase module - Rna14/Rna15 - CYC1 
RNA complex. (a) Size exclusion chromatography of the ternary complex (b) SDS-
PAGE of the peak showing all the polymerase module subunits and Rna14/Rna15. (c) 
Representative cryo-EM micrograph of polymerase module - Rna14/Rna15-CYC1 
complex taken at 59k X magnification. (d) Selected 2D class averages of aligned 
particles reveals sample heterogeneity. The HAT-domain of Rna14 is highlighted by 
cream arrowhead. The isolated polymerase module is highlighted by green arrowhead. 
Grey arrowhead shows the fuzzy density found near the HAT-domain in many of the 
classes. Classes highlighted by red squares show the HAT-domains of Rna14 
positioned below the beta-propeller of Cft1. 
 
Further stabilization of the sample is therefore likely required to proceed with cryo-EM 
analysis. One possible remedy is to use a mild cross-linker to fix the complex in one 
particular conformation. 
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Despite the presence of RNA in the sample, no density for RNA could be observed in 
the 2-D classes. A likely explanation is that the RNA used in the study (42 nucleotides 
long) is too small to be observed in 2-D classes at the current magnifications used in 
imaging. A high-resolution 3D reconstruction would be necessary to validate the 
presence of RNA.  
 
In summary, cryo-EM studies have shown that the HAT domain of Rna14 subunit 
interacts with the polymerase module. It is likely that Rna14 interacts with polymerase 
module at many sites. This is further supported by cross-linking data where the HAT 
domain cross-links across all the subunits of polymerase module. It is possible that the 
conformation where Rna14-Rna15 is bound to BP2 is preferred, as they constituted 2-D 
classes, which were best resolved in preliminary cryo-EM analysis. These data also 
suggest that Rna14 harbours the main binding site of CF IA to the polymerase module. 
However, in the absence of any cross-linking and cryo-EM data on the Rna15 subunit, 
one cannot rule out the possibility that Rna15 could harbour a polymerase module 
interaction surface.  
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3.5 An RNA binding mutant of Rna14/Rna15 fails to stimulate 
polyadenylation 
 
 
While CF IA stimulates the polyadenylation activity of CPF and CPF interacts with CF 
IA via Rna14/Rna15 and polymerase module subunits, the exact mechanism underlying 
the stimulation remains unknown. There are at least two possible mechanisms of 
stimulation. Firstly, because HDX experiments found an Rna14/Rna15 interaction 
surface in the conserved flexible domain of Fip1, it was hypothesized that the 
Rna14/Rna15 creates a conformational change in this region of Fip1, thereby 
modulating Pap1 activity. On the other hand, in vitro assays showed that the activity of 
the polymerase module could be stimulated by Rna14/Rna15 even in the absence of this 
central region of Fip1. Thus, another possible mechanism by which Rna14/Rna15 
stimulates polyadenylation is by providing additional RNA binding surface for the 
polymerase module. Together with the surface-exposed positively charged residues on 
top of Pfs2 and the ZnF2/3 of Yth1, the RRM domain of Rna15 can form a composite 
RNA binding surface. Such a cooperative binding would increase the overall affinity for 
RNA and result in stimulation of polyadenylation.  
 
In order to test this hypothesis, I generated an RNA binding mutant of Rna14/Rna15 
(Figure 3.12a). It is thought that Rna14/Rna15 binds RNA mainly through the RRM 
domain of Rna15, whose structure has been determined in complex with a GU 
dinucleotide (Pancevac et al. 2010). In the structure, guanine is stacked against the 
aromatic ring of Y21 (Figure 3.12a). Furthermore, heteronuclear NMR experiments 
suggests that the aromatic rings of Y61 and F63 could be a part of a nucleobase binding 
site (Pancevac et al. 2010). I cloned, expressed and purified a mutant Rna14/Rna15 that 
carried a Y21A, Y61A, F63A triple mutant in the RRM domain of Rna15 (Section 
6.4.5). EMSA experiments show that the mutant Rna14/Rna15 has a significant 
reduction in its ability to bind RNA (Figure 3.12b). In contrast with the wild-type 
Rna14/Rna15, in vitro assays show that the mutant Rna14/Rna15 does not stimulate the 
polyadenylation activity of polymerase module (Figure 3.12c). Interestingly, the 
polymerase module has reduced activity in the presence of the mutant Rna14/Rna15 in 
comparison to an assay performed without any Rna14/Rna15 (Figure 3.12c).  The RNA 
binding mutant of Rna14/Rna15 can likely still interact with polymerase module and 
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therefore sequesters the polymerase module from binding RNA. This may explain why 
there is a reduced polyadenylation activity in the presence of mutant Rna14/Rna15.  
 
 
 
Figure 3.12: Rna14/Rna15 stimulates polyadenylation by tethering the polymerase 
module to the RNA. (a) X-ray crystal structure of the RRM domain of Rna15 bound 
to GU (PDB ID: 2X1F) showing residues involved in base recognition. (b) An RRM 
domain triple mutant Y21A, Y61A, F63A in Rna15 loses its ability to bind RNA as 
shown by the EMSA experiment. (c) A mutant of Rna14/Rna15 that does not bind 
RNA, no longer stimulates polyadenylation of the polymerase module. 
 
The inability of the mutant Rna14/Rna15 to stimulate polyadenylation suggests that CF 
IA (and Rna14/Rna15) enhances the activity of CPF (and polymerase module) by 
providing additional RNA binding surfaces. However the allosteric model for 
polyadenylation stimulation cannot be completely ruled out in the absence of complete 
structural information about the CF IA - polymerase module interaction.  
(c) Rna14/Rna15 RRM mutant does not stimulate polyadenylation
(b) Rna14/Rna15 RRM mutant does not bind CYC1 (a) Structure of Rna15 RRM with bound RNA  
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3.6 Model for stimulation of polyadenylation by CF IA 
 
Taken together, these results enable us to hypothesize a model of polyadenylation by 
the polymerase module. In the absence of any CF IA (and Rna14/Rna15), the 
polymerase interacts with RNA at ~ 500 nM affinity (figure 2.8). In this scenario, the 
polymerase module is weakly processive and only adds ~10 to 15 As before the 
polymerase module falls off the product RNA (Figure 3.2a). The polymerase module is 
then competent to bind a new substrate RNA to further continue addition of poly(A) 
tails. This model of polyadenylation is illustrated in Figure 3.13a.  
 
On the other hand, the presence of CF IA provides the polymerase module with 
additional RNA binding surfaces via the RRM domain of Rna15 subunit. In this 
scenario, the complex of polymerase module and CF IA (or Rna14/Rna15) binds more 
tightly to RNA and the resulting complex has a longer half-life. The polymerase module 
then adds poly(A) tail to the substrate RNA without the complex falling off the RNA. 
This tethering of the polymerase module to the substrate RNA by CF IA results in the 
longer poly(A) tails being rapidly added. This agrees with a previous study showing that 
physical tethering of Pap1 to RNA results in an increase in its polyadenylation activity 
(Ezeokonkwo et al. 2011). Such a model of processive polyadenylation is illustrated in 
Figure 3.13b. 
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Figure 3.13: A model for polyadenylation stimulation by cleavage factor IA. Model 
obtained by combining data from cryo-EM, cross-linking–mass spectrometry, 
biochemical assays and in vitro pull-downs. (a) In the absence of the cleavage factor 
IA, polymerase module binds the substrate RNA, adds ~ 10 - 15 As and falls off the 
product RNA. Then the free polymerase module binds another substrate or product 
RNA, continues adding poly(A) tails in this manner. (b) In the presence of CF IA, the 
polymerase module remains tethered to the substrate RNA. Rna14/Rna15 interacts 
with the polymerase module, and provides additional RNA binding surface. This results 
in stimulation of polyadenylation. 
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4 Progress Towards Understanding Poly(A) Tail Length 
Control  
 
As pre-mRNA emerges from Pol II, specific cis-acting elements within its 3′ UTR are 
bound by CPF and CF I. This results in the assembly of the entire 3' end processing 
complex poised to carry out an endonucleolytic cleavage at the poly(A) site, followed 
by the addition of a poly(A) tail to the free 3' hydroxyl of the terminal nucleotide. 
  
In mammals, the poly(A) tails of mRNAs are synthesized to ~ 200 As. In vitro 
biochemical studies have highlighted the role of the nuclear poly(A) binding protein 
PABN1 in poly(A) tail length control (Wahle 1995). PABN1 bound to a short poly(A) 
tail promotes the interaction between CPSF and PAP. This interaction results in the 
cooperative stimulation of poly(A) tail addition by PAP. PAP then adds ~ 200 to 250 
As in a single processive synthesis step (Kühn et al. 2009). PABN1 can measure the 
length of the poly(A) tail and terminates the processive polyadenylation by disrupting 
the interaction between CPSF and PAP. 
     
In S. cerevisiae, on the other hand, the poly(A) tail length of newly made pre-mRNAs 
is ~ 60 A’s (Mclaughlin et al. 1973; Groner, Hynes, and Phillips 1974). Despite the 
absence of a functionally similar protein for PABN1 in S. cerevisiae, previous studies 
have highlighted the role of Pab1 and Nab2 in the regulation of mRNA poly(A) tail 
length control (Amrani, Minet, Le Gouar, et al. 1997; Minvielle-Sebastia et al. 1997; 
Schmid et al. 2012, 2015). It has been shown in yeast that the cytoplasmic poly(A) 
binding protein Pab1 physically associates with CF IA and is involved in the control 
of poly(A) tail length in vitro (Amrani, Minet, Le Gouar, et al. 1997; Minvielle-
Sebastia et al. 1997). It was hypothesized that poly(A)-associated Pab1 could recruit 
the deadenylase complex Pan2/Pan3, which in turn trims the hyperadenylated tails to 
appropriate lengths. However, a later study revealed that in vitro poly(A) tail lengths 
were regulated in the absence of Pab1 dependent poly(A) nuclease activity, thus 
suggesting that poly(A) tail lengths were controlled via a different mechanism not 
involving Pan2/Pan3 (Dheur et al. 2005). The nuclear poly(A) binding protein Nab2 
has also been implicated in control of poly(A) tail length both in vivo and in vitro 
(Hector et al. 2002).  Nab2 binds poly(A) RNA with high affinity  (Kd = 30 nM) and 
this interaction is mediated by the tandem CCCH family of zinc finger repeats in its C-
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terminal end (Kelly et al. 2007; Aibara et al. 2017). Cells expressing a mutant allele of 
Nab2 that can no longer strongly bind poly(A) RNA, results in defects in poly(A) 
lengths (Kelly et al. 2010).  
 
Previous biochemical studies have clarified the role of Nab2 in poly(A) tail length 
control and have provided valuable clues towards a mechanism for the same (Hector et 
al. 2002; Viphakone, Voisinet-Hakil, and Minvielle-Sebastia 2008). In the current 
model for poly(A) tail length control, Nab2 interacts with CPF components or likely 
alters the poly(A) conformation resulting in restriction of polyadenylation by Pap1. 
This leads to poly(A) tails of proper lengths being sythesized. However, several 
questions including why the poly(A) tail addition stops exactly after ~ 60As and what 
are the molecular players that trigger the termination of polyadenylation after ~ 60As 
remain unanswered. The lack of a pure and homogenous preparation of the 3' end 
processing complexes has hindered the systematic dissection of length control 
mechanism in vitro. Furthermore, we do not yet understand the contributions of CPF 
towards poly(A) tail length control, and how does Nab2 influence this. To address this 
major obstacle in the field, I describe the construction, recombinant expression and 
purification of the fourteen-subunit CPF complex. Moreover, I describe a robust and 
reproducible protocol for the in vitro reconstitution of cleavage and polyadenylation of 
a substrate mRNA 3' UTR using CPF from recombinant or endogenous expression. 
The experiments were designed taking into consideration the exact molarity of the 
reaction components. Remarkably, the experiments presented herein reveal the 
intrinsic capacity of CPF to restrict poly(A) tail length in the absence of Nab2. 
Further, establishing a recombinant system to produce CPF has now provided a means 
to make mutant complexes that was hitherto impractical. This will act as a future tool 
for dissecting the molecular mechanism of poly(A) tail length control by CPF.  
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4.1 CPF restricts poly(A) tail length  
 
4.1.1 CPF purified from S. cerevisiae has intrinsic poly(A) tail length control 
 
Native CPF was purified as described in section 3.1. A flow chart describing the 
purification protocol is illustrated in Figure 4.1a. The identities of the purified proteins 
were assessed by tandem mass spectrometry.  
 
 
 
 
Figure 4.1: Purification of native CPF from Saccharomyces cerevisiae (a) Flow chart 
describing the different steps involved in the purification of native CPF. (b) The peak 
from the MonoQ anion exchange chromatography was analyzed using SDS-PAGE.  
The preparation contains all fourteen-subunits of CPF from S. cerevisiae. 
 
Previous work from our lab has shown that addition of Nab2 to an in vitro 
polyadenylation assay results in RNAs with a poly(A) tail length mimicking in vivo 
lengths of  ~ 60 As.  In vitro cleavage and polyadenylation assays carried out in the 
absence of a poly(A) binding protein, only led to hyper-polyadenylation of the 
substrate RNA (Easter 2014). 
 
I performed coupled cleavage and polyadenylation assays of an in vitro transcribed 3′ 
UTR of the CYC1 mRNA. The assays consisted of CPF purified from yeast (Figure 
4.1a) as well as CF IA and CFI B purified from E. coli (section 6.4.3, 6.4.4). The 
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reactions contained 100 nM substrate RNA, 50 nM CPF, and the cleavage factors were 
added in threefold excess (300 nM). It is found that polyadenylation of the cleaved 
RNA was surprisingly stalled after addition of around ~150 As (Figure 4.2a). 
Quantification of the reaction products by densitometry show a distribution of poly(A) 
tail lengths ranging from ~80 As to ~200 As (Figure 4.2b). It is to be noted that the 
length of the observed poly(A) tails is longer than what is observed in vivo in the 
presence of Nab2. Furthermore, not all the cleaved RNA 5′ fragments are 
polyadenylated. A band corresponding to the cleaved RNA (5'-CYC1-pc) remains 
throughout the time-scale of the experiment (Figure 4.2a). This observation is in 
contrast with previous assays (Casañal et al. 2017a).  
 
The main difference between the current assay and the one performed previously lies 
in the concentrations of RNA and protein factors. In the earlier study, 87.5 nM RNA, 
18 nM CPF and 48 nM CF IA/CF IB were used (Easter 2014). In the current study, 
100 nM RNA, 50 nM CPF and 300 nM CF IA/CF IB are used (hereafter referred to as 
length control conditions). Under the current conditions, the cleavage factors are 
present in threefold excess over the substrate RNA. This could result in the occupancy 
of cleavage factors on RNAs being higher for a given RNA concentration. 
Furthermore, it has been shown earlier that CPF directly interacts with CF IA via the 
polymerase module (Figure 3.6). Therefore, CPF, CFs and the product RNA could 
form a stable ternary complex after addition of ~ 80 to ~ 200As, explaining why a 
fraction of the cleaved RNA (5'-CYC1-pc) remains unprocessed without a poly(A) tail. 
To test this hypothesis, assays carried out with increasing amounts of the CPF or CFs 
or reducing the RNA concentration should result in the disappearance of the 5'-CYC1-
pc band. Alternatively, it is also plausible that the newly added poly(A) tail is bound 
by the excess cleavage factors in the absence of any poly(A) binding proteins.  
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Figure 4.2: CPF has intrinsic capacity to restrict the poly(A) tail length to ~ 150As. 
(a) Schematic of cleavage and polyadenylation of a substrate RNA 3ʹ UTR (in left).  
The 5ʹ cleavage product shown in orange gets polyadenylated after cleavage. Coupled 
cleavage and polyadenylation assay of purified CPF analyzed by denaturing urea-PAGE 
(in right). CYC1 is the substrate RNA. Cleavage products are 5ʹ-CYC1 (in orange) and 
CYC1-3ʹ (in pink). (b) Quantification of the band intensities of the cleavage and 
polyadenylation assay to estimate the length distribution of the poly(A) tails. 
Highlighted in a grey box are the band intensities corresponding to polyadenylated 
RNAs. Arrows point the peaks of the poly(A) tail intensities. (c) Denaturing urea-
PAGE of the assay performed for band quantification.  The gel is run longer compared 
to the gel in (a), resulting in disappearance of the downstream cleavage product from 
the view. 
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When assays were performed with lower amounts of cleavage factors (150 nM each), 
it is seen that the 5'-CYC1-pc disappears eventually (Compare time points 96 and 128 
in Figure 4.3a and 4.3b). Furthermore, under such conditions, CPF no longer restricts 
the length of the poly(A) tails at longer time points. This observation supports my 
hypothesis that, at concentrations lower than the possible Kd for RNA binding, CFs 
(and in turn CPF) disassociates from the poly(A) containing product RNA. The tight 
binding between CPF/CF and the product RNA with poly(A) tail is reduced. The CFs 
are now available for acting on the 5'-CYC1-pc.  
 
 
 
 
Figure 4.3: Influence of the concentration of the cleavage factors on poly(A) tail 
length control. Coupled cleavage and polyadenylation assay of purified CPF analyzed 
by denaturing urea-PAGE. CYC1 is the substrate RNA. Cleavage products are 5ʹ-CYC1 
(in orange) and CYC1-3ʹ (in pink).  (a) Regulated poly(A) tail addition by CPF is 
observed when CF IA and CF IB are present at 300 nM.  (b) Unregulated poly(A) tail 
addition by CPF when cleavage factors are present at 150 nM. (Compare the 96 and 
128 min time points). 
 
Thus, it has been found that CPF and cleavage factors have an intrinsic capacity to 
restrict the length of the poly(A) tails. 
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4.1.2 Intrinsic length control is not salt dependent 
 
It has been observed that CF IA has a tendency to precipitate in buffers containing 
salts lesser than ~ 100 mM in concentration. The aforementioned intrinsic length 
control assays are carried out in a well-defined polyadenylation buffer that contains 
75mM potassium acetate (section 6.6.1.1), raising the possibility that the observed 
length control exhibited by CPF could be an artifact caused by precipitating proteins. 
To test whether the observed intrinsic poly(A) tail length control  of CPF is sensitive 
to salt concentrations, I performed cleavage and polyadenylation assays in buffers 
containing 150 mM and 225 mM potassium acetate. The results show that the intrinsic 
ability of CPF to restrict poly(A) tail length is not dependent on the salt concentration. 
Under both the salt conditions, a distribution of poly(A) tails from ~80 to 200 As were 
observed (Figure 4.4). However, at later time points in the assay carried our at 225 
mM salt, the distribution of poly(A) containing RNAs is wider. Interestingly, the rate 
of cleavage at 225 mM salt was slower than when compared to that at 150 mM salt 
(Figure 4.4b). Such changes in cleavage and polyadenylation at higher salt conditions 
is likely due to a reduction in protein-RNA binding, suggesting that the interactions 
are possibly ionic in nature. 
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Figure 4.4: The intrinsic capacity of CPF to restrict the poly(A) tail length to ~150As 
is not disrupted at higher salt concentration. Coupled cleavage and polyadenylation 
assay of purified CPF analyzed by denaturing urea-PAGE. CYC1 is the substrate RNA. 
Cleavage products are 5ʹ-CYC1(in orange) and CYC1-3ʹ (in pink).  CPF has intrinsic 
capacity to restrict the poly(A) tail length to ~ 150 As.  (a) The reaction carried out in 
a buffer containing 150 mM salt (b) The reaction carried out in buffer containing 225 
mM salt.  The rate of cleavage is reduced at higher salt conditions likely reflecting the 
disruption of ionic interactions between protein-RNA. 
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4.1.3 Cleavage is not coupled to intrinsic poly(A) tail length control 
 
Previous work has shown that cleavage and polyadenylation operate as independent 
reactions (Claire L Moore and Sharp 1985). Furthermore, there is no significant 
difference in the rates of cleavage or polyadenylation when the reactions were 
performed either in a coupled or uncoupled manner (Casañal et al. 2017a). However, 
the functional connection between cleavage and the newly observed intrinsic poly(A) 
tail length control by CPF is not known. To test this potential coupling, 
polyadenylation only assays were carried out using a pre-cleaved CYC1 RNA (5'-
CYC1-pc) and under length control conditions (100 nM RNA, 50 nM CPF and 300 nM 
CF IA, 300 nM CF IB). The data show that cleavage activity of CPF is not coupled to 
its intrinsic poly(A) tail length restriction property (Figure 4.5). CPF has the intrinsic 
capacity to restrict the poly(A) tail length of a pre-cleaved RNA to ~ 80 - ~ 200 As 
independent of the initial cleavage step.  
 
   
 
 
Figure 4.5: Cleavage activity of CPF is not coupled to it's intrinsic poly(A) tail 
length restriction property. Polyadenylation assay of purified CPF analyzed by 
denaturing urea-PAGE. CYC1-pc is the substrate RNA. CPF has intrinsic capacity to 
restrict the poly(A) tail length of a pre-cleaved RNA to ~ 150 As .  
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4.1.4 The entire 3' end processing machinery is required for length control  
 
In order to dissect the contributions of the individual components of the 3' end 
processing machinery towards poly(A) tail length control, I carried out dropout 
experiments (Figure 6). CPF could restrict the lengths of newly added poly(A) tails 
only when the assay contained both CF IA and CF IB (Figure 4.6). In the absence of 
CF IA, the cleavage activity of CPF was highly impaired and only non-specific 
polyadenylation of the un-cleaved CYC1 RNA was observed (Figure 4.6b). In 
contrast, in the absence of CF IB, cleavage could still occur (Figure 4.6c). However, 
polyadenylation by CPF was not restricted as the polyadenylated RNAs were seen as a 
smear in the gel and have a wide length distribution.  Interestingly, unlike the 
reactions that contained both CF IA and CF IB, the 5'-CYC1-pc product disappeared in 
this assay. The absence of CF IB might disrupt the hypothesized co-operative binding 
of CPF and CF IA to RNA, allowing the protein complexes to act on any remaining 
substrate RNAs. Taken together CF IA and CF IB are required and have unique roles 
in imparting intrinsic length control on the growing polyA tail by CPF.  
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Figure 4.6: Cleavage factors are required for regulated poly(A) tail by CPF.  Coupled 
cleavage and polyadenylation assay of purified CPF analyzed by denaturing urea-PAGE. 
CYC1 is the substrate RNA. Cleavage products are 5ʹ-CYC1 (in orange) and CYC1-3ʹ (in 
pink).  (a) Reactions carried out using CPF, CF IA and CF IB under length control 
conditions. (b) Reactions carried out in the absence of CF IA did not result in efficient 
cleavage and led to longer poly(A) tails.  (c) In the reactions carried out in the absence 
of CF IB, all the 5ʹ-CYC1cleaved product are consumed. However regulated poly(A) 
tail addition is not observed. 
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4.1.4.1 The absence of CF IA or CF IB results in hyper-polyadenylation 
 
In cleavage and polyadenylation assays of CYC1 RNA carried out in the absence of 
CF IA, cleavage was highly impaired (Figure 4.6b). Hence, the role of CF IA in 
regulated poly(A) tail addition could not be examined. To clarify CF IA function, 
polyadenylation only assays of a pre-cleaved CYC1 RNA were carried out in the 
presence and absence of CF IA/CF IB. As mentioned in section 4.1.4, the newly made 
poly(A) RNAs had a tail length of ~ 80 to ~ 200 As in reactions with CPF, CF IA and 
CF IB (Figure 4.7a). Removing either CF IA or CF IB from the reaction results in 
RNAs with longer poly(A) tails (Figure 4.7b and 4.7c). This hyper polyadenylation is 
also observed in polyadenylation assays carried out with only CPF and substrate RNA 
(Figure 4.7d).   
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Figure 4.7: Cleavage factors are required for regulated poly(A) tail addition by CPF. 
Polyadenylation assay of purified CPF analyzed by denaturing urea-PAGE. CYC1-pc is 
the substrate RNA. (a) CPF has intrinsic capacity to restrict the poly(A) tail length of 
a pre-cleaved RNA to ~ 150 As. Reactions carried out in the absence of (b) CF IB  
or (c) CF IA or (d) both led to hyperadenylation.  Marked in asterisk (*) are 
contaminant RNA bands.  
 
In summary, in the absence of any poly(A) binding proteins, CPF functions together 
with CF IA and CF IB in order to restrict the poly(A) tail length of the substrate RNA 
to ~80 A’s - ~200 A’s. From our preliminary observations, I speculate that CPF and 
the cleavage factors form a stable complex with the polyadenylated RNA, eventually 
resulting in the stalling or slowdown of polyadenylation. When either CF IA or CF IB 
is dropped out from the assays, CPF no longer forms a stable complex with the 
polyadenylated RNA. Free CPF is available to add poly(A) tails to the remaining 
substrate RNA, eventually leading to hyper-polyadenylation. 
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4.1.4.2 Core-CPF does not have intrinsic poly(A) tail length control 
 
A minimal 8-subunit core-CPF is sufficient for cleavage and polyadenylation of a 
substrate RNA in vitro (Hill et al. 2019). To understand whether this minimal CPF 
would be sufficient to restrict the poly(A) tails of a substrate RNA, cleavage and 
polyadenylation assays of CYC1 RNA was carried out with core-CPF and the cleavage 
factors under length control conditions. Surprisingly, core-CPF does not have the 
intrinsic ability to restrict the lengths of poly(A) tails in the assays (Figure 4.8). Thus, 
the phosphatase module of CPF is important in poly(A) tail length restriction. This 
result further supports the requirement of the entire 3' end processing machinery in 
regulated poly(A) tail addition.  
 
 
 
Figure 4.8: Core-CPF does not have an intrinsic capacity to restrict the poly(A) tail 
length. Coupled cleavage and polyadenylation assay of purified core-CPF analyzed by 
denaturing urea-PAGE. CYC1 is the substrate RNA. Cleavage products are 5ʹ-CYC1 
(in orange) and CYC1-3ʹ (in pink). The cleaved 5ʹ-CYC1 gets hyper-polyadenylated. 
 
The above three sections highlight the contributions from the protein components of 
the 3' end processing machinery to restrict poly(A) tail length. However, contributions 
from cis-elements in the substrate RNA remain to be explored.  
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4.1.5 Cleaved RNA remains bound to CPF and Cleavage factors 
 
In my current model, under non-length control conditions CPF adds an initial ~ 80 to ~ 
200 As in the initial burst of polyadenylation and then falls off the substrate RNA. It 
can then re-bind and repositions itself on the polyadenylated RNA to continue adding 
more As. In the assays carried under length control conditions, CPF and the CFs 
remain bound to the polyadenylated RNA product. Under these conditions, CPF does 
not dissociate from the poly(A) RNA product to reposition itself for further 
polyadenylation. Such a tight binding between the 3' end processing complex and the 
polyadenylated RNA could prevent CPF from extending poly(A) tails beyond ~ 200 
As. 
 
In order to test this hypothesis, I carried out in vitro pull down experiments of CPF 
from the cleavage reaction mixture (Figure 4.9a). I started by performing cleavage 
only experiments to optimize wash conditions for the pull-downs. Once conditions for 
the pull-downs are established, I intend to carry out the pull-down experiments for 
cleavage coupled with polyadenylation assays.  CPF was first immobilized onto 
StrepTavidin beads that were pre-equilibrated with the poly(A) reaction buffer. Excess 
unbound CPF was washed off. A cleavage reaction master mix containing CF IA, CF 
IB and the substrate RNA CYC1 is then added to the CPF loaded Streptavidin beads. 
On beads cleavage assay was carried out for 30 minutes. The slurry was gently 
centrifuged to separate the beads from the solution. The beads were then washed three 
times with wash buffer containing 0.01% Tween-20. CPF was then eluted from the 
beads using a denaturing buffer. The elution fraction was then analyzed by denaturing 
urea-PAGE (Figure 4.9b). In parallel, a control reaction was carried out using a similar 
protocol but without any CPF on the Streptavidin beads. This would inform us 
whether the RNA binds to the Streptavidin beads in a nonspecific manner. Lane 1 
shows the un-cleaved substrate RNA used in the reaction (Figure 4.9b). Lane 2 shows 
the cleavage reaction products from slurry containing CPF, CF IA and CF IB (Figure 
49B). Lane 3 shows the cleavage reaction products in the slurry without any CPF 
(Figure 4.9b). There is no cleavage reaction in the absence of CPF. Lanes 4 and 5 
show the unbound excess RNA that is separated from the Streptavidin beads (Figure 
4.9b). Lane 6 shows the cleaved RNA products that were eluted from the Streptavidin 
beads containing CPF and the cleavage factors (Figure 4.9b). It can be seen that CPF 
and the cleavage factors remain bound to both the upstream and downstream RNA 
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products after cleavage. Lane 7 shows the elution fraction from the assay carried out in 
the absence of any CPF (Figure 4.9b). Compared to lane 6, only a trace amount of 
non-specific RNA binding can be seen in lane 7 (Figure 4.9b). These results show that 
CPF and the cleavage factors remain bound to both the fragments of the cleaved RNA 
products.  
 
 
 
Figure 4.9: The cleaved RNA remains bound to CPF. (a) Schematic of the pull-
down carried out on cleavage assay of CPF.  CPF was immobilized on to StrepTactin 
(ST) beads, which was then incubated with a cleavage factor-RNA mixture.  The on-
bead cleavage reaction was performed for 30 minutes. The complex bound to ST 
beads were washed three times with buffer containing 0.01% Tween-20. Samples 
were taken for analysis (as indicated in red in the schematic). (b) The ST beads pull 
downs of cleavage assays with CPF analyzed by denaturing urea-PAGE. CYC1 is the 
substrate RNA. Cleavage products are 5ʹ-CYC1 (in orange) and CYC1-3ʹ (in pink). IP = 
Input protein-RNA mix, FT = Flow through or unbound protein-RNA mix, Elu = 
Elution of the bound complex. 
It remains to be tested whether CPF and the cleavage factors also remain bound to 
polyadenylated RNA products. Repeating the aforementioned pull-downs in the 
presence of ATP would clarify this. Furthermore, it would be interesting to repeat the 
same pull down experiment under different protein concentration conditions to 
observe whether complex formation would be disrupted.  
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4.2 Length control: Molecular Ruler or Kinetic Effect?  
 
Despite our investigations, the exact molecular mechanism behind how CPF restricts 
poly(A) tail synthesis is unknown. More specifically, it is unknown if CPF possesses a 
molecular ruler that can “measure” the number of As being added, or if the observed 
poly(A) tail length restriction results from kinetic effects associated with cleavage 
factor and RNA binding. In order to address the aforementioned hypotheses, I 
produced a cleaved CYC1 RNA containing ~30 As at the 3′ end. The molecular ruler 
hypothesis would suggest that polyadenylation is terminated when the poly(A) tail 
reaches  ~ 200 As. On the other hand, a kinetic effect hypothesis would result in RNA 
products with poly(A) tails longer than ~ 200As.  
 
4.2.1 Purification of mature polyadenylated RNA 
 
A pre-cleaved CYC1 3' UTR (5'-CYC1-pc) harbouring 30 As at the 3′ end was 
synthesized as follows. In brief, the RNA was generated by PCR of a CYC1 RNA 3′ 
UTR, with a forward primer containing the T7 polymerase start site and a reverse 
primer ending in poly (T)30. The PCR product was used as a template for in vitro 
transcription. The resulting RNA was analyzed by denaturing PAGE. The desired 
band from the gel was excised and purified by electro-elution. A detailed protocol is 
described in sections 6.5 and 6.2.10. 
 
4.2.2 CPF cleaves a mature polyadenylated RNA  
 
A cleavage and polyadenylation assay was carried out using the CYC1-A30 RNA as a 
substrate. Surprisingly, rather than continuing adding poly(A) tails to the mature RNA, 
CPF cleaved the 30 As and added adenosines to the 182 nt 5'-CYC1-pc product 
(Figure 4.10). This is surprising, as the RNA contains only adenosines downstream of 
the cleavage site. It is well known that a U-rich downstream element after the pre-
mRNA cleavage sites in UTRs plays an important role in enhancing the efficiency of 
cleavage (Dichtl and Keller 2001).  
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Figure 4.10: CPF cleaves a polyadenylated CYC1 RNA. Polyadenylation assay of 
purified CPF analyzed by denaturing urea-PAGE.  A polyadenylated CYC1-pc with 30 As 
is used as the substrate. CPF cleaves the 30As and polyadenylates the cleaved CYC1-pc 
product. 
 
A similar observation has been previously reported (Viphakone, Voisinet-Hakil, and 
Minvielle-Sebastia 2008), showing that CPF could cleave a mature polyadenylated 
RNA in the absence of Nab2 or Pab1, and that poly(A) binding proteins protect the 
mature RNAs from being re-cleaved. The assays carried out here do not contain any 
poly(A) binding proteins. Nonetheless, previous work from our lab has shown that the 
cleavage factors CFI A and CFI B do not bind to poly(A) stretches, whereas the 8-
subunit core-CPF can weakly bind poly(A) RNA (Hill et al. 2019). This suggests that 
CPF could putatively bind the downstream As in a manner similar to its binding to 
downstream Us, thereby providing this unexpected cleavage. This also poses the 
question of whether CPF doesn’t re-cleave a poly(A) tail in vivo.  It is likely that the 
poly(A) tail is immediately bound by poly(A) binding proteins that protects it from 
being re-cleaved.  
 
 
 
 
 
 
Size 
(nt)
100
200
300
400
500
700
CPF cleaves a polyadenylated CYC1 RNA
5ʹ-CYC1-pc
5ʹ-CYC1-pc- poly(A)AAAN}
5ʹ-CYC1-pc- A30A30
  151 
4.2.3 The eight subunit core-CPF does not re-cleave a polyadenylated RNA  
 
To assess if core-CPF can recapitulate the cleavage of CYC1-A30 by CPF, I repeated 
cleavage and polyadenylation assays of CYC1-A30 with core-CPF and the cleavage 
factors (Figure 4.11). Surprisingly, core-CPF did not cleave a mature polyadenylated 
RNA. Instead, it continued to add poly(A) tails to the mature transcript. Consistent 
with our previous observations, assays with core-CPF resulted in hyper-
polyadenylated transcripts (Figure 4.8, Figure 4.11).  As the only difference between 
core-CPF and CPF is the phosphatase module, it is conceivable that the phosphatase 
module is involved in re-cleavage and poly(A) tail length restriction, either by 
providing additional RNA binding surfaces or by providing an allosteric effect in 
cleavage and polyadenylation activity. The above result could act as a starting point 
towards further research aimed at understanding how phosphatase module of CPF 
contributes to cleavage. 
 
 
 
 
Figure 4.11: Core-CPF does not cleave a polyadenylated CYC1 RNA. 
Polyadenylation assay of purified core-CPF analyzed by denaturing urea-PAGE.  A 
mature polyadenylated CYC1-pc with 30 As is the substrate RNA. Core-CPF continues 
to polyadenylate the mature RNA substrate. There is not poly(A) tail length control.  
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The findings described so far reveal for the first time that CPF/CFs have intrinsic 
length control of polyadenylation and that this property is dependent on the ternary 
CPF-CF I assembly on a substrate RNA. Despite these findings, it remains unclear 
how CPF is able to restrict poly(A) tails to certain lengths. The observed re-cleavage 
of previously polyadenylated RNAs hinders experiments to test the hypotheses of 
poly(A) tail length control mechanism. There are two ways by which the re-cleavage 
of RNA could be circumvented. Firstly, the length control polyadenylation assays 
could be carried out in the presence of a small molecule cleavage inhibitor, preventing 
re-cleavage. Nonetheless, there is no known inhibitor of S. cerevisiae Ysh1, 
complicating this approach. The alternative would involve establishing a recombinant 
system to produce fourteen-subunit CPF. Establishing a recombinant system to 
produce CPF will provide a means to make mutant complexes that was not previously 
possible. For example, creating a Ysh1 catalytic mutant within CPF will allow us to 
carry out polyadenylation assay of CYC1-A30, enabling us to understand the 
molecular mechanism of poly(A) tail length control by CPF.  
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4.3 Production and Characterization of a 14-subunit recombinant CPF  
 
The full fourteen-subunit CPF has been traditionally purified in the lab using a TAPS-
tag on the Ref2 subunit (Nedea et al. 2003; Schreieck et al. 2014). Although the 
preparation yields a pure protein complex (Figure 4.1b), the yield of the purification is 
very low. Starting from ~1 kg of S. cerevisiae cells typically yields ~1 mg of CPF. 
This process thus requires the impractical use of a fermenter to obtain sufficient CPF 
to carry out extensive biochemical assays. Furthermore, the entire purification process 
involves multiple carefully controlled steps and is difficult to reproduce consistently. 
The process is also laborious and time consuming. Finally, purification from 
endogenous sources often results in CPF, which is contaminated by trace amounts of 
other yeast proteins. Moving to a fully recombinant system for CPF production would 
lead to sufficient yields from only a few liters of insect cells. Furthermore, the larger 
amount of protein will enable more stringent purification of the CPF complex. Here I 
describe my efforts towards producing a fully recombinant fourteen-subunit CPF.   
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4.3.1 Producing a fully recombinant CPF (rCPF) 
 
There are several ways to recombinantly assemble a protein complex. A cost effective 
method would involve using a bacterial overexpression system consisting of a 
bacteriophage T7 promoter (Studier and Moffatt 1986). A straightforward approach to 
reconstitute multi-protein complexes is to purify the individual proteins separately 
using such a system, mix the individual components, and carry out size exclusion 
chromatography to purify the larger complex. Simpler complexes such as the cleavage 
factor I A sub-complexes Rna14/Rna15 and Pcf11-Clp1 can be recombinantly 
expressed using pETDuet and pRSFDuet vectors respectively (Noble et al. 2004; 
Gordon et al. 2011). In the aforementioned vector systems, individual genes are cloned 
into different open reading frames (ORFs), and both the genes are simultaneously 
expressed in bacterial cells. However, eukaryotic protein machineries including CPF 
often require co-translational assembly in order to form a properly folded complex. In 
addition, eukaryotic proteins also often carry post-translational modifications (PTMs) 
that are unique. Using a bacterial expression system to express yeast or mammalian 
proteins could lead to lack of PTM patterns. The requirement for complex PTMs can 
be met by using mammalian expression systems such as HeLa or HEK-293 cells 
(Bandaranayake and Almo 2014). However, scaling up of mammalian protein 
production platforms for higher yields of proteins remains difficult. The usage of 
baculovirus-mediated insect cell over-expression allows both high yield and 
preservation of most PTMs.  
 
The baculovirus-mediated insect cell over-expression system uses a late polyhedron 
promoter that includes a tetra nucleotide TAAG transcription start site (O’Reilly, 
Miller, and Luckow 1994). The baculovirus rod-shaped capsid usually encloses a 
circular, double stranded and supercoiled DNA of ~ 80 to 180 kbp (Harrap 1972; 
Chambers et al. 2018). The capsid dimensions can be expanded to make space for 
bigger genomes, making it suitable for use in recombinant protein production. Current 
protocols use a Tn7 transposition system in bacterial cells in order to generate 
bacmids. Bacmids are shuttle vectors containing the genes of interest (GOI) and can 
be propagated in both bacterial and insect cells. Bacmids are transfected into adherent 
insect cells to produce the initial virus. The initial virus is subjected to further rounds 
of amplification to increase the titer before being used to infect large scale insect cell 
cultures.  
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Some of the commonly used baculovirus systems include MultiBac and OmniBac 
systems (Bieniossek et al. 2012; Thimiri Govinda Raj, Vijayachandran, and Berger 
2014). These systems enable the expression of multiple subunits from a single 
baculoviral DNA, which is advantageous because only one DNA construct is 
transfected into the insect cells in order to produce the protein complex, reducing 
heterogeneity. One of the drawbacks of the MultiBac or OmniBac systems is the time 
required to generate large DNA constructs by restriction enzyme based cloning. In 
addition, the Cre-loxP based recombination method of the MultiBac system makes it 
challenging to control the number of genes that can be incorporated into the final 
vector to be used in protein expression.  
 
The use of a Gibson assembly reaction for the generation of baculoviral expression 
vectors has now enabled the user to have precise control over the number of gene 
copies that are introduced into the final vector (Weissmann et al. 2016). The usage of 
Gibson assembly as opposed to traditional techniques has enabled rapid and efficient 
generation of many expression vectors in parallel (Gibson et al. 2009; Weissmann et 
al. 2016). This new modified system is referred to as biGBac. In this system, the 
efficiency of the Gibson assembly is greatly enhanced due to computationally 
identified "optimal" linker overhang sequences, characterized by melting 
temperatures, propensity to form higher order structures and minimal probability to 
result in incorrect assembly. The first step of cloning in biGBac includes assembling 
the GOIs, each containing their own promoter and terminator, into the pBig1 family of 
vectors, each of which can be used to assemble up to five gene of interest. Multi-gene 
fragments from the pBig1 family of vectors can be integrated into the linearized pBig2 
family of vectors in a hierarchical fashion by unique linker sequences from the pBig1 
plasmids flanking the multi-gene insert. In this manner, a final pBig2 vector that can 
contain up to twenty-five GOI can be assembled. This method was adopted for the 
production of recombinant CPF. More details about the biGBac system can be found 
in methods sections 6.2.2 and 6.2.9.  
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4.3.1.1 Cloning a full 14-subunit complex into a single vector  
 
In order to produce the entire CPF recombinantly, I cloned all fourteen subunits of 
CPF, including a C-terminally tagged Ref2 subunit similar to endogenous 
purifications, into a single vector using the biGBac system. The polymerase module 
subunits (Cft1, Pfs2, Yth1, Fip1 and Pap1) were assembled into pBIG1a, the nuclease 
module subunits (Cft2, Ysh1 and Mpe1) into pBIG1b, five of the phosphatase module 
subunits (Ssu72, Pti1, Glc7, Ref2-SII and Swd2) into pBIG1c and the sixth 
phosphatase subunit (Pta1) into pBIG1d (Figure 4.12 a). The genes of interest 
contained a Swa1 restriction site at both ends, whereby Swa1 digestion can be used to 
confirm the incorporation of the individual CPF genes into the pBIG1 family of 
vectors. Following incorporation into the pBIG2 plasmid, PacI restriction sites either 
side of the multigene fragments enable confirmation of the incorporation of fragments 
into pBIG2 (Figure 4.12b). 
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Figure 4.12: Cloning strategy to make recombinant CPF. (a) The individual genes of 
CPF are first cloned into pBIG1 family of vectors by means of Gibson assembly.  The 
presence of individual genes within pBIG1 is verified by digesting with SwaI. Each one 
of the genes contain a SwaI digestion site both upstream and downstream as shown by 
a red arrow head.  The gene fragments from each one of the pBIG1 series of vectors 
are isolated by digesting with PmeI enzyme. (b) The gene assemblies isolated by PmeI 
are assembled in a hierarchical order into a pBIG2 vector that has also been digested 
with PmeI.  The incorporation of the gene assemblies into the pBIG2abcd is verified by 
digestion with PacI enzyme. The gene cassettes are flanked by PacI sites as shown by a 
grey arrowhead.   
  
The incorporation of such gene fragments into pBIG2abcd was verified by using 
diagnostic restriction digestion tests and PCR using gene specific primers (Figure 
4.13a, 4.13b). Digesting pBIG2abcd with Pac1 would release all the gene expression 
cassettes and would result in a pattern with five bands. Four of those bands would 
correspond to each one of the expression cassettes and one band for the backbone of 
pBIG2abcd (Figure 4.13a). After screening more than ~60 colonies, two colonies 
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referred to as CPF1 and CPF2 were found to have Pac1 digestion pattern that could 
likely correspond to the correct clone. The presence of all the fourteen genes within 
CPF1 and CPF2 clones was further confirmed by carrying out PCRs with gene-
specific primers (Figure 4.13b).  
 
 
 
 
Figure 4.13: Verification of the cloning of recombinant CPF and testing the protein 
expression. (a) The enzyme Pac I cleaves the pBIG2 series of vectors at the cloning 
site. Digestion pattern would reveal the size of the gene fragments inserted into 
pBIG2. In case of CPF cloning, the expected size of the gene fragments are A ~12000, 
C ~8100, B ~8900,  D ~3200 and pBIG2 ~3000 nucleotides. (b) The construct CPF 1 
and CPF 2 are further verified for the presence of all the fourteen subunits by 
performing PCR using gene specific primers. The products were analyzed on a 1% 
agarose-TAE gel (c) Time course expression test of a virus carrying all fourteen CPF 
subunit genes. Protein complexes were pulled down with Streptavidin beads. Ref2 
subunit contains two strep tags.  The isolated proteins were analyzed by SDS-PAGE. 
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4.3.1.2 Attempts at over-expressing the 14-subunit bacmid  
 
Once the gene composition of CPF1 and CPF2 was verified by PCR, the ~44 kb 
plasmids were transformed into EMBACYTM E. coli cells. Bacmids were generated 
from the cells using the protocol described in section 6.3.3.1. The isolated bacmids 
were transfected into Sf9 cells to produce a primary virus that is further amplified to 
yield higher titer viruses. The resulting virus was used to infect 50 ml cultures of Sf9 
cells to carry out protein expression tests. The pull-downs revealed that a full fourteen-
subunit CPF was not produced using neither CPF1 nor CPF2 viruses (Figure 4.13c). 
CPF1-infected Sf9 cells yielded no protein, likely because all CPF genes were 
removed from the viral genetic material. The size of the gene cassette that contains all 
fourteen CPF subunits is ~ 44 kb, approximately 50% of the viral genome. Under 
selection pressure, it is often the case that inserted gene constructs are eliminated from 
the genome. On the other hand, CPF2-infected Sf9 cells yielded a sub-complex of CPF 
containing Ref2, Pti1 (or Fip1), Swd2 (or Glc7) and Ssu72 subunits. However, the full 
stoichiometric CPF complex was not pulled down. It is plausible that the nuclease and 
polymerase module subunits (core-CPF) were not expressed in the cells because their 
genes were similarly ejected out from the virus. An alternative explanation is that the 
genes corresponding to core-CPF were in fact expressed, but do not get pulled down 
via the Strep-II tag on the phosphatase module subunit Ref2. Thus, the strategy of 
simultaneously expressing all fourteen subunits of CPF from a single vector did not 
yield full CPF and an alternative strategy was required to generate recombinantly 
expressed full CPF.  
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Figure 4.14: Revised strategy to make rCPF. Schematic representation of the 
strategy used to produce recombinant CPF.  (a) The nuclease and polymerase module 
was cloned into a single vector pBIG2ab. (b) The six-subunit phosphatase module was 
cloned into a separate pBIG2ab (c) The constructs core and phos are verified for the 
presence of all core-CPF and phosphatase module subunits respectively. Swa1 
digestion of the corresponding pBIG2ab vectors were analyzed on a 1% -agarose TAE 
gel (d) Time course expression test of co-infecting a virus carrying all the core-CPF 
genes with a virus with all the phosphatase subunits. The infections were performed in 
different ratios of the core and phos viruses. Protein complexes were pulled down 
with Streptavidin beads. Ref2 subunit contains two strep tags.  The isolated proteins 
were analyzed by SDS-PAGE. 
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4.3.1.3 Co-infection of core-CPF and phosphatase module viruses results in 
production of recombinant full CPF  
 
Previous work from our lab had shown that mixing Sf9 cell pellets overexpressing 
core-CPF and the phosphatase module during lysis and subsequent purification from 
the mixture of cells did not result in the assembly of the full CPF. This highlights the 
importance of in vivo assembly in the formation of CPF, despite the modules being 
functionally separate.  
I therefore adopted an approach where core-CPF and the phosphatase module would 
be co-expressed from separate vectors (viruses) in the same cells. I cloned an eight-
subunit core-CPF into the pBIG2ab vector without any affinity tags and a six-subunit 
phosphatase module into a separate pBIG2ab vector with a Strep-II tag on the Ref2 
subunit (Figure 4.14a and Figure 4.14b).  
 
The clones (named "Core" and "Phos") were verified by performing restriction 
digestion using Swa1. This released individual gene fragments contained within the 
pBIG2ab vector (Figure 4.14c). The verified clones were then transformed separately 
into EMBACYTM cells to generate bacmids and viruses of each multigene cassette 
were produced separately. High-titer viruses containing Core and Phos were produced 
and mixed together in different ratios for infections. I tested three different ratios 
(Core:Phos of 1:3, 1:1, and 3:1 by volume) for co-infection of Sf9 cells. Pull-downs 
were carried out from Sf9 cell lysate (Figure 4.14d). All virus ratios resulted in the 
production of a full fourteen-subunit CPF as analyzed by SDS-PAGE (Figure 4.15a). 
Interestingly, the amount of complex obtained from Sf9 cells was higher when Core 
and Phos viruses were mixed in equal volume amounts (1:1 ratio) or when Phos was 
present in excess (1:3). This is likely because the affinity tag is on the phosphatase 
module subunit Ref2. Thus, when the phosphatase module is present in excess, the 
total amount of CPF being pulled down is maximized. The identities of the fourteen 
different proteins were further examined using tandem mass spectrometry to ensure 
that the preparation contained all bona-fide S. cerevisiae CPF proteins and that there 
were no contaminants or homologues from Sf9 cells incorporated into CPF. Figure 15b 
lists the fourteen identified CPF subunits and describes the total number of spectra 
uniquely assigned to the individual proteins identified.  
 
Here I show a reliable and robust protocol for the over-expression of full CPF.  
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Figure 4.15: Tandem mass spectrometry confirms the subunit identities of 
recombinant CPF (rCPF) (a) SDS-PAGE of recombinant CPF isolated from Sf9 cells 
using Strep pull down (b) Tandem mass spectrometry confirms the presence of all 
fourteen CPF subunits in the recombinant preparation from Sf9 cells. The total 
number of spectra uniquely assigned to a protein is represented as exclusive spectrum 
count. 
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4.3.2 Purifying and characterizing recombinant CPF 
 
4.3.2.1 Overall purification strategy 
 
The higher yields of recombinantly expressed CPF allow more stringent purification to 
be carried out. I developed a purification protocol for recombinant CPF (hereafter 
referred to as rCPF) resulting in a highly pure and homogenous preparation.  
 
The various steps in the purification of rCPF are illustrated in figure 4.16a. The first 
step involves pulling down the Ref2 subunit of CPF via its C-terminal Strep-II tag. 
SDS-PAGE of the protein complexes isolated after Streptavidin pull downs reveal a ~ 
200 kDa contaminant along with the other CPF bands (shown by * in figure 4.16b). 
Furthermore, the eluted fractions did not contain stoichiometric amounts of the CPF 
subunits. The phosphatase and nuclease module subunits are present in higher 
amounts relative to the polymerase module subunits (Figure 4.16b). To remove the 
additional contaminating proteins and to clarify the subunit heterogeneity present 
within CPF, the eluted fractions from Strep pull downs were subjected to anion-
exchange chromatography. The bound proteins were separated by a shallow gradient 
elution starting from 150 mM KCl to 1 M KCl containing buffer (Figure 4.16c).  
 
The chromatogram of the anion-exchange step shows two protein peaks (peak 1 and 
peak 2) and two nucleic acid rich peaks (peak 3 and peak). SDS-PAGE analysis of 
peak 1 revealed a nine-subunit nuclease-phosphatase complex (Figure 4.16d). The 
existence of such a complex has not been previously described before. During the 
purification of native CPF, we usually isolate a seven-subunit APT complex along 
with full CPF (Lidschreiber et al. 2018). APT is a seven-subunit complex made up of 
all the six phosphatase module subunits along with the protein Syc1 (Nedea et al. 
2003; Lidschreiber et al. 2018). In the recombinant system, however, Syc1 is not 
present. I hypothesize that the Syc1-interacting region in the phosphatase module 
interacts with Ysh1 instead as the C-termini of Ysh1 and Syc1 are homologous. In this 
complex, it is possible that Ysh1 can be further associated with Mpe1 and Cft2, 
resulting in the novel nuclease-phosphatase module. Interestingly, later experiments 
revealed that the nuclease-phosphatase complex is unable to cleave a substrate CYC1 
RNA (appendix 8.9), highlighting the importance of the polymerase module subunits 
in the nuclease activity of CPF.  Peak 2 contains full CPF as revealed by SDS-PAGE 
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(Figure 4.16d). It is interesting to note that the stoichiometry of Pap1 seems to vary 
across the peak (highlighted by a pink box). This is reminiscent of the shallow 
gradient anion-exchange purification of native CPF carried out previously in the lab, 
where CPF associated with two, one, or no copies of Pap1 was observed (Easter 
2014). Purification of the recombinant polymerase module described in section 2.1.1 
also revealed a similar polymerase complex that contains two, one, or no copies of 
Pap1. The CPF with differential Pap1 stoichiometry can partially explain the non-
Gaussian nature of the profile. This can be further explained by the lack of the  ~200 
kDa Sf9 contaminant at higher salt elution. The fractions without this contaminant 
(and containing one copy of Pap1) were used in further purification, as highlighted by 
curly brackets in Figure 4.16d. 
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Figure 4.16: Purification of recombinant CPF (rCPF). (a) Flow chart describing the 
different steps involved in the purification of rCPF. (b) Streptavidin pull down of the 
Sf9 cell lysate was analyzed by SDS-PAGE. (c) Anion exchange chromatography using a 
Resource Q column. (d) The four different peaks observed in the anion exchange step 
were analyzed using SDS-PAGE. Peak 1 was found to contain the nuclease-phosphatase 
module. Peak 2 contains the full recombinant CPF.  It can be seen that across peak 2, 
the stoichiometry of Pap1 polymerase is varying (highlighted by a red box). Peak 2 
fractions highlighted by pink curly bracket were pooled together for further 
purification by size exclusion chromatography.    
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CPF fractions from anion exchange chromatography were further purified by size 
exclusion chromatography (Figure 4.17a). CPF eluted from the Superose 6 Increase 
3.2/300 column at 1.25 ml. SDS-PAGE of this peak revealed a highly pure CPF 
preparation with stoichiometric amounts of each subunit (Figure 4.17b). The CPF 
sample was concentrated, flash frozen in liquid nitrogen, and stored at -80 °C for 
future biochemical experiments. The frozen sample was later thawed and run on a size 
exclusion column to assess its integrity. It was found that the frozen CPF did not show 
significant aggregation or differences in behavior on a size exclusion column 
(appendix 8.10).  
 
 
 
Figure 4.17: Negative stain electron microscopy of rCPF (a) Chromatogram of rCPF 
run on a Superose 6 Increase 3.2/300 column in SEC buffer. (b) The peak fractions 
were analyzed using SDS-PAGE. (c) Negative stain electron microscopy analysis of 
rCPF.  A representative micrograph at 21K x magnification and -1.7 µM defocus.  A 
red circle highlights a single particle of CPF. (d) Selected 2-D class averages of aligned 
particles highlighting sample heterogeneity. Red arrow points to the density likely to be 
Ysh1, blue arrow to Cft2 and green arrow to phosphatase subunits.   
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4.3.2.2 Negative stain electron microscopy of rCPF 
 
To further assess sample homogeneity, I carried out negative stain electron 
microscopy of un-crosslinked rCPF immediately following size exclusion 
chromatography. The micrographs revealed well-distributed individual particles that 
were roughly ~20 nm in their maximum dimension (highlighted by a red circle in 
figure 4.17c). However, aggregates and smaller particles were also visible. Selected 2-
D class averages of aligned CPF particles reveal distinct ~20 nm particles (Figure 
4.17d). The best-aligned density looks very similar to the Cft1-Pfs2-Yth1 subunits of 
the polymerase module (Figure 2.9a). The scaffold seems to anchor several other 
modules that appear as globular densities. The globular density appears to be very 
dynamic with respect to the central scaffold, likely reflecting the inherent flexibility of 
CPF. The identities of the densities cannot be ascertained. However, the density shown 
using blue arrows in Figure 4.17d could correspond to Cft2 (Hill et al. 2019), the beta 
propeller containing protein known to closely associate with the polymerase module. 
The density shown using red arrow in Figure 4.17d could correspond to the 
endonuclease Ysh1 that is flexibly tethered to CPF via Mpe1 (Hill et al. 2019). The 
densities resembling three circular dots (highlighted using green arrows) in figure 
4.17d could be the phosphatase module subunits.  
 
In summary, the 2-D class averages show that the sample contains ~20 nm particles 
and that subunits within CPF are flexibly tethered to the polymerase module, which 
acts as the central scaffold.  
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4.3.3 Biochemistry of rCPF 
 
Having established a protocol for the production of highly pure milligram quantities of 
recombinant CPF from practical volumes of insect cells, I then tested the biochemical 
activity of the complex. In vitro assays reveal that rCPF can cleave and polyadenylate 
a substrate CYC1 RNA (appendix 8.11).  
 
4.3.3.1 rCPF does not have inherent length control 
 
As rCPF showed similar biochemical activity compared to endogenously purified 
CPF, I sought to test if rCPF could restrict the length of poly(A) tails in a similar 
manner. Coupled cleavage and polyadenylation assays of an in vitro transcribed CYC1 
RNA were performed using recombinant S. cerevisiae CPF purified from Sf9 cells, as 
well as CF IA and CF IB recombinantly purified from E.coli. Surprisingly, despite the 
apparent identical subunit composition and reaction conditions, rCPF does not restrict 
the length of the poly(A) tails in assays (Figure 4.18b), unlike native CPF (Figure 
4.2a). Urea-PAGE analysis of the reaction shows the polyadenylated products as a 
widely distributed smear ranging from ~ 100 A's to 600 A's. 
 
 
 
Figure 4.18: rCPF does not have the intrinsic capacity to restrict the length of 
poly(A) tails (a) SDS-PAGE showing purified rCPF after size exclusion 
chromatography that was used in the assay. (b) Coupled cleavage and polyadenylation 
assay of purified rCPF analyzed by denaturing urea-PAGE. CYC1 is the substrate RNA. 
Cleavage products are 5ʹ-CYC1(in orange) and CYC1-3ʹ (in pink).   
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The intrinsic length control property of CPF is sensitive to the relative concentrations 
of CPF and the cleavage factors to that of the substrate RNA. In endogenous 
preparations of CPF, the final concentration is in the range of 0.5 mg/ml, whereas for 
rCPF, this is around 2 mg/ml. Significant error in the estimated concentrations could 
potentially explain the lack of poly(A) tail length control by rCPF. To clarify this 
hypothesis, more accurate estimates of protein concentration may be required, and 
length control assays should be carried out while titrating the amount of rCPF.  An 
alternative explanation could be that the native CPF preparation contains trace 
amounts of impurities or other co-factors that could influence its biochemical 
property, due to the less stringent protein purification process, whereas the preparation 
of rCPF is sufficiently stringent and contains no such impurities or co-factors. 
 
It has been shown that phosphorylation of Pap1 affects its ability to add a poly(A) tail 
(Mizrahi and Moore 2000). It is not uncommon to find different levels of 
posttranslational modifications in proteins from higher eukaryotes when compared to 
the yeasts or bacterial counterparts. Therefore, a third possible explanation to why 
rCPF does not have an intrinsic ability to restrict the poly(A) tail length could stem 
from different PTMs in native and recombinant preparations.  
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4.3.3.2 rCPF and native CPF has different post-translational modifications 
 
To understand whether recombinant expression of CPF influences the pattern of its 
posttranslational modifications, tandem mass spectrometry was used.  Samples from a 
Streptavidin pull-down of rCPF from Sf9 cell lysate and were analyzed by SDS-PAGE 
and compared to endogenously purified CPF from S. cerevisiae cells. The bands 
corresponding to each of the individual CPF subunits were excised from the gel and 
subjected to tandem mass spectrometry (detailed protocol in methods 6.8.2). rCPF and 
native CPF harbour very different phosphorylation patterns (Figure 19). Only the 
phosphatase subunits Pta1 and Ssu72 contain similar phosphorylation mark in both the 
yeast and insect cell preparations. In light of lack of any structural data on full CPF, it 
is unclear how these phosphorylation marks might influence the structure and function 
of CPF. 
 
 
 
Figure 4.19: Recombinant and native CPF preparations contain different 
phosphorylation patterns. Tandem mass spectrometry reveals different 
phosphorylation marks in the two CPF preparations. The total number of spectra 
uniquely assigned to a protein is represented as exclusive spectrum count.  
   
 
 
 
Phosphorylation sites identified in rCPF(a) Phosphorylation sites identified in native CPF(b)
Protein Residues phosphorylated
Cft2
Pta1
Ysh1
Mpe1
Fip1
Ssu72
S583
S366, S370, T380, S500, S553
S15, S27, S38, S50, S163
S338, S441
S221
S43
Protein Residues phosphorylated
Pta1
Ref2
Mpe1
Pfs2
Fip1
Pti1
T378, T380, S390
S396, S438
S56
S199
Y9
S267, S268, T271, S272, 
S274, S407, S410
Ssu72 S43
  171 
4.4 Discussion 
 
Previous assays performed in the absence of Nab2 resulted in hyper-polyadenylation 
of the substrate RNAs. It is thought that Nab2 can bind to the elongating poly(A) tail 
and restrict the lengths of the poly(A) tails to ~ 60 As. Surprisingly, the nuclear 
poly(A) binding protein Nab2 is not essential for in vitro poly(A) tail length control, as 
demonstrated in this chapter. I have demonstrated that CPF and cleavage factors have 
the intrinsic ability to restrict the lengths of newly added poly(A) tails to ~80-200 A’s. 
Interestingly, poly(A) tail lengths observed here are longer than the in vivo poly(A) 
tail length i.e. ~ 60As.   Nonetheless, the mechanism by which CPF and the cleavage 
factors impart poly(A) tail length control without Nab2 remains unknown.  
 
By dissecting the requirements of different protein factors for poly(A) tail length 
restriction, I have found that cleavage factors CF IA and CF IB are essential for 
intrinsic poly(A) tail length control. When the RNA is at a concentration of 100 nM, 
CPF at 50 or 100 nM, and the cleavage factors are present in threefold excess, poly(A) 
tail length control by CPF is observed. It is hypothesized that CFs are present 
presumably in excess of their Kd for RNA binding, resulting in the formation of a 
stable complex with the product RNA. In order to clarify this, the exact affinities of 
CF IA and CF IB towards binding substrate (and product) RNA have to be 
determined. One candidate for RNA binding is the Rna15 subunit of CF IA, which 
contains RRM domains that are known to contact U and G/U rich sequences. The 
affinity of the RRM domain of Rna15 to binding a poly(U) RNA has been estimated to 
be 10 µM (Pancevac et al. 2010). Nonetheless, there are no reported studies of the 
exact RNA binding affinities of highly pure cleavage factors. However, estimation of 
affinities from EMSA experiments reveal a Kd of ~ 250 nM for CF IA - RNA binding 
(Hill et al. 2019). Understanding the RNA-binding affinities of cleavage factors could 
allow the estimation of binding saturation under reaction conditions, potentially 
providing an explanation for the stoichiometry of cleavage factors required for 
poly(A) tail length restriction to be observed. These experiments should be 
accompanied by further polyadenylation assays where the cleavage factors are titrated 
to observe the minimum concentrations (and stoichiometry) required to observe 
poly(A) tail length control, and to observe if a larger proportion of the un-
polyadenylated 5′ CYC1-pc becomes polyadenylated. 
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In general, enzymes do not remain tightly bound to their substrates or products, in 
order to allow efficient catalysis. I hypothesized that CPF, along with the cleavage 
factors, remain tightly bound to the polyadenylated RNA (figure 4.20). This likely 
results in termination of poly(A) tail addition after ~ 80 to ~ 200 As. To this end, I 
have shown via in vitro pull down experiments that the cleaved RNA products remain 
bound to CPF and the cleavage factors. This pull-down has also enabled us to 
understand the experimental conditions at which such pull-downs can be 
unambiguously performed. The next step would be to carry out pull-downs of 
cleavage coupled with polyadenylation reactions. This will provide insight into 
whether the polyadenylated RNA product remains bound to CPF (and the cleavage 
factors). Further single molecule fluorescence experiments on CPF/CF I bound RNA 
will be required to confirm this hypothesis.  
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Figure 4.20: A model for poly(A) tail length control by CPF, CF IA and CF IB.  
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The in vivo poly(A) tail length of a model RNA in the absence of Nab2 is longer than 
~ 60As (Schmid et al. 2015). The assays described here could recapitulate a situation 
in the cell, when Nab2 is unavailable to act on the newly made poly(A) containing 
mRNAs. This may happen during a rapid increase in transcription rate or in case of 
mRNA export defects when all the available Nab2 would be sequestered by poly(A) 
containing RNAs in the nucleus. The intrinsic poly(A) tail length control property of 
CPF described here would ensure that the mRNAs are not massively hyper–adenylated 
and that nuclear ATP is not rapidly depleted by polyadenylation. These newly made 
RNAs with poly(A) tail lengths of ~200 A’s could either be subjected to exosome 
mediated decay or later be bound by Nab2, and exported into the cytoplasm. Thus, the 
intrinsic poly(A) tail length control of CPF discussed in this chapter could be a quality 
control pathway that prevents abnormal long polyadenylation of transcripts. It will be 
interesting to know how Nab2 can regulate polyadenylation alongside CPF's intrinsic 
capacity to control poly(A) tail lengths. Perhaps Nab2 can bind and sequester polyA 
RNAs from the CPF/CFI complex, and shuttle such sequestered poly(A) containing 
RNAs for export to the cytoplasm. This scenario can be tested using the in vitro pull 
down described in 4.1.5, as the addition of Nab2 to the pull-downs of cleavage and 
polyadenylation assays may sequester the polyadenylated RNA product from CPF and 
the cleavage factors. Furthermore, addition of Nab2 to polyadenylation assays may 
release the tightly bound CPF so that it can act on cleaved but non-polyadenylated 
transcript. Such experiments could clarify the role of Nab2 in termination of 
polyadenylation.  
 
A method to recombinantly produce a fourteen-subunit rCPF has been described. The 
purity and homogeneity of the purified proteins were assessed by size exclusion 
chromatography, SDS-PAGE, and negative stain electron microscopy. rCPF could 
cleave a substrate RNA and add a poly(A) tail and showed comparable activity to 
endogenously purified CPF. Surprisingly, rCPF differed from the natively purified 
CPF in its ability to intrinsically impart poly(A) tail length control. At this point, the 
reason behind such a difference remains unclear. However, tandem mass spectrometry 
revealed different phosphorylation patterns in the subunits of native and 
recombinantly produced CPF. It will be interesting to de-phosphorylate both native 
and recombinant CPF using a generic phosphatase, and repeating polyadenylation 
assays under length control conditions. Such an experiment could elucidate the 
importance of post-translational modifications in the intrinsic ability of CPF to restrict 
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poly(A) tail lengths. Alternatively, treatment of the CPF preparations with kinases 
from yeast such as Ctk1 could write the missing marks and prime CPF for intrinsic 
poly(A) tail length control.   
 
The lack of protocols to efficiently purify large quantities of highly pure CPF has thus 
far hindered our progress towards understanding the structure and function of CPF. For 
the first time, the recombinant system allows us to generate high amounts of sample, 
allowing us to perform the necessary experiments (i.e. cross-linking mass spectrometry, 
hydrogen–deuterium exchange coupled with mass spectrometry, fluorescence 
polarization studies) to thoroughly biophysically characterize CPF. These studies open 
new experimental possibilities to study the protein-protein interaction network within 
CPF, affinity measurements for substrate binding, etc.  Establishing a recombinant 
system to produce CPF has also provided a means to make mutant complexes that was 
hitherto impractical. Thus, I have generated a new tool that facilitates progress towards 
our understanding the mechanism of cleavage and polyadenylation by CPF. 
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5 Conclusion and Future Directions 
 
In this dissertation, I have studied the mRNA 3' end polyadenylation reaction by using a 
biochemical and structural approach. The main questions under investigation were as 
follows:  
 
1. Why does Pap1 exist in the context of a complex and what is the functional 
significance of this? 
2. What are the roles of the non-enzymatic subunits in CPF? 
3. How are the CPF subunits arranged in 3D space? 
4. How do accessory factors influence the function of CPF? 
5. What are the mechanisms governing how poly(A) tail lengths are regulated?   
 
In the next few sections, I summarize the important findings of this dissertation and 
provide future perspectives.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  178 
5.1 Structural Architecture of the Polymerase Module 
 
By using baculovirus mediated insect cell over-expression, I expressed and purified a 
five-subunit polymerase module of CPF. Biochemical assays revealed that isolated 
Pap1 and the polymerase module add poly(A) tail to a substrate RNA in a similar 
manner. Cryo-EM analysis of a four-subunit polymerase module (without Pap1) 
resulted in a 3.5 Å resolution map. An atomic model of almost all of the Cft1, Pfs2 and 
Yth1 subunits were built into the map, revealing an architecture that was highly similar 
to other nucleic acid processing complexes involved in DNA damage repair and 
splicing. Around the same time, the structures of the human CPSF160-WDR33-CPSF30 
in complex with an AAUAAA containing RNA were published (Sun et al. 2018; Clerici 
et al. 2018), revealing a high degree of similarity between the human and yeast 
complexes. The structures also provide insights into understanding how the yeast and 
human complexes might employ slightly different mechanisms to recognize substrate 
RNA. This is further reflected in the differences in the yeast and human cis-RNA 
elements.  
 
In the future, a 3D structure of the yeast polymerase module in complex with a substrate 
RNA will enable better appreciation of the differences. Specifically, the structure will 
elucidate the determinants of RNA binding specificity. Furthermore, cryo-EM and 
cross-linking mass spectrometry have revealed that Pap1 is flexibly associated with the 
polymerase module. An RNA-bound polymerase module sample might aid in 
stabilizing Fip1 and Pap1 that are currently not visible in the cryo-EM map.  
 
A previous study had shown that a terminal deoxyadenosine residue at the 3' end of a 
pre-cleaved RNA enables a stable protein -RNA complex formation (Zarkower and 
Wickens 1987). Performing an in vitro polyadenylation assay (as described in section 
2.2) in the presence of cordycepin (abscence of ATP) may allow in stabilizing Pap1 and 
polymerase module on RNA. This may result in an improved sample for structural 
studies by cryo-EM. The key to the aforementioned future direction would be in 
identifying the right substrate RNA, as yeast mRNA sequences do not contain a 
conserved consensus recognition sequence, unlike AAUAAA in human mRNAs. For 
example, two of the most well studied substrates for cleavage and polyadenylation i.e 
CYC1 and GAL7 share a considerable amount of differences in RNA elements (Zhao et 
al. 1999; Dichtl and Keller 2001). One possible method to overcome this challenge 
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would be to characterize the RNA sequence (and structure) specificity of polymerase 
module. RNA Bind-n-Seq is a recently published method that allows the determination 
of high-affinity binding motifs (Lambert et al. 2014).  
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5.2 Effects of Cleavage Factors 
 
In chapter 3 of this dissertation, I have shown that the accessory cleavage factor CF IA 
(but not CF IB) can stimulate poly(A) tail addition of CPF. By using a minimal in vitro 
reconstituted system, I further show that Rna14/Rna15 subunits of CF IA are sufficient 
to stimulate poly(A) tail addition by polymerase module. Interesting, CF IA (or 
Rna14/Rna15) has no effect on polyadenylation activity of Pap1. Thus, the non-
enzymatic subunits in polymerase module (and hence CPF) are required for its 
stimulation by CF IA.  In vitro pull downs reveal that CF IA directly contacts CPF 
through an interaction between Rna14/Rna15 and the non-enzymatic polymerase 
module subunits. By using a mutant Rna14/Rna15 that can no longer strongly bind 
RNA, I show that RNA binding of Rna14/Rna15 is important for its polyadenylation 
stimulation property. I present a model where CF IA provides accessory RNA binding 
surfaces for polymerase module to bind RNA, tethering polymerase module to the 
substrate RNA and resulting in processive polyadenylation.  
 
This model of polyadenylation can be compared to the model for human poly(A) tail 
addition. In both cases, the polymerase enzyme appears to be distributive in nature. 
However, in humans, the incorporation of PAP within CPSF makes the polyadenylation 
reaction processive by providing additional RNA binding surfaces (Schönemann et al. 
2014; Chan, Huppertz, Yao, Weng, Moresco, Yates, et al. 2014). In contrast, in yeast, 
Pap1 incorporation into the polymerase module does not markedly increase 
polyadenylation activity. Instead, processive polyadenylation is only achieved when 
Rna14/Rna15 or CF IA is present, whereby the affinity for RNA of the whole 3'-end 
processing complex is increased. Unlike the yeast machinery, the human complex 
achieves such high substrate affinities without the need for any cleavage factor subunits. 
Such a difference between the yeast and human machinery could stem from the subtle 
differences in sequences and sequence preferences for cis-RNA elements.  
 
A method to assemble a complex between polymerase module and Rna14/Rna15 in 
vitro has been presented. This now allows us to study not only the RNA binding 
affinities of the individual components but also perform detailed kinetic analysis. I 
speculate that the koff for RNA binding by the polymerase module will be lower when it 
binds RNA cooperatively with CF IA (or Rna14/Rna15), explaining the differences in 
activity in the presence or absence of CF IA.  
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Furthermore, it is imperative to test the effects of CF IA on polyadenylation using a 
different substrate RNAs. This will inform us whether this mechanism is conserved 
across different cis-RNA elements. 
 
It is known that cleavage precedes polyadenylation in vivo and that CF IA activates 
cleavage by CPF. However, the exact mechanism by which CF IA activates cleavage is 
unknown. A recent study from our lab has shown that Rna14/Rna15 alone cannot 
activate cleavage by CPF and that Pcf11/Clp1 are required for its activation (Hill et al. 
2019). This raises the possibility that activation of cleavage by CF IA could not simply 
be an effect of RNA binding. A future experiment would be to test the effect of the 
RNA binding mutant of CF IA (similar to the one described here) on activation of 
cleavage. The observed effect will raise new questions about the activation mechanism 
of CF IA. It will be interesting to know whether CF IA activates CPF endonuclease and 
polymerase activities via two different mechanisms.  
 
 By using a combination of biophysical techniques including HDX, cross-linking mass 
spectrometry and cryo-EM, I have characterized the interaction between Rna14/Rna15 
and polymerase module. Although HDX experiments revealed that the Fip1 subunit of 
polymerase module potentially interacts with Rna14/Rna15, biochemical assays suggest 
that there might be multiple interaction surfaces between the two complexes. Cryo-EM 
analysis showed that the HAT-domain of Rna14 likely associates with the Cft1 subunit 
of polymerase module. In agreement with this, several cross-links were found between 
them. In the absence of a high-resolution structure of the complex, molecular details of 
these interactions remain unknown, impeding our understanding of the possible 
allosteric effects of cleavage factors on the function of polymerase module. However, 
the preliminary cryo-EM analysis presented in this dissertation revealed the inherent 
heterogeneity (or flexibility with respect to each other) of the polymerase module - 
Rna14/Rna15 sample.  Mild cross-linking using a water-soluble cross-linker like BS3 
might aid in fixing the complex in one conformation, possibly reducing the flexibility.  
 
In the cell, CPF functions alongside with CF IA and CF IB. Therefore the model 
presented here on the role of CF IA in polyadenylation may reflect a scenario happening 
in vivo. Similarly, there are many other protein-nucleic acid complexes in the cell that 
could potentially influence the function of CPF. A previous in vitro study using human 
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proteins has show that U1A snRNP complex stimulates polyadenylation by interacting 
with CPSF-160 (Lutz and Alwine 1994). Further research is needed to understand the 
effects of other complexes on cleavage and polyadenylation, which might clarify the 
roles of the other non-enzymatic subunits of CPF subunits.   
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5.3 Polyadenylation mechanism 
 
Using highly pure protein components, I have investigated the polyadenylation 
activity of a fourteen-subunit CPF in an in vitro biochemical system. Surprisingly, the 
assays revealed that CPF has an intrinsic ability to stall polyadenylation after adding ~ 
80 - 200 As without the need for the nuclear poly(A) binding protein Nab2. Drop out 
experiments then revealed that the cleavage factors CF IA and IB and the phosphatase 
module of CPF were indispensible for this observed poly(A) tail length control.  
 
While investigating the mechanism of intrinsic length control, I serendipitously 
discovered that CPF can cleave the poly(A) tail of a CYC1-A30 in vitro. It has been 
shown that the presence of the nuclear poly(A) binding protein Nab2 can prevent such 
re-cleavage events in cells (Viphakone, Voisinet-Hakil, and Minvielle-Sebastia 2008). 
This raises several interesting questions. Firstly, it is not known if CPF can re-cleave 
it's own product RNA with poly(A) tail in an in vitro assay in the absence of Nab2. 
Secondly, under length control conditions, significant amounts of the cleaved 5'-
CYC1-pc RNA remains without a poly(A) tail. It is not known if these non-
polyadenylated RNA products are the result of CPF re-cleavage. Thirdly, I 
demonstrated that a minimal eight-subunit core-CPF cannot re-cleave the poly(A) tail 
of CYC1-A30 RNA, highlighting the contribution of the phosphatase module towards 
the cleavage activity of CPF. We know that CF IA and CF IB do not tightly bind 
poly(A) RNAs, and that core-CPF can only weakly bind to poly(A) stretches (Hill et 
al. 2019). Nonetheless, it is unknown whether the presence of the phosphatase module 
in CPF enables CPF to bind tightly to poly(A) stretches and result in re-cleavage 
activity. Alternatively, phosphatase module subunits could impart an allosteric 
influence on the cleavage activity of CPF. Investigations of the role of phosphatase 
module in influencing the cleavage of CPF would clarify the significance of the 
presence of all CPF subunits in recapitulating the in vivo behaviour of CPF. 
 
So far, all assays demonstrating intrinsic length control have been carried out using 
either a 259 nt CYC1 full or a 182 nt pre-cleaved CYC1 as a model substrate. It 
remains to be tested whether the 3' end processing machinery will have intrinsic 
poly(A) tail length control on a shorter CYC1 such as the well characterized pre-
cleaved CYC1 42-mer. Such an experiment will enable us to understand the 
contributions from the cis-elements of CYC1 such as the efficiency or positioning 
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element, to the observed intrinsic length control. Additionally, in order to understand 
whether this could be conserved across a variety of CPF substrates, it is important to 
test different RNA substrates. The other most commonly studied model RNA is GAL7. 
However, in vitro assays of a full-length GAL7 using purified CPF and cleavage 
factors resulted in no detectable RNA cleavage of the RNA (appendix 8.12). A similar 
observation was reported earlier where a wild-type GAL7 RNA could not be cleaved 
by CPF (Dichtl and Keller 2001). I have thus identified and produced the 3' UTR of 
two new RNAs: GCN4 and MFA2 (appendix 8.13). GCN4 consists of a complex 
polyadenylation signal that differs greatly from the most commonly studied CYC1 
RNA (Egli, Springer, and Braus 1995). MFA2 is a very small mRNA where a long-
range interaction between the 5' and 3' UTR has been shown in vivo (Doktycz et al. 
1998). The choice of such RNAs (with very different properties compared to CYC1) 
would enable us to elucidate whether the observed intrinsic length control 
phenomenon is conserved across diverse RNA elements. Additionally, it will serve as 
a platform to investigate the effects of various cis-acting elements towards cleavage 
and polyadenylation.  
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5.4 Final conclusions 
 
The field of mRNA 3'-end processing has greatly advanced since the discovery of 
poly(A) polymerase in 1960. The tremendous progress made can be attributed to the 
advancements made in modern molecular biology including recombinant DNA 
technology, sequencing and protein engineering. Although the identities of the 
individual components of the mRNA 3'-end processing machinery were known, there 
remained a lack of understanding of how the components were structurally organised 
into one whole complex and how this affects the function. Taking advantage of the 
recent progress in the fields of recombinant protein production and cryo-EM, I was 
able to visualise the intricate and extensive contacts between different protein subunits 
that constitute a major part of CPF. Together with various biophysical techniques and 
in vitro assays described in this dissertation, I provide new insights into how CPF adds 
poly(A) tails and how it restricts the length of poly(A) tails. Moreover, I have also 
described a method to recombinantly produce a full fourteen-subunit CPF. This will 
have a long lasting impact on our ability to probe the function and structure of CPF. 
We are only beginning to understand the workings of this poorly studied yet essential 
step in the central dogma of molecular biology.  
 
 
 
 
 
 
 
 
 
 
 
 
 
  186 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  187 
6 Materials and Methods 
 
6.1 Common reagents and methods 
 
6.1.1 Generic buffers 
 
The following are the description of some of the commonly used buffers: 
 
• Elution Buffer (EB): 10 mM Tris pH 8.0. 
• Tris Borate EDTA (TBE): 10 mM Tris-borate pH 8.0, 1 mM EDTA pH 8.0. 
• Tris EDTA (TE): 10 mM Tris pH 8.0, 1 mM EDTA pH 8.0. 
• Competent cell buffer 1 (CCB1): 10 mM MES, 100 mM RbCl2, 50 mM MnCl2, 
10 mM CaCl2, pH 5.8 with acetic acid. 
• Competent cell buffer 2 (CCB2): 10 mM MOPS, 100 mM CaCl2, 10 mM RbCl2, 
15% glycerol v/v, pH 6.5 with NaOH. 
• Phosphate buffered saline (PBS): 137 mM NaCl, 10 mM Phosphate, 2.7 mM 
KCl, pH 7.4. 
 
The buffers used in protein purifications are described in later sections.  
6.1.2 Media 
 
6.1.2.1 Bacterial overexpression 
 
6.1.2.1.1 Liquid media 
 
• 2xTY: 10 g yeast extract, 16 g tryptone, 5 g NaCl, ~ 2.5 ml 1 M NaOH (to pH 
7.4), adjust to 1 L with milliQ H20 (MQ), autoclave. 
 
• LB: 5 g yeast extract, 10 g tryptone, 10 g NaCl, 900 ml MQ, ~2.5 ml 1 M 
NaOH(to pH 7.0), adjust to 1 L with MQ, autoclave. 
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• SOC: 5 g yeast extract, 20 g tryptone, 0.6 g NaCl, 0.2 g KCl, 900 ml MQ, 3.5 ml 
1M NaOH (to pH 7.2), adjust to 1 L with MQ, autoclave, add: 10 ml 1 M 
MgCl2, 10 ml 1 M MgSO4, add 10 ml 20% w/v glucose immediately before use. 
 
6.1.2.1.2 Plates 
 
• TYE: 5 g yeast extract, 10 g tryotone, 8 g NaCl, 15 g agar, ~2.5 ml 1 M NaOH 
(to pH 7.0), adjust to 1 L with MQ, autoclave. 
 
• LB: 15 g agar, 5 g yeast extract, 10 g tryptone, 10 g NaCl, 900 mL MQ, ~2.5 
mL 1M NaOH (to pH 7.5), adjust to 1 L with MQ, autoclave. 
 
6.1.2.2 Insect cells over expression 
 
• Sf9 Media: Insect-XPRESS™ protein-free insect cell medium with L-glutamine 
from Lonza. 
 
6.1.2.3 E.coli minimal media for isotope labelling 
 
• K-MOPS: 10x stock: 1.0 M MOPS, 0.1 M Tricine mix, pH to 8.0 with KOH 
(800 ml);10 mM FeCl2 (10 ml); 1 mM CaCl2 (10 ml); 1 mM MgCl2 (10 ml), 20 
mM H3BO3, 5 mM CoCl2, 2 mM CuCl2, 10 mM MnCl2, 2 mM ZnCl2, 2 mM 
NaMoO4 mix (10 ml); 4.0 M NaCl (10 ml); dilute 10x stock to 1x with MQ and 
autoclave; add directly before use 20 mM NH4Cl, 4 mM KPi, 1% w/v glucose, 
10 mg thiamine, 2 mg D-biotin, 2 mg choline chloride, 2 mg folic acid, 2 mg 
niacinamide, 2 mg D-phantothenic acid, 2 mg pyridoxal, 2 mg riboflavin. K-
MOPS minimal medium containing 15NH4Cl was used for 2-D NMR 
experiments. For 3D experiments, media also contained [13C] glucose. 
 
6.1.2.4 Antibiotics  
 
Antibiotics were made at the following stock concentrations in autoclaved MQ H2O: 
kanamycin 50 mg/ml in MQ H2O, chloramphenicol 35 mg/ml in 100% EtOH and 
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gentamycin 10 mg/ml in MQ H2O. The final concentrations of the antibiotics are also 
mentioned as follows: kanamycin 50 µg/ml, chloramphenicol 35 µg/ml and gentamycin 
10 µg/ml in liquid media or 7 µg/ml in bacmid plates.  
 
6.1.3 Cells and strains 
 
Strain Genotype 
TOP10 F-mcrAΔ(mrr-hsdRMS-mcrBC) 
Φ80lacZΔM15 ΔlacX74 recA1 
araD139 Δ(araleu)7697 galU 
galK rpsL (StrR) endA1 nupG 
BL21 Star (DE3) F-ompT hsdSB(rB–,mB–) gal 
dcm rne131 (DE3) 
DH10EmBacY  F-mcrA Δ(mrr-hsdRMS -
mcrBC) Φ80lacZΔM15 ΔlacX74 
recA1 endA1 araD139 Δ(ara, 
leu)7697 galU galK λ-rpsL nupG 
(bEmBacY, pTn7helper) 
 
Table 6.1: E.coli strains used in this dissertation 
 
 
6.1.4 Making competent cells 
 
Terence Tang and James Stowell prepared the competent cells. Four colonies of a 
desired E.coli strain from a freshly streaked plate is grown in 5 mL of LB media at 200 
rpm (37 °C) for 2 h until an OD550 of 0.3. 2 mL of this pre-culture is used as a starter 
culture to inoculate 40 mL of pre-warmed LB and grown at 200 rpm (37 °C) to an 
OD550 of 0.45.  
 
The next few steps were all carried out on ice. The cells grown to OD550 of 0.45 were 
decanted into 50 mL falcon tubes, incubated on ice for 15 min, pelleted at 1300 rcf (4 
°C) for 15 min, and suspended in 2 mL of CCB1 by swirling the tube gently. The total 
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volume was brought to 16 mL with CCB1, and the suspension was incubated on ice for 
15 min. Cells were gently harvested at 1300 rcf (4 °C) for 15 min. The pellet was 
resuspended in 1.6 mL CCB2 and the suspension was incubated on ice for 15 min. The 
suspension was aliquoted either as 50 or 100 µL volume into 1.5 mL tubes, slowly 
frozen, and stored at -80 °C. 
 
6.1.5 Plasmid transformation 
 
~ 10 ng of plasmid DNA was gently mixed with 50 µl of chemically competent E. coli 
in a 1.5 mL tube and incubated for 30 min on ice. The tube was swiftly transferred into 
a water bath at 42 ºC for 45 sec, and subsequently transferred on to ice for 2 minutes. 
400 µl of SOC medium were added to the tubes and the cells were recovered at 200 rpm 
(37 ºC) for 1 hr.  
 
For transformations of intact plasmids, 50 µl cell suspension were plated on 
TYE/antibiotic plates. For transformations of ligation reactions, cells were pelleted at 
500 rcf for 1.5 min, the supernatant decanted, resuspended in 50 µl SOC medium and 
plated on TYE/antibiotic plates.  
   
6.1.6 Bacmid transformation 
 
For transformations of pBIG1/2 family of plasmids into EmBacY cells to generate 
bacmids, the transposition / recovery step was performed for three to four hours. 
Following such a long recovery, 500 µl of cell suspension were plated on 
TYE/antibiotic plates. Plates were incubated overnight at 37 ºC. 
 
6.1.7 Plasmid isolation 
 
A single colony of a desired E.coli strain from a freshly streaked plate is grown in 5 mL 
of LB media (with the appropriate antibiotic) at 200 rpm (37 °C) overnight.  
The cells were pelleted at 3200 rcf, 10 min, 4 ºC and the supernatant discarded. 
Plasmids were isolated using the QIAprep Spin Miniprep kit(Qiagen), following the 
standard protocol. 
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6.1.8 Nucleic acids quantification 
 
The absorbance at 260 nm on a NanoDrop ND-1000 spectrophotometer (Thermo 
Scientific) was measured. The extinction co-efficients reported in table 6.24 were used 
to calculate the nucleic acid concentration. 
 
6.1.9 DNA Sanger sequencing 
 
5 µL of the following samples per reaction was provided to Source Bioscience 
(Cambridge, UK) for Sanger sequencing: 100 ng/µL of plasmid DNA and 3.2 µM 
primer DNA. The samples were diluted from their stocks in milliQ water. The 
sequencing data was analysed by MacVector (MacVector, Inc.). 
 
6.1.10 Nucleic acid electrophoresis 
 
6.1.10.1 DNA agarose gel 
 
1 g of agarose (BioGene) was dissolved in 100 mL 1x TAE by microwaving the 
mixture on high (900 W). After cooling to ~50 ºC, SybrSafe (Life Technologies) was 
added, and the mixture was poured into a running apparatus. The gel sets in ~ 45 min 
after which the combs were removed. The samples are loaded after TAE buffer 
completely covers the gel and the electrodes. Gels were run at constant 100 V until the 
bands were separated as required. Gels were visualized on a Gel Doc XR+(BioRad). 
 
The following is the 6x concentration of a DNA loading dye: 30% w/v glycerol, 0.25% 
w/v bromphenol blue, 0.25% w/v xylene cyanol FF. 
 
6.1.10.2 RNA polyacrylamide gel  
 
RNA acrylamide gels were casted using the MINI-Protean electrophoresis system 
(Biorad). Gel recipes for 6%TBE-urea and 15% TBE-urea gels are given below (Table 
6.2). In the case of a preparative gel, the solution was poured between two 20 x 18.5 cm 
glass plates with 2 mm spacers and was sealed with polypropylene-based sellotapes. 
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Once the gesl were set, the tapes were removed and the gels were pre-run in 1 x TBE 
buffer at 30 W for 15 min using a PowerPac HV power supply (BioRad). Then 
appropriate amounts of sample was loaded and the gel was run for ~ 10 to 20 min 
depending on the size of the RNA sample. Preparative gels were run for ~ 2 hours until 
the loading dye runs off the gel.  
 
 
6% Urea acrylamide 15% Urea acrylamide 
220 g Urea 189 g Urea 
50 ml 10x TBE 45 ml 10x TBE 
75 ml 40% Acrylamide/Bis 
Solution, 19:1 
169 ml 40% Acrylamide/Bis 
Solution, 19:1 
up to 500 ml Nuclease free H20 up to 450 ml Nuclease free H20 
 
Table 6.2: Composition of the Urea-acrylamide solutions used to cast the gels 
 
 The following is the recipe for making a 6% - urea acrylamide mix: Dissolve the urea 
in ~ 300 ml of milliQ water on a stirrer. Set the temperature to 90 °C while dissolving 
the urea. As it is dissolving, add the required amounts of 19:1 bis acrylamide and 10x 
TBE to this mixture. After all the urea has dissolved, make up to 500 ml or 450 ml with 
MQ and cool down the mixture.  
 
For analytical gels, 10 ml of the urea-acrylamide mixture was mixed with 10 µl of 
TEMED (Sigma) and 100 µl of Ammonium persulphate solution. For preparative gels, 
the above mixture was scaled up five times.  
 
2x RNA loading dye contained the following: 960 µl of Formamide (Thermofisher), 10 
µl of 0.08 % w/v bromophenol blue, 0.08 % w/v 10 µl of xylene cyanol and 20 µl 0.5 M 
EDTA.  
 
6.1.11 SDS-PAGE  
 
4 µl OF 4x LDS (106mM Tris HCl, 141mM Tris base, 2% LDS, 10% glycerol, 0.51mM 
EDTA, 0.22mM SERVA Blue G250, 0.175mM Phenol Red, pH 8.5) (Thermo Fisher) 
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sample buffer was added to 12 µl of protein samples up to ~ 500 nm in concentration. 
For higher concentrations of proteins, 2 µl OF 4x LDS was mixed with 6 µl of proteins. 
Samples were run on a pre-cast 15 well 4-12% Bis-Tris gradient (Thermofisher) gel at 
180 volts for 60 minutes. MOPS based running buffer was used for the electrophoresis. 
For the analysis of cross-linked protein samples, 3-8% tris-acetate gels (Thermofisher) 
were used and were run at 140 volts for > 2 hours. This was to allow the cross-linked 
protein complexes to run into the wells. In case of the Yth1 and Fip1 constructs for 
NMR, 20% tris-tricine gels were used. The gels were then stained with a coomassie 
based InstantBlue™ (Expedion) for several hours. The stain was then removed and 
replaced with MQ water for de-staining. The de-stained gels were visualized by imaging 
on a Gel Doc™ (Biorad).  
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6.2 Cloning 
6.2.1 Restriction based cloning 
 
Using 'traditional cloning', a plasmid was digested with either one or two restriction 
enzymes. The gene of interest to be cloned into the plasmid is produced by PCR and the 
PCR product is digested with the same set of enzymes that were used to cut open the 
plasmid. The digested gene of interest is then ligated into the plasmid that is cut open.  
6.2.1.1 PCR 
 
To amplify genes from plasmid DNA, PCR reactions using High Fidelity Phusion DNA 
polymerase (NEB) were performed. PCR primers were obtained at the 100-nmol scale 
from Sigma Aldrich and suspended to a final concentration of 100 µM in milliQ. A 
standard 50 µL PCR reaction mixture is described in Table 6.3 and the reaction 
conditions are given in Table 6.4. The reactions were performed in a Veriti 96-well 
Thermal Cycler (Applied Biosystems). 
 
 
Component name Final concentration 
Nuclease free water (DEPC) N/A 
5X Phusion HF buffer (NEB) 1X 
dNTPs 200 µM 
Forward primer 0.5 µM 
Reverse primer 0.5 µM 
Template DNA ~10 ng 
DMSO ~2 to 3 % 
Phusion HF enzyme (NEB) 1 unit per 50 µl reaction 
 
Table 6.3: Setting up a cloning PCR 
 
The annealing temperature (Tm) for the PCR reaction was calculated for a set of 
primers by using the NEB Tm Calculator v1.10.1. The extension time in the annealing 
step was calculated based on the size of the gene being clones. For example, for Cft1 
gene which is ~ 4.6 kb in size, an extension time of ~ 70 sec was used 
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Number of 
cycles 
Step Temperature Time 
1 Initial denaturation 98 °C 30 sec 
30  Annealing 98 °C 
Tm °C 
72 °C 
10 sec 
30 sec 
15 sec per kb 
1 Extension 72 °C 10 min 
1 Hold 4 °C Until further use 
 
Table 6.4: PCR conditions 
.  
6.2.1.2 PCR purification and gel extraction 
 
50 µl of the PCR reaction product is mixed with 10 µl of 6x DNA loading dye and is 
run on a 1 % agarose TAE gel. The desired bands are then excised and purified using 
the QIAquick Gel Extraction kit (Qiagen), following the standard protocol and eluted in 
30 - 50 µl EB. 
 
6.2.1.3 Restriction digestion 
 
The purified PCR products and the host vector, into which the gene of interest is about 
to be cloned, are digested with the same set of enzymes.  
 
Component name Final concentration 
Nuclease free water (DEPC) N/A 
10x buffer 1X 
PCR product or plasmid ~1 µg 
Enzyme 1 10 units 
Enzyme 2 10 units 
 
Table 6.5: Setting up a restriction digestion for cloning 
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The choice of the 10x buffer is dictated by the combination of the enzymes used in the 
cloning.  This can be decided by analyzing the list of available enzyme and their activity 
in the respective buffers using the tool NEBcloner v1.3.9.  
 
6.2.1.4 Ligation 
 
The products of the restriction digestion are analysed by running them in a 1% agarose 
TAE gel. The desired bands are then excised and purified using the QIAquick Gel 
Extraction kit (Qiagen), following the standard protocol and eluted in 10 µl EB. The EB 
is pre-warmed at 70 °C before usage. The following protocol was used to ligate the gene 
of interest (PCR product) into the host vector. 
 
Component name Final concentration 
Nuclease free water (DEPC) N/A 
T4 DNA Ligase Buffer (10x) 1X 
Vector 0.02 pmol 
Insert 0.06 pmol 
T4 DNA Ligase 1 µl per 10 µl reaction  
 
Table 6.6: Setting up a sticky end DNA ligation 
 
NEBioCalculator v1.9.0 is used to calculate the mass of insert required to set up ligation 
reactions at different ratios of vector:insert. The assembled reaction is incubated at 16 
°C for 20 minutes. All of the reaction is transformed into TOP10 competent cells and 
plated on TYE plates with appropriate antibiotics depending on the vector being used.  
 
6.2.1.5 Verification of clones  
 
Plasmids from a few different colonies (usually I screened four colonies per new 
construct) were extracted based on Section 6.1.7 and their sequences verified based on 
Section 6.1.9.  
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6.2.2 biGBac cloning 
 
The biGBac system allows for the cloning of up to twenty-five individual genes into 
one single vector. This method involves the usage of computationally optimal DNA 
linker sequences, which allows efficient assembly of DNA fragments by Gibson cloning 
in order to produce such large synthetic genomes (Weissmann et al. 2016). The DNA 
linker sequences for Gibson assembly were selected in such a manner that the 
propensity to form incorrectly assembled products is minimized.  
 
The first step in this system is to clone the gene of interest (GoI) using Gibson assembly 
or restriction digestion based cloning techniques into a vector containing an expression 
cassette with a polyhedrin (polh) promoter and a SV40 late terminator (SV40). In our 
lab, GoIs were first cloned either into pACEBac1, pIDC or pIDS.  
 
Then, gene expression cassettes are amplified by PCR using primers that contain the 
alpha, beta, gamma, delta, epsilon or omega Gibson linker overhangs (Weissmann et al. 
2016).  
 
 
Primer overhangs Sequence 
Alpha AACGCTCTATGGTCTAAAG 
Beta AAACGTGCAATAGTATCCAGTT 
Gamma AAACATCAGGCATCATTAGGTTT 
Delta AAACTAAGCTATGTGAACCGTT 
Epsilon AAACCAAGTCAATGTCAGTGTTT 
Omega AACCCCGATTGAGATATAGATT 
 
Table 6.7: Sequences of optimized linker DNA involved in Gibson assembly 
 
The first level of multi-gene assembly involves carrying a Gibson assembly reaction 
with up to five genes (PCR products from the earlier step) and one of the five pBIG1 
series of vectors (pBIG1a - pBIG1e). A modified version of the biGBac system 
(Weissmann et al. 2016) was used in our lab. An equivalent version of the vectors 
pBIG1a,b,c,d,e were created by cloning the necessary Gibson overhangs, spacers and 
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Swa1 sites into pACEBac1. The resulting pBIG1 series vectors were selectable using 
gentamycin rather than ampicillin and spectinomycin.  
It is important to note that the first GoI that will occupy the 5' end of pBIG1 vector 
needs to have the alpha linker sequence in the 5' end. Similarly, the final GoI occupying 
the 3' end of pBIG1 vector needs to carry the omega linker sequence in the 3' end. For 
example, the first GoI will have alpha sequence in its 5' end and beta sequence in the 3' 
end. The second GoI will have beta sequence in its 5' end and gamma sequence in its 3' 
end. If one wishes to clone only two GoIs into pBIG1 vector, then the second GoI needs 
to carry omega sequence in its 3' end.  
 
The above step leads to the generation of a polygene cassette (PGC) in circular pBIG1 
vector. The pBIG1 series of vectors can be propagated in E.coli cells. In order to verify 
whether all the desired GoIs have been successfully incorporated into pBIG1 vectors, I 
made use of the Swa1 restriction sites that flanks all the GoIs. So upon Swa1 digestion 
of the pBIG1 vectors containing the GoIs and analysing the resulting digestion pattern 
by running a TAE agarose gel, one can confirm the incorporation of all the GoIs into 
pBIG1 series of vector. Furthermore, PmeI sites flank the PGCs in the pBIG1 vectors. 
So an alternative approach to confirm the incorporation of all the GoIs is to perform a 
diagnostic restriction digestion with PmeI.  
 
The digestion of pBIG1 vectors with PmeI also results in generation of a PGC that is 
flanked by optimized Gibson linker sequences at their ends. These linker sequences can 
then be used in a second of Gibson assembly to assemble up to five PGCs from the five 
different pBIG1 series of vectors, into one of the four pBIG2 series of vectors. An 
equivalent version of the vectors pBIG2ab,abc,abcd,abcde from the original biGBac 
system were created by cloning the necessary Gibson overhangs, spacers and Swa1 sites 
into pACEBac1. In order to differentiate the selection between pBIG1 and pBIG2 series 
of vectors, an additional chloramphenicol resistance gene was added to the pBIG2 
equivalents. Mathias Girbig from the Carter lab created the pBIG equivalent versions.  
 
The vector pBIG2ab can accommodate the PGCs from pBIG1a and 1b. Similarly 
pBIG2abc can accommodate PGCs from pBIG1a, 1b and 1c. And so on. By doing so, a 
final vector pBIG2abcde containing five PGCs and a total of twenty-five genes can be 
assembled.  
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6.2.2.1 PCR for making gene expression cassettes 
 
The PCR protocol is same as section 6.2.1.1. The only difference is the choice of 
primers. The primers used for carrying out the PCR are listed as follows:  
 
 
Name Sequence  
pB_pIDC_Cas
I_F 
AACGCTCTATGGTCTAAAGATTTAAATCGACCTACTCCGGA
ATATTAATAGATC 
pB_pIDC_Cas
I_R 
AAACGTGCAATAGTATCCAGTTTATTTAAATGGTTATGATA
GTTATTGCTCAGCG 
pB_pIDC_Cas
II_F 
AAACTGGATACTATTGCACGTTTAAATCGACCTACTCCGGA
ATATTAATAGATC 
pB_pIDC_Cas
II_R 
AAACATCAGGCATCATTAGGTTTATTTAAATGGTTATGATA
GTTATTGCTCAGCG 
pB_pIDC_Cas
III_F 
AAACCTAATGATGCCTGATGTTTAAATCGACCTACTCCGGA
ATATTAATAGATC 
pB_pIDC_Cas
III_R 
AAACTAAGCTATGTGAACCGTTTATTTAAATGGTTATGATA
GTTATTGCTCAGCG 
pB_pIDC_Cas
IV_F 
AAACGGTTCACATAGCTTAGTTTAAATCGACCTACTCCGGA
ATATTAATAGATC 
pB_pIDC_Cas
IV_R 
AAACCAAGTCAATGTCAGTGTTTATTTAAATGGTTATGATA
GTTATTGCTCAGCG 
pB_pIDC_Cas
V_F 
AAACACTGACATTGACTTGGTTTAAATCGACCTACTCCGGA
ATATTAATAGATC 
pB_pIDC_Cas
w_R 
AACCCCGATTGAGATATAGATTTATTTAAATGGTTATGATA
GTTATTGCTCAGCG 
pIDS_CasI_F 
AACGCTCTATGGTCTAAAGATTTAAATGGCACCTAGGTATC
GATACTAGTATAC 
pIDS_CasI_R 
AAACGTGCAATAGTATCCAGTTTATTTAAATGTACCCGTAG
TGGCTATGGCAGGG 
pIDS_CasII_F 
AAACTGGATACTATTGCACGTTTAAATGGCACCTAGGTATC
GATACTAGTATAC 
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pIDS_CasII_R 
AAACATCAGGCATCATTAGGTTTATTTAAATGTACCCGTAG
TGGCTATGGCAGGG 
pIDS_CasIII_F 
AAACCTAATGATGCCTGATGTTTAAATGGCACCTAGGTATC
GATACTAGTATAC 
pIDS_CasIII_
R 
AAACTAAGCTATGTGAACCGTTTATTTAAATGTACCCGTAG
TGGCTATGGCAGGG 
pIDS_CasIV_
F 
AAACGGTTCACATAGCTTAGTTTAAATGGCACCTAGGTATC
GATACTAGTATAC 
pIDS_CasIV_
R 
AAACCAAGTCAATGTCAGTGTTTATTTAAATGTACCCGTAG
TGGCTATGGCAGGG 
pIDS_CasV_F 
AAACACTGACATTGACTTGGTTTAAATGGCACCTAGGTATC
GATACTAGTATAC 
pIDS_Casw_
R 
AACCCCGATTGAGATATAGATTTATTTAAATGTACCCGTAG
TGGCTATGGCAGGG 
 
Table 6.8: Sequences of cloning primers used in the PCR for making gene expression 
cassettes 
 
The abovementioned primers do not contain any gene specific sequences. Before 
assembling the multi-gene complex, the individual subunit genes are cloned into 
pACEBAC1 or pIDC or pIDS. The choice of the cloning primer depends on the vector 
within which the GoI lies. The GoI is PCRed out of pACEBac1 or pIDC or pIDS. 1 µl 
Dpn1 (NEB) is added to the 50 uL PCR reaction mixture, incubated for 1 h at 37 °C. 
The product is purified according to protocol described in section 6.2.1.2. 
 
6.2.2.2 Gibson assembly 
 
Before assembling the GoI PCR products or gene expression cassettes into pBIG1 
vector, it is necessary to linearize the vector.  ~ 1 µg of pBIG1 vector is digested using 
Swa1 enzyme in a 10 µl reaction containing NEB 3.1 buffer (Table 6.12). The digestion 
is carried overnight at 25 °C. The linearized pBIG1 series of vectors are then purified 
according to protocol described in section 6.2.1.2. 
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Component name Concentration (pmol) 
Swa1 digested pBIG1  ~ 0.02 
Gene expression cassette 1  ~ 0.06 to 0.1 
Gene expression cassette 2 ~ 0.06 to 0.1 
Gene expression cassette 3 ~ 0.06 to 0.1 
Gene expression cassette 4 ~ 0.06 to 0.1 
Gene expression cassette 5 ~ 0.06 to 0.1 
Nuclease free water  up to 5 µl 
 
Table 6.9: Making the DNA mix to be used in the Gibson assembly 
 
The DNA mixture is prepared as described above. The Gene expression cassettes are 
added in three or five fold molar excess compared to the pBIG1 vectors. The final DNA 
mixture volume should not exceed 5 µl. The DNA mix is then added to 15 µl of the 
Gibson mix 1 (KGB 1), mixed well and incubated in a thermo cycler at 50 °C for 60 
minutes.  
 
Component name Amount  
1M Tris-HCl pH 7.4 3000 µl 
1M MgCl2 300 µl 
10 mM dNTPs 600 µl 
1 mM DTT 300 µl 
PEG-8000 1.5 g 
50 mM NAD 600 µl 
Nuclease free water up to 6000 µl 
 
Table 6.10: Preparation of 5X Isothermal assembly buffer (IAB) 
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Component name Volume (µl) 
Taq DNA Ligase  (NEB) 160 
T5 exonuclease (NEB) 1.5 
Phusion HF DNA (NEB) 20 
1X IAB 320 
Nuclease free water 700 
 
Table 6.11: Preparation of KGB 1 
 
After 60 min, transform all 20 µl of the Gibson reaction mix into chemically competent 
TOP10 cells. Plate the cells on TYE plates containing Gentamycin.  
 
6.2.2.3 Verifying clones by Swa1 digestion 
 
From the TYE Gentamycin plates, pick a few colonies and isolate plasmid DNA from 
them according to section 6.1.7. Swa1 digestion is used to verify the incorporation of 
the gene expression cassettes into pBIG1 series of vectors.  
 
 
Component name Final concentration 
Nuclease free water (DEPC) up to 10 µl 
10x NEB 3.1 buffer (NEB) 1 µl 
Plasmid ~1 µg 
Swa1 (NEB) 1 unit 
 
Table 6.12: Preparing Swa1 digestion reaction 
 
The reaction is carried out for 4 hours at 25 °C. 10 µl of the reaction mixture is analysed 
by gel electrophoresis as described in section 6.1.10.1. The pBIG1 constructs showing 
the correct or expected Swa1 digestion pattern are sequenced as described in section 
6.1.9. 
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6.2.2.4 Cloning into pBIG2 series of vectors 
 
Once the identities of the pBIG1 series of vectors were verified and it was confirmed 
that they carry all the necessary gene expression cassettes, they were digested with 
Pme1 to be cloned into pBIG2 series of vectors. pBIG2 series of vectors are linearized 
by digestion with Pme1 using a protocol similar to table 6.12. The reaction is carried 
out for 2 hours at 37 °C. The linearized pBIG2 series of vectors are then purified 
according to protocol described in section 6.2.1.2. 
The second Gibson assembly reaction is set up as follows: 
 
Component name Concentration (pmol) 
Pme1 digested pBIG2abcd  ~ 0.02 
pBIG1a  ~ 0.06 to 0.1 
pBIG1b ~ 0.06 to 0.1 
pBIG1c ~ 0.06 to 0.1 
pBIG1d ~ 0.06 to 0.1 
pBIG1e ~ 0.06 to 0.1 
5X IRB 4 µl 
Nuclease free water  up to 12.5 µl 
Pme1 1 µl 
 
Table 6.13: Making the DNA mix to be used in the second step of Gibson assembly 
 
The DNA mix is incubated at 37 °C for 2 hours. Then 2.5 µl of Gibson mix 2 (KGB 2) 
is added to the reaction and is incubated at 50 °C for 60 min. Transform all 20 µl of the 
Gibson reaction mix into chemically competent TOP10 cells. Plate the cells on TYE 
plates containing chloramphenicol.  
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Component name Volume (µl) 
Taq DNA Ligase  (NEB) 24 
T5 exonuclease (NEB) 
[Diluted 1:30 in 1X IAB] 
3 
Phusion HF DNA (NEB) 3 
 
Table 6.14: Preparation of KGB 2 
 
6.2.2.5 Verifying clones by Pac1 digestion 
 
From the TYE chloramphenicol plates, pick a few colonies and isolate plasmid DNA 
from them according to section 6.1.6. Pac1 digestion is used to verify the incorporation 
of the polygene cassettes into pBIG2 series of vectors.  
 
 
Component name Final concentration 
Nuclease free water (DEPC) up to 10 µl 
10x CutSmart Buffer (NEB) 1 µl 
Plasmid ~1 µg 
Pac1 (NEB) 1 unit 
 
Table 6.15: Preparing Pac1 digestion reaction 
 
The reaction is carried out for 1 hour at 37 °C. 10 µl of the reaction mixture is analysed 
by gel electrophoresis as described in section 6.1.10.1. The pBIG2 constructs showing 
the correct or expected Pac1 digestion pattern are sequenced. 35 µl of the plasmid DNA 
( at ~ 40 to 65 ng/µl) are submitted for complete plasmid sequencing at MGH CCIB 
DNA Core, Massachusetts General Hospital.  
 
The subsequent steps involved in biGBac cloning leading to protein expression are 
described in section 6.3.3. The following sections 6.2.3 until 6.2.9 provide details about 
the specific protein or protein complexes that were cloned for study in this dissertation.  
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6.2.3 Pap1 
 
The PAP1 gene was cloned into a pET-28a(+) vector, fusing it to an N-terminal Histag. 
The gene was cloned from an already existing plasmid pMK-RQ containing the PAP1 
gene. The following were the primers used for cloning: 
 
Forward primer (FP): 5′-GGAATTC CATATG ATGAGCAGCCAGAAAGTT-3′ 
 
Reverse primer (RP): 5′- CCCA AAGCTT TTAATTAACATCAACTGCTG -3′ 
 
The PCR product and the circular pET-28a(+) vector was digested with NdeI and 
HindIII. The PAP1 gene expression cassette was ligated into linear pET-28(+) 
according to section 6.2.1.3 and 6.2.1.4. 
 
6.2.4 Polymerase module  
 
The polymerase module constructs were made by Gillian Dornan using the 
MultiBacTurbo Expression System (EMBL) and the individual subunit genes were 
synthesised by GeneArt. Cft1, 8His-3C-Yth1 and Pfs2-3C-SII were cloned into 
pACEBac1, and Pap1 and Fip1 were cloned into pIDC. All the cloning was done using 
BamHI/XbaI sites. The polymerase module construct was assembled using cre-lox 
recombination (Bieniossek et al. 2012).  
 
6.2.4.1 Polymerase module truncations 
 
The biGBac system was used for cloning for the polymerase module variants described 
in section 3.5.3. Splicing by overlap extension was used to generate truncations in the 
Fip1 gene (Higuchi, Krummel, and Saiki 1988). Fip1 gene in pIDC was used as the 
template for the splicing PCR. The final gene cassettes were digested with BamhI and 
XbaI before introducing them into pACEBac1.  
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• The primers used in making Fip1 Δ190-220 are as follows:  
 
5′-GGAATTC GGATCCCTCGAG ATGAGCAGCAGCGAAGATG-3′ 
 
5′-ACGCGGATTGTAATCCTGCTGCGGTTTTTCTTTCAGAACTTC-3′ 
 
5′-GAAGTTCTGAAAGAAAAACCGCAGCAGGATTACAATCCGCGT-3′ 
 
5′-GCCCCATCTAGAGGTACCTCATTATTATTTGCTATTCTGGTTCTGATTCTG-
3′ 
 
• The primers used in making Fip1 Δ145-170 are as follows: 
 
5′-GGAATTC GGATCCCTCGAG ATGAGCAGCAGCGAAGATG-3′ 
 
5′-GATGCCCACGCTATCAAAAATTGCGGTAACACCCTGATTTG-3′ 
 
5′-CAAATCAGGGTGTTACCGCAATTTTTGATAGCGTGGGCATC-3′ 
 
5′-GCCCCATCTAGAGGTACCTCATTATTATTTGCTATTCTGGTTCTGATTCTG-
3′ 
 
• Yth1 ΔZnF45C was created using pACEBac1-Yth1 as the template and the 
following primers were used: 
 
5′- GGAATTC GGATCCCTCGAG ATGAGCCTGATTCATCC-3′ 
 
5′- GCCCCA TCTAGA GGTACC TCA TTA CGGATCAATATGCAGATATTG -3′ 
 
The PCR product was digested with BamHI and XbaI before introducing them into 
pACEBac1. The pACEBac1 plasmids containing the truncated versions of Fip1 or Yth1 
were isolated, their sequences verified as described in section 6.1.9. A polymerase 
module vector containing all the five-subunit genes including the truncated Fip1 or 
Yth1 was generated as described in section 6.2.2.1 and 6.2.2.2. Pfs2 contained a C-
terminal twin strep tag.  
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6.2.5 CF IA/CF IB  
 
CF IB or HRP1 gene was cloned into a pOPINB vector (Oxford Protein Production 
Facility) and verified by sequencing, yielding an N-terminally His-tagged Hrp1.  
The plasmids used in the over-expression of CF IA were provided by Andrew Bohm 
(Tufts School of Medicine, Boston). The genes coding for RNA14 and RNA15 were 
cloned into a pETDuet vector to enable co-expression of the proteins. Rna15 harboured 
an N-terminal 6xHis tag. Pcf11 and Clp1 were cloned into a pRSFDuet vector. Pcf11 
harboured an N-terminal 6xHis tag.  
6.2.5.1 Rna14/Rna15 RRM mutants 
 
A QuikChange Lightning kit (Agilent) was used to generate a triple point mutant in 
Rna15. The residues Y21, Y61 and F63 were mutated into alanine. His tagged RNA15 
gene in pACEBac1 was used as a template for the QuikChange PCR.  First, a double 
mutant Y61A, F63A was generated in pACEBac1-His-Rna15 using the following 
protocol.  
 
Component name Amount 
Nuclease free water (DEPC) 39 µl 
10x QC buffer (Agilent) 5 µl 
dNTPs (10 mM) 1 µl 
Forward primer (10 µM) 1 µl 
Reverse primer (10 µM) 1 µl 
Template DNA (200 ng/µl) 0.5 µl 
Quik solution (Agilent) 1.5 µl 
QuikChange Lightning (Agilent) 1 µl  
 
Table 6.16: Setting up a QuikChange Lightning PCR 
 
The primers to make the point mutants were generated using QuikChange Primer 
Design program (Agilent).  
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Number of 
cycles 
Step Temperature Time 
1 Initial denaturation 95 °C 2 min 
18  Annealing 95 °C 
60 °C 
68 °C 
20 sec 
10 sec 
2 min 
1 Extension 68 °C 5 min 
1 Hold 4 °C Until further use 
 
Table 6.17: PCR setup 
 
The PCR products were treated with 1 µl DpnI at 37 °C for 1 hour. 2 µl of the reaction 
mixture was transformed into XL10 Gold ultra competent cells (Agilent) according to 
section 6.1.5. Plasmid was isolated from several colonies and the sequence verified by 
sequencing (Section 6.1.7 and 6.1.9).  The generated double mutant of Rna15 was then 
used as a template to perform a second QuikChange PCR where Y21A mutation was 
introduced. The final pACEBac1 plasmid contained 6xHis tagged RNA15 gene with 
Y21A, Y61A and F63A mutations. A pBIG1a containing both RNA14 and RNA15 
genes were created as described in section 6.2.2.1 and 6.2.2.2. 
 
6.2.6 Yth1 and Fip1 constructs for NMR 
 
Fip1 residues 180-220, Yth1 residues 118-170 (ZnF 4 and 5) and Yth1 residues 118-208 
(ZnF 4, 5 and the C-terminal end) were cloned into pGEX-6P-2 (Addgene) using the 
BamHI and EcoRI sites as described in section 6.2.1. pIDC-Fip1 and pACEBAC1-Yth1 
were used as the template plasmid for the cloning PCR.  
 
The following primers were used in the cloning: 
 
• Fip1 residues 180-220 
 
5′- ATTAA GGATCC ATG ATTGATCCGGAAGTTCTG-3′ 
 
5′- ATAAT GAATTC TTATTA CAGTTTTTCTTGACGGTGC-3′ 
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• Yth1 residues 118-170 (ZnF 4 and 5) 
 
5′- ATTAA GGATCC ATG GCAAGCAAAATTCCGAAA-3′ 
 
5′- ATAAT GAATTC TTATTA AAACTGCGGATGTTCCATATCA-3′ 
 
• Yth1 residues 118-208 (ZnF 4, 5 and the C-terminal end) 
 
5′- ATTAA GGATCC ATG GCAAGCAAAATTCCGAAA -3′ 
 
5′- ATAAT GAATTC TTATTA TTAAACTTCACCGTTAATAATGGCG -3′ 
 
6.2.7 Phosphatase module 
 
All the six individual subunit genes were synthesised by GeneArt. All the genes were 
first cloned into pACEBac1 from pMK vector using BamHI and XbaI sites as described 
in section 6.2.1. The gene cassettes were digested from pMK vector, separated by 
running a 1% agarose TAE gel and purified using the QIAquick Gel Extraction kit 
(Qiagen). The inserts were ligated into pACEBac1 as described in section 6.2.1.4. The 
clones were then verified by sequencing. Once the genes were cloned into pACEBac1, 
Pta1 was cloned into pBIG1a; Ssu72, Pti1, Glc7, Ref2-SII and Swd2 were cloned into 
pBIG1b as described in section 6.2.2.1 and 6.2.2.2. A pBIG2ab vector containing all the 
six phosphatase module subunits was then assembled using the second Gibson assembly 
(KGB2) as described in 6.2.2.4.  
 
6.2.8 Core-CPF 
 
Polymerase module genes were cloned into pBIG1a as described in section 6.2.2.1 and 
6.2.2.2. There were two pBIG1a polymerase module constructs generated. One of the 
constructs contained Pfs2 with a twin Strep tag. This tagged polymerase module was 
later used in assembling core-CPF (Figure 3.6). The second polymerase module 
construct generated did not contain any tags (Figure 5.14a). This untagged polymerase 
module was later used in assembling the full fourteen-subunit CPF (Figure 5.14d). 
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Similarly the nuclease module subunits were cloned into pBIG1b. Core-CPF was 
generated by assembling the polymerase and nuclease polygene cassettes into pBIG2ab 
as described in 6.2.2.4.  
 
Nuclease module subunit Cft2 was cloned into pBIG1b. Polymerase module polygene 
cassette from pBIG1a was then assembled together with Cft2 from pBIG1b to generate 
a six-subunit polymerase module containing Cft2 (Figure 3.6).  
 
6.2.9 Full CPF 
 
The strategy used to clone a full fourteen-subunit CPF is illustrated in figure 5.12. An 
untagged polymerase module was assembled into pBIG1a (referred to as construct A), 
untagged nuclease into pBIG1b (referred to as construct B), a twin Strep tag containing 
Ref2, Ssu72, Pti1, Glc7, Swd2 were assembled into pBIG1c (referred to as construct C) 
and a lone Pta1 was coned into pBIG1d (referred to as construct D). I tried to assemble 
all the CPF subunits into one single vector namely pBIG2abcd. Initial attempts at 
generating pBIG2abcd containing CPF using the protocol described in section 6.2.2.4 
failed. This second step of Gibson assembly was trickier than previously thought. If 
assembled correctly into one single vector, the entire CPF polygene cassette is expected 
to be around 44,000 nt in length. The individual polygene cassettes are of the following 
size: A ~12000, B ~ 8900, C ~8100, D ~ 3200 and the pBIG2abcd backbone ~ 3000 
nucleotides. Many often, the Gibson assembly reactions yielded no colonies after 
transformation into TOP10 cells. The transformation efficiency of such big gene 
assemblies is probably very low.  Next, in the protocol for the second Gibson assembly, 
only the receiving vector is linearized prior to the reaction (Section 6.2.2.4). The pBIG1 
series of plasmid containing the polygene cassette are linearized simultaneously 
together in 1x IRB by the addition of Pme1 (Table 6.13). This likely results in reduced 
efficiency of Gibson assembly. Next, I tried the Gibson assembly in a variety of 
different conditions in addition to the protocol described in 6.2.2.4.  First, I tried to 
increase the total amounts of all the individual plasmids used in the assembly. Next, I 
resorted to a 'cleaner' second Gibson assembly step. Along with the pBIG2abcd 
plasmid, the pBIG1a,b,c and d plasmids were also linearized by Pme1 in separate 
reactions. The desired polygene cassettes (A,B,C and D) were then separated from the 
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backbone of pBIG1 by running a 1% TAE agarose gel and purified using the QIAquick 
Gel Extraction kit (Qiagen). Now, we have purified linear vector pBIG2abcd, and 
polygene cassettes A, B, C and D with desired Gibson overhangs. I set up a Gibson 
assembly reaction as described as follows:  
 
Component name Concentration (pmol) 
Pme1 digested pBIG2abcd  0.04 
Polymerase module cassette  0.09 
Nuclease module cassette 0.028 
Ssu72-Pti1-Glc7-Ref2SII-
Swd2' cassette 
0.014 
Pta1  0.017 
Nuclease free water  up to 5 µl 
 
Table 6.18: Making the DNA mix to be used in the CPF Gibson assembly 
 
The DNA mixture is prepared as described above. The DNA mix is then added to 15 µl 
of the Gibson mix 1 (KGB 1), well suspended and incubated in a thermo cycler at 50 °C 
for 60 minutes. The rest of the protocol is similar to the one described in section 6.2.2.2. 
Interestingly, there were only very few colonies grown on the TYE plates containing 
chlormaphenicol. After screening several (~ 60) colonies by PacI digestion, two 
colonies CPF1 and CPF2 were found to contain the correct Pac1 digestion pattern 
(Figure 5.13a).  
 
6.2.10 RNA production 
 
DNA coding for the 3′ UTR of CYC1 mRNA cloned into pIDTSmart Kan was 
purchased from IDT. The construct named CYC1 3′-UTR contained 259 nucleotides 
from the 3′ UTR of CYC1 mRNA. The construct named 5′-CYC1-pc contained 182 
nucleotides from 3′ UTR of CYC1 mRNA.  The 5′-CYC1-pc RNA ends in the poly(A) 
site whereas CYC1 3′-UTR RNA contained sequences downstream of the poly(A) site 
as well. CYC1 3′-UTR was synthesized as described in Jana Wolf, 2014.  
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PCR primers were designed such that sequence corresponding to 5′-CYC1-pc (used in 
Figure 5.5) or 5′-CYC1-pc-A30 (used in Figure 5.10) were amplified from the vector 
plasmid pIDTSMART-Kan-EcoR1-T7-CYC1-BamH1. The vector contains the T7 
RNA polymerase transcription promoter site TAATACGACTCACTATAGGG just 
before the sequence of our desired RNA. The PCR products would then contain the T7 
promoter site and the DNA coding for our RNA of interest. This PCR product is then 
used as a template for in vitro transcription reaction (section 6.5).  
 
The following are the primers used to amplify 5′-CYC1-pc 
 
5′- CCCGTGTAAAACGACGGCCAGTTTA-3′ 
5′- TTGAAATATAAATAACGTTCTTAATACTAACATAAC-3′ 
 
The following are the primers used to amplify 5′-CYC1-pc-A30 
 
5′- CCCGTGTAAAACGACGGCCAGTTTA-3′ 
5′- TTTTTTTTTTTTTTTTTTTTTTTTTTTTTTGAAATATAAATAA-3′ 
 
Similarly the 3′ UTR of GAL7 mRNA cloned into pIDTSmart Kan was purchased from 
IDT. The construct named GAL7 3′-UTR contained 251 nucleotides from the 3′ UTR of 
GAL7 mRNA. The following are the primers used to amplify GAL7 3′-UTR from the 
plasmid pIDTSMART-Kan-EcoR1-T7-GAL7-BamH1 
 
5′- CCCGTGTAAAACGACGG-3′ 
5′- TACAGATAATGATGTCATTATTATATATATATATATATATTGCTACTCC-3′ 
 
For the production of GCN4 and MFA2 RNAs, I ordered a gBlocks gene fragments 
from IDT containing the DNA sequence of the respective RNAs. The 417-nucleotide 
long MFA2 gene fragment contains the full MFA2 gene including its 5′ UTR and 3′ 
UTR. The 300-nucleotide long GCN4 gene fragment contains only the 3′ UTR 
sequence. PCR was employed to amplify the gene fragments for use in in vitro 
transcription reaction. The forward primer used contains T7 Polymerase promoter site.  
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The following are the primers used to amplify 5′-UTR MFA2 3′-UTR  
 
5′-
TAATACGACTCACTATAGGGAGAGACACCAGCGAGCTATCATCTTCATACA
A-3′ 
5′- ATAATTAAAAAAAAAATCGAATGTAATGGGTGG -3′ 
 
The following are the primers used to amplify GCN4 3′-UTR  
 
5′- TAATACGACTCACTATAGGG TTTCATTTACCTTTTATTTTATATTTTTTA -
3′ 
5′- ACACGTTAATATGGTGGAGTCAGCTGAGA -3′ 
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6.3 Protein expression 
 
6.3.1 Bacterial expression 
 
Plasmids containing the gene of interest were transformed into BL21 (DE3) star cells as 
described in section 6.1.5. A single colony was picked from the transformation plates 
and a 50 ml 2xTY starter culture with appropriate antibiotics was set up in a 250 mL 
Corning Erlenmeyer flask (Sigma) and incubated overnight at 37 °C, 180 rpm in an 
multitron standard shaker (Infors-ht). The next day, 1L of 2xTY media containing the 
appropriate antibiotic is inoculated with 10 ml of the starter culture in a 2L glass 
Erlenmeyer flask. The cells are grown until a 0D600 of 0.6 and protein expression is 
induced by the addition of 1 mM IPTG. For the expression of pET-28a(+)-Pap1 and 
pETDuet–His-Rna15–Rna14, induction was done at 16 °C over night and the cells were 
harvested the next day. For the expression of pOPINB-Hrp1, induction was done at 37 
°C for 3 hours after which the cells were harvested. For the expression of pRSFDuet–
His-Pcf11–Clp1, cells were grown in baffled flasks at 37 °C in media containing 0.5% 
glucose and 1 mM MgSO4 to an OD600 of 2.0. Protein expression was induced by 
adding 500 ml of fresh 2xTY media containing IPTG (final 1 mM IPTG, 30 °C, 3 h). 
 
6.3.2 Bacterial expression of Isotopically labelled proteins 
 
The Yth1 residues 118-170 (ZnF 4 and 5) and residues 118-208 (ZnF 4, 5 and the C-
terminal end) were expressed as 15N, 15N-13C labelled proteins in E. coli using MOPS 
minimal medium (Section 6.1.2.3). 100 ml of 10x K-MOPS stock was diluted in 800 ml 
MQ H2O. The media was then autoclaved, cooled and 100 ml of the following 
components were added: 20 mM NH4Cl, 4 mM KPi, 1% w/v glucose, 10 mg thiamine, 
2 mg D-biotin, 2 mg choline chloride, 2 mg folic acid, 2 mg niacinamide, 2 mg D-
phantothenic acid, 2 mg pyridoxal, 2 mg riboflavin. For 15N labeling 15NH4Cl was used 
in H. For 13C labeling 13C-glucose was used.  
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6.3.3 Baculovirus mediated insect cell over-expression  
 
Once the incorporation of the gene cassettes into pBIG1 or the polygene cassettes into 
PBIG2 series of vectors have been assessed by restriction enzyme digestion or 
sequencing (section 6.1.9, 6.2.2.3 and 6.2.2.5), the plasmids are transformed into 
EmBacY cells (Section 6.1.6).  
 
6.3.3.1 Bacmid preparation 
 
The transformation colonies were grown on bacmid plates for ~ 24 hours. The bacmid 
incorporation can be verified by classical blue white selection. A few white colonies 
were picked and used to inoculate 5ml LB medium supplemented with kanamycin, 
gentamycin. chloramphenicol was additionally added for vectors containing the pIDC 
backbone and spectinomycin for vectors containing the pIDS backbone. Cultures were 
grown overnight and cells harvested by centrifugation at 3500rpm for 15 minutes. The 
supernatant was discarded and the cells were resuspended in 250 µl buffer P1 (50 mM 
Tris.Cl pH 8, 10 mM EDTA. P1 buffer containing blue lysis indicator is avoided. Cell 
lysis was carried out by adding 250 µl buffer P2 (200 mM NaOH, 1% SDS), gently 
inverting the tube ~ 5 times and incubating for 5 min at rom temperature. Adding 350 µl 
of buffer N3 (4.2 M GnHCl, 0.9 M KAc pH 4.8) results in the formation of thick white 
precipitate. The mixture was centrifuged for 10 minutes at 20,000 rcf. The resulting 
supernatant was carefully transferred into a tube containing 800 µl of isopropanol.  The 
tube is mixed well by inverting 4 to 5 times and place on ice for 20 mins. The solution 
is centrifuged at maximum speed, supernatant removed and 500 µl of 70 % ethanol 
added to the pellets. The tube was inverted several times to wash the pellet. The mixture 
is centrifuged for 10 mins at maximum speed and the supernatant removed.  The 70 % 
ethanol wash step is repeated again. This time, the supernatant ethanol is removed using 
sterile pipette tips inside a flow hood. From this step onwards, all samples are handled 
under sterile conditions. Air-dry the pellets for less than 2 minutes once the ethanol is 
completely removed. Care is taken not to over dry the pellets. The pelleted DNA is 
suspended in 40 µl sterile elution buffer (10 mM Tris pH 8.5). In some instances, a 
white pellet can be seen along with the DNA pellet. It is likely to be precipitated salt.  
Resuspended bacmids were transfected into Sf9 cells on the same day after verifying the 
presence of all the GoIs by PCR. The remaining bacmids after transfections were stored 
in the cold room at 4 °C for several months until they are discarded.  
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6.3.3.2 Verifying clones by PCR  
 
Performing bacmid PCR using gene specific primers is an approach to check the 
bacmids for the presence of the desired gene expression or polygene cassettes. PCR was 
performed as described in 6.2.1.1. The following are the gene specific primers used to 
verify bacmids constructs generated in this dissertation.  
Protein Primers 
Cft1 ATGAATGTTTATGATGATGTTCTGG 
TTATTTACCCTGACACAGGCTAC 
 
Pfs2 ATGGATGGTCATAATCAGAATCAG 
CAGGCAGGGTGCTGC 
 
Yth1 ATGAGCCTGATTCATCCGGA 
CACCGTTAATAATGGCGTTC 
 
Fip1 ATGAGCAGCAGCGAAGATG 
TTATTTGCTATTCTGGTTCTGATT 
 
Pap1 ATGAGCAGCCAGAAAGTTTTT 
TTAATTAACATCAACTGCTGCGG 
 
Mpe1 ATGAGCAGCACCATCTTTTAT 
CGGGCTTGCATCTGCC 
 
Cft2 ATGACCTATAAATACAATTGTTGTG 
AATTTTGGCCAGCATATCTGTC 
 
Ysh1 ATGGAACGTACCAATACCACC 
ACACAGCGGTGTAACCAGATTA 
 
Pta1 CCGTCCCACCATCGGGCGCGGATCCATGAGCAGCGCAGAAATG 
GCTTGTCGAGACTGCAGGCTCTAGATTATTTCAGACGATCCAGC 
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Pti1 CCGTCCCACCATCGGGCGCGGATCCATGACCGATCCGCGTCGTC 
GCTTGTCGAGACTGCAGGCTCTAGATTAAATAATGTACTCTTTGCGAAAATTTTCCAC
C 
 
Ref2 CCGTCCCACCATCGGGCGCGGATCCATGAGCGCTCCGGTTCCG 
GCTTGTCGAGACTGCAGGCTCTAGATTATTTCTCAAACTGAGGATGGCTCC 
 
Swd2 CCGTCCCACCATCGGGCGCGGATCCATGACCACCGTTAGCATTAAC 
GCTTGTCGAGACTGCAGGCTCTAGATTATTCATCATACACATAGAAATCAAC 
 
Gl7                                CCGTCCCACCATCGGGCGCGGATCCATGGATAGCCAGCCGGTTG 
GCTTGTCGAGACTGCAGGCTCTAGATTATTTCTTTTTACGACCGCCTG 
 
Ssu72 CCGTCCCACCATCGGGCGCGGATCCATGCCTAGCCATCGTAATAG 
GCTTGTCGAGACTGCAGGCTCTAGATTAATAATAGCTCGGTGCATAC 
 
Table 6.19: Gene specific primer used in the verification of CPF clones described in 
section 5.3.1.1. 
 
6.3.3.3 Sf9 cell transfections 
 
All the following steps were performed in sterile conditions in a laminar flow hood. Sf9 
cells in log phase were diluted to a cell count of 0.5 x106 cells/ml. 2 ml of the diluted 
cells were added to each well of a 6-well corning tissue culture plate (Corning Costar, 
Sigma). The cells were left to adhere to the plates for around 20 minutes. In the 
meantime, a DNA master mix was prepared for use in five out of the six wells. Cells in 
the sixth well were treated as positive control for transfection. The five well master mix 
contains 10 µg of bacmid DNA in total. The master mix is prepared by adding the 
appropriate volume of bacmid DNA and warm Sf9 media to a final volume of 980 µl. 20 
µl of Fugene transfect HD reagent (promega) is mixed well and pipetted into the DNA 
media mixture. This mixture is incubated for 10 mins before adding 200 µl per well. 
The plates are placed into a box along with a damp tissue paper and incubated at 27 °C 
for 48 to 72 hours. The cells are checked at every 24 hours to monitor the viability and 
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fluorescence from YFP marker. At 72 hours, the supernatant from all the five wells 
were removed and pooled together in a 50 ml falcon tube. The supernatant was diluted 
with Sf9 media up to 50 ml and FBS was added to a final concentration of 20% v/v. 
FBS is used to stabilize the virus. The final mixture (hereafter referred to as P1 virus) is 
sterile filtered using a 50 ml 0.45 µm steriflip. The tube is covered with an aluminium 
foil and stored in the cold room until further use. 
 
6.3.3.4 Primary virus amplification 
 
100 ml of Sf9 cells at concentration of 0.5 x106 cells/ml were grown until 2 x106 
cells/ml in an 500ml Erlenmeyer flask. 5 ml of P1 virus was added to these cells. Cell 
growth and YFP fluorescence were monitored for every 24 hours. In case the 
concentration doubled to 4 x106 cells/ml after 24 hours, additional media was added to 
dilute the cells back to 2 x106 cells/ml. Usually, the cell growth arrests after 24 or 48 
hours and the YFP fluorescence begin to appear. The supernatant (hereafter referred to 
as P2 virus) is harvested before the viability starts dropping below 90%. This step is 
performed around 48 to 72 hours post infection. An ideal condition for harvesting P2 
virus is cell count 2 or 3 x106 cells/ml, 90% cell viability and > 80% YPF fluorescence. 
P2 virus is harvested by centrifuging the Sf9 cultures in a refrigerated tabletop 
centrifuge (Rotana 460 R) at 2000 g for 10 mins. The supernatant is filtered using two 
50 ml 0.45 µm steriflip. The resulting P2 virus is immediately used up to infect larger 
cultures.  
 
 
6.3.3.5 Protein over-expression 
 
Before going ahead to infect large-scale (~ 2 L) Sf9 cultures for protein-expression, a 
small-scale (50 ml) time course expression test is carried out. 50 ml of Sf9 cells at 
concentration of 2 x106 cells/ml (viability > 90%) growing in a 200 ml Erlenmeyer flask 
are infected using 0.5 ml P2 virus. Samples containing 107 cells in total are taken at 
every 24 hour interval from the growing Sf9 cell culture. The cells harvested by 
centrifugation are flash frozen in liquid nitrogen and stored at -80 °C. Cells are taken 
every 24 hours until the 96-hour time point. Then, the protein(s) of interest are isolated 
from the cell pellets by carrying out Streptactin or Ni-NTA pull down depending on the 
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affinity tag present in the construct.  The pellets are resuspended in 1 ml of lysis buffer 
(100 mM HEPES pH 8, 300 mM NaCl, 5% glycerol, 1mM TCEP) and a tiny scoop of 
glass beads (GE) are added to the cell suspension. Cell lysis is carried out by vortexing 
for two min and the lysate clarified by ultracentrifugation at 4  °C for 30 minutes. The 
supernatant is mixed with 20 µl pre-equilibrated Strep or His resins and incubated for 1 
hour at 4 °C in an end-over end rotor. The unbound proteins are removed by 
centrifugation at 600 g for 10 mins at 4 °C. The resins are washed twice with 1 ml wash 
buffer (100 mM HEPES pH 8, 300 mM NaCl, 1mM TCEP) and the bound-proteins 
eluted by adding 20 µl of 4x LDS sample buffer. 12 µl of the eluted proteins are 
analyzed by SDS-PAGE as described in 6.1.11. After analyzing the protein gels, a 
decision is made about the best time to harvest the infected Sf9 cells so that the protein 
expression is maximal. Then, 500 ml of Sf9 cells at concentration of 2 x106 cells/ml 
(viability > 90%) growing in a 2L roller bottle flask is infected with 5 ml of P2 virus. 
Cell growth parameters are monitored every 24 hours. At the appropriate time (when 
cell growth is arrested, YFP fluorescence and protein expression is maximum), the Sf9 
cell culture is harvested by centrifuging at 4000 rpm for 20 min in 2L bottles.  The cell 
pellets are washed in pre-chilled PBS and flash frozen in liquid nitrogen and stored at - 
80 °C.  
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6.4 Protein purification 
 
6.4.1 Polymerase module 
 
Cell pellets from 2 l Sf9 cells were resuspended in ~120 ml of buffer A (50 mM HEPES 
pH 7.9, 300 mM NaCl, 1 mM TCEP) supplemented with 50 µg/ml RNAse, 50 µg/ml 
DNAse and EDTA-free protease inhibitors (PI) (Roche). The cells were lysed by 
sonication using a 10mm tip (big tip) on a VC 750 ultrasonic processor (Sonics) (3 min 
total ON time, 70% amplitude, 5 sec ON time and 10 sec OFF time). The resuspended 
cells were split into two 60 ml halves in a 100 ml kimax glass beaker (Kimble Glass 
Products, Fisher Scientific) and were sonicated separately. Lysate was cleared by 
ultracentrifugation at 100,000g (4 °C) for 30 min in a pre-chilled JA25.50 rotor in a 
Avanti J26 XPI (Beckman Coulter).  The clarified lysate was then incubated at 4 °C for 
2 hours with 2 ml of StrepTactin Sepharose HP resin (GE) pre-equilibrated with buffer 
A, on an end over end rotor. Beads were loaded onto a gravity column and washed with 
150 ml buffer A prior to elution with buffer E (buffer E is essentially buffer A 
supplemented with 6 mM of desthiobiotin). Elution was carried out in 2 ml volume per 
fraction, ten fractions in total. 2m of buffer E were added, the StrepTactin resins were 
mixed well with it and incubated for 5 min before elution. The elution fractions (20 ml) 
were pooled together and diluted with 50 mM HEPES pH 7.9 to reduce the salt 
concentration to 150 mM NaCl. The sample was then filtered using a 0.45 µm 
membrane filter (Merk) and loaded onto a 1 ml Mono Q 5/50 GL column (GE 
Healthcare). Elution was performed over a 45 CV gradient from 300–450 mM NaCl. 
This separated polymerase modules with and without Pap1 (Figure 2.2). The four-
subunit complex (without Pap1) was the most abundant species. Individual peak 
fractions from the anion exchange step were concentrated using a 50 kDa centrifugal 
filters (Millipore) and was subsequently purified by size exclusion chromatography 
using a Superose 6 3.2/300 Increase column (GE Healthcare). The size exclusion 
column was pre-equilibrated with buffer A (Figure 2.3). Purified polymerase module 
complexes were either used immediately for making cryo-EM grids, or was 
concentrated using a 50 kDa centrifugal filter (Millipore) to 10–20 µM concentrations. 
The protein was then flash frozen in liquid nitrogen and stored at -80 °C for future use 
in biochemical experiments. The same protocol was used to purify polymerase module 
variant carrying Fip1 Δ 145-170 (Figure 3.9a).  
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6.4.2 Pap1 
 
BL21(DE3) Star cells containing pET-28a-His-Pap1 from 2 l cultures were resuspended 
in ~ 70 ml buffer B (50 mM HEPES pH 8.0, 1 M NaCl, 20 mM imidazole, 5% w/v 
glycerol, 1 mM TCEP, 2 µg/ml DNase I, 2 µg/ml RNase A, PI). The cells were lysed by 
sonication using a 10 mm tip on a VC 750 ultrasonic processor (Sonics) (10 min total 
ON time, 100% amplitude, 5 sec ON time and 20 sec OFF time). The glass beaker 
containing the cell suspension was checked every 3 minutes to ensure that the samples 
were not over-heated during sonication. If the beaker was found to become warm, the 
ice bucket carrying the glass beaker was replaced with fresh ice. The lysate was 
clarified as described in section 6.4.1 and was mixed with 1 ml bed volume of Ni-NTA 
resin. The resins were pre-equilibrated with buffer C (50 mM HEPES pH 8.0, 500 mM 
NaCl, 20 mM imidazole, 1 mM TCEP). The resin-lysate mixture was incubated for 2 
hours at 4 °C on an end over end rotor (9rpm). The resin was then washed two times 
with 50 ml of buffer C. Beads were transferred to a gravity column before elution with 
buffer D (50 mM HEPES pH 8.0, 500 mM NaCl, 300 mM imidazole). Elution was 
carried in 1ml buffer volume. The elution fractions were collected instantaneously after 
the buffer was added; there was no incubation time involved. Fractions containing Pap1 
were exchanged into buffer F (50 mM HEPES pH 8.0, 100 mM NaCl, 0.5 mM TCEP), 
and loaded onto a 1 ml HiTrap Heparin HP (GE). Proteins were eluted over a 30 CV 
gradient up to 100% buffer G (50 mM HEPES pH 8.0, 1 M NaCl, 0.5 mM TCEP). The 
samples from heparin step were polished using a Superdex 200 10/300 column 
equilibrated in buffer H (50 mM HEPES pH 8.0, 150 mM NaCl, 1 mM TCEP) (Figure 
2.4c). Pap1 was then concentrated to 36 µM using a 30kDa centrifugal filter (Millipore), 
flash-frozen in liquid nitrogen and stored at -80 °C. 
 
6.4.3 CF IA 
 
BL21(pLysS) Rosetta expressing Rna14–Rna15 from 4l of cultures were suspended in 
buffer I (50 mM HEPES pH 8.0, 250 mM NaCl, 30 mM imidazole, 5% w/v glycerol, 
0.5 mM TCEP, 2 µg/ml DNase I (Sigma), PI). Lysed cells were separated from the cell 
debris by ultracentrifugation at 75,000g for 30 min.  A 5 ml HisTrap HP column (GE) 
was equilibrated with buffer J (20 mM HEPES pH 8.0, 250 mM NaCl, 0.5 mM TCEP). 
The clarified lysate was filtered using a 0.45 µm membrane filter (Millipore) and loaded 
onto the column. Elution was carried out using a 10 CV gradient up to 500 mM 
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imidazole. Elution fractions were pooled, concentrated using a 50 kDa centrifugal filter 
(Millipore) at 4000g and polished on a Superdex 200 16/600 column (GE). Buffer J was 
used in the size exclusion step. Peak fractions were pooled and concentrated to ~ 11.2 
mg /ml or 100 µM. Aliquots were flash-frozen in liquid nitrogen and stored at -80 °C.  
 
Cells expressing His-Pcf11–Clp1 from 6l culture were suspended in 200 ml buffer K 
(50 mM Tris pH 8.0, 250 mM NaCl, 5% w/v glycerol, 1 mM TCEP, 2 µg/ml DNase I, 2 
µg/ml RNase A, 1 tablet of PI per 50 ml). Cells were split in two 100 ml volumes and 
lysed as described earlier. The lysate was separated from cell debris by 
ultracentrifugation (JA 25.50, 76,000g, 40 min, 4 °C). A 5 ml HisTrap FF crude column 
(GE) was equilibrated with buffer L (20 mM Tris pH 8.0, 250 mM NaCl, 1 mM TCEP). 
The clarified lysate was filtered using a 0.45 µm membrane filter (Millipore) and loaded 
onto the column. A 50 ml wash was done using 20 mM Tris pH 8.0, 20 mM imidazole, 
250 mM NaCl, 1 mM TCEP and the proteins were eluted by a 10 CV gradient elution 
up to 500 mM imidazole.  
 
30 mg of Rna14–Rna15 after the size exclusion step was mixed with 30 mg of Pcf11–
Clp1 from the HisTrap column. The mixture was incubated at 4 °C overnight. The 
complex mixture was diluted to 100 mM NaCl by adding 20 mM Tris (no salt) up to 40 
ml volume. There were signs of some precipitation. The precipitants were separated by 
by centrifugation at 8000g for 10 min. The complex was then filtered using a 0.45 µm 
membrane filter (Millipore) and loaded onto a 5 ml HiTrap Q HP column (GE). The 
column was washed with 25 ml of 20 mM Tris pH 8.0, 100 mM NaCl, 1 mM TCEP. 
Elution was carried out using a 6 CV gradient up to 1 M NaCl. The elution fractions 
were analyzed by SDS-PAGE. The central fractions containing the complex were 
polished on a Superdex 200 26/600 column (GE). The size exclusion step was run in 
buffer L. CF IA was concentrated to 10 mg/ml or 24 µM and stored at -80 °C for further 
use. 
 
6.4.4 CF IB 
 
Cells from a 2l culture were suspended in 60 ml of buffer M (50 mM HEPES pH 8.0, 
300 mM NaCl, 20 mM imidazole, 0.5 mM TCEP supplemented with 10% w/v glycerol, 
2 µg/ml DNase I, 2 µg/ml RNase A, PI). Cells were lysed as described in section 6.4.2. 
The lysate was clarified as described earlier. The lysate was mixed with 1 ml bed 
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volume of Ni-NTA beads and incubated in the cold room at 9 rpm on an end-over end 
rotor for an hour. The beads were pre-equilibrated in buffer M. Then the resins were 
washed with 100 ml buffer M followed by 50 ml of buffer N (50 mM HEPES pH 8.0, 
300 mM NaCl, 30 mM imidazole, 0.5 mM TCEP). Elution was performed in a gravity 
column and with buffer O (50 mM HEPES pH 8.0, 150 mM NaCl, 300 mM imidazole, 
0.5 mM TCEP). The eluted Protein was then loaded onto a 1 ml HiTrap Heparin 
column (GE) at 1 ml per min. The column was washed with 5 ml of buffer O containing 
250 mM NaCl. CF IB was eluted using a 20 CV salt gradient step up to 1M NaCl. 
Fractions containing Hrp1 were pooled and concentrated with a 10 kDa centrifugal 
filter. CF IB was polished on a Superdex 200 10/300 column (GE). The size exclusion 
step was run in buffer J. Hrp1 was concentrated in a 30kDa centrifugal filter and stored 
at -80 °C for future biochemical assays. 
 
6.4.5 Rna14/Rna15 Y21A, Y61A, F63A 
 
2l of Sf9 cells expressing pBIG1a Rna14/Rna15 were resuspended in buffer P (50 mM 
HEPES pH 8, 250 mM NaCl, 30 mM imidazole, 5% w/v glycerol, 0.5 mM TCEP, 2 
µg/ml DNAse I and PI). The cells were sonicated for 3 minutes at 70% amplitude (4 °C, 
5 ON, 10 OFF) using a 10 mm tip on a VC 750 ultrasonic processor (Sonics). The 
lysate was clarified by ultracentrifugation (4 °C, 18000 rpm, JA 25.50, 35 min). 1 ml 
bed volume Ni-NTA resin was pre-equilibrated in buffer P and mixed with lysate. The 
binding reaction was carried at 4 °C for 90 mins in an end over end shaker (9 rpm). The 
resins were separated by spinning them at 600 g for 5 min. Resins containing bound 
Rna14/Rna15 is washed with 120 ml of buffer P. Elution is carried by buffer containing 
500 mM imidazole. Ten fractions each containing 2 ml elution buffer were collected. 
All the fractions were pooled together and concentrated in a 30kDa centrifugal filter and 
exchanged into buffer J during this process. The concentrated samples were filtered 
using a 0.45 µm membrane filter (Merk) and loaded onto a HiLoad 16/600 Superdex 
200 pg (GE) column at 1 ml per min. The mutant complex runs around the same elution 
volume as the wild type Rna14/Rna15 purified from E.coli. The fractions were analyzed 
by SDS-PAGE. Rna14/Rna15 mutant complex was concentrated up to 24 µM and 
stored at - 80°C.  
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6.4.6 Yth1 and Fip1 constructs for SEC-MALS and NMR 
 
The following were the constructs purified: Fip1 residues 180-220, Yth1 residues 118-
170 (ZnF 4 and 5) and Yth1 residues 118-208 (ZnF 4, 5 and the C-terminal end). Cells 
overexpressing pGEX-6P-2 vector containing the above constructs were produced as 
described in 6.3.1 and 6.3.2. All the constructs were purified using a similar protocol as 
described in this section. Cells from 1l of culture was suspended in ~ 60 ml of buffer Q 
(50 mM Tris pH 8, 250 mM NaCl, 1mM TCEP, 2 µg/ml DNAse / RNAse and EDTA-
free protease inhibitors). The cells were sonicated and the lysate clarified as described 
in section 6.4.2. 3 ml of Glutathione Sepharose® 4B (GE) were pre-equilibrated with 
buffer Q. The lysate and the resins were mixed, binding reaction was carried at 4 °C for 
90 mins in an end over end rotor (9 rpm). The resins were transferred to a gravity 
column after the binding reaction. 2 ml of buffer Q supplemented with glutathione  (1g 
per 50 ml buffer, pH adjusted to 8) were used to elute the GST tagged Yth1/Fip1 
constructs. In total, ten elution fractions were collected. The elution fractions were 
pooled together and the 3C site between GST and the proteins are cleaved overnight 
using PreScission Protease. 200 µl of protease (5 mg/ml stock) was used to cleave ~ 35 
ml of GST tagged proteins at ~ 1 mg/ml. The overnight cleavage reaction contained 
EDTA-free protease inhibitor as well. The overnight cleavage reaction was concentrated 
using a 3kDa centrifugal filter and the buffer was exchanged to the size exclusion buffer 
during this step. Size exclusion can either be done using 20 mM Bis-Tris pH 6, 150 mM 
NaCl, 0.1 mM TCEP as the buffer or alternatively simply by using PBS. HiLoad 26/600 
Superdex 75 pg (GE) was used. Yth1 constructs containing residues ZnF 4 and 5 elutes 
around ~ 225 ml, ZnF 4, 5 and the C-terminal elutes around ~ 190 ml. The Fip1 180 - 
220 construct elutes at ~ 285 ml.  
 
6.4.7 Core-CPF 
 
Core-CPF contains a StrepII-tag on the Pfs2 subunit (similar to polymerase module). So 
the purification strategy was very similar to that of the polymerase module as described 
in section 6.4.1. However, there were a few modifications made to the protocol. Firstly, 
the lysis buffer for core-CPF was 50 mM HEPES pH 7.9, 150 mM NaCl, 1 mM TCEP, 
1mM Mg(OAc)2, 50 µg/ml RNAse and DNAse, and EDTA-free protease inhibitors.  It 
is to be noted that 18 tablets of protease inhibitors were added to 250 ml of lysis buffer. 
Second, after the shallow gradient elution on the monoQ (GE), all the peak fractions 
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were combined together unlike the polymerase module purification where three 
different peaks were purified separately afterwards. Interestingly, core-CPF did not 
separate into three diferent Pap1 varying species on monoQ. The pooled fractions from 
monoQ were concentrated and loaded onto a Superose 6 Increase 10/300 GL (GE). The 
final size exclusion buffer was 20 mM HEPES pH 7.9, 150 mM NaCl, 1 mM TCEP, 
1mM Mg(OAc)2.  
 
6.4.8 Recombinant CPF 
 
In order to produce recombinant full CPF, a co-infection strategy was used. The protein 
expression protocol differs from the routinely used procedure described in section 
6.3.3.5. P2 virus corresponding to a six-subunit phosphatase module (Ref2 subunit with 
a StrepII-tag) and another P2 virus corresponding to an eight-subunit core-CPF 
(containing no affinity tags) were mixed in 1:3, 1:1 or 3:1 v/v ratio. 10 ml of the 
combined P2 virus was then used to infect 500 ml of Sf9 cells (2 x106 cells/ml, viability 
> 90%) growing in a 2L roller bottle flask. Cells are harvested after 72 hours post 
infection as described in 6.3.3.5.   
 
CPF lysis buffer: 200 mM HEPES pH8,  200 mM KCl, 0.5 mM Mg(OAc)2, 1mM 
TCEP, 10% w/v glycerol,  2 µg/ml DNaseI (add fresh), 2 µg/ml RNaseA (add fresh) and 
PI(14 tablets per 120 ml).  
 
CPF wash buffer: 50 mM HEPES pH 8,150 mM KCl, 0.5 mM Mg(OAc)2, 1 mM 
TCEP 
 
CPF elution buffer: 1.2mg/ml D-desthiobiotin in wash buffer 
 
 
2L worth of Sf9 cell pellets were suspended in ~ 120ml CPF lysis buffer (up to 60ml 
lysis buffer for every 1L of cells harvested). Sonication and clarification of lysate was 
done as described in section 6.4.1. The clarified lysate was incubated with 2 ml (bed 
volume) of pre-equilibrated StrepTactin Sepharose HP resin (GE). Binding reaction was 
performed for 2 hours at 4 °C in an end over end shaker (9 rpm). The resins are 
separated from the unbound lysate by centrifugation at 600g for 10 mins. The resins 
were washed with 200 ml CPF wash buffer in a gravity column. The Strep elution step 
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was done at room temperature. 3ml CPF elution buffer was added to the resin, mixed 
well using a 2 ml glass pipette tip and the elution slurry was incubated for 5 mins. Ten 
elution fractions each containing 3 ml volume was collected. The eluates were then 
pooled together. The ~ 30 ml recovery solution was filtered by passing it through a 0.45 
µm membrane filter (Merk). The solution was then loaded onto a 1 ml resource Q 
column (GE) pre-equilibrated with CPF wash buffer. Elution was carried out over a 100 
CV gradient up to 1M salts. The elution fractions were analysed by SDS-PAGE. Such a 
shallow gradient on an anion-exchange column results in the separation of CPF with 
varying amounts of Pap1. Only those fractions containing stoichiometric amounts of 
Pap1 were pooled together and concentrated using a 50 kDa centrifugal filter upto ~ 50 
to 100 µl volume. The CPF preparation was polished by running a superose 6 3.2/300 
Increase column (GE). The size exclusion column was pre-equilibrated with CPF wash 
buffer. Purified CPF was used immediately for making negative stain EM grids. The 
samples used in biochemical assays were from concentrated CPF that had been flash 
frozen in liquid nitrogen and stored at -80 °C. To test whether rCPF could survive 
freezing and thawing, 50 µl of recovery from the resQ column were frozen. The frozen 
sample was allowed to thaw at room temperature and subjected to size exclusion 
chromatography as described earlier.  
 
Native CPF was purified as described earlier (Schreieck et al. 2014; Easter 2014) .  
 
6.4.9 Nuclease module subunits 
 
Cft2 and Ysh1/Mpe1 were purified as described earlier (Hill et al. 2019).  
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6.5 RNA production 
 
The DNA template to be used in in vitro transcription (IVT) was obtained as described 
in section 6.2.10. The PCR to make the DNA template was carried out in a 150 µl 
volume (scaled up in comparison to table 6.3). The PCR products were purified by 
QIAquick PCR Purification Kit (Qiagen).  
 
 
 
IVT was set-up as follows: 
 
Component name Amount 
Nuclease free water  up to 500 µl 
10x transcription buffer  50 µl 
rNTP (25 mM) 125 µl 
DNA template ~ 5 - 10 µg 
Pyrophosphatase (100 U/µl) 5 µl 
RiboLock (40 U/µl)  5 µl 
T7 RNA Pol (0.5 mg/ml) 100 µl 
MgCl2 (400 mM) 50 µl 
 
Table 6.20: Setting up IVT 
 
IVT reaction was carried out for 1 hour at 37 °C. The reaction was stopped by adding 
500 µl of 2X RNA loading dye to the mix. The products were run on a preparative 6% 
urea-acrylamide gel (Section 6.1.10.2). The RNA band of interest was identified by UV 
shadowing (Hassur and Whitlock 1974). The band was excised and RNA extracted from 
the gel using electro-elution in a Whatman Elutrap electroelution system kit 
(Thermofisher) running on 1x TBE (made with nuclease free H20). Elution fractions 
were collected every one-hour and the final time point taken at 5 or 6 hours after the 
beginning. The fractions were analyzed by running a 6% ureapolyacrylamide gel. 
Fractions containing pure RNA were concentrated using a 15 ml 3 kDa centrifugal 
filter, flash frozen in liquid nitrogen and stored in - 80°C until future use.  
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6.6 Biochemical assays 
 
6.6.1 In vitro cleavage and polyadenylation assays 
 
6.6.1.1 Polyadenylation assays of 5ʹ-FAM-CYC1-pc 
 
A 42 nt sequence from the 3ʹ UTR of CYC1 was chemically synthesized with a 5ʹ 6-
FAM fluorophore (IDT). This was the substrate RNA used in all the assays described in 
chapter 3 and 4. In vitro assays were carried out in a polyadenylation buffer that 
consisted of 10 mM HEPES pH 7.9, 150 mM KOAc, 2 mM Mg(OAc)2, 0.05 mM 
EDTA, 2% PEG (v/v) and 1 mM DTT. Sub-stocks of the purified proteins were made 
from their frozen stock in a standard buffer (50 mM HEPES pH 7.9, 150 mM NaCl, 1 
mM TCEP). The sub-stock concentration was 500 nM for polymerase module, Pap1 
and CPF, and 4 µM for the accessory factors CF IA and Rna14/Rna15. The reaction 
was assembled as follows: 
 
Component name Per reaction / time point  
Nuclease free water  up to 20 µl 
5X polyadenylation buffer  4 µl 
5ʹ-FAM-CYC1 (4 µM) 2 µl 
DTT (10 mM) 2 µl 
RiboLock (10 U/µl)  1 µl 
Accessory factors (4 µM) 2 µl 
Polymerase (500 nM) 2 µl 
ATP (20 mM) 2 µl 
 
Table 6.21: Setting up in vitro polyadenylation assays 
 
If a reaction with ten time points was to be performed (Figure 2.7), a 220 µl reaction 
mix was made. The assays were performed at 30 °C on a heat block. The reaction time 
point 'zero' was taken before the addition of ATP. At every time point, 20 µl of the 
reaction solution was removed from the master mix and mixed with 20 µl of 2x RNA 
loading dye. Products were analyzed by running on a 15% w/v ureapolyacrylamide gel 
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for 30 minutes at 400 V. The gel was imaged on a Typhoon FLA-7000 laser scanner 
(GE Healthcare).  
 
For assays with accessory factors (Figures 4.1, 4.2, 4.3, 4.4 and 4.5), the master mix 
containing 5ʹ-FAM-CYC1 was pre-incubated with equal molar amounts of accessory 
factors for 5 minutes before the addition of polymerase. For assays comparing the 
activity of Pap1 and the polymerase module variants, purified proteins were first 
resolved by 4–12% SDS-PAGE (Invitrogen) and visualized by staining with 
InstantBlue™ (Expedion) (Figure 2.5). 8 µl of 150 nM amounts of polymerase module 
variants (with and without Pap1) and isolated Pap1 were loaded per lane of the gel 
(Figure 2.5a). 3 µl of 500 nM amount of polymerase module variant and 3 µl of 1000 
nM amount of isolated Pap1 were loaded per lane (Figure 2.5b). Intensity of Pap1 bands 
were analyzed by Image J. After normalising for the intensity of Pap1, the proteins were 
further used in polyadenylation assay described in Figure 6 and 7.  
 
6.6.1.2 Cleavage and polyadenylation assays of CYC13ʹ-UTR, 5ʹ-CYC1-pc and 
5ʹ-CYC1-pc-A30 
 
The cleavage and polyadenylation assays shown in chapter 5 were performed in a very 
similar manner to section 6.6.1.1, barring a few modifications. The concentrations of the 
RNA substrate were 100 nM in all the assays, different from the earlier ones in section 
6.6.1.1. Secondly, the cleavage and polyadenylation reactions were stopped by adding 4 
µl of STOP solution (130 mM EDTA, 5% (w/v) SDS, 12 mg/ml proteinase K made in 
assay buffer) to 20 µl time reaction mix. The STOP reaction mix was incubated at 37 °C 
for 10 min, and on ice for 20 min before adding 24 µl of 2x RNA loading dye to it. 18 
µl of the final sample were loaded per well on a 15% w/v ureapolyacrylamide gel and 
run for 30 minutes at 400 V. The RNA used in the cleavage and polyadenylation assays 
were not fluorescently labelled. So the gels were visualized by staining with SyBr 
Green II and were imaged on a ChemiDoc XRS+ (BioRad). Third, the order of addition 
of the reaction components was different from that of table 6.21. In these assays, the 
substrate RNA was added in the end (before ATP). In case of cleavage only assays as 
shown in appendix 8.13, reaction was started by the addition of RNA in the end.  
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6.6.2 In vitro pull downs 
 
Bait proteins and complexes containing a StrepII-tag were diluted to a concentration of 
1.5 µM in pull-down buffer (10 mM HEPES pH 7.9, 150 mM NaCl, 0.5 mM 
Mg(OAc)2) containing 0.05% Tween-20. 100 µl of bait protein was mixed with 40 µl 
bed volume of StrepTactin resins (GE) and this mixture was topped up to 1 ml with 
pull-down buffer. The negative control reaction did not contain any bait protein added 
to the resins; instead only 100 µl buffer was added.  The binding reaction was carried 
out for 1 hour at 4°C. The unbound proteins (supernatant) were separated from the 
resins by centrifugation at 600g for 5 min. The supernatant was removed; the pelleted 
resins were washed with 1 ml of pull-down buffer. The wash step was repeated again. 1 
ml of pull-down buffer was added and the resins were mixed well. The slurry was split 
into four tubes. Each tube contained 10 µl bait-loaded resins in 250 µl pull-down buffer. 
20 µL of untagged prey proteins at 4 µM concentration were added to each of the four 
tubes. The second binding reaction was performed for 60 min at 4°C. The supernatant 
was removed by centrifugation; resins were washed four times with 1 ml pull-down 
buffer as described earlier.  Proteins were eluted from the resins by the addition of 4x 
LDS and incubation at 95°C for 2 min. The elution samples were analyzed by SDS-
PAGE. A 4%–12% gradient gel was used to run the samples in MOPS-SDS buffer at 
200 V for 50 min. Proteins were visualized by staining with InstantBlueTM (Expedeon). 
 
6.6.3 EMSA 
 
A 96-well plate was used to assemble the protein-RNA mixture. In a single well, 8 µl of 
purified protein was incubated with 1 µl of 500 nM RNA and 1 µl of 10x orange 
loading dye (0.4% w/v orange G, 1 mM EDTA pH 8, 50% v/v glycerol). In a similar 
manner, six wells in a row were filled with protein-RNA mix. The protein-RNA mix 
was incubated on ice for 20 minutes. The final concentrations of proteins were 0 nM, 
125 nM, 250 nM, 500 nM, 1 µM and 2 µM in each of the wells. The protein was diluted 
to various concentrations from the stock using a buffer (50 mM HEPES pH 7.9, 150 
mM NaCl, 1 mM TCEP) containing 1 U RiboLock Inhibitor (ThermoScientific). The 
sample from each of the wells was analyzed by running a native-polyacrylamide gel 
(6% [w/v] 19:1 acrylamide: bisacrylamide, 1xTBE) for 40 minutes at 100 V. The gel 
was imaged on a Typhoon FLA-7000 laser scanner (GE Healthcare).  
 
  231 
6.6.4 Protein-RNA pull downs 
 
30 µl of StrepTactin Sepharose HP resin (GE) were washed with 1 ml of nuclease free 
H20, followed by 1 ml of polyadenylation buffer. Washes were separated from the 
StrepTactin resins by centrifuging at 600g for 5 min. To the resins, 56 µl of 268 nM 
purified CPF was added. The slurry was topped up to 300 µl with polyadenylation 
buffer. The binding reaction was performed for 45 min at 4 °C. The unbound CPF was 
removed by centrifugation and the resins washed once with 1 ml polyadenylation 
buffer. Care was taken not to leave the resins dry at any point of time during the entire 
procedure. Then 300 µl of the cleavage reaction mixture was added to the resins bound 
to CPF and the cleavage reaction performed for 10 min at 30 °C.  
 
Component name Total amount added  
  
1X polyadenylation buffer  454.2 µl 
RiboLock (40 U/µl)  15 µl 
DTT (60 mM) 30 µl 
CF IA (2.4 µM) 75 µl 
CF IB (10.4 µM) 17.4 µl 
CYC13ʹ-UTR (7.2 µM) 8.4 µl 
 
Table 6.22: Preparing the cleavage reaction mix 
 
The slurry is then centrifuged at 600g for 10 mins and supernatant removed. The resins 
are washed three times with 1 ml of polymerase buffer containing 0.01 % Tween-20. 20 
µl of 2x RNA loading dye are added to the resins to elute the protein-RNA complex. 
The control pull-down was performed alongside where there was no CPF used. 56 µl of 
polyadenylation buffer was used in the first bait-binding step instead.  
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6.6.5 Analytical Size Exclusion Chromatography  
 
6.6.5.1 Cross-linking of polymerase module 
 
12 µl of polymerase module (with two copies of Pap1) at 8.4 mg/ml (22 µM) was mixed 
with 88 µl of buffer J and 25 µl of BS3 at 10 mM concentration. The mixture was 
incubated on ice for 30 min. The reaction was quenched by addition of 25 µl of 
NH4HCo3. The cross-linked sample was loaded onto a Superose 6 Increase 3.2/300 
column using a 100 µl loop. The column was run at a flow rate of 0.06 ml/min.  
 
6.6.5.2 Interaction between Rna14/Rna15  
 
40 µl of purified polymerase module (without Pap1) at 29 µM was mixed with 50 µl of 
Rna14/Rna15 at 90 µM and 20 µl of buffer J. The mixture was incubated on ice for 15 
minutes. The mixture was loaded onto a Superose 6 Increase 3.2/300 column in a 100 µl 
loop. The column was run at a flow rate of 0.06 ml/min. The control experiment 
consisted of performing size exclusion chromatography of the following two samples: 
40 µl of polymerase module (without Pap1) at 29 µM mixed with 70 µl of buffer J; and 
50 µl of Rna14/Rna15 at 90 µM mixed with 60 µl of buffer J.  
 
The ternary complex of polymerase module, Rna14/Rna15 subunits and 5ʹ-FAM-CYC1-
pc were prepared as follows: 50 µl of purified polymerase module (without Pap1) at 40 
µM was mixed with 25 µl of purified Rna14/Rna15 at 100 µM, 10 µl of 5ʹ-FAM-CYC1-
pc at 100 µM and 25 µl of 50 mM HEPES pH 7.9, 175 mM NaCl, 1 mM TCEP. The 
mixture was incubated on ice for 30 min. Size exclusion chromatography was 
performed as mentioned in the previous paragraph.  
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6.7 Electron microscopy studies 
 
6.7.1 Negative stain electron microscopy 
 
The following were the samples assessed by negative stain electron microscopy in this 
dissertation: the three polymerase module variants and recombinant CPF. Uranyl acetate 
(1.5% w/v) solution was used as a stain in making the samples. The stain was filtered 
using a 0.22 µM syringe filter before use in grid making. The final concentration of the 
protein samples while making the grids were as follows: 
130 nM polymerase module (with one Pap1), 100 nM polymerase module (without 
Pap1), 100 nM polymerase module (With two Pap1s) and 30 nM rCPF. Continuous 
carbon grids CF400-Cu-UL (EMS) were used to make sample for negative stain EM. 
The grids were glow-discharged for 30 s before 3 µl of freshly purified proteins (at the 
aforementioned concentrations) were added to the surface of the grids. The proteins 
were allowed to adsorb on the grids for 45 seconds. Using a pointed tip of a whatman 
filter paper, the protein droplet is blotted. The surface of the grid containing the 
adsorbed proteins is immersed on to a 40 µl drop of uranyl acetate placed on a clean 
strip of parafilm tape (Partec Premium). After 15 seconds, the grid is moved on to a 
nearby 40 µl drop and immersed for 15 more seconds. The drop of uranyl acetate is 
removed by blotting with a pointed tip of a whatman filter paper. The grids are now 
ready for imaging in the microscope. Micrographs were acquired on a Tecnai Spirit 
microscope (FEI) operating at 120 keV. Images were recorded on a Ultrascan 1000 
CCD camera (Gatan). The polymerase module data set was collected at 21,000x 
magnification. A total of 133 and 120 micrographs were acquired for the polymerase 
module without Pap1 and with Pap1 respectively. For the polymerase module, particle 
picking was done using E2boxer swarm software (Tang et al. 2007) and subsequent data 
processing was done using Relion 1.4 (Scheres 2012). In order to clean the data sets, 
several rounds of reference-free 2D classification was performed. Finally, the 2-D 
classes shown in Figure 2.9a contained 6068 particles for the polymerase without Pap1 
and 3363 particles for the sample polymerase with Pap1. A featureless spherical blob 
was used as the initial model to perform 3D refinement (Figure 2.9b).  
 
Whereas for rCPF, a larger data set consisting of 472 micrographs were collected at 
−1.78 µm defocus and with a total electron dose of ~ 30 e-/Å2 over 1 s. All the data 
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processing including particle picking were done in Relion 2.0. Owing to inherent 
sample heterogeneity, I did not preceded further with data processing beyond 
preliminary 2D classification.  
 
6.7.2 Electron cryomicroscopy 
 
Cryo-EM analyses of four different samples are presented in this dissertation - 
polymerase module (without Pap1), polymerase module (with Pap1), cross-linked 
polymerase module (with two Pap1s) and a ternary complex of polymerase module, 
Rna14/Rna15 and CYC1 RNA.  
 
6.7.3 Sample screening  
 
Ultrastable gold supports (UltraAuFoil R1.2/1.3) grids were used for preparing all the 
samples (C. J. Russo and Passmore 2014). Only protein complexes freshly eluted from 
size exclusion column were vitrified on cryo-EM grids. No frozen materials were used. 
Aliquots of 3 µl of sample were applied onto glow-discharged gold grids. There was no 
specified waiting time between sample application and blotting.  Blotting was done for 
3 s with a blot force of -10 and using filter papers that were pre-incubated in the 
Vitrobot chamber 40 minutes prior to the start of the grid making session. The grids 
were plunge-frozen in liquid ethane using an FEI Vitrobot MKIII, at 100% humidity 
and 4 °C. The grids were stored in liquid nitrogen until further use. Preliminary 
screening of the sample was done in a FEI Tecnai G2-F20 using a model 626 70° tilt 
cryo-holder at liquid nitrogen temperatures. During screening, I was looking for grids 
that resulted in micrographs with well-separated and homogenous particles. Replica of 
such grids were used in collecting larger data sets on a FEI Titan Krios.   
 
6.7.4 Data acquisition and image processing 
 
For the preliminary cryo-EM analysis of polymerase module (without Pap1), 
micrographs were collected on FEI Titan Krios microscope (MRC LMB, Krios 2) 
operated at 300 keV equipped with a Falcon-II direct electron detector (FEI). Data was 
collected at a magnification of 47000x and a calibrated pixel size of 1.77 Å. Images 
were recorded over 2.3 seconds with a total dose of ~ 40 e– /Å2 in linear mode. Two 
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data sets were collected with 722 micrographs in the first one and 651 in the second. 
Both the data sets were collected in the same microscope under similar imaging 
conditions.  The data sets were processed separately and the particles were merged 
together after several rounds of 2D classification of the individual data sets (Figure 11). 
A mask diameter of 180 Å and a box size of 130 pixels were used.  
 
The structure determination of polymerase module was performed together with Ana 
Casañal. For subsequent cryo-EM studies of polymerase module, a large data set 
consisting of 4,227 micrographs were collected on a FEI Titan Krios equipped with a 
K2 detector. An energy filter (Gatan Imaging Filter) with a slit width of 20 eV was used 
to improve the signal to noise in the final images. 3,413 micrographs were collected 
over three two-day session at MRC LMB (Krios 2) with a calibrated pixel size of 1.4 Å, 
and 814 micrographs were collected at Diamond Light Source (DLS) electron Bio-
Imaging Centre (eBIC) with a calibrated pixel size of 1.27 Å. Movies (consisting of 20 
frames) were recorded in superresolution mode over 16 s (0.8 s per frame).  The total 
electron dose was 45 e– /Å2.  Images were collected over a defocus range of 1.5–3.5 
µm. All data processing was performed in RELION-2 (Kimanius et al. 2016). 
MotionCor 2 embedded within RELION-2 was used to correct for the beam-induced 
motion (Zheng et al. 2016). A 3D model of full CPF from an earlier study in the lab 
(Casañal et al. 2017b), was low-pass filtered to 40 Å and was used as an initial model to 
perform 3D refinements. The two data sets were processed individually until the 3D 
refine step, the individual maps were compared in Chimera (Pettersen et al. 2004) to 
calculate a scaling factor (appendix 8.3). The scaling factor was then used to re-scale 
the micrographs collected at Diamond to 1.4 Å pixel size in RELION-2. The re-scaled 
data set was processed further. RELION-2 was used to perform particle polishing and 
per-frame B-factor weighting independently for each dataset. These shiny particles from 
the original LMB and re-scaled Diamond data sets were combined resulting in 460,167 
particles in total. This was subjected to further data processing as described in Figure 
2.13.  The final polymerase module map had an overall resolution of 3.5 Å. The 
resolution estimation was based on the gold standard Fourier shell correlation (FSC) at 
0.143. The FSC is obtained from comparisons between two independently refined half-
sets. Local resolution map was estimated in RELION-2. It is worth noting that a small 
data set using Quantifoil R1.2/1.3 grids coated with graphene oxide was also collected 
in addition to the above two data sets. It was rationalized that the use of such supports 
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would enable us to get more rare views in the 3D reconstruction. However it did not 
result in additional views.  
 
For the sample of polymerase module containing Pap1, and cross-linked polymerase 
module containing two copies of Pap1, data was collected on a FEI Titan Krios 
microscope operated at 300 keV with a Falcon-III direct electron detector (FEI).  
 
A total of 852 micrographs containing polymerase module with Pap1 were acquired at a 
magnification of 47000x corresponding to a calibrated pixel size of 1.77 Å, and in linear 
mode. The total electron dose was ~ 35 e– /Å2.  628 micrographs were chosen for 
further data processing after manually removing the bad micrographs after CTF 
estimation. Gctf embedded in RELION-2 was used in the CTF estimation (Zhang 
2016). A mask diameter of 200 Å and a box size of 140 pixels were used in the data 
processing. A total of 216,375 particles were extracted and subjected to 2D 
classification. 
 
A total of 116 micrographs of cross-linked polymerase module containing two copies of 
Pap1 were collected at a magnification of 59000x corresponding to a calibrated pixel 
size of 1.33 Å. Movies (consisting of 75 frames) with 60 s exposure time and a total 
electron dose of ~ 25 e– /Å2 were recorded while the camera was operating in counting 
mode. 50,471 particles were extracted from the micrographs and subjected to reference 
free 2-D classification with a mask diameter of 220 Å and a box size of 150 pixels.  
 
For the sample of the ternary complex, 644 micrographs were collected on a FEI Titan 
Krios microscope (MRC LMB, Krios 1) operated at 300 keV with a Falcon-III direct 
electron detector (FEI). Images were collected at a magnification of 59000x 
corresponding to a calibrated pixel size of 1.37 Å and in linear mode with a total 
electron dose of ~ 52 e– /Å2. 132,717 particles were extracted from the micrographs 
and subjected to reference free 2-D classification with a mask diameter of 260 Å and a 
box size of 220 pixels.  
 
6.7.5 Model building and refinement of Cft1-Pfs2-Yth1 subunits 
 
Homology models of Cft1 and Pfs2 from Phyre2 (Kelley et al. 2015) along with the 
crystal structure of DDB1 and DDB2 subunits (PDB 3EI3) were used in building Cft1 
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and Pfs2 atomic models. In total, Cft1 and Pfs2 homology models contained four beta-
propellers. Each beta-propeller domains were fitted into the map and refined using 
jiggle fit and morphing in Coot (Emsley et al. 2010). At this point, it was uncertain 
where Yth1 and Fip1 residues could fit into the map. The shape of the remaining un-
modeled density resembled that of a zinc finger domain. The ZnF2 from the crystal 
structure of the ZnF 2 and 3 of CPSF30 (PDB 2RHK) was used in molecular 
replacement. This resulted in assignment of the un-modeled density to Yth1 ZnF 1 and 
2. However, there was no additional density where Fip1 residues could be modeled. The 
final model consisting of Cft1-Pfs2-Yth1 was refined with Refmac v.5.8 (Nicholls, 
Long, and Murshudov 2012; Brown et al. 2015) and phenix.refine (Afonine et al. 2012). 
The model was validated with MolProbity (V. B. Chen et al. 2010).  
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6.8 Biophysical techniques 
 
6.8.1 Protein and nucleic acid quantification 
 
UV spectrometry on a NanoDrop ND- 1000 spectrophotometer (Thermo Scientific) was 
used to measure protein and nucleic acid concentrations. Absorbance at 280 nm for 
proteins and 260 nm for nucleic acids were used to estimate concentrations along with 
the extinction coefficients presented in the following table:  
 
Protein Extinction coefficient 
(M-1 cm-1) 
Molecular mass  
(kDa) 
Pap1 63830 65 
Polymerase 
module+0Pap1 
245700 273 
Polymerase 
module+1Pap1  
309530 337 
Polymerase 
module+2Pap1 
373360 402 
Polymerase 
module+1Cft2 
330960 369 
CF IA 417710 348 
Rna14/Rna15 291080 225 
Pcf11/Clp1 126630 122 
Core-CPF 477070 571 
Full CPF 676360 860 
Ysh1/Mpe1 82280 137 
 
Table 6.23: Extinction coefficients of protein complexes studied in this dissertation 
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RNA Extinction coefficient 
(mM-1 cm-1) 
Length  
(nucleotides) 
CYC13ʹ-UTR  3272 259 
5ʹ-CYC1-pc  2295 181 
5ʹ-CYC1-pc-A30 2757 211 
5′-UTR MFA2 3′-UTR   5310 417 
GCN4 3′-UTR 3804 
300 
 
Table 6.24: Extinction coefficients of RNA used in this dissertation 
 
6.8.2 Tandem mass spectrometry 
 
The protein complex being studied is analyzed by SDS-PAGE and the individual 
subunits are separated. The gel is stained using InstantBlue™ (Expedion) for 30 
minutes. The gel was placed on a sterile Saran wrap (pre-cleaned with 70% ethanol), the 
desired band of interest was excised using fresh blades. The bands are stored in a 1.5 ml 
eppendorf tube with a few µl of milliQ H2O. Farida Begum from the LMB mass 
spectrometry facility performed all further steps. The band was destained, reduced, 
alkylated and digested in-gel by trypsin. Liquid chromatography coupled with tandem 
mass spectrometry was performed. The acquired data was searched against a protein 
database using the Mascot search engine. The data was analyzed using Scaffold 
(Proteome software).  
 
6.8.3 Cross-linking mass spectrometry  
 
Gianluca Degliesposti from the LMB mass spectrometry facility performed all the 
cross-linking mass spectrometry experiments. The cross-linking reaction was performed 
using purified polymerase module (with and without Pap1) or polymerase module (with 
and without Rna14/Rna15) at a concentration of 1 mg/ml proteins resuspended in 50 
mM HEPES pH 7.9 buffer. For the former samples, BS3 (Creative Molecules, Canada) 
was used at 600 µM concentration to chemically cross-link lysine, whereas the latter 
samples were cross-linked by N-hydroxysuccinimide (NHS) esters disuccinimidyl 
dibutyric urea (BuUrBu also known as DSBU). The cross-linking reaction was 
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performed at 45 min at 37 °C; the reaction quenched by addition of 50 mM ammonium 
carbonate and incubation for 15 min. The cross-linked samples were freeze-dried, 
reduced and alkylated. Trypsin digestion was carried out over night at 37 °C. The 
digests were run on a Superdex Peptide 3.2/300 (GE Healthcare) and the collected 
fractions were exchanged into 2% v/v acetonitrile and 2% v/v formic acid. Next, nano-
scale capillary LC-MS/MS was carried out using an Ultimate U3000 HPLC 
(ThermoScientific Dionex, San Jose, USA). A C18 Acclaim PepMap100 nanoViper 
(ThermoScientific Dionex), trapped and separated the peptides. A gradient of 
acetonitrile was used to elute the peptides. The column outlet was connected to a hybrid 
dual pressure linear ion trap mass spectrometer (Orbitrap Velos, ThermoScientific) 
through a nano-flow electrospray ionization source. With a resolution of 30,000, data 
dependent analysis was carried out for the full MS spectrum and ten MS/MS. MS 
spectra were obtained across a m/z range of 300–2000 and a threshold energy of 35 for 
collision-induced dissociation. 
 
MS data were analysed with XQuest (Rinner et al. 2008) and MeroX (Götze et al. 2015) 
according to the XL reagent used (BS3 --> XQuest, DSBU --> MeroX. Searches were 
carried out against a database containing all the polymerase module, Rna14 and Rna15 
sequences plus their reversed sequences used as decoy for the calculation of false 
discovery rate. Each MS/MS spectra was manually inspected and validated. 
 
6.8.4 HDX 
 
Sarah Maslen from the LMB mass spectrometry facility performed all the HDX 
experiments. Deuterium exchange reactions of polymerase module (with and without 
Pap1), complex of polymerase module with Rna14/Rna15 were initiated by diluting the 
complexes in D2O (99.8% D2O ACROS, Sigma, UK) in 50 mM HEPES pH 7.9, 150 
mM NaCl, 1mM TCEP to give a final D2O percentage of ∼95%. Deuterium labeling 
was carried out at 23°C and at four time points, 0.3 s (3 s on ice), 3 s, 30 s and 300 s in 
triplicate. Chilled 2.4% v/v formic acid in 2 M guanidinium hydrochloride is used to 
quench the reaction. The samples are immediately frozen in liquid nitrogen and stored 
at −80°C for further analysis. The samples were thawed and proteolytic digestion was 
performed with pepsin. The digested peptides were separated by reverse phase HPLC 
(Acquity UPLC BEH C18 column 1.7 µm, 100 mm x 1 mm, Waters, UK). Peptide 
detection was carried out over a over a m/z of 300–2000 on a SYNAPT G2-Si HDMS 
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mass spectrometer (Waters, UK). The source temperature of the spectrometer was 80°C 
and spray voltage 2.6 kV. Spectra were collected in positive ion mode. Peptide 
identification was performed as described in Silva et al, 2005. DynamX software was 
used for peptide identification and analysis. Back-exchange of deuterium from the 
amide into the buffer was not corrected for. Only relative (not absolute) deuterium 
incorporation levels were measured. The HD exchange in a peptide could stem from 
either a single amide or multiple amides within the peptide.  
 
6.8.5 NMR 
 
Conny Yu from the NMR facility performed all the NMR experiments and the SEC-
MALS. Isotopically-labeled proteins were overexpressed in M9 minimal medium 
containing 1.7g/L yeast nitrogen base (Sigma Y1251), 1g/L 15NH4Cl and for 3D-
experiments additionally [13C]-glucose. All experiments, including binding studies, 
were carried out in the same buffer (50 mM HEPES pH 7.4, 150 mM NaCl, 5% D2O). 
For backbone assignment experiments, data were collected at 278 K using Bruker 
Avance II+ 700 MHz for optimal signal-to-noise and protein stability. Assignment was 
transferred to 298K for binding studies, by following the chemical shift perturbation in 
5K intervals.  
 
1H-15N BEST–TROSY (Band Selective Excitation short Transients Transverse 
Relaxation Optimized SpectroscopY) experiments were collected with an in-house 
optimized pulse sequence (Favier and Brutscher 2011; Schanda, Van Melckebeke, and 
Brutscher 2006).  
 
Assignment of backbone amide peaks was completed using standard triple resonance 
spectra: HNCO, HN(CA)CO, HNCA, HN(CO)CA, HNCACB and CBCACONH. An 
HN(COCA)NNH spectra was collected to confirm backbone assignment. Backbone 
datasets were acquired using non-uniform sampling protocols and processed with 
qMDD using compressed sensing reconstruction (Kazimierczuk and Orekhov 2011).  
 
All spectra were processed using Topspin 3.5 and analyzed with NMRFAM-Sparky 
1.412, with assignment aided by MARS (Jung and Zweckstetter 2004). 
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Weighted chemical shift perturbations were calculated using the equation 
√(Δδ1H)2+(0.2(Δδ15N)2) with Δδ1H and Δδ15N being the chemical shift differences 
between free and bound states. Secondary structure was derived from 13C chemical 
shifts of Ca, Cb and Co using TALOS (Shen et al. 2009; Shen and Bax 2013). 
 
6.8.6 SEC MALS 
 
100 µl of Yth1:Fip1 complex at 4 mg/ml was injected onto a Superdex 75 increase 
10/300gl (GE) column. The run was carried at 0.5 ml/min. An Agilent 1200 series LC 
system with an on-line Dawn Helios ii (Wyatt), a QELS+ module (Wyatt) and an 
Optilab rEX differential refractive index detector (Wyatt) was used. QELS module was 
used to replace the detector 12 in the light scattering cell.  
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6.9 Bioinformatics  
 
6.9.1 Sequence analysis 
 
Balaji Santhanam from the Babu lab performed the sequence analysis of the interaction 
surface between Pfs2 and Cft1. Orthologs of Pfs2 and Cft1 were identified by PSI-
BLAST and JackHMMER (Johnson, Eddy, and Portugaly 2010). MSAProbs (Liu, 
Schmidt, and Maskell 2010) was used to make multiple sequence alignments that were 
then refined based on PSI-BLAST and JackHMMER profiles and DSSP (Kabsch and 
Sander 1983; Touw et al. 2015) secondary structures assignments. The equivalent 
interaction residues between Cft1 and pfs2 orthologs in humans were identified based 
on the multiples sequence alignment file. The BLOSUM6 scores for the interaction 
mediating residues in yeast and humans were analysed. Any score above zero was 
regarded as conserved. The interaction was visualized using Cytoscape (Cline et al. 
2007; Shannon et al. 2003).  
 
6.9.2 Structural analysis 
 
Electrostatic surface potentials were calculated by solving the Poisson– Boltzmann 
equation at pH 7.  The APBS plugin in PyMOL was used for the calculation (Baker et 
al. 2001). Hydrophobic surface representation was performed using the color_h.py 
script obtained from the Laboratory of Supramolecular Crystallography, Institute for 
Protein Research, Osaka University.  
 
All solvent atoms and ligands were removed from Pap1 and Cft1 structures (PDB: 
1FAO, 6EOJ). Docking was performed with HADDOCK 2.2 (van Zundert et al. 2016). 
For preparation of ambiguous interactions restraints, the Cft1 residues K609, K1330, 
K1325 and Pap1 residues K 183 and K536 were specified as active. For both molecules, 
passive residues were defined automatically within a 6.5 Å radius of active residues.  
 
Structures used in Figures were rendered in PyMOL (Schrödinger LLC). Figures of EM 
maps were rendered in Chimera (Pettersen et al. 2004). 
 
 
  244 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  245 
7 References 
 
Abe, A, Y Hiraoka, and T Fukasawa. 1990. “Signal Sequence for Generation of MRNA 
3’ End in the Saccharomyces Cerevisiae GAL7 Gene.” The EMBO Journal 9 (11): 
3691–97. 
Afonine, Pavel V., Ralf W. Grosse-Kunstleve, Nathaniel Echols, Jeffrey J. Headd, 
Nigel W. Moriarty, Marat Mustyakimov, Thomas C. Terwilliger, Alexandre 
Urzhumtsev, Peter H. Zwart, and Paul D. Adams. 2012. “Towards Automated 
Crystallographic Structure Refinement with Phenix.Refine.” Acta 
Crystallographica Section D Biological Crystallography 68 (4): 352–67. 
https://doi.org/10.1107/S0907444912001308. 
Agirrezabala, Xabier, and Mikel Valle. 2015. “Structural Insights into TRNA Dynamics 
on the Ribosome.” International Journal of Molecular Sciences 16 (5): 9866–95. 
https://doi.org/10.3390/ijms16059866. 
Aibara, Shintaro, James M. B. Gordon, Anja S. Riesterer, Stephen H. McLaughlin, and 
Murray Stewart. 2017. “Structural Basis for the Dimerization of Nab2 Generated 
by RNA Binding Provides Insight into Its Contribution to Both Poly(A) Tail 
Length Determination and Transcript Compaction in Saccharomyces Cerevisiae.” 
Nucleic Acids Research 45 (3): 1529–38. https://doi.org/10.1093/nar/gkw1224. 
Amrani, N, M Minet, M Le Gouar, F Lacroute, and F Wyers. 1997. “Yeast Pab1 
Interacts with Rna15 and Participates in the Control of the Poly(A) Tail Length in 
Vitro.” Molecular and Cellular Biology 17 (7): 3694–3701. 
Amrani, N, M Minet, F Wyers, M E Dufour, L P Aggerbeck, and F Lacroute. 1997. 
“PCF11 Encodes a Third Protein Component of Yeast Cleavage and 
Polyadenylation Factor I.” Molecular and Cellular Biology 17 (3): 1102–9. 
Anderson, J T, S M Wilson, K V Datar, and M S Swanson. 1993. “NAB2: A Yeast 
Nuclear Polyadenylated RNA-Binding Protein Essential for Cell Viability.” 
Molecular and Cellular Biology 13 (5): 2730–41. 
Baejen, Carlo, Phillipp Torkler, Saskia Gressel, Katharina Essig, Johannes Söding, and 
Patrick Cramer. 2014. “Transcriptome Maps of MRNP Biogenesis Factors Define 
Pre-MRNA Recognition.” Molecular Cell 55 (5): 745–57. 
https://doi.org/10.1016/J.MOLCEL.2014.08.005. 
Bai, Yun, Thierry C Auperin, Chi-Yuan Chou, Gu-Gang Chang, James L Manley, and 
Liang Tong. 2007. “Crystal Structure of Murine CstF-77: Dimeric Association and 
Implications for Polyadenylation of MRNA Precursors.” Molecular Cell 25 (6): 
  246 
863–75. https://doi.org/10.1016/j.molcel.2007.01.034. 
Baker, N A, D Sept, S Joseph, M J Holst, and J A McCammon. 2001. “Electrostatics of 
Nanosystems: Application to Microtubules and the Ribosome.” Proceedings of the 
National Academy of Sciences of the United States of America 98 (18): 10037–41. 
https://doi.org/10.1073/pnas.181342398. 
Balbo, Paul B., and Andrew Bohm. 2007. “Mechanism of Poly(A) Polymerase: 
Structure of the Enzyme-MgATP-RNA Ternary Complex and Kinetic Analysis.” 
Structure 15 (9): 1117–31. https://doi.org/10.1016/j.str.2007.07.010. 
Bandaranayake, Ashok D., and Steven C. Almo. 2014. “Recent Advances in 
Mammalian Protein Production.” FEBS Letters 588 (2): 253–60. 
https://doi.org/10.1016/j.febslet.2013.11.035. 
Barabino, W Hübner, A Jenny, L Minvielle-Sebastia, and W Keller. 1997. “The 30-KD 
Subunit of Mammalian Cleavage and Polyadenylation Specificity Factor and Its 
Yeast Homolog Are RNA-Binding Zinc Finger Proteins.” Genes & Development 
11 (13): 1703–16. https://doi.org/10.1101/GAD.11.13.1703. 
Barabino, Martin Ohnacker, and Walter Keller. 2000a. “Distinct Roles of Two Yth1p 
Domains in 3′-End Cleavage and Polyadenylation of Yeast Pre-MRNAs.” The 
EMBO Journal 19 (14): 3778–87. https://doi.org/10.1093/emboj/19.14.3778. 
Barabino, Silvia M.L., Martin Ohnacker, and Walter Keller. 2000b. “Distinct Roles of 
Two Yth1p Domains in 3′-End Cleavage and Polyadenylation of Yeast Pre-
MRNAs.” The EMBO Journal 19 (14): 3778–87. 
https://doi.org/10.1093/emboj/19.14.3778. 
Bard, J, A M Zhelkovsky, S Helmling, T N Earnest, C L Moore, and A Bohm. 2000. 
“Structure of Yeast Poly(A) Polymerase Alone and in Complex with 3’-DATP.” 
Science (New York, N.Y.) 289 (5483): 1346–49. 
Barilla, D., B A Lee, and N J Proudfoot. 2001. “Cleavage/Polyadenylation Factor IA 
Associates with the Carboxyl-Terminal Domain of RNA Polymerase II in 
Saccharomycescerevisiae.” Proceedings of the National Academy of Sciences 98 
(2): 445–50. https://doi.org/10.1073/pnas.021545298. 
Barnwal, Ravi Pratap, Susan D Lee, Claire Moore, and Gabriele Varani. 2012. 
“Structural and Biochemical Analysis of the Assembly and Function of the Yeast 
Pre-MRNA 3’ End Processing Complex CF I.” Proceedings of the National 
Academy of Sciences of the United States of America 109 (52): 21342–47. 
https://doi.org/10.1073/pnas.1214102110. 
Beaudoing, E, S Freier, J R Wyatt, J M Claverie, and D Gautheret. 2000. “Patterns of 
  247 
Variant Polyadenylation Signal Usage in Human Genes.” Genome Research 10 
(7): 1001–10. 
Beilharz, T. H., and T. Preiss. 2007. “Widespread Use of Poly(A) Tail Length Control 
to Accentuate Expression of the Yeast Transcriptome.” RNA 13 (7): 982–97. 
https://doi.org/10.1261/rna.569407. 
Bennetzen, J L, and B D Hall. 1982. “The Primary Structure of the Saccharomyces 
Cerevisiae Gene for Alcohol Dehydrogenase.” The Journal of Biological 
Chemistry 257 (6): 3018–25. 
Berkovits, Binyamin D., and Christine Mayr. 2015. “Alternative 3′ UTRs Act as 
Scaffolds to Regulate Membrane Protein Localization.” Nature 522 (7556): 363–
67. https://doi.org/10.1038/nature14321. 
Bieniossek, Christoph, Tsuyoshi Imasaki, Yuichiro Takagi, and Imre Berger. 2012. 
“MultiBac: Expanding the Research Toolbox for Multiprotein Complexes.” Trends 
in Biochemical Sciences 37 (2): 49–57. https://doi.org/10.1016/j.tibs.2011.10.005. 
Bienroth, S, W Keller, and E Wahle. 1993. “Assembly of a Processive Messenger RNA 
Polyadenylation Complex.” The EMBO Journal 12 (2): 585–94. 
Brimacombe, Richard, and Wolfgang Stiege. 1985. “ARTICLE Structure and Function 
of Ribosomal RNA.” Biochem. J. Vol. 229. 
Brown, Alan, Fei Long, Robert A. Nicholls, Jaan Toots, Paul Emsley, and Garib 
Murshudov. 2015. “Tools for Macromolecular Model Building and Refinement 
into Electron Cryo-Microscopy Reconstructions.” Acta Crystallographica Section 
D Biological Crystallography 71 (1): 136–53. 
https://doi.org/10.1107/S1399004714021683. 
Brune, C., Sarah E Munchel, Nicole Fischer, Alexandre V Podtelejnikov, and Karsten 
Weis. 2005. “Yeast Poly(A)-Binding Protein Pab1 Shuttles between the Nucleus 
and the Cytoplasm and Functions in MRNA Export.” RNA 11 (4): 517–31. 
https://doi.org/10.1261/rna.7291205. 
Bucheli, M. E., X. He, C. D. Kaplan, C. L. Moore, and S. Buratowski. 2007. 
“Polyadenylation Site Choice in Yeast Is Affected by Competition between Npl3 
and Polyadenylation Factor CFI.” RNA 13 (10): 1756–64. 
https://doi.org/10.1261/rna.607207. 
Butler, J S, and T Platt. 1988. “RNA Processing Generates the Mature 3’ End of Yeast 
CYC1 Messenger RNA in Vitro.” Science (New York, N.Y.) 242 (4883): 1270–74. 
Casañal, A. Kumar, C.H. Hill, A.D. Easter, P. Emsley, G. Degliesposti, Y. Gordiyenko, 
et al. 2017a. “Architecture of Eukaryotic MRNA 3′-End Processing Machinery.” 
  248 
Science 358 (6366). https://doi.org/10.1126/science.aao6535. 
Casañal, Ananthanarayanan Kumar, Chris H Hill, Ashley D Easter, Paul Emsley, 
Gianluca Degliesposti, Yuliya Gordiyenko, et al. 2017b. “Architecture of 
Eukaryotic MRNA 3’-End Processing Machinery.” Science (New York, N.Y.) 358 
(6366): 1056–59. https://doi.org/10.1126/science.aao6535. 
Chambers, Adam C., Mine Aksular, Leo P. Graves, Sarah L. Irons, Robert D. Possee, 
and Linda A. King. 2018. “Overview of the Baculovirus Expression System.” In 
Current Protocols in Protein Science, 5.4.1-5.4.6. Hoboken, NJ, USA: John Wiley 
& Sons, Inc. https://doi.org/10.1002/cpps.47. 
Chan, Serena L, Ina Huppertz, Chengguo Yao, Lingjie Weng, James J Moresco, John R 
Yates Iii, Jernej Ule, James L Manley, and Yongsheng Shi. 2014. “CPSF30 and 
Wdr33 Directly Bind to AAUAAA in Mammalian MRNA 39 Processing.” 
https://doi.org/10.1101/gad.250993.114. 
Chan, Serena L, Ina Huppertz, Chengguo Yao, Lingjie Weng, James J Moresco, John R 
Yates, Jernej Ule, James L Manley, Yongsheng Shi, and Yongsheng Shi. 2014. 
“CPSF30 and Wdr33 Directly Bind to AAUAAA in Mammalian MRNA 3’ 
Processing.” Genes & Development 28 (21): 2370–80. 
https://doi.org/10.1101/gad.250993.114. 
Chen, and Hyman. 1998. “A Specific RNA-Protein Interaction at Yeast Polyadenylation 
Efficiency Elements.” Nucleic Acids Research 26 (21): 4965–74. 
Chen, Jie, and Claire Moore. 1992. “Separation of Factors Required for Cleavage and 
Polyadenylation of Yeast Pre-MRNA.” Molecular and Cellular Biology. 
Chen, Vincent B., W. Bryan Arendall, Jeffrey J. Headd, Daniel A. Keedy, Robert M. 
Immormino, Gary J. Kapral, Laura W. Murray, Jane S. Richardson, and David C. 
Richardson. 2010. “MolProbity : All-Atom Structure Validation for 
Macromolecular Crystallography.” Acta Crystallographica Section D Biological 
Crystallography 66 (1): 12–21. https://doi.org/10.1107/S0907444909042073. 
Cheng, Hailing, Xiaoyuan He, and Claire Moore. 2004. “The Essential WD Repeat 
Protein Swd2 Has Dual Functions in RNA Polymerase II Transcription 
Termination and Lysine 4 Methylation of Histone H3.” Molecular and Cellular 
Biology 24 (7): 2932–43. 
Christofori, Gerhard, and Walter Keller. 1988. “3′ Cleavage and Polyadenylation of 
MRNA Precursors in Vitro Requires a Poly(A) Polymerase, a Cleavage Factor, 
and a SnRNP.” Cell 54 (6): 875–89. https://doi.org/10.1016/S0092-
8674(88)91263-9. 
  249 
Clerici, Marcello, Marco Faini, Ruedi Aebersold, and Martin Jinek. 2017. “Structural 
Insights into the Assembly and PolyA Signal Recognition Mechanism of the 
Human CPSF Complex.” ELife 6 (December). https://doi.org/10.7554/eLife.33111. 
Clerici, Marcello, Marco Faini, Lena M. Muckenfuss, Ruedi Aebersold, and Martin 
Jinek. 2018. “Structural Basis of AAUAAA Polyadenylation Signal Recognition 
by the Human CPSF Complex.” Nature Structural & Molecular Biology 25 (2): 
135–38. https://doi.org/10.1038/s41594-017-0020-6. 
Cline, Melissa S, Michael Smoot, Ethan Cerami, Allan Kuchinsky, Nerius Landys, 
Chris Workman, Rowan Christmas, et al. 2007. “Integration of Biological 
Networks and Gene Expression Data Using Cytoscape.” Nature Protocols 2 (10): 
2366–82. https://doi.org/10.1038/nprot.2007.324. 
Cretu, Constantin, Jana Schmitzová, Almudena Ponce-Salvatierra, Olexandr Dybkov, 
Evelina I. De Laurentiis, Kundan Sharma, Cindy L. Will, Henning Urlaub, 
Reinhard Lührmann, and Vladimir Pena. 2016. “Molecular Architecture of SF3b 
and Structural Consequences of Its Cancer-Related Mutations.” Molecular Cell 64 
(2): 307–19. https://doi.org/10.1016/J.MOLCEL.2016.08.036. 
Curinha, Ana, Sandra Oliveira Braz, Isabel Pereira-Castro, Andrea Cruz, and Alexandra 
Moreira. 2014. “Implications of Polyadenylation in Health and Disease.” Nucleus 
(Austin, Tex.) 5 (6): 508–19. https://doi.org/10.4161/nucl.36360. 
Cyril Dominguez, And Rolf Boelens, and Alexandre M. J. J. Bonvin. 2003. 
“HADDOCK: A Protein−Protein Docking Approach Based on Biochemical or 
Biophysical Information.” https://doi.org/10.1021/JA026939X. 
Das, Kalyan, Li-Chung Ma, Rong Xiao, Brian Radvansky, James Aramini, Li Zhao, 
Jesper Marklund, et al. 2008. “Structural Basis for Suppression of a Host Antiviral 
Response by Influenza A Virus.” Proceedings of the National Academy of Sciences 
of the United States of America 105 (35): 13093–98. 
https://doi.org/10.1073/pnas.0805213105. 
Derti, Adnan, Philip Garrett-Engele, Kenzie D. MacIsaac, Richard C. Stevens, 
Shreedharan Sriram, Ronghua Chen, Carol A. Rohl, Jason M. Johnson, and Tomas 
Babak. 2012. “A Quantitative Atlas of Polyadenylation in Five Mammals.” 
Genome Research 22 (6): 1173–83. https://doi.org/10.1101/gr.132563.111. 
Dheur, Sonia, Keith R Nykamp, Nicolas Viphakone, Maurice S Swanson, and Lionel 
Minvielle-Sebastia. 2005. “Yeast MRNA Poly(A) Tail Length Control Can Be 
Reconstituted in Vitro in the Absence of Pab1p-Dependent Poly(A) Nuclease 
Activity.” The Journal of Biological Chemistry 280 (26): 24532–38. 
  250 
https://doi.org/10.1074/jbc.M504720200. 
Dheur, Sonia, Le Thuy Anh Vo, Florence Voisinet-Hakil, Michèle Minet, Jean-Marie 
Schmitter, François Lacroute, Françoise Wyers, and Lionel Minvielle-Sebastia. 
2003. “Pti1p and Ref2p Found in Association with the MRNA 3’ End Formation 
Complex Direct SnoRNA Maturation.” The EMBO Journal 22 (11): 2831–40. 
https://doi.org/10.1093/emboj/cdg253. 
Dichtl, B, and W Keller. 2001. “Recognition of Polyadenylation Sites in Yeast Pre-
MRNAs by Cleavage and Polyadenylation Factor.” The EMBO Journal 20 (12): 
3197–3209. https://doi.org/10.1093/emboj/20.12.3197. 
Dichtl, Diana Blank, Martin Sadowski, Wolfgang Hübner, Stefan Weiser, and Walter 
Keller. 2002. “Yhh1p/Cft1p Directly Links Poly(A) Site Recognition and RNA 
Polymerase II Transcription Termination.” The EMBO Journal 21 (15): 4125–35. 
Doktycz, Mitchel J, Frank W Larimer, Miro Pastrnak, and Audrey Stevens. 1998. “This 
Contribution Is Part of the Special Series of Inaugural Articles by Members of the 
Comparative Analyses of the Secondary Structures of Synthetic and Intracellular 
Yeast MFA2 MRNAs.” Biochemistry National Academy of Sciences. Vol. 95. 
Easter, Ashley. 2014. “The Structure and Function of Cleavage and Polyadenylation 
Factor from Saccharomyces Cerevisiae.” Doctoral Thesis, no. May. 
Edmonds, M. 1990. “Polyadenylate Polymerases.” Methods in Enzymology 181: 161–
70. 
Edmonds, M, M H Vaughan, and H Nakazato. 1971. “Polyadenylic Acid Sequences in 
the Heterogeneous Nuclear RNA and Rapidly-Labeled Polyribosomal RNA of 
HeLa Cells: Possible Evidence for a Precursor Relationship.” Proceedings of the 
National Academy of Sciences of the United States of America 68 (6): 1336–40. 
Edmonds, Mary, and Richard Abrams. 1960. “Polynucleotide Biosynthesis: Formation 
of a Sequence Adenylate Units from Adenosine Triphosphate by an Enzyme from 
Thymus Nuclei.” The Journal of Biological Chemistry. Vol. 235. 
Edmonds, Mary, and Mary Ann Winters. 1976. “Polyadenylate Polymerases.” In , 149–
79. https://doi.org/10.1016/S0079-6603(08)60069-0. 
Edmund P. Walsh, Douglas J. Lamont, and Kenneth A. Beattie, and Michael J. R. 
Stark*. 2002. “Novel Interactions of Saccharomyces Cerevisiae Type 1 Protein 
Phosphatase Identified by Single-Step Affinity Purification and Mass 
Spectrometry†.” https://doi.org/10.1021/BI015815E. 
Egli, Christoph M, Christoph Springer, and Gerhard H Braus. 1995. “A Complex 
Unidirectional Signal Element Mediates GCN4 MRNA 3 End Formation in 
  251 
Saccharomyces Cerevisiae.” Molecular and Cellular Biology. Vol. 15. 
Eick, Dirk, and Matthias Geyer. 2013. “The RNA Polymerase II Carboxy-Terminal 
Domain (CTD) Code.” Chemical Reviews 113 (11): 8456–90. 
https://doi.org/10.1021/cr400071f. 
Emsley, P., B. Lohkamp, W. G. Scott, and K. Cowtan. 2010. “Features and 
Development of Coot.” Acta Crystallographica Section D Biological 
Crystallography 66 (4): 486–501. https://doi.org/10.1107/S0907444910007493. 
Ezeokonkwo, Chukwudi, Mohamed A Ghazy, Alexander Zhelkovsky, Pei-Chun Yeh, 
and Claire Moore. 2012. “Novel Interactions at the Essential N-Terminus of 
Poly(A) Polymerase That Could Regulate Poly(A) Addition in Saccharomyces 
Cerevisiae.” https://doi.org/10.1016/j.febslet.2012.03.036. 
Ezeokonkwo, Chukwudi, Alexander Zhelkovsky, Rosanna Lee, Andrew Bohm, and 
Claire L Moore. 2011. “A Flexible Linker Region in Fip1 Is Needed for Efficient 
MRNA Polyadenylation.” https://doi.org/10.1261/rna.2273111. 
Fasken, Milo B., Murray Stewart, and Anita H. Corbett. 2008. “Functional Significance 
of the Interaction between the MRNA-Binding Protein, Nab2, and the Nuclear 
Pore-Associated Protein, Mlp1, in MRNA Export.” Journal of Biological 
Chemistry 283 (40): 27130–43. https://doi.org/10.1074/jbc.M803649200. 
Favier, Adrien, and Bernhard Brutscher. 2011. “Recovering Lost Magnetization: 
Polarization Enhancement in Biomolecular NMR.” Journal of Biomolecular NMR 
49 (1): 9–15. https://doi.org/10.1007/s10858-010-9461-5. 
Fitzgerald, M, and T Shenk. 1981. “The Sequence 5’-AAUAAA-3’forms Parts of the 
Recognition Site for Polyadenylation of Late SV40 MRNAs.” Cell 24 (1): 251–60. 
Garas, M., B. Dichtl, and W. Keller. 2008. “The Role of the Putative 3’ End Processing 
Endonuclease Ysh1p in MRNA and SnoRNA Synthesis.” RNA 14 (12): 2671–84. 
https://doi.org/10.1261/rna.1293008. 
Gavin, Anne-Claude, Markus Bösche, Roland Krause, Paola Grandi, Martina Marzioch, 
Andreas Bauer, Jörg Schultz, et al. 2002. “Functional Organization of the Yeast 
Proteome by Systematic Analysis of Protein Complexes.” Nature 415 (6868): 141–
47. https://doi.org/10.1038/415141a. 
Giammartino, Dafne Campigli, and James L Manley. 2014. “New Links between 
MRNA Polyadenylation and Diverse Nuclear Pathways.” Molecules and Cells 37 
(9): 644–49. https://doi.org/10.14348/molcells.2014.0177. 
Gibson, Daniel G, Lei Young, Ray-Yuan Chuang, J Craig Venter, Clyde A Hutchison, 
and Hamilton O Smith. 2009. “Enzymatic Assembly of DNA Molecules up to 
  252 
Several Hundred Kilobases.” Nature Methods 6 (5): 343–45. 
https://doi.org/10.1038/nmeth.1318. 
Gordon, James M B, Sergei Shikov, Jason N Kuehner, Melissa Liriano, Eunhee Lee, 
Walter Stafford, Mathias Bach Poulsen, Celia Harrison, Claire Moore, and Andrew 
Bohm. 2011. “Reconstitution of CF IA from Overexpressed Subunits Reveals 
Stoichiometry and Provides Insights into Molecular Topology.” 
https://doi.org/10.1021/bi200964p. 
Götze, Michael, Jens Pettelkau, Romy Fritzsche, Christian H. Ihling, Mathias Schäfer, 
and Andrea Sinz. 2015. “Automated Assignment of MS/MS Cleavable Cross-
Links in Protein 3D-Structure Analysis.” Journal of The American Society for 
Mass Spectrometry 26 (1): 83–97. https://doi.org/10.1007/s13361-014-1001-1. 
Graber, J. H., C. R. Cantor, S. C. Mohr, and T. F. Smith. 1999. “Genomic Detection of 
New Yeast Pre-MRNA 3’-End-Processing Signals.” Nucleic Acids Research 27 
(3): 888–94. https://doi.org/10.1093/nar/27.3.888. 
Green, Deanna M, Kavita A Marfatia, Emily B Crafton, Xing Zhang, Xiaodong Cheng, 
and Anita H Corbett. 2002. “Nab2p Is Required for Poly(A) RNA Export in 
Saccharomyces Cerevisiae and Is Regulated by Arginine Methylation via Hmt1p.” 
The Journal of Biological Chemistry 277 (10): 7752–60. 
https://doi.org/10.1074/jbc.M110053200. 
Groner, N Hynes, and S Phillips. 1974. “Length Heterogeneity in the Poly (Adenylic 
Acid) Region of Yeast Messenger Ribonucleic Acid.” Biochemistry 13 (26): 5378–
83. 
Groner, and Stephen L Phillips. 1975. “Polyadenylate Metabolism in the Nuclei and 
Cytoplasm of Saccharomyces Cerevisiae.” The Journal of Biological Chemistry. 
Vol. 250. 
Gross, S., and C. Moore. 2001. “Five Subunits Are Required for Reconstitution of the 
Cleavage and Polyadenylation Activities of Saccharomyces Cerevisiae Cleavage 
Factor I.” Proceedings of the National Academy of Sciences 98 (11): 6080–85. 
https://doi.org/10.1073/pnas.101046598. 
Guéguéniat, Julia, Adrien F. Dupin, Johan Stojko, Lionel Beaurepaire, Sarah 
Cianférani, Cameron D. Mackereth, Lionel Minvielle-Sébastia, and Sébastien 
Fribourg. 2017. “Distinct Roles of Pcf11 Zinc-Binding Domains in Pre-MRNA 3′-
End Processing.” Nucleic Acids Research 45 (17): 10115–31. 
https://doi.org/10.1093/nar/gkx674. 
Gunderson, S I, K Beyer, G Martin, W Keller, W C Boelens, and L W Mattaj. 1994. 
  253 
“The Human U1A SnRNP Protein Regulates Polyadenylation via a Direct 
Interaction with Poly(A) Polymerase.” Cell 76 (3): 531–41. 
Guo, Z, P Russo, D F Yun, J S Butler, and F Sherman. 1995. “Redundant 3’ End-
Forming Signals for the Yeast CYC1 MRNA.” Proceedings of the National 
Academy of Sciences of the United States of America 92 (10): 4211–14. 
Harrap, K.A. 1972. “The Structure of Nuclear Polyhedrosis Viruses: II. The Virus 
Particle.” Virology 50 (1): 124–32. https://doi.org/10.1016/0042-6822(72)90352-2. 
Hassur, Steven M., and Howard W. Whitlock. 1974. “UV Shadowing—A New and 
Convenient Method for the Location of Ultraviolet-Absorbing Species in 
Polyacrylamide Gels.” Analytical Biochemistry 59 (1): 162–64. 
https://doi.org/10.1016/0003-2697(74)90020-7. 
He, Xiaoyuan, Asad U Khan, Hailing Cheng, Donald L Pappas, Michael Hampsey, and 
Claire L Moore. 2003. “Functional Interactions between the Transcription and 
MRNA 3’ End Processing Machineries Mediated by Ssu72 and Sub1.” Genes & 
Development 17 (8): 1030–42. https://doi.org/10.1101/gad.1075203. 
Hector, R. E., Keith R Nykamp, Sonia Dheur, James T Anderson, Priscilla J Non, Carl 
R Urbinati, Scott M Wilson, Lionel Minvielle-Sebastia, and Maurice S Swanson. 
2002. “Dual Requirement for Yeast HnRNP Nab2p in MRNA Poly(A) Tail Length 
Control and Nuclear Export.” The EMBO Journal 21 (7): 1800–1810. 
https://doi.org/10.1093/emboj/21.7.1800. 
Heidmann, S, B Obermaier, K Vogel, and H Domdey. 1992. “Identification of Pre-
MRNA Polyadenylation Sites in Saccharomyces Cerevisiae.” Molecular and 
Cellular Biology 12 (9): 4215–29. 
Heidmann, S, C Schindewolf, G Stumpf, and H Domdey. 1994. “Flexibility and 
Interchangeability of Polyadenylation Signals in Saccharomyces Cerevisiae.” 
Molecular and Cellular Biology 14 (7): 4633–42. 
https://doi.org/10.1128/MCB.14.7.4633. 
Helmling, Steffen, Alexander Zhelkovsky, and Claire L Moore. 2001. “Fip1 Regulates 
the Activity of Poly(A) Polymerase through Multiple Interactions.” MOLECULAR 
AND CELLULAR BIOLOGY 21 (6): 2026–37. 
https://doi.org/10.1128/MCB.21.6.2026-2037.2001. 
Henry, M, C Z Borland, M Bossie, and P A Silver. 1996. “Potential RNA Binding 
Proteins in Saccharomyces Cerevisiae Identified as Suppressors of Temperature-
Sensitive Mutations in NPL3.” Genetics 142 (1): 103–15. 
Higgs, D. R., S. E. Y. Goodbourn, J. Lamb, J. B. Clegg, D. J. Weatherall, and N. J. 
  254 
Proudfoot. 1983. “α-Thalassaemia Caused by a Polyadenylation Signal Mutation.” 
Nature 306 (5941): 398–400. https://doi.org/10.1038/306398a0. 
Higuchi, Russell, Barbara Krummel, and Randall Saiki. 1988. “A General Method of in 
Vitro Preparation and Specific Mutagenesis of DNA Fragments: Study of Protein 
and DNA Interactions.” Nucleic Acids Research 16 (15): 7351–67. 
https://doi.org/10.1093/nar/16.15.7351. 
Hill, Chris H, Ananthanarayanan Kumar, Mathias Girbig, Mark Skehel, and Lori A 
Passmore. 2019. “Activation of the Endonuclease That Defines MRNA 3 0 Ends 
Requires Incorporation into an 8-Subunit Core Cleavage and Polyadenylation 
Factor Complex Correspondence.” Molecular Cell 73. 
https://doi.org/10.1016/j.molcel.2018.12.023. 
Hirose, Yutaka, and James L. Manley. 1998. “RNA Polymerase II Is an Essential 
MRNA Polyadenylation Factor.” Nature 395 (6697): 93–96. 
https://doi.org/10.1038/25786. 
Hockert, J Andrew, Hsiang-Jui Yeh, and Clinton C MacDonald. 2010. “The Hinge 
Domain of the Cleavage Stimulation Factor Protein CstF-64 Is Essential for CstF-
77 Interaction, Nuclear Localization, and Polyadenylation.” The Journal of 
Biological Chemistry 285 (1): 695–704. https://doi.org/10.1074/jbc.M109.061705. 
Hollerer, Ina, Kerstin Grund, Matthias W Hentze, and Andreas E Kulozik. 2014. 
“MRNA 3’end Processing: A Tale of the Tail Reaches the Clinic.” EMBO 
Molecular Medicine 6 (1): 16–26. https://doi.org/10.1002/emmm.201303300. 
Hsin, J.-P., and J. L. Manley. 2012. “The RNA Polymerase II CTD Coordinates 
Transcription and RNA Processing.” Genes & Development 26 (19): 2119–37. 
https://doi.org/10.1101/gad.200303.112. 
Hu, Jun, Carol S Lutz, Jeffrey Wilusz, and Bin Tian. 2005. “Bioinformatic 
Identification of Candidate Cis-Regulatory Elements Involved in Human MRNA 
Polyadenylation.” RNA (New York, N.Y.) 11 (10): 1485–93. 
https://doi.org/10.1261/rna.2107305. 
Huez, G., G. MARBAIX, E. HUBERT, Y. CLEUTER, D. GALLWITZ, E. 
WEINBERG, and R. DEVOS. 1978. “Functional Stabilisation of HeLa Cell 
Histone Messenger RNAs Injected into Xenopus Oocytes by 3′- OH 
Polyadenylation.” Nature 271 (5645): 572–73. https://doi.org/10.1038/271572a0. 
Huez, Georges, Gerard Marbaix, Evelyne Hubert, Yvette Cleuter, Madeleine Leclercq, 
Hubert Chantrenne, Hermona Soreq, Uri Nudel, and Uriel Z Littauer. 1975. 
“Readenylation of Polyadenylate-Free Globin Messenger RNA Restores Its 
  255 
Stability in Vivo.” Eur. J. Biochem. Vol. 59. 
Humphrey, Tim, Gerhard Christofori2, Vlatka Lucijanic, and Walter Keller2. 1987. 
“Cleavage and Polyadenylation of Messenger RNA Precursors in Vitro Occurs 
within Large and Specific 3’ Processing Complexes.” The EMBO Journal. Vol. 6. 
Hyman, Linda E, Stephanie H Seiler, John Whoriskey, and Claire L Moore. 1991. 
“Point Mutations Upstream of the Yeast ADH2 Poly(A) Site Significantly Reduce 
the Efficiency of 3’-End Formation.” Molecular and Cellular Biology. Vol. 11. 
Iglesias, N., E. Tutucci, C. Gwizdek, P. Vinciguerra, E. Von Dach, A. H. Corbett, C. 
Dargemont, and F. Stutz. 2010. “Ubiquitin-Mediated MRNP Dynamics and 
Surveillance Prior to Budding Yeast MRNA Export.” Genes & Development 24 
(17): 1927–38. https://doi.org/10.1101/gad.583310. 
Irniger, S, and G H Braus. 1994. “Saturation Mutagenesis of a Polyadenylation Signal 
Reveals a Hexanucleotide Element Essential for MRNA 3’ End Formation in 
Saccharomyces Cerevisiae.” Proceedings of the National Academy of Sciences of 
the United States of America 91 (1): 257–61. 
Irniger, S, C M Egli, and G H Braus. 1991. “Different Classes of Polyadenylation Sites 
in the Yeast Saccharomyces Cerevisiae.” Molecular and Cellular Biology 11 (6): 
3060–69. 
Ishida, T., and K. Kinoshita. 2007. “PrDOS: Prediction of Disordered Protein Regions 
from Amino Acid Sequence.” Nucleic Acids Research 35 (Web Server): W460–64. 
https://doi.org/10.1093/nar/gkm363. 
Jin, Wenxing, Yi Wang, Chao-Pei Liu, Na Yang, Mingliang Jin, Yao Cong, Mingzhu 
Wang, and Rui-Ming Xu. 2016. “Structural Basis for SnRNA Recognition by the 
Double-WD40 Repeat Domain of Gemin5.” Genes & Development 30 (21): 2391–
2403. https://doi.org/10.1101/gad.291377.116. 
Johnson, L Steven, Sean R Eddy, and Elon Portugaly. 2010. “Hidden Markov Model 
Speed Heuristic and Iterative HMM Search Procedure.” BMC Bioinformatics 11 
(1): 431. https://doi.org/10.1186/1471-2105-11-431. 
Jung, Young-Sang, and Markus Zweckstetter. 2004. “Mars – Robust Automatic 
Backbone Assignment of Proteins.” Journal of Biomolecular NMR 30 (1): 11–23. 
https://doi.org/10.1023/B:JNMR.0000042954.99056.ad. 
Kabsch, Wolfgang, and Christian Sander. 1983. “Dictionary of Protein Secondary 
Structure: Pattern Recognition of Hydrogen-Bonded and Geometrical Features.” 
Biopolymers 22 (12): 2577–2637. https://doi.org/10.1002/bip.360221211. 
Kaufmann, Isabelle, Georges Martin, Arno Friedlein, Hanno Langen, and Walter Keller. 
  256 
2004. “Human Fip1 Is a Subunit of CPSF That Binds to U-Rich RNA Elements 
and Stimulates Poly(A) Polymerase.” The EMBO Journal 23 (3): 616–26. 
https://doi.org/10.1038/sj.emboj.7600070. 
Kazimierczuk, Krzysztof, and Vladislav Yu. Orekhov. 2011. “Accelerated NMR 
Spectroscopy by Using Compressed Sensing.” Angewandte Chemie International 
Edition 50 (24): 5556–59. https://doi.org/10.1002/anie.201100370. 
Keller, W, S Bienroth, K M Lang, and G Christofori. 1991. “Cleavage and 
Polyadenylation Factor CPF Specifically Interacts with the Pre-MRNA 3’ 
Processing Signal AAUAAA.” The EMBO Journal 10 (13): 4241–49. 
Kelley, Lawrence A, Stefans Mezulis, Christopher M Yates, Mark N Wass, and Michael 
J E Sternberg. 2015. “The Phyre2 Web Portal for Protein Modeling, Prediction and 
Analysis.” Nature Protocols 10 (6): 845–58. 
https://doi.org/10.1038/nprot.2015.053. 
Kelly, Sara W. Leung, Luciano H. Apponi, Anna M. Bramley, Elizabeth J. Tran, Julia 
A. Chekanova, Susan R. Wente, and Anita H. Corbett. 2010. “Recognition of 
Polyadenosine RNA by the Zinc Finger Domain of Nuclear Poly(A) RNA-Binding 
Protein 2 (Nab2) Is Required for Correct MRNA 3′-End Formation.” Journal of 
Biological Chemistry 285 (34): 26022–32. 
https://doi.org/10.1074/jbc.M110.141127. 
Kelly, S. M., S. A. Pabit, C. M. Kitchen, P. Guo, K. A. Marfatia, T. J. Murphy, A. H. 
Corbett, and K. M. Berland. 2007. “Recognition of Polyadenosine RNA by Zinc 
Finger Proteins.” Proceedings of the National Academy of Sciences 104 (30): 
12306–11. https://doi.org/10.1073/pnas.0701244104. 
Kennedy, Sarah A, Monica L Frazier, Mindy Steiniger, Ann M Mast, William F 
Marzluff, and Matthew R Redinbo. 2009. “Crystal Structure of the HEAT Domain 
from the Pre-MRNA Processing Factor Symplekin.” Journal of Molecular Biology 
392 (1): 115–28. https://doi.org/10.1016/j.jmb.2009.06.062. 
Kessler, M F Henry, E Shen, J Zhao, S Gross, P A Silver, and C L Moore. 1997. “Hrp1, 
a Sequence-Specific RNA-Binding Protein That Shuttles between the Nucleus and 
the Cytoplasm, Is Required for MRNA 3’-End Formation in Yeast.” Genes & 
Development 11 (19): 2545–56. https://doi.org/10.1101/GAD.11.19.2545. 
Kessler, M M, Jing Zhao, and Claire L Moore. 1996. “Purification of the 
Saccharomyces Cerevisiae Cleavage/Polyadenylation Factor I.” 
Kim Guisbert, Karen S., Hao Li, and Christine Guthrie. 2006. “Alternative 3′ Pre-
MRNA Processing in Saccharomyces Cerevisiae Is Modulated by Nab4/Hrp1 In 
  257 
Vivo.” Edited by Nick J Proudfoot. PLoS Biology 5 (1): e6. 
https://doi.org/10.1371/journal.pbio.0050006. 
Kimanius, Dari, Björn O Forsberg, Sjors HW Scheres, and Erik Lindahl. 2016. 
“Accelerated Cryo-EM Structure Determination with Parallelisation Using GPUs 
in RELION-2.” ELife 5 (November). https://doi.org/10.7554/eLife.18722. 
Kiselev, N A, M B Sherman, and V L Tsuprun. 1990. “Negative Staining of Proteins.” 
Electron Microscopy Reviews 3 (1): 43–72. https://doi.org/10.1016/0892-
0354(90)90013-I. 
Krishnamurthy, Shankarling, Xiaoyuan He, Mariela Reyes-Reyes, Claire Moore, and 
Michael Hampsey. 2004. “Ssu72 Is an RNA Polymerase II CTD Phosphatase.” 
Molecular Cell 14 (3): 387–94. https://doi.org/10.1016/S1097-2765(04)00235-7. 
Kühn, Uwe, Miriam Gündel, Anne Knoth, Yvonne Kerwitz, Sabine Rüdel, and Elmar 
Wahle. 2009. “Poly(A) Tail Length Is Controlled by the Nuclear Poly(A)-Binding 
Protein Regulating the Interaction between Poly(A) Polymerase and the Cleavage 
and Polyadenylation Specificity Factor.” Journal of Biological Chemistry 284 (34): 
22803–14. https://doi.org/10.1074/jbc.M109.018226. 
Kyburz, Andrea, Martin Sadowski, Bernhard Dichtl, and Walter Keller. 2003. “The 
Role of the Yeast Cleavage and Polyadenylation Factor Subunit Ydh1p/Cft2p in 
Pre-MRNA 3¢-End Formation.” https://doi.org/10.1093/nar/gkg478. 
Laishram, Rakesh S. 2014. “Poly(A) Polymerase (PAP) Diversity in Gene Expression – 
Star-PAP vs Canonical PAP.” FEBS Letters 588 (14): 2185–97. 
https://doi.org/10.1016/J.FEBSLET.2014.05.029. 
Lambert, Nicole, Alex Robertson, Mohini Jangi, Sean McGeary, Phillip A Sharp, and 
Christopher B Burge. 2014. “RNA Bind-n-Seq: Quantitative Assessment of the 
Sequence and Structural Binding Specificity of RNA Binding Proteins.” Molecular 
Cell 54 (5): 887–900. https://doi.org/10.1016/j.molcel.2014.04.016. 
Lee, S. D., and C. L. Moore. 2014. “Efficient MRNA Polyadenylation Requires a 
Ubiquitin-Like Domain, a Zinc Knuckle, and a RING Finger Domain, All 
Contained in the Mpe1 Protein.” Molecular and Cellular Biology 34 (21): 3955–
67. https://doi.org/10.1128/MCB.00077-14. 
Leeper, Thomas C., Xiangping Qu, Connie Lu, Claire Moore, and Gabriele Varani. 
2010. “Novel Protein–Protein Contacts Facilitate MRNA 3′-Processing Signal 
Recognition by Rna15 and Hrp1.” Journal of Molecular Biology 401 (3): 334–49. 
https://doi.org/10.1016/J.JMB.2010.06.032. 
Leitner, Alexander, Thomas Walzthoeni, and Ruedi Aebersold. 2014. “Lysine-Specific 
  258 
Chemical Cross-Linking of Protein Complexes and Identification of Cross-Linking 
Sites Using LC-MS/MS and the XQuest/XProphet Software Pipeline.” Nature 
Protocols 9 (1): 120–37. https://doi.org/10.1038/nprot.2013.168. 
Li, Jinyou, Qi-En Wang, Qianzheng Zhu, Mohamed A. El-Mahdy, Gulzar Wani, Mette 
Prætorius-Ibba, and Altaf A. Wani. 2006. “DNA Damage Binding Protein 
Component DDB1 Participates in Nucleotide Excision Repair through DDB2 
DNA-Binding and Cullin 4A Ubiquitin Ligase Activity.” Cancer Research 66 
(17): 8590–97. https://doi.org/10.1158/0008-5472.CAN-06-1115. 
Lidschreiber, Michael, Ashley D Easter, Sofia Battaglia, Juan B Rodríguez-Molina, Ana 
Casañal, Manuel Carminati, Carlo Baejen, et al. 2018. “The APT Complex Is 
Involved in Non-Coding RNA Transcription and Is Distinct from CPF.” Nucleic 
Acids Research 46 (21): 11528–38. https://doi.org/10.1093/nar/gky845. 
Lingner, Joachim, Isabelle Radtke, Elmar Wahles, and Walter Keller. 1991. 
“Purification and Characterization of Poly(A) Polymerase from Saccharomyces 
Cereuisiae.” Vol. 266. 
Liu, Y., B. Schmidt, and D. L. Maskell. 2010. “MSAProbs: Multiple Sequence 
Alignment Based on Pair Hidden Markov Models and Partition Function Posterior 
Probabilities.” Bioinformatics 26 (16): 1958–64. 
https://doi.org/10.1093/bioinformatics/btq338. 
Lutz, C S, and J C Alwine. 1994. “Direct Interaction of the U1 SnRNP-A Protein with 
the Upstream Efficiency Element of the SV40 Late Polyadenylation Signal.” 
Genes & Development 8 (5): 576–86. https://doi.org/10.1101/GAD.8.5.576. 
Mandel, Corey R., Syuzo Kaneko, Hailong Zhang, Damara Gebauer, Vasupradha 
Vethantham, James L. Manley, and Liang Tong. 2006. “Polyadenylation Factor 
CPSF-73 Is the Pre-MRNA 3’-End-Processing Endonuclease.” Nature 444 (7121): 
953–56. https://doi.org/10.1038/nature05363. 
Manley, J L. 1983. “Accurate and Specific Polyadenylation of MRNA Precursors in a 
Soluble Whole-Cell Lysate.” Cell 33 (2): 595–605. https://doi.org/10.1016/0092-
8674(83)90440-3. 
Manley, James L. 1988. “Polyadenylation of MRNA Precursors.” Biochimica et 
Biophysica Acta (BBA) - Gene Structure and Expression 950 (1): 1–12. 
https://doi.org/10.1016/0167-4781(88)90067-X. 
Masson, Glenn R., Meredith L. Jenkins, and John E. Burke. 2017. “An Overview of 
Hydrogen Deuterium Exchange Mass Spectrometry (HDX-MS) in Drug 
Discovery.” Expert Opinion on Drug Discovery 12 (10): 981–94. 
  259 
https://doi.org/10.1080/17460441.2017.1363734. 
McCracken, Susan, Nova Fong, Krassimir Yankulov, Scott Ballantyne, Guohua Pan, 
Jack Greenblatt, Scott D. Patterson, Marvin Wickens, and David L. Bentley. 1997. 
“The C-Terminal Domain of RNA Polymerase II Couples MRNA Processing to 
Transcription.” Nature 385 (6614): 357–61. https://doi.org/10.1038/385357a0. 
Mcdevitt, Michael A, Gregory M Gilmartin/’^, Westley H Reeves, and Joseph R 
Nevins. 1988. “Multiple Factors Are Required for Poly(A) Addition to a MRNA 3’ 
End.” 
Mclaughlin, Calvin S, Jonathan R Warner, Mary Edmonds, Hiroshi Nakazato, and 
Maurice H Vaughan. 1973. “Polyadenylic Acid Sequences in Yeast Messenger 
Ribonucleic Acid.” Journal of Biological Chemistry. Vol. 248. 
McMullan, G., A.R. Faruqi, D. Clare, and R. Henderson. 2014. “Comparison of 
Optimal Performance at 300keV of Three Direct Electron Detectors for Use in 
Low Dose Electron Microscopy.” Ultramicroscopy 147 (December): 156–63. 
https://doi.org/10.1016/j.ultramic.2014.08.002. 
Meinke, Gretchen, Chukwudi Ezeokonkwo, Paul Balbo, Walter Stafford, Claire Moore, 
and Andrew Bohm. 2008. “Structure of Yeast Poly(A) Polymerase in Complex 
with a Peptide from Fip1, an Intrinsically Disordered Protein.” Biochemistry 47 
(26): 6859–69. https://doi.org/10.1021/bi800204k. 
Millevoi, Stefania, Adrien Decorsière, Clarisse Loulergue, Jason Iacovoni, Sandra 
Bernat, Michael Antoniou, and Stéphan Vagner. 2009. “A Physical and Functional 
Link between Splicing Factors Promotes Pre-MRNA 3’ End Processing.” Nucleic 
Acids Research 37 (14): 4672–83. https://doi.org/10.1093/nar/gkp470. 
Minvielle-Sebastia, L., K Beyer, A M Krecic, R E Hector, M S Swanson, and W Keller. 
1998. “Control of Cleavage Site Selection during MRNA 3’ End Formation by a 
Yeast HnRNP.” The EMBO Journal 17 (24): 7454–68. 
https://doi.org/10.1093/emboj/17.24.7454. 
Minvielle-Sebastia, L, P J Preker, and W Keller. 1994. “RNA14 and RNA15 Proteins as 
Components of a Yeast Pre-MRNA 3’-End Processing Factor.” Science (New 
York, N.Y.) 266 (5191): 1702–5. 
Minvielle-Sebastia, L, P J Preker, T Wiederkehr, Y Strahm, and W Keller. 1997. “The 
Major Yeast Poly(A)-Binding Protein Is Associated with Cleavage Factor IA and 
Functions in Premessenger RNA 3’-End Formation.” Proceedings of the National 
Academy of Sciences of the United States of America 94 (15): 7897–7902. 
https://doi.org/10.1073/PNAS.94.15.7897. 
  260 
Minvielle-Sebastia, L, B Winsor, N Bonneaud, and F Lacroute. 1991. “Mutations in the 
Yeast RNA14 and RNA15 Genes Result in an Abnormal MRNA Decay Rate; 
Sequence Analysis Reveals an RNA-Binding Domain in the RNA15 Protein.” 
Molecular and Cellular Biology 11 (6): 3075–87. 
Mizrahi, N, and C Moore. 2000. “Posttranslational Phosphorylation and Ubiquitination 
of the Saccharomyces Cerevisiae Poly(A) Polymerase at the S/G(2) Stage of the 
Cell Cycle.” Molecular and Cellular Biology 20 (8): 2794–2802. 
Moore, C L, and P A Sharp. 1984. “Site-Specific Polyadenylation in a Cell-Free 
Reaction.” Cell 36 (3): 581–91. 
Moore, C L, H Skolnik-David, and P A Sharp. 1986. “Analysis of RNA Cleavage at the 
Adenovirus-2 L3 Polyadenylation Site.” The EMBO Journal 5 (8): 1929–38. 
Moore, Claire L, and Phillip A. Sharp. 1985. “Accurate Cleavage and Polyadenylation 
of Exogenous RNA Substrate.” Cell 41 (3): 845–55. 
https://doi.org/10.1016/S0092-8674(85)80065-9. 
Moreno-Morcillo, Maria, Lionel Minvielle-Sébastia, Sébastien Fribourg, and 
Cameron D. Mackereth. 2011. “Locked Tether Formation by Cooperative Folding 
of Rna14p Monkeytail and Rna15p Hinge Domains in the Yeast CF IA Complex.” 
Structure 19 (4): 534–45. https://doi.org/10.1016/J.STR.2011.02.003. 
Müller, Mathias Q., Frank Dreiocker, Christian H. Ihling, Mathias Schäfer, and Andrea 
Sinz. 2010. “Cleavable Cross-Linker for Protein Structure Analysis: Reliable 
Identification of Cross-Linking Products by Tandem MS.” Analytical Chemistry 82 
(16): 6958–68. https://doi.org/10.1021/ac101241t. 
Murthy, K G, and J L Manley. 1992. “Characterization of the Multisubunit Cleavage-
Polyadenylation Specificity Factor from Calf Thymus.” The Journal of Biological 
Chemistry 267 (21): 14804–11. 
Nedea, Eduard, Xiaoyuan He, Minkyu Kim, Jeff Pootoolal, Guoqing Zhong, Veronica 
Canadien, Timothy Hughes, Stephen Buratowski, Claire L Moore, and Jack 
Greenblatt. 2003. “Organization and Function of APT, a Subcomplex of the Yeast 
Cleavage and Polyadenylation Factor Involved in the Formation of MRNA and 
Small Nucleolar RNA 3’-Ends.” The Journal of Biological Chemistry 278 (35): 
33000–10. https://doi.org/10.1074/jbc.M304454200. 
Nevins, Joseph R, and James E Darnell. 1978. “Steps in the Processing of Ad2 MRNA: 
Poly(A)+ Nuclear Sequences Are Conserved and Poly(A) Addition Precedes 
Splicing.” Cell. Vol. 15. 
Nicholls, Robert A., Fei Long, and Garib N. Murshudov. 2012. “Low-Resolution 
  261 
Refinement Tools in REFMAC 5.” Acta Crystallographica Section D Biological 
Crystallography 68 (4): 404–17. https://doi.org/10.1107/S090744491105606X. 
Noble, C. G., Philip A. Walker, Lesley J. Calder, and Ian A. Taylor. 2004. “Rna14-
Rna15 Assembly Mediates the RNA-Binding Capability of Saccharomyces 
Cerevisiae Cleavage Factor IA.” Nucleic Acids Research 32 (11): 3364–75. 
https://doi.org/10.1093/nar/gkh664. 
O’Connor, J P, and C L Peebles. 1992. “PTA1, an Essential Gene of Saccharomyces 
Cerevisiae Affecting Pre-TRNA Processing.” Molecular and Cellular Biology 12 
(9): 3843–56. 
O’Reilly, David R., Lois. Miller, and Verne A. Luckow. 1994. Baculovirus Expression 
Vectors : A Laboratory Manual. Oxford University Press. 
Ohnacker, M., Silvia M. L. Barabino, Pascal J. Preker, and Walter Keller. 2000. “The 
WD-Repeat Protein Pfs2p Bridges Two Essential Factors within the Yeast Pre-
MRNA 3’-End-Processing Complex.” The EMBO Journal 19 (1): 37–47. 
https://doi.org/10.1093/emboj/19.1.37. 
Pancevac, Christina, David C Goldstone, Andres Ramos, and Ian A Taylor. 2010. 
“Structure of the Rna15 RRM-RNA Complex Reveals the Molecular Basis of GU 
Specificity in Transcriptional 3’-End Processing Factors.” Nucleic Acids Research 
38 (9): 3119–32. https://doi.org/10.1093/nar/gkq002. 
Paule, M R, and R J White. 2000. “Survey and Summary: Transcription by RNA 
Polymerases I and III.” Nucleic Acids Research 28 (6): 1283–98. 
Paulson, A. R., and L. Tong. 2012. “Crystal Structure of the Rna14-Rna15 Complex.” 
RNA 18 (6): 1154–62. https://doi.org/10.1261/rna.032524.112. 
Pérez-Cañadillas, José Manuel. 2006. “Grabbing the Message: Structural Basis of 
MRNA 3′UTR Recognition by Hrp1.” The EMBO Journal 25 (13): 3167–78. 
https://doi.org/10.1038/sj.emboj.7601190. 
Perez Canadillas, J. M., and Gabriele Varani. 2003. “Recognition of GU-Rich 
Polyadenylation Regulatory Elements by Human CstF-64 Protein.” The EMBO 
Journal 22 (11): 2821–30. https://doi.org/10.1093/emboj/cdg259. 
Pettersen, Eric F., Thomas D. Goddard, Conrad C. Huang, Gregory S. Couch, Daniel 
M. Greenblatt, Elaine C. Meng, and Thomas E. Ferrin. 2004. “UCSF Chimera?A 
Visualization System for Exploratory Research and Analysis.” Journal of 
Computational Chemistry 25 (13): 1605–12. https://doi.org/10.1002/jcc.20084. 
Plaschka, Clemens, Pei-Chun Lin, and Kiyoshi Nagai. 2017. “Structure of a Pre-
Catalytic Spliceosome.” Nature 546 (7660): 617–21. 
  262 
https://doi.org/10.1038/nature22799. 
Preiss, T, M Muckenthaler, and M W Hentze. 1998. “Poly(A)-Tail-Promoted 
Translation in Yeast: Implications for Translational Control.” RNA (New York, 
N.Y.) 4 (11): 1321–31. 
Preker, P J, and W Keller. 1998. “The HAT Helix, a Repetitive Motif Implicated in 
RNA Processing.” Trends in Biochemical Sciences 23 (1): 15–16. 
Preker, P J, J Lingner, L Minvielle-Sebastia, and W Keller. 1995. “The FIP1 Gene 
Encodes a Component of a Yeast Pre-MRNA Polyadenylation Factor That Directly 
Interacts with Poly(A) Polymerase.” Cell 81 (3): 379–89. 
https://doi.org/10.1016/0092-8674(95)90391-7. 
Preker, P J, M Ohnacker, L Minvielle-Sebastia, and W Keller. 1997. “A Multisubunit 3’ 
End Processing Factor from Yeast Containing Poly(A) Polymerase and 
Homologues of the Subunits of Mammalian Cleavage and Polyadenylation 
Specificity Factor.” The EMBO Journal 16 (15): 4727–37. 
https://doi.org/10.1093/emboj/16.15.4727. 
Proudfoot, N. J., and G. G. Brownlee. 1976. “3′ Non-Coding Region Sequences in 
Eukaryotic Messenger RNA.” Nature 263 (5574): 211–14. 
https://doi.org/10.1038/263211a0. 
Qu, Xiangping, Jose-Manuel Perez-Canadillas, Shipra Agrawal, Julia De Baecke, 
Hailing Cheng, Gabriele Varani, and Claire Moore. 2007. “The C-Terminal 
Domains of Vertebrate CstF-64 and Its Yeast Orthologue Rna15 Form a New 
Structure Critical for MRNA 3′-End Processing.” Journal of Biological Chemistry 
282 (3): 2101–15. https://doi.org/10.1074/jbc.M609981200. 
Reyes-Reyes, Mariela, and Michael Hampsey. 2007. “Role for the Ssu72 C-Terminal 
Domain Phosphatase in RNA Polymerase II Transcription Elongation.” Molecular 
and Cellular Biology 27 (3): 926–36. https://doi.org/10.1128/MCB.01361-06. 
Rinner, Oliver, Jan Seebacher, Thomas Walzthoeni, Lukas N Mueller, Martin Beck, 
Alexander Schmidt, Markus Mueller, and Ruedi Aebersold. 2008. “Identification 
of Cross-Linked Peptides from Large Sequence Databases.” Nature Methods 5 (4): 
315–18. https://doi.org/10.1038/nmeth.1192. 
Roguev, A., D Schaft, A Shevchenko, W W Pijnappel, M Wilm, R Aasland, and A F 
Stewart. 2001. “The Saccharomyces Cerevisiae Set1 Complex Includes an Ash2 
Homologue and Methylates Histone 3 Lysine 4.” The EMBO Journal 20 (24): 
7137–48. https://doi.org/10.1093/emboj/20.24.7137. 
Rosado-Lugo, Jesús D, and Michael Hampsey. 2014. “The Ssu72 Phosphatase Mediates 
  263 
the RNA Polymerase II Initiation-Elongation Transition.” The Journal of 
Biological Chemistry 289 (49): 33916–26. 
https://doi.org/10.1074/jbc.M114.608695. 
Rüegsegger, U, D Blank, and W Keller. 1998. “Human Pre-MRNA Cleavage Factor Im 
Is Related to Spliceosomal SR Proteins and Can Be Reconstituted in Vitro from 
Recombinant Subunits.” Molecular Cell 1 (2): 243–53. 
Russnak, R, K W Nehrke, and T Platt. 1995. “REF2 Encodes an RNA-Binding Protein 
Directly Involved in Yeast MRNA 3’-End Formation.” Molecular and Cellular 
Biology 15 (3): 1689–97. 
Russo, Christopher J, and Lori A Passmore. 2014. “Electron Microscopy: Ultrastable 
Gold Substrates for Electron Cryomicroscopy.” Science (New York, N.Y.) 346 
(6215): 1377–80. https://doi.org/10.1126/science.1259530. 
Russo, P, W Z Li, D M Hampsey, K S Zaret, and F Sherman. 1991. “Distinct Cis-
Acting Signals Enhance 3’ Endpoint Formation of CYC1 MRNA in the Yeast 
Saccharomyces Cerevisiae.” The EMBO Journal 10 (3): 563–71. 
Ryan, Kevin, Olga Calvo, and James L Manley. 2004. “Evidence That Polyadenylation 
Factor CPSF-73 Is the MRNA 3’ Processing Endonuclease.” RNA (New York, 
N.Y.) 10 (4): 565–73. 
Sachs, Alan B., and Ronald W. Davis. 1989. “The Poly(A) Binding Protein Is Required 
for Poly(A) Shortening and 60S Ribosomal Subunit-Dependent Translation 
Initiation.” Cell 58 (5): 857–67. https://doi.org/10.1016/0092-8674(89)90938-0. 
Sadowski, M., Bernhard Dichtl, Wolfgang Hübner, and Walter Keller. 2003. 
“Independent Functions of Yeast Pcf11p in Pre-MRNA 3’ End Processing and in 
Transcription Termination.” The EMBO Journal 22 (9): 2167–77. 
https://doi.org/10.1093/emboj/cdg200. 
Salisbury, Jesse, Keith W Hutchison, and Joel H Graber. 2006. “A Multispecies 
Comparison of the Metazoan 3’-Processing Downstream Elements and the CstF-64 
RNA Recognition Motif.” BMC Genomics 7 (1): 55. https://doi.org/10.1186/1471-
2164-7-55. 
Schanda, Paul, Hélène Van Melckebeke, and Bernhard Brutscher. 2006. “Speeding Up 
Three-Dimensional Protein NMR Experiments to a Few Minutes.” Journal of the 
American Chemical Society 128 (28): 9042–43. https://doi.org/10.1021/ja062025p. 
Scheres, Sjors H.W. 2012. “RELION: Implementation of a Bayesian Approach to Cryo-
EM Structure Determination.” Journal of Structural Biology 180 (3): 519–30. 
https://doi.org/10.1016/J.JSB.2012.09.006. 
  264 
Schmid, Manfred, Pawel Olszewski, Vicent Pelechano, Ishaan Gupta, Lars M. 
Steinmetz, and Torben Heick Jensen. 2015. “The Nuclear PolyA-Binding Protein 
Nab2p Is Essential for MRNA Production.” Cell Reports 12 (1): 128–39. 
https://doi.org/10.1016/j.celrep.2015.06.008. 
Schmid, Manfred, Mathias Bach Poulsen, Pawel Olszewski, Vicent Pelechano, Cyril 
Saguez, Ishaan Gupta, Lars M. Steinmetz, Claire Moore, and Torben Heick Jensen. 
2012. “Rrp6p Controls MRNA Poly(A) Tail Length and Its Decoration with 
Poly(A) Binding Proteins.” Molecular Cell 47 (2): 267–80. 
https://doi.org/10.1016/j.molcel.2012.05.005. 
Schmidt, Karyn, and J. Scott Butler. 2013. “Nuclear RNA Surveillance: Role of 
TRAMP in Controlling Exosome Specificity.” Wiley Interdisciplinary Reviews: 
RNA 4 (2): 217–31. https://doi.org/10.1002/wrna.1155. 
Schneider, Caroline A, Wayne S Rasband, and Kevin W Eliceiri. 2012. “NIH Image to 
ImageJ: 25 Years of Image Analysis.” Nature Methods 2012 9:7, June. 
Schönemann, Lars, Uwe Kühn, Georges Martin, Peter Schäfer, Andreas R. Gruber, 
Walter Keller, Mihaela Zavolan, and Elmar Wahle. 2014. “Reconstitution of CPSF 
Active in Polyadenylation: Recognition of the Polyadenylation Signal by 
WDR33.” Genes & Development 28 (21): 2381–93. 
https://doi.org/10.1101/gad.250985.114. 
Schreieck, Amelie, Ashley D Easter, Stefanie Etzold, Katrin Wiederhold, Michael 
Lidschreiber, Patrick Cramer, and Lori A Passmore. 2014. “RNA Polymerase II 
Termination Involves CTD Tyrosine Dephosphorylation by CPF Subunit Glc7 
Europe PMC Funders Group.” Nat Struct Mol Biol 21 (2): 175–79. 
https://doi.org/10.1038/nsmb.2753. 
Scrima, Andrea, Renata Konícková, Bryan K Czyzewski, Yusuke Kawasaki, Philip D 
Jeffrey, Regina Groisman, Yoshihiro Nakatani, Shigenori Iwai, Nikola P Pavletich, 
and Nicolas H Thomä. 2008. “Structural Basis of UV DNA-Damage Recognition 
by the DDB1-DDB2 Complex.” Cell 135 (7): 1213–23. 
https://doi.org/10.1016/j.cell.2008.10.045. 
Seckler, James M., Mary D. Barkley, and Patrick L. Wintrode. 2011. “Allosteric 
Suppression of HIV-1 Reverse Transcriptase Structural Dynamics upon Inhibitor 
Binding.” Biophysical Journal 100 (1): 144–53. 
https://doi.org/10.1016/j.bpj.2010.11.004. 
Shannon, Paul, Andrew Markiel, Owen Ozier, Nitin S Baliga, Jonathan T Wang, Daniel 
Ramage, Nada Amin, Benno Schwikowski, and Trey Ideker. 2003. “Cytoscape: A 
  265 
Software Environment for Integrated Models of Biomolecular Interaction 
Networks.” Genome Research 13 (11): 2498–2504. 
https://doi.org/10.1101/gr.1239303. 
Shen, Yang, and Ad Bax. 2013. “Protein Backbone and Sidechain Torsion Angles 
Predicted from NMR Chemical Shifts Using Artificial Neural Networks.” Journal 
of Biomolecular NMR 56 (3): 227. https://doi.org/10.1007/S10858-013-9741-Y. 
Shen, Yang, Frank Delaglio, Gabriel Cornilescu, and Ad Bax. 2009. “TALOS+: A 
Hybrid Method for Predicting Protein Backbone Torsion Angles from NMR 
Chemical Shifts.” Journal of Biomolecular NMR 44 (4): 213–23. 
https://doi.org/10.1007/s10858-009-9333-z. 
Shi, Yongsheng, Dafne Campigli, Di Giammartino, Derek Taylor, Ali Sarkeshik, 
William J Rice, John R Yates Iii, Joachim Frank, and James L Manley. 2009. 
“Molecular Architecture of the Human Pre-MRNA 3′ Processing Complex.” 
https://doi.org/10.1016/j.molcel.2008.12.028. 
Shukla, Arun K., Gerwin H. Westfield, Kunhong Xiao, Rosana I. Reis, Li-Yin Huang, 
Prachi Tripathi-Shukla, Jiang Qian, et al. 2014. “Visualization of Arrestin 
Recruitment by a G-Protein-Coupled Receptor.” Nature 512 (7513): 218–22. 
https://doi.org/10.1038/nature13430. 
Sierra-Gallay, Léna Zig, Ailar Jamalli, and Harald Putzer. 2008. “Structural Insights 
into the Dual Activity of RNase J.” Nature Structural & Molecular Biology 15 (2): 
206–12. https://doi.org/10.1038/nsmb.1376. 
Soucek, Sharon, Anita H. Corbett, and Milo B. Fasken. 2012. “The Long and the Short 
of It: The Role of the Zinc Finger Polyadenosine RNA Binding Protein, Nab2, in 
Control of Poly(A) Tail Length.” Biochimica et Biophysica Acta (BBA) - Gene 
Regulatory Mechanisms 1819 (6): 546–54. 
https://doi.org/10.1016/j.bbagrm.2012.03.006. 
Steitz, T A, and J A Steitz. 1993. “A General Two-Metal-Ion Mechanism for Catalytic 
RNA.” Proceedings of the National Academy of Sciences of the United States of 
America 90 (14): 6498–6502. 
Studier, F W, and B A Moffatt. 1986. “Use of Bacteriophage T7 RNA Polymerase to 
Direct Selective High-Level Expression of Cloned Genes.” Journal of Molecular 
Biology 189 (1): 113–30. 
Stumpf, G, and H Domdey. 1996. “Dependence of Yeast Pre-MRNA 3’-End Processing 
on CFT1: A Sequence Homolog of the Mammalian AAUAAA Binding Factor.” 
Science (New York, N.Y.) 274 (5292): 1517–20. 
  266 
Sullivan, Kelly D, Mindy Steiniger, and William F Marzluff. 2009. “A Core Complex 
of CPSF73, CPSF100, and Symplekin May Form Two Different Cleavage Factors 
for Processing of Poly(A) and Histone MRNAs.” Molecular Cell 34 (3): 322–32. 
https://doi.org/10.1016/j.molcel.2009.04.024. 
Sun, Yadong, Yixiao Zhang, Keith Hamilton, James L Manley, Yongsheng Shi, 
Thomas Walz, and Liang Tong. 2018. “Molecular Basis for the Recognition of the 
Human AAUAAA Polyadenylation Signal.” Proceedings of the National Academy 
of Sciences of the United States of America 115 (7): E1419–28. 
https://doi.org/10.1073/pnas.1718723115. 
Tacahashi, Yoko, Steffen Helmling, and Claire L Moore. 2003. “Functional Dissection 
of the Zinc Fnger and Fanking Domains of the Yth1 Cleavage/Polyadenylation 
Factor.” https://doi.org/10.1093/nar/gkg265. 
Takagaki, Y, C C MacDonald, T Shenk, and J L Manley. 1992. “The Human 64-KDa 
Polyadenylylation Factor Contains a Ribonucleoprotein-Type RNA Binding 
Domain and Unusual Auxiliary Motifs.” Proceedings of the National Academy of 
Sciences of the United States of America 89 (4): 1403–7. 
Tang, Guang, Liwei Peng, Philip R. Baldwin, Deepinder S. Mann, Wen Jiang, Ian Rees, 
and Steven J. Ludtke. 2007. “EMAN2: An Extensible Image Processing Suite for 
Electron Microscopy.” Journal of Structural Biology 157 (1): 38–46. 
https://doi.org/10.1016/J.JSB.2006.05.009. 
Tarun, S Z, and A B Sachs. 1995. “A Common Function for MRNA 5’ and 3’ Ends in 
Translation Initiation in Yeast.” Genes & Development 9 (23): 2997–3007. 
Thimiri Govinda Raj, Deepak B., Lakshmi S. Vijayachandran, and Imre Berger. 2014. 
“OmniBac: Universal Multigene Transfer Plasmids for Baculovirus Expression 
Vector Systems.” In , 123–30. https://doi.org/10.1007/978-1-62703-691-7_7. 
Tian, B., Jun Hu, Haibo Zhang, and Carol S Lutz. 2005. “A Large-Scale Analysis of 
MRNA Polyadenylation of Human and Mouse Genes.” Nucleic Acids Research 33 
(1): 201–12. https://doi.org/10.1093/nar/gki158. 
Tian, Bin, and Joel H Graber. 2012. “Signals for Pre-MRNA Cleavage and 
Polyadenylation.” Wiley Interdisciplinary Reviews. RNA 3 (3): 385–96. 
https://doi.org/10.1002/wrna.116. 
Touw, Wouter G., Coos Baakman, Jon Black, Tim A. H. te Beek, E. Krieger, Robbie P. 
Joosten, and Gert Vriend. 2015. “A Series of PDB-Related Databanks for 
Everyday Needs.” Nucleic Acids Research 43 (D1): D364–68. 
https://doi.org/10.1093/nar/gku1028. 
  267 
Tsiapalis, Chris M, John W Dorson, and I ? J Bollum. 1975. “Purification of Terminal 
Riboadenylate Transferase from Calf Thymus Gland.” The Journal of Biological 
Chemistry. Vol. 250. 
Tudek, Agnieszka, Marta Lloret-Llinares, and Torben Heick Jensen. 2018. “The 
Multitasking PolyA Tail: Nuclear RNA Maturation, Degradation and Export.” 
Philosophical Transactions of the Royal Society B: Biological Sciences 373 
(1762): 20180169. https://doi.org/10.1098/rstb.2018.0169. 
Vagner, S, C Vagner, and I W Mattaj. 2000. “The Carboxyl Terminus of Vertebrate 
Poly(A) Polymerase Interacts with U2AF 65 to Couple 3’-End Processing and 
Splicing.” Genes & Development 14 (4): 403–13. 
Vaňáčová, Štěpánka, Jeannette Wolf, Georges Martin, Diana Blank, Sabine Dettwiler, 
Arno Friedlein, Hanno Langen, Gérard Keith, and Walter Keller. 2005. “A New 
Yeast Poly(A) Polymerase Complex Involved in RNA Quality Control.” Edited by 
Phillip Zamore. PLoS Biology 3 (6): e189. 
https://doi.org/10.1371/journal.pbio.0030189. 
Venkatesan, S, N Elango, and R M Chanock. 1983. “Construction and Characterization 
of CDNA Clones for Four Respiratory Syncytial Viral Genes.” Proceedings of the 
National Academy of Sciences of the United States of America 80 (5): 1280–84. 
https://doi.org/10.1073/PNAS.80.5.1280. 
Viphakone, Nicolas, Florence Voisinet-Hakil, and Lionel Minvielle-Sebastia. 2008. 
“Molecular Dissection of MRNA Poly(A) Tail Length Control in Yeast.” Nucleic 
Acids Research 36 (7): 2418–33. https://doi.org/10.1093/nar/gkn080. 
Vo, L. T. A., M. Minet, J.-M. Schmitter, F. Lacroute, and F. Wyers. 2001. “Mpe1, a 
Zinc Knuckle Protein, Is an Essential Component of Yeast Cleavage and 
Polyadenylation Factor Required for the Cleavage and Polyadenylation of 
MRNA.” Molecular and Cellular Biology 21 (24): 8346–56. 
https://doi.org/10.1128/MCB.21.24.8346-8356.2001. 
Voorn, L van der, and H L Ploegh. 1992. “The WD-40 Repeat.” FEBS Letters 307 (2): 
131–34. 
Wahle, E. 1991. “Purification and Characterization of a Mammalian Polyadenylate 
Polymerase Involved in the 3’ End Processing of Messenger RNA Precursors.” 
The Journal of Biological Chemistry 266 (5): 3131–39. 
———. 1995. “Poly(A) Tail Length Control Is Caused by Termination of Processive 
Synthesis.” The Journal of Biological Chemistry 270 (6): 2800–2808. 
https://doi.org/10.1074/jbc.270.6.2800. 
  268 
Wales, Thomas E., and John R. Engen. 2006. “Hydrogen Exchange Mass Spectrometry 
for the Analysis of Protein Dynamics.” Mass Spectrometry Reviews 25 (1): 158–
70. https://doi.org/10.1002/mas.20064. 
Wang, Xiao, and Chuan He. 2014. “Dynamic RNA Modifications in Posttranscriptional 
Regulation.” Molecular Cell 56 (1): 5–12. 
https://doi.org/10.1016/J.MOLCEL.2014.09.001. 
Weissmann, Florian, Georg Petzold, Ryan VanderLinden, Pim J Huis In ’t Veld, 
Nicholas G Brown, Fabienne Lampert, Stefan Westermann, Holger Stark, Brenda 
A Schulman, and Jan-Michael Peters. 2016. “BiGBac Enables Rapid Gene 
Assembly for the Expression of Large Multisubunit Protein Complexes.” 
Proceedings of the National Academy of Sciences of the United States of America 
113 (19): E2564-9. https://doi.org/10.1073/pnas.1604935113. 
Werner-Allen, Jon W, Chul-Jin Lee, Pengda Liu, Nathan I Nicely, Su Wang, Arno L 
Greenleaf, and Pei Zhou. 2011. “Cis-Proline-Mediated Ser(P)5 Dephosphorylation 
by the RNA Polymerase II C-Terminal Domain Phosphatase Ssu72.” The Journal 
of Biological Chemistry 286 (7): 5717–26. 
https://doi.org/10.1074/jbc.M110.197129. 
Winters, Mary Ann, and Mary Edmonds. 1973. “A Poly (A) Polymerase from Calf 
Thymus.” The Journal of Biological Chemistry. Vol. 248. 
Wu, Xuebing, and David P. Bartel. 2017. “Widespread Influence of 3′-End Structures 
on Mammalian MRNA Processing and Stability.” Cell 169 (5): 905-917.e11. 
https://doi.org/10.1016/j.cell.2017.04.036. 
Xiang, Kehui, James L Manley, and Liang Tong. 2012. “An Unexpected Binding Mode 
for a Pol II CTD Peptide Phosphorylated at Ser7 in the Active Site of the CTD 
Phosphatase Ssu72.” Genes & Development 26 (20): 2265–70. 
https://doi.org/10.1101/gad.198853.112. 
Xiang, Kehui, Takashi Nagaike, Song Xiang, Turgay Kilic, Maia M. Beh, James L. 
Manley, and Liang Tong. 2010. “Crystal Structure of the Human Symplekin–
Ssu72–CTD Phosphopeptide Complex.” Nature 467 (7316): 729–33. 
https://doi.org/10.1038/nature09391. 
Xiang, Kehui, Liang Tong, and James L. Manley. 2014. “Delineating the Structural 
Blueprint of the Pre-MRNA 3′-End Processing Machinery.” Molecular and 
Cellular Biology 34 (11): 1894–1910. https://doi.org/10.1128/MCB.00084-14. 
Yan, Chuangye, Ruixue Wan, Rui Bai, Gaoxingyu Huang, and Yigong Shi. 2016. 
“Structure of a Yeast Activated Spliceosome at 3.5 Å Resolution.” Science (New 
  269 
York, N.Y.) 353 (6302): 904–11. https://doi.org/10.1126/science.aag0291. 
Yang, Qin, and Sylvie Doublié. 2011. “Structural Biology of Poly(A) Site Definition.” 
Wiley Interdisciplinary Reviews: RNA 2 (5): 732–47. 
https://doi.org/10.1002/wrna.88. 
Yang, Qin, Gregory M Gilmartin, and Sylvie Doublié. 2010. “Structural Basis of 
UGUA Recognition by the Nudix Protein CFI(m)25 and Implications for a 
Regulatory Role in MRNA 3’ Processing.” Proceedings of the National Academy 
of Sciences of the United States of America 107 (22): 10062–67. 
https://doi.org/10.1073/pnas.1000848107. 
Zarkower, David, and Marvin Wickens. 1987. “Formation of MRNA 3’ Termini: 
Stability and Dissociation of a Complex Involving the AAUAAA Sequence.” The 
EMBO Journal. Vol. 6. 
Zhang, Kai. 2016. “Gctf: Real-Time CTF Determination and Correction.” Journal of 
Structural Biology 193 (1): 1–12. https://doi.org/10.1016/j.jsb.2015.11.003. 
Zhao, J, M Kessler, S Helmling, J P O’Connor, and C Moore. 1999. “Pta1, a 
Component of Yeast CF II, Is Required for Both Cleavage and Poly(A) Addition 
of MRNA Precursor.” Molecular and Cellular Biology 19 (11): 7733–40. 
Zhao, J, M M Kessler, and C L Moore. 1997. “Cleavage Factor II of Saccharomyces 
Cerevisiae Contains Homologues to Subunits of the Mammalian Cleavage/ 
Polyadenylation Specificity Factor and Exhibits Sequence-Specific, ATP-
Dependent Interaction with Precursor RNA.” The Journal of Biological Chemistry 
272 (16): 10831–38. https://doi.org/10.1074/JBC.272.16.10831. 
Zhelkovsky, A., Yoko Tacahashi, Tommy Nasser, Xiaoyuan He, Ulrike Sterzer, Torben 
Heick Jensen, Horst Domdey, and Claire Moore. 2006. “The Role of the 
Brr5/Ysh1 C-Terminal Domain and Its Homolog Syc1 in MRNA 3’-End 
Processing in Saccharomyces Cerevisiae.” RNA 12 (3): 435–45. 
https://doi.org/10.1261/rna.2267606. 
Zhelkovsky, Kessler, and Moore. 1995. “Structure-Function Relationships in the 
Saccharomyces Cerevisiae Poly(A) Polymerase.” The Journal of Biological 
Chemistry. Vol. 270. 
Zheng, Shawn Q., Eugene Palovcak, Jean-Paul Armache, Yifan Cheng, and David A. 
Agard. 2016. “Anisotropic Correction of Beam-Induced Motion for Improved 
Single-Particle Electron Cryo-Microscopy.” BioRxiv, July, 061960. 
https://doi.org/10.1101/061960. 
Zundert, G.C.P. van, J.P.G.L.M. Rodrigues, M. Trellet, C. Schmitz, P.L. Kastritis, E. 
  270 
Karaca, A.S.J. Melquiond, M. van Dijk, S.J. de Vries, and A.M.J.J. Bonvin. 2016. 
“The HADDOCK2.2 Web Server: User-Friendly Integrative Modeling of 
Biomolecular Complexes.” Journal of Molecular Biology 428 (4): 720–25. 
https://doi.org/10.1016/J.JMB.2015.09.014. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  271 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  272 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  273 
8 Appendix 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  274 
 
 
 
 
Appendix 8.1: Yeast and human CPF subunits 
Yeast
protein 
Yeast
complex
M.W
(kDa)
Ssu72 24
Human
protein 
Human
complex
M.W
(kDa)
SSU72 23
Glc7 36 PP1A 38
Swd2 37 WDR82 35
Ref2 60 - -
Pti1 47 - -
Pta1 89 Symplekin 141
Cft2 96 CPSF100 88
Mpe1 50 RBBP6 202
Ysh1 88 CPSF73 77
Pap1 65 PAPOLA 83
Fip1 36 hFip1 67
Yth1 25 CPSF30 30
Pfs2 53 WDR33 146
Cft1 153 CPSF160 161
Polymerase
module
Nuclease
module
Phosphatase
module
CPSF
Cleavage
Factor IA 
Pcf11 72 hPcf11
Clp1 50 hClp1
Rna15 33 Cstf-64
Rna14 78 Cstf-77
Cstf-50-
CstF
CF IIm
Cleavage
Factor IB Hrp1 60 - -
CF I 68
CF I 25
CF I 59
CF Im
-
-
-
-
-
-
-
44 / 65
26 / 42
27/ 41
85 / 93
34 / 52
-
-
17 / 37
22 / 41
28 / 48
44 / 65
40 / 59
22 / 34
36 / 51
37 / 57
17 / 34
Sequence identity 
/ similarity (%)
Essential
(Yes/No)
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
Yes
No
Yes
Yes
Yes
-
27/44
Yes
Yes
Yes
Yes
Yes
- Yes
Yes
Yes
Yes
-
-
-
21/32
CF I
CF II
PF I
CF II
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Appendix 8.2: DQE measured as a function of spatial frequency for different 
detectors. (Adapted from McMullan et al, 2014) 
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Appendix 8.3: Workflow for merging cryo-EM data sets from different 
microscopes. The original micrographs from the Diamond data set are rescaled and 
the particles extracted from these rescaled micrographs are merged with particles 
from the LMB data set. Further processing can be carried out using standard 
procedures. 
Data set from Diamond Data set from MRC-LMB
Particles from
data set 1
Particles from
data set 2
Motion correction
CTF estimation
Particle picking
Particle extraction
Motion correction
CTF estimation
Particle picking
Particle extraction
Compare 3D map
Calculate scaling 
factor
Rescaling
Join particles
Merged data
processing 
Processing Processing
Map 1 Map 2
Rescale 
micrographs
Redo CTF
Rescale 
coordinates
New 
picking
particle
extraction
particle
extraction
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Appendix 8.4: Cryo-EM data collection and statistics of refinement. 
 
 
Data Collection
Pixel size (Å)
Defocus (µm)
Voltage (keV)
No. of particles
Electron dose (e-/Å2)
1.4
1.5 - 3.5
300
77,917
45
13,745
1,717
2
3.5
-120
0.78
0.38
Model composition
Model refinement
Non-hydrogen atoms
Protein residues
Zinc ions
Resolution (Å)
Average B-factor (Å2)
Fourier shell correlation 
Rfactor
Bonds (Å)
Rfactor (°)
Molprobity score
Clash score, all atoms
Good rotamers (%)
Favoured (%)
Outliers (%)
RMS deviations
Validation
Ramachandran plot
0.0067
1.26
2.92
11.73
91.78
86.19
2.06
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Appendix 8.5: Protein disorder prediction using PrDOS. Plots demonstrating the 
probability of disorder against amino acid residue for Pfs2, Yth1, Fip1 and Cft1. Plots 
were generated using PrDOS (Ishida and Kinoshita 2007). The false positive rate is 5%. 
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Appendix 8.6: Conservation of yeast Cft1–Pfs2 interactions in human CPSF160–
WDR33. Residues mediating Cft1 and Pfs2 interactions are listed. The interactions 
include salt bridges or hydrogen bonds; van der Waals contacts; and hydrophobic 
contacts. Shown in orange and green dotted lines are equivalent residues from the 
human orthologs. Thick and dark grey lines represent the conserved interactions 
between yeast and humans. Also shown in thin, light grey lines are non-conserved 
interactions. 
 
 
Human ortholog CPSF160 Yeast Cft1 Yeast Pfs2 Human ortholog WDR33
A:1041
N:1016
E:1017
A:986
F:989
V:1014
E:1132
E:1131
Q:1129
L:1127
M:1128
C:1102
G:1130
P:1069
H:1068
E:1058
I:1067
Y:1066
T:1044
D:1047
N:1042
A:1043
E:1046
T:1045
P:984
H:985
V:976
D:980
I:977
V:983
H:1099
K:1055
E:1072
T:1101
E:1054
S:36
L:42
S:60
V:54
W:149
D:146
P:103
S:147
P:385
N:60
I:64
G:87
Y:59
P:84
Y:89
M:174
R:132
W:175
V:35
R:106
P:38
T:62
P:57
I:40
D:148
P:360
P:61
D:214
R:74
R:77
L:67
N:172
D:173
P:129
R:70
Y:66
A:81
Y:43
L:50
R:46
D:189
R:47
S:37
E:317
R:76
R:292
K:273
L:334
L:335
H:145
N:406
E:104
I:63
E:58
W:401
H:48
N:188
I:383
N:52
Y:61
A:387
D:75
I:78
P:51
P:382
L:343
L:53
V:33
Y:39
R:379
Y:44
S:32
D:384
R:381
E:56
D:389
N:41
F:403
P:385
D:64
F:402
N:69
V:77
Q:336
L:338
I:342
R:74
I:65
V:55
H:1023
A:476
H:506
A:232
P:474
L:339
T:321
D:323
L:303
V:233
T:1021
R:338
F:317
E:339
I:243
N:240
K:340
M:336
T:242
D:972
K:946
C:961
R:963
E:971
Y:966
R:230
N:224
P:228
Q:225
E:222
W:227
L:235
A:238
K:234
K:211
I:214
N:212
Q:232
W:237
Q:134
I:204
N:202
R:129
G:131
L:201
F:132
L:128
V:133
N:1041
Y:1024
S:1039
R:1049
M:1050
C:1044
S:113
G:111
L:114
K:110
E:116
V:115
T:512
Q:945
N:545
L:368
P:510
T:943
V:63
T:56
D:409
V:428
R:406
S:62
I:57
R:404
M:423
E:68
D:91
G:368
G:408
M:411
K:65
Q:83
E:425
I:96
D:78
R:80
M:79
N:104
P:407
Y:88
H:171
T:213
D:75
N:90
E:130
S:424
D:85
K:410
E:344
I:82
V:367
N:101
N:299
P:102
V:361
L:92
V:363
R:318
M:103
Q:1209
Y:1211
V:1227
D:1207
H:1213
L:1210
R:1295
V:1255
R:1248
M:1228
A:1250
N:1309
K:1229
R:1274
E:1254
Y:1256
H:1307
M:1172
L:1207
A:1190
S:1225
Q:1170
R:1211
T:1171
T:1223
G:1187
T:1173
T:1134
Q:1188
V:1133
C:1135
P:1171
Q:1103
D:1123
T:1086
P:1125
P:1049
P:1050
T:1048
S:1102
S:1088
V:1126
M:1144
A:1143
R:1164
M:1166
Q:1145
F:1127
T:1129
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Appendix 8.7: Amino acids involved in protein-protein cross-linking, identified by 
mass spectrometry. 
Intra-protein 
crosslinks mapped 
on to the structure
Inter-protein 
crosslinks mapped 
on to the structure
Cft1_K685 Cft1_K689 9.5   
Cft1_K842 Cft1_Y1266 22.2   
Cft1_K926 Cft1_K1002 27.4   
Cft1_K930 Cft1_K1002 15.5   
Cft1_K930 Cft1_S1000 13.4   
Cft1_K933 Cft1_K1002 9.3   
Cft1_Y941 Cft1_K1006 10.01   
Cft1_K942 Cft1_S959 10.2   
Cft1_K942 Cft1_K962 4.9   
Cft1_K942 Cft1_K1006 13.5   
Cft1_K942 Cft1_K1011 14.5   
Cft1_S959 Cft1_K1006 9.3   
Cft1_K942 Cft1_S1013 14.6   
Yth1_K44 Yth1_K54 15   
Yth1_K44 Yth1_K64 23.5   
Pap1_K53 Pap1_K128 15   
Pap1_K70 Pap1_K109 11.8   
Pap1_K183 Pap1_K290 27   
     
Cft1_S1027 Yth1_K54 16   
Cft1_K1028 Yth1_K54 15.3   
Pfs2_K210 Yth1_K44 32.8   
Cft1_K184 Cft1_K189 N/A   
Cft1_K184 Cft1_K224 N/A   
Cft1_K184 Cft1_K1330 N/A   
Cft1_K186 Cft1_S198 N/A   
Cft1_K189 Cft1_S198 N/A   
Cft1_S416 Cft1_K440 N/A   
Cft1_S591 Cft1_K609 N/A   
Cft1_Y585 Pap1_K5 N/A   
Cft1_K609 Pap1_K183 N/A   
Cft1_K1330 Pap1_K183 N/A   
Cft1_K1325 Pap1_K536 N/A   
Cft1_K1011 Pfs2_K25 N/A   
Cft1_K1104 Pfs2_K25 N/A   
Cft1_K1104 Pfs2_Y26 N/A   
Cft1_K1330 Pfs2_S207 N/A   
Cft1_K1330 Pfs2_K210 N/A   
Cft1_K1330 Pfs2_Y393 N/A   
Cft1_S1027 Yth1_K145 N/A   
Cft1_K1028 Yth1_K145 N/A   
Cft1_K1330 Yth1_K44 N/A   
Cft1_S591 Fip1_K44 N/A   
Cft1_S591 Fip1_K47 N/A   
Cft1_S591 Fip1_K148 N/A   
Cft1_K609 Fip1_K126 N/A   
Cft1_S1027 Fip1_K148 N/A   
Cft1_S1349 Fip1_K148 N/A   
Pap1_K34 Pap1_S38 N/A   
Pap1_S344 Pap1_K536 N/A   
Pap1_K527 Pap1_K536 N/A   
Pap1_K432 Pap1_K536 N/A   
Pap1_K536 Pap1_K546 N/A   
Pap1_K536 Pap1_K549 N/A   
Pap1_K536 Pap1_S550 N/A   
Pap1_K290 Pfs2_Y393 N/A   
Pap1_K290 Pfs2_K396 N/A   
Pap1_K183 Yth1_K44 N/A   
Pap1_K290 Yth1_K44 N/A   
Pap1_K290 Yth1_54 N/A   
Pap1_K34 Fip1_K44 N/A   
Pap1_K290 Fip1_S121 N/A   
Pap1_K290 Fip1_K148 N/A   
Pap1_K290 Fip1_K219 N/A   
Pap1_K292 Fip1_K148 N/A   
Pfs2_Y26 Yth1_K76 N/A   
Pfs2_K244 Yth1_K44 54.4   
Pfs2_S453 Yth1_K76 N/A   
Fip1_S38 Fip1_K47 N/A   
Fip1_K44 Fip1_K47 N/A   
Fip1_K44 Fip1_S50 N/A   
Fip1_K148 Fip1_K219 N/A   
Fip1_S152 Fip1_K219 N/A   
Fip1_K219 Yth1_K182 N/A   
Fip1_K219 Yth1_K191 N/A   
Fip1_K219 Yth1_K196 N/A   
Yth1_K182 Yth1_K191 N/A   
Yth1_K182 Yth1_K196 N/A   
Protein 1 Protein 2 Distance (Å) pAm pAm + Pap1
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Appendix 8.8: SEC-MALS profile of Yth1/Fip1 complex with excess Fip1. The 
theoretical molecular masses for Yth1 (118-208) and Fip1 (180-220) are 6.2 and 5 kDa 
respectively. 
 
 
 
Appendix 8.9: Nuclease-phosphatase module is not sufficient to cleave mRNA 3' 
end  (a) SDS-PAGE showing purified nucleo-phosphatase after size exclusion 
chromatography that was used in the assay. (b) Cleavage and polyadenylation assay of 
purified nucleo-phosphatase analyzed by denaturing urea-PAGE.  The control reaction 
was performed with rCPF. CYC1 is the substrate RNA. Cleavage products are 5ʹ- CYC1 
(in orange) and CYC1-3ʹ (in pink).   
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Appendix 8.10: Frozen and thawed rCPF behaves similar to fresh rCPF on a size 
exclusion column (a) Chromatogram of frozen and thawed rCPF run on a Superose 6 
Increase 3.2/300 column in SEC buffer. (b) The peak fractions were analyzed using 
SDS-PAGE. 
 
 
 
Appendix 8.11: Testing the functional activity of rCPF.  Coupled cleavage and 
polyadenylation assay of purified rCPF analyzed by denaturing urea-PAGE. The activity 
of the sample after anion exchange column was compared to the sample after size 
exclusion. CYC1 is the substrate RNA. Cleavage products are 5ʹ-CYC1(in orange) and 
CYC1-3ʹ (in pink). The cleaved 5ʹ-CYC1 gets hyper-polyadenylated. 
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Appendix 8.12: CPF cannot cleave GAL7 3ʹ UTR.  Coupled cleavage and 
polyadenylation assay of native CPF analyzed by denaturing urea-PAGE.  It is found that 
CPF cannot cleave GAL7 RNA. Cleavage products are 5ʹ-GAL7 (in dark brown) and 
GAL7-3ʹ (in light brown). * denotes non-specific cleavage. The reaction contained both 
CF IA and CF I B, in addition to CPF. 
 
 
 
 
Appendix 8.13: Introducing new substrate RNAs to study 3ʹend processing.  (a) 
The products of the in vitro transcription (IVT) reaction of GCN4 3ʹUTR and MFA2 
RNA are analyzed by denaturing urea-PAGE along with the purified fractions from 
electroelution. (b) Cleavage assay of GCN4 and MFA2 are analyzed by denaturing urea-
PAGE. GCN4 undergoes cleavage at it’s major poly(A) site to yield downstream 
(magenta) and upstream (blue) products of 203 nt and 97 nt respectively.  Whereas 
MFA2 RNA contains multiple cleavage sites and the cleaved RNA products are 
depicted in yellow and two different shades of green. 
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The deep Stillness  
Seeping into the rocks  
The voice of the Cicada 
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